Statistica 2021

UDC 61
«Health and Health Care» Yearbook, Republic of Armenia 2021/
D. Andreasyan, A. Bazarchyan,N. Galstyan, M. Matevosyan, L. Mirzoyan, L. Mosoyan,G. Muradyan, I.

Torgomyan,A. Simonyan, S. Simonyan.– Yerevan: National Institute of Health Named after
Academician S. Avdalbekyan, 2021.– 302 pages.
Health and Health Care Yearbook presents the key indicators on the activities of health and health
care system of Armenia population.
The Yearbook represents data on performance ofhealthcare facilities of the Republic of Armenia
collected by the National Health Information Analytic Center of the National Institute of
Healthnamed after academician S.Avdalbekyan based on the annual administrative reportsof the
Ministry of Health.
The Yearbook is designed for health system organizershealth expertsphysicians and other health care
professionals.
ISBN 978-9939-879-75-8
© National Institute of Health named after academician S. Avdalbekyan, Ministry of Health, 2021
2
MINISTRY OF HEALTH OF THE REPUBLIC OF ARMENIA
NATIONAL INSTITUTE OF HEALTH NAMED AFTER ACADEMICIAN

S. AVDALBEKYAN
National Health Information Analytic Center
HEALTH AND HEALTHCARE
Statistical yearbook
Yerevan 2021
INTRODUCTION
Title Page
CHAPTER 1 DEMOGRAPHIC CHARACTERISTICS 13
Table 1.1 Number of De Jure Population (as of the beginning of the year) 14
Table 1.2 De jure population by regions (thsd. persons) 14
Table 1.3 Average life expectancy at birth 15
Table 1.4 Natural movement of population by regions 16
Table 1.5 Natural movement of population by regions and by sex 18
Mortality 19
Table 1.6 Weekly mortality by all causes of death, by sex 2019, 2020 20
Table 1.6.1 Weight (%) of death of ra population (%) by causes in the structure of all deaths 24
Table 1.6.2 Deaths by main causes 25
Table 1.6.3 Mortality by causes of death, by regions, 27
Table 1.6.4 Mortality by main ncd's death, by regions, 29
Table 1.6.5 Mortality by causes of death, by age groups and by sex, 30
Table 1.7 Male mortality by age 32
Table 1.8 Female mortality by age 33
Table 1.8.1 Mortality of the RA population from COVID-19, regions 34
Table 1.9 Natural movement of population and child mortality 35
Table 1.10 Maternal mortality 36
Table 1.11 Maternal mortality (tri-annual average ratio) * 36
CHAPTER 2 HEALTH CHARACTERISTICS 37
Table 2.1.1 Incidence of diseases (15 years and above ) 38
Table 2.1.2 Incidence of diseases (0-14 years old) 42
Table 2.1.3 Pravelence of diseases (15 years and above) 46
Table 2.1.4 Pravelence of diseases (0-14 years old) 50
Table 2.2.1 Incidence of diseases by regions (18 years and above) 54
Table 2.2.2 Incidence of diseases by regions (15-17 years old) 58
Table 2.2.3 Incidence of diseases by regions (0-14 years old) 62
Table 2.2.4 Pravelence of disease by regions (18 years and above) 66
Table 2.2.5 Pravelence of disease by regions (15-17 years old) 70
Table 2.2.6 Pravelence of disease by regions (0-14 years old) 74
Table 2.2.7 Prevalence of diseases in children aged 0-14 years by specific diseases 78
Table 2.2.8 Prevalence of diseases in children aged 15-17 years by specific diseases 79
Table 2.2.9 Incidence of women’s diseases by specific diseases 80
Table 2.2.10 Incidence of women’s diseases by specific diseases 80
Table 2.3.1 Incidence of mental/psychic disorders by age group 2019 81
4
Table 2.3.2 Number of intentional suicides by age group 2019 81
Table 2.3.3 Prevalence of alcoholic psychosis alcoholism narcomania and toxicomania 82
Incidence of alcoholic psychosis alcoholism narcomania and toxicomania by sex and age
Table 2.3.4 82
group 2019
Number of the alcoholic psychosis alcoholism narcomania and toxicomania patients under the
Table 2.3.5 83
dispensary control at the end of the year by sex and age group 2019
Table 2.3.6 Number of narcological patients under the dispensary control at the end of the year 83
Table 2.4.1 Prevalence of infection diseases 84
Table 2.4.2 Incidence of diseases (15 years and above ) 84
Table 2.5.1 Incidence of diseases (0-14 years old) 85
Table 2.5.2 Pravelence of diseases (15 years and above) 86
Table 2.6 Pravelence of diseases (0-14 years old) 87
Table 2.7.1 Prevalence of active tuberculosis 88
Table 2.7.2 Incidence of active tuberculosis by sex and age group 2018 88
Table 2.8.1 Prevalence of sexual transmitted diseases in Republic of Armenia 90
Table 2.8.2 Incidence of syphilis by age and sex 2018 90
Table 2.9.1 Prevalence of HIV/AIDS by sex 91
Table 2.9.2 HIV/AIDS test results 92
Table 2.9.3 Number of HIV/AIDS tested citizens by sex, age and residence place (absolute value) 2018 92
Table 2.9.4 Number of HIV/AIDS tested by citizens sex, age and residence place (absolute value) 2019 93
Table 2.9.5 Number of HIV/AIDS tested citizens by sex, age and residence place (absolute value) 2020 93
Table 2.10 Number of poisonings, 2018 94
Table 2.11 Number of poisonings, burns and corrosions, 2019 95
Table 2.12 Number of poisonings, burns and corrosions, 2020 96
Table 2.12.1 Number of traumas and poisoning recorded by primary healthcare facilities 97
Table 2.12.2 Number of recorded poisonings, 2018-2020 98
NON-COMMUNICABLE DISEASES
CHAPTER 2 a 99
Diseases of the circulatory system
Table 2 a 1 Incidence of CSD among the adult population in regions 101
Table 2 a 2 Incidence of CSD among adolescents aged 15-17 years old in regions 101
Table 2 a 3 Incidence of CSD among children aged 0-14 years old in regions 101
Prevalence of CSD among the adult population in regions

Table 2 a 4 103
(total number of patients)
5
Prevalence of CSD among adolescents from 15 to 17 years old in regions
Table 2 a 5 103
(total number of patients)
Prevalence of CSD among the children in regions (total number of patients) from 0 to14 years
Table 2 a 6 103
old
Table 2 a 7 Pravelence of CSD among RA population (total number of registered patients) 105
Table 2 a 8 Incidence of CSD among RA population by sex and age group 105
Table 2 a 9 Prevalence of CSD among Yerevan population (total number of registered patients) 106
Table 2 a 10 Incidence of CSD among Yerevan population by sex and age group 106
Table 2 a 11 Prevalence of CSD among Aragatsotn population (total number of registered patients) 107
Table 2 a 12 Incidence of CSD among Aragatsotn population by sex and age group 107
Table 2 a 13 Prevalence of CSD among Ararat population (total number of registered patients) 108
Table 2 a 14 Incidence of CSD among Ararat population by sex and age group 108
Table 2 a 15 Prevalence of CSD among Armavir population (total number of registered patients) 109
Table 2 a 16 Incidence of CSD among Armavir population by sex and age group 109
Table 2 a 17 Prevalence of CSD among Gegharkunik population (total number of registered patients) 110
Table 2 a 18 Incidence of CSD among Gegharkunik population by sex and age group 110
Table 2 a 19 Prevalence of CSD among Lori population (total number of registered patients) 111
Table 2 a 20 Incidence of CSD among Lori population by sex and age group 111
Table 2 a 21 Prevalence of CSD among Kotayk population (total number of registered patients) 112
Table 2 a 22 Incidence of CSD among Kotayk population by sex and age group 112
Table 2 a 23 Prevalence of CSD among Shirak population (total number of registered patients) 113
Table 2 a 24 Incidence of CSD among Shirak population by sex and age group 113
Table 2 a 25 Prevalence of CSD among Syunik population (total number of registered patients) 114
Table 2 a 26 Incidence of CSD among Syunik population by sex and age group 114
Table 2 a 27 Prevalence of CSD among Vayots Dzor population (total number of registered patients) 115
Table 2 a 28 Incidence of CSD among Vayots Dzor population by sex and age group 115
Table 2 a 29 Prevalence of CSD among Tavush population (total number of registered patients) 116
Table 2 a 30 Incidence of CSD among Tavush population by sex and age group 116
CHAPTER 2 e 117
ENDOCRINE NUTRITIONAL AND METABOLIC DISEASES
Table 2 e.1 Incidence of ED among RA population by regions 117
Table 2 e.2 Incidence of ED among adolescents aged 15 to 17 y.o. by regions 117
Table 2 e.3 Incidence of ED among children aged 0 to 14 y.o. by regions 117
Table 2 e.4 Prevalence of ED among the adult population in regions (total number of patients) 119
Table 2 e.5 Pravelence of ED among adolescents aged 15- 17 y.o. in regions (total number of patients) 119
Table 2 e.6 Prevalence of ED among children aged 0 to 14 y.o. in regions (total number of patients) 119
Table 2 e.7 Prevalence of ED among RA population (total number of registered patients) 121
6
Table 2 e.8 Incidence of ED among RA population by sex and age group 121
Table 2 e.9 Prevalence of ED among Yerevan population (total number of registered patients) 122
Table 2 e.10 Incidence of ED among Yerevan population by sex and age group 122
Table 2 e.11 Prevalence of ED among Aragatsotn population (total number of registered patients) 123
Table 2 e.12 Incidence of ED among Aragatsotn population by sex and age group 123
Table 2 e.13 Prevalence of ED among Ararat population (total number of registered patients) 124
Table 2 e.14 Incidence of ED among Ararat population by sex and age group 124
Table 2 e.15 Prevalence of ED among Armavir population (total number of registered patients) 125
Table 2 e.16 Incidence of ED among Armavir population by sex and age group 125
Table 2 e.17 Prevalence of ED among Gegharkunik population (total number of registered patients) 126
Table 2 e.18 Incidence of ED among Gegharkunik population by sex and age group 126
Table 2 e.19 Prevalence of ED among Lori population (total number of registered patients) 127
Table 2 e.20 Incidence of ED among Lori population by sex and age group 127
Table 2 ն .21 Prevalence of ED among Kotayk population (total number of registered patients) 128
Table 2 e.22 Incidence of ED among Kotayk population by sex and age group 128
Table 2 e.23 Prevalence of ED among Shirak population (total number of registered patients) 129
Table 2 e.24 Incidence of ED among Shirak population by sex and age group 129
Table 2 e.25 Prevalence of ED among Syunik population (total number of registered patients) 130
Table 2 e.26 Incidence of ED among Syunik population by sex and age group 130
Table 2 e.27 Prevalence of ED among Vayots Dzor population (total number of registered patients) 131
Table 2 e.28 Incidence of ED among Vayots Dzor population by sex and age group 131
Table 2 e.29 Prevalence of ED among Tavush population (total number of registered patients) 132
Table 2 e.30 Incidence of ED among Tavush population by sex and age group 132
CHAPTER 2 m.n 133
NEOPLASMES
Table 2 m.n. 1 Malignant neoplasm prevalence in RA 133
Table 2 m.n. 2 Prevalence of malignant neoplasm’s by age group 2018-2019 134
Table 2 m.n. 3 Prevalence of malignant neoplasm’s by age group, 2020 134
Table 2 m.n. 4 Incidence of confirmed common malignant neoplasm by sex and age group (a.v.)2018 135
Table 2 m.n. 7 Prevalence of malignant neoplasm’s among RA population 138
Table 2 m.n. 8 Prevalence of malignant neoplasm’s among Yerevan population 139
Table 2 m.n. 9 Prevalence of malignant neoplasm’s among Aragatsotn population 140
Table 2 m.n. 10 Prevalence of malignant neoplasm’s among Ararat population 141
Table 2 m.n. 11 Prevalence of malignant neoplasm’s among Armavir population 142
Table 2 m.n. 12 Prevalence of malignant neoplasm’s among Gegharkunik population 143
7
Table 2 m.n. 13 Prevalence of malignant neoplasm’s among Lori population 144
Table 2 m.n. 14 Prevalence of malignant neoplasm’s among Kotayk population 145
Table 2 m.n. 15 Prevalence of malignant neoplasm’s among Shirak population 146
Table 2 m.n. 16 Prevalence of malignant neoplasm’s among Syunik population 147
Table 2 m.n. 17 Prevalence of malignant neoplasm’s among Vayots Dzor population 148
Table 2 m.n. 18 Prevalence of malignant neoplasm’s among Tavush population 149
Table 2 m.n. 19 Incidence of malignant neoplasm’s among RA population by age and sex group 150
Table 2 m.n. 20 Incidence of malignant neoplasm’s in Yerevan by age and sex group 152
Table 2 m.n. 21 Incidence of malignant neoplasm’s in Aragatsotn region by sex and age group 154
Table 2 m.n. 22 Incidence of malignant neoplasm’s in Ararat region by sex and age group 156
Table 2 m.n. 23 Incidence of malignant neoplasm’s in Armavir region by sex and age group 158
Table 2 m.n. 24 Incidence of malignant neoplasm’s in Gegharkunik region by sex and age group 160
Table 2 m.n. 25 Incidence of malignant neoplasm’s in Lori region by sex and age group 162
Table 2 m.n. 26 Incidence of malignant neoplasm’s in Kotayk region by sex and age group 164
Table 2 m.n. 27 Incidence of malignant neoplasm’s in Shirak region by sex and age group 166
Table 2 m.n. 28 Incidence of malignant neoplasm’s in Syunik region by sex and age group 168
Table 2 m.n. 29 Incidence of malignant neoplasm’s in Vayots Dzor region by sex and age group 170
Table 2 m.n. 30 Incidence of malignant neoplasm’s in Tavush region by sex and age group 172
Table 2 m.n. 31 Number of patients receiving treatment, RA 2020 174
Table 2 m.n. 32 Number of patients receiving treatment ,Yerevan, 2020 175
Table 2 m.n. 33 Number of patients receiving treatment , Aragatsotn, 2020 176
Table 2 m.n. 34 Number of patients receiving treatment , Ararat, 2020 177
Table 2 m.n. 35 Number of patients receiving treatment , Armavir, 2020 178
Table 2 m.n. 36 Number of patients receiving treatment , Gegharkunik, 2020 179
Table 2 m.n. 37 Number of patients receiving treatment , Lori, 2020 180
Table 2 m.n. 38 Number of patients receiving treatment ,Kotayk, 2020 181
Table 2 m.n. 39 Number of patients receiving treatment , Shirak, 2020 182
Table 2 m.n. 40 Number of patients receiving treatment , Syunik, 2020 183
Table 2 m.n. 41 Number of patients receiving treatment , Vayots Dzor, 2020 184
Table 2 m.n. 42 Number of patients receiving treatment , Tavush, 2020 185
CHAPTER 3 MATERNAL AND CHILD HEALTH 186
Table 3.1 Number of pregnancies and health characteristics 187
Table 3.2 Childbirth and postpartum complications 188
Table 3.3 Surgical operations 189
Table 3.4 Childbirth at medical obstetrics and gynecology facilities 190
Table 3.5 Use of contraceptives 190
Table 3.6 NUMBER OF MISCARRIAGES (ABORTIONS) 191
8
Table 3.7 Number of miscarriages (abortions) by causes and regions 192
Table 3.8 Number of abortion by vacuum aspiration (mini) and through medicine by region 192
Table 3.9 Number of abortions by period and by regions 193
Table 3.10 Number of abortions per 1000 fertile age women by regions 193
Table 3.11 Breakdown of live births by body weight 194
Prematurity prenatal mortality and stillbirths in the medical obstetrics and gynecology
Table 3.12 195
facilities
Table 3.13 Morbidity of newborns 196
Table 3.14 Lethality of newborns (with weight of 1000 g. and above) 197
Table 3.15 Birthslive births early neonatal and perinatal mortality rates by regions 198
Table 3.16 Lethality of newborns (0-27 days) in RA 198
Table 3.17 Early neonatal mortality (0-6 days) /maternal and neonatal departments/ 198
Table 3.18 Illness of children 0-2 years old, Republic of Armenia, 2020 199
Table 3.19 Distribution of children with disabilities , Yerevan 200
Table 3.20 Distribution of children with disabilities , Aragatsotn 201
Table 3.21 Distribution of children with disabilities , Ararat 202
Table 3.22 Distribution of children with disabilities , Armavir 203
Table 3.23 Distribution of children with disabilities , Gegharkunik 204
Table 3.24 Distribution of children with disabilities , Lori 205
Table 3.25 Distribution of children with disabilities , Kotayk 206
Table 3.26 Distribution of children with disabilities , Shirak 207
Table 3.27 Distribution of children with disabilities , Syunik 208
Table 3.28 Distribution of children with disabilities , Vayots dzor 209
Table 3.29 Distribution of children with disabilities , Tavush 210
CHAPTER 4 IMMUNIZATION 212
Table 4.1 Communicable diseases covered by immunization program 213
Table 4.2 Rate of vaccination among children (%) 213
CHAPTER 5 HEALTH RESOURCES AND FACILITIES 214
Table 5.1 Main resources 215
Table 5.2 Main health resources and service utilization 216
Table 5.3 Resources and private sector utilization 217
Table 5.4 Inpatient and outpatient facilities (excluding health posts) 218
Table 5.5 Distribution of primary health care facilities by types (excluding health posts) 219
Table 5.6 PHC and hospital facilities (excluding health posts) 220
Table 5.7 Breakdown of inpatient healthcare facilities by type and by number of beds 2019 222
Table 5.8 Breakdown of primary health care facilities by types /including health posts /2019 224
Table 5.9.1 Availability and distribution of inpatient facilities providing medical care by types and by 226
9
regions 2019
Table 5.9.1.1 Medical facilities by different institutions and by regions 2018 227
Availability and distribution of PHC units providing medical care by types and by regions
Table 5.9.2 228
2019
Table 5.10 Outpatient care activities /excluding health posts / 229
Table 5.11 Primary health care visits /excluding health posts and private dental cabinets/ 230
Table 5.12 Preventive examinations and detected deviations of 0-14 years old children 231
Number of patients on dispensary control by different diseases at the end of the year (15 years
Table 5.13.1 232
and above)
Number of patients on dispensary control by different diseases at the end of the year (0-14
Table 5.13.2 233
years old)
Table 5.14 Number of patients on dispensary control at the end of year 234
Table 5.15 Service utilization and bed capacity 235
Table 5.16 Service utilization and bed capacity by regions 236
Table 5.17 Service utilization and bed capacity 2001-2020 238
Table 5.18 Number of hospital deaths and hospital lethality 2000-2001 238
Table 5.19 Number of hospital deaths and hospital lethality 2002-2020 239
Table 5.20 Number of beds by main specialties 240
Table 5.21 Distribution of patients discharged (discharged or dead) from hospital by main diseases 2019 241
Table 5.22 Hospital lethality from different diseases 243
Table 5.23 Infant lethality / under 1 year / in hospital 244
Table 5.24 Early neonatal /0-6 days/ and infant lethality within the first 24 hours of hospital admission. 245
Table 5.25 Emergency care 246
Table 5.26 Inpatient emergency surgical care 247
Table 5.27 Dental care (excluding private dental clinics) 255
CHAPTER 6 HUMAN RESOURCES 256
Table 6.1 Number of graduates from higher medical education institutes by specialties, 2014-2020 257
Table 6.2 Graduates number of Yerevan State Medical University named after M.Heratsi 257
Table 6.3 Number of graduates from secondary medical education institutes by specialties 2014-2020 258
Number of graduates from secondary medical education institutions (state educational

Table 6.4 258
institutions)
Table 6.5 Healthcare personnel by regions, 2018-2020 259
Number of physycians and mid-level personnel of medical and educational institutions of RA

Table 6.6.1 261
2017

Table 6.6.2 261
2018
10
Table 6.6.3 262
2019

Table 6.6.4 262
2020
Table 6.7 Provision of physicians, 2019 263
Table 6.8 Provision of physicians, 2020 264
Table 6.9 Human resources in RA (physicians by professions) 265
Table 6.10 Human resources in RA (mid-level, junior and other personnel) 269
Table 6.10.1 Human resources in Yerevan (physicians by professions) 270
Table 6.10.2 Human resources in Yerevan (mid-level, junior and other personnel) 274
Table 6.11.1 Human resources in Aragatsotn region (physicians by professions) 275
Table 6.11.2 Human resources in Aragatsotn region (mid-level, junior and other personnel) 276
Table 6.12.1 Human resources in Ararat region (physicians by professions) 277
Table 6.12.2 Human resources in Ararat region (mid-level, junior and other personnel) 279
Table 6.13.1 Human resources in Armavir region (physicians by professions) 280
Table 6.13.2 Human resources in Armavir region (mid-level, junior and other personnel) 282
Table 6.14.1 Human resources in Gegharkunik region (physicians by professions) 283
Table 6.14.2 Human resources in Gegharkunik region (mid-level, junior and other personnel) 285
Table 6.15.1 Human resources in Lori region (physicians by professions) 286
Table 6.15.2 Human resources in Lori region (mid-level, junior and other personnel) 288
Table 6.16.1 Human resources in Kotayk region (physicians by professions) 289
Table 6.16.2 Human resources in Kotayk region (mid-level, junior and other personnel) 291
Table 6.17.1 Human resources in Shirak region (physicians by professions) 292
Table 6.17.2 Human resources in Shirak region (mid-level, junior and other personnel) 294
Table 6.18.1 Human resources in Syunik region (physicians by professions) 295
Table 6.18.2 Human resources in Syunik region (mid-level, junior and other personnel) 297
Table 6.19.1 Human resources in Vayots Dzor region (physicians by professions) 298
Table 6.19.2 Human resources in Vayots Dzor region (middlejunior and other staff) 299
Table 6.20.1 Human resources in Tavush region (physicians by professions) 300
Table 6.20.2 Human resources in Tavush region (mid-level, junior and other personnel) 302
11
ABBREVIATIONS
RA Republic of Armenia
MoH Ministry of Health
NSS National Statistical Service
MoH Reg. Ministry of Health regional and community
PHC Primary healthcare center
NHIAC National health information analytic center
ICD 10 International Statistical Classification of Diseases and Related Health Problems 10 th Revision
HIV/ AIDS Human immunodeficiency virus infection/ Acquired immunodeficiency syndrome
a.v absolute value
r.v relative value
Incidence rate Number of registered diseases set for the first time in life
Prevalence Number of registered diseases
12
NHIAC
DEMOGRAPHIC
CHARACTERISTICS
13
NHIAC
NUMBER OF DE JURE POPULATION (as of the beginning of the year)
Table 1.1
Population/thousand/ % from the total number of the population
Urban Urban
Years Rural
Total (absolute Total (absolute 0-14 y.o. Total
a.v.
value) value)
1980 3073.9 2029.2 1044.7 66.0 34.0 30.5 -
1985 3316.6 2241.8 1074.8 67.6 32.4 28.4 -
1990 3514.9 2427.6 1087.3 69.1 39.9 30.5 -
1994 3356.7 2274.9 1081.8 67.8 32.2 29.6 -
1995 3260.3 2166.4 1093.9 66.4 33.6 29.0 -
1997 3246.0 2138.4 1107.6 65.9 34.1 27.4 -
1998 3238.2 2122.9 1115.3 65.6 34.4 26.5 -
1999 3232.1 2111.6 1120.5 65.3 34.7 25.6 -
2000 3226.9 2095.8 1131.1 64.9 35.1 24.7 -
2001 3213.0 2066.1 1146.9 64.3 35.7 24.3 -
2002 3212.9 2065.6 1147.3 64.3 35.7 24.5 6.1
2003 3210.3 2062.2 1148.1 64.2 35.8 21.5 6.1
2004 3212.2 2061.7 1150.5 64.2 35.8 22.5 6.0
2005 3215.8 2062.3 1153.5 64.1 35.9 21.6 5.9
2006 3219.2 2062.6 1156.6 64.1 35.9 20.6 5.9
2007 3222.9 2065.9 1157.0 64.1 35.9 19.7 6.0
2008 3230.1 2069.4 1160.7 64.1 35.9 19.0 5.9
2009 3238.0 2073.4 1164.6 64.0 36.0 18.6 5.5
2010 3249.5 2081.0 1168.5 64.0 36.0 18.3 4.9
2011 3262.6 2088.5 1174.1 64.0 36.0 18.2 4.5
2012 3274.3 2096.0 1178.3 64.0 36.0 18.0 4.3
2013 3026.9 1917.5 1109.4 63.3 36.7 18.9 4.1
2014 3017.1 1914.1 1103.0 63.4 36.6 19.1 3.8
2015 3010.6 1912.9 1097.7 63.5 36.5 19.4 3.6
2016 2998.6 1907.0 1091.6 63.6 36.4 19.6 3.4
2017 2986.1 1901.4 1084.7 63.7 36.3 20.0 3.3
2018 2972.7 1895.8 1076.9 63.8 36.2 20.2 3.3
2019 2965.3 1894.9 1070.4 63.9 36.1 20.2 3.4
2020 2959.7 1892.1 1067.6 63.9 36.1 20.3 3.5
2021 2963.3 1895.6 1067.7 64.0 36.0 20.2 3.7
* The indicator is calculated from 2002
DE JURE POPULATION BY REGIONS (thsd. persons)
Table 1.2
as of 01.01.2019 as of 01.01.2020 as of 01.01.2021
Total Urban Rural Total Urban Rural Total Urban Rural

RA 2965.3 1894.9 1070.4 2959.7 1892.1 1067.6 2963.3 1895.6 1067.7
Yerevan 1081.8 1081.8 - 1084.0 1084.0 - 1091.7 1091.7 -
Aragatsotn 125.4 27.0 98.4 124.7 26.8 97.9 124.5 26.6 97.9
Ararat 256.7 72.2 184.5 256.6 72.1 184.5 256.6 72.0 184.6
Armavir 263.9 82.6 181.3 263.8 82.4 181.4 264.0 82.5 181.5
Gegharkunik 228.3 67.0 161.3 227.7 66.6 161.1 227.3 66.2 161.1
Lori 215.5 127.6 87.9 213.3 126.1 87.2 212.6 125.4 87.2
Kotayk 251.6 137.4 114.2 250.9 136.8 114.1 251.2 136.8 114.4
Shirak 233.3 136.9 96.4 231.4 135.6 95.8 231.0 135.2 95.8
Syunik 137.6 93.4 44.2 137.3 93.2 44.1 135.8 91.8 44.0
Vayots Dzor 49.0 17.3 31.7 48.5 17.1 31.4 48.1 16.8 31.3
Tavush 122.2 51.7 70.5 121.5 51.4 70.1 120.5 50.6 69.9
Source: Statistical Committee RA
14
DEMOGRAPHIC CHARACTERISTICS
AVERAGE LIFE EXPECTANCY AT BIRTH
Table 1.3
Years Total Male Female
1986 73.3 70.5 75.7
1988 62.3 61.6 62.4
1989* 62.3 61.6 62.4
1990* 70.7 67.9 73.4
1991* 70.4 67.4 73.3
1992* 71.8 68.3 75.1
1995* 70.7 66.5 74.7
1997* 71.5 68.2 74.7
2000* 72.9 70.1 75.8
2001* 73.1 70.0 76.1
2002* 73.0 69.8 75.9
2003* 72.9 69.9 75.8
2004 73.4 70.3 76.4
2005 73.5 70.3 76.5
2006 73.3 70.0 76.4
2007 73.5 70.2 76.6
2008 73.8 70.4 76.9
2009 73.9 70.6 77.0
2010 74.1 70.6 77.2
2011 74.2 70.7 77.5
2012 74.3 70.9 77.5
2013 74.8 71.5 77.9
2014 75.0 71.8 78.1
2015 75.0 71.7 78.2
2016 75.0 71.6 78.3
2017 75.4 71.9 78.7
2018 75.9 72.4 79.0
2019 76.5 73.1 79.5
2020** 73.5 68.4 78.6
* Source: Statistical Committee RA, 2019

The recalculation was made by the Statistical Committee RA
** The data are provided by the National Statistical Committee of the Republic of Armenia after the publication of the data
15
NHIAC
NATURAL MOVEMENT OF POPULATION BY REGIONS
Table 1.4
Number of Live Births * Number of Deaths *
2018 2019 2020 2018 2019 2020
a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
RA 36574 12.319 36041 12.166 36353 12.28 25751 8.673 26186 8.839 36170 12.21
YEREVAN 14218 13.168 14001 12.928 16426 15.10 8506 7.878 8675 8.01 12455 11.45
ARAGATSOTN 1502 11.892 1435 11.471 1330 10.67 1161 9.192 1168 9.337 1535 12.32
Ashtarak 775 13.047 748 12.786 654 11.22 593 9.983 592 10.12 837 14.36
Aparan 214 10.047 228 10.775 209 9.91 193 9.061 148 6.981 223 10.57
Aragats 154 11.407 156 11.471 141 10.44 99 7.333 107 7.868 116 8.59
Talin 359 11.184 303 9.528 326 10.28 276 8.598 321 10.094 359 11.33
ARARAT 3271 12.713 3255 12.685 2556 9.96 2177 8.461 2149 8.375 3036 11.83
Artashat 1147 12.946 1232 14.00 867 9.89 850 9.594 829 9.42 1218 13.89
Vedi 980 14.141 887 12.818 - - 537 7.749 524 7.572 - -
Masis 942 11.924 951 12.038 673 8.50 670 8.481 671 8.494 906 11.44
Ararat 202 9.902 185 9.069 1016 11.33 120 5.882 125 10.57 912 10.17
ARMAVIR 3046 11.525 3071 11.637 2490 9.44 2109 7.98 2162 8.192 3075 11.65
Armavir 1262 12.241 1226 11.903 1062 9.53 818 7.934 833 8.087 1375 12.34
Baghramyan 244 12.577 240 12.435 194 10.10 139 7.165 122 6.321 181 9.43
Vagharshapat 1448 10.871 1518 11.405 1234 9.26 1096 8.228 1138 8.55 1519 11.40
Metsamor 92 10.698 87 10.235 - - 56 6.512 69 8.118 - -
GEGHARKUNIK 2696 11.773 2636 11.561 2501 10.99 1770 7.729 1755 7.697 2374 10.44
Vardenis 397 10.559 407 10.853 389 10.43 327 8.697 273 7.28 428 11.48
Gavar 598 12.13 524 10.738 511 10.54 421 8.54 431 8.832 578 11.92
Martuni 1124 12.658 1089 12.291 1019 11.49 556 6.261 547 6.174 744 8.39
Chambarak 120 9.023 125 9.47 113 8.63 144 10.827 154 11.667 187 14.28
Sevan 457 11.425 491 12.306 469 11.75 322 8.05 350 8.772 437 10.95
Lori 2474 11.433 2567 11.973 2603 12.23 2556 11.811 2591 12.085 3177 14.92
Gugark 211 10.933 273 14.293 281 14.87 230 11.917 237 12.408 240 12.70
Spitak 456 12.809 464 13.07 479 13.49 298 8.371 329 9.268 419 11.80
Stephanavan 319 12.176 302 11.571 312 12.05 304 11.603 300 11.494 390 15.06
Tashir 233 12.802 243 13.652 261 14.75 215 11.813 219 12.303 233 13.16
Tumanyan 403 10.522 418 10.971 398 10.50 498 13.003 506 13.281 584 15.41
Vanadzor 852 10.812 867 11.144 872 11.33 1011 12.83 1000 12.853 1311 17.03
KOTAYK 3158 12.552 3075 12.241 2789 11.11 2243 8.915 2290 9.116 3393 13.52
Kotayk 1420 12.781 1393 12.538 1291 11.60 970 8.731 992 8.929 1542 13.85
Nairi 600 10.471 588 10.28 451 7.89 465 8.115 495 8.654 677 11.84
Hrazdan 856 13.652 827 13.253 1047 12.69 597 9.522 614 9.84 1174 14.23
Charentsavan 282 13.756 267 13.024 - - 211 10.293 189 9.22 - -
SHIRAK 2900 12.377 2834 12.200 2750 11.89 2364 10.09 2445 10.525 3068 13.27
Amasia 63 10.161 50 8.065 64 10.49 37 5.968 35 5.645 56 9.18
Ani 238 12.66 216 11.551 235 12.57 146 7.766 144 7.701 203 10.86
Artik 559 11.55 581 12.155 525 11.03 384 7.934 414 8.661 515 10.82
Akhuryan 594 15.798 529 14.182 525 14.11 365 9.707 366 9.812 450 12.10
Ashotsk 103 11.075 122 13.118 99 10.65 95 10.215 90 9.677 130 13.98
Gyumri 1343 11.781 1336 11.823 1302 11.59 1337 11.728 1396 12.354 1714 15.26
SYUNIK 1454 10.536 1344 9.775 1302 9.53 1181 8.558 1194 8.684 1730 12.67
Goris 533 13.128 531 13.111 486 12.06 352 8.67 348 8.593 553 13.72
Kapan 496 8.732 458 8.106 504 8.95 460 8.099 458 8.106 667 11.85
Meghri 104 9.63 77 7.196 79 7.52 97 8.981 118 11.028 151 14.38
Sisian 321 10.772 278 9.329 233 7.90 272 9.128 270 9.06 359 12.17
VAYOTS DZOR 568 11.521 502 10.308 431 8.92 425 8.621 477 9.795 728 15.07
Vayk 158 12.951 114 9.500 135 7.99 83 6.803 97 8.083 253 14.97
Yeghegnadzor 357 11.156 335 10.601 296 9.43 293 9.156 324 10.253 475 15.13
Jermuk 53 10.392 53 10.392 - - 49 9.608 56 10.98 - -
TAVUSH 1287 10.48 1321 10.846 1175 9.71 1259 10.252 1280 10.509 1599 13.22
Ijevan 533 11.221 532 11.224 479 10.13 371 7.811 388 8.186 505 10.68
Noyemberyan 341 12.355 350 12.774 262 9.63 316 11.449 311 11.35 367 13.49
Tavush 191 7.733 209 8.636 195 8.19 352 14.251 328 13.554 407 17.10
Dilijan 222 9.652 230 10.088 239 10.53 220 9.565 253 11.096 320 14.10
r.v.* per 1000 residents
r.v.**- per 1000 live births
16
NATURAL MOVEMENT OF POPULATION BY REGIONS
Table 1.4
including infants (under-1)** Natural growth*
2018 2019 2020 2018 2019 2020
261 7.10 219 6.07 267 7.35 10823 3.646 9855 3.327 183 0.07 RA
70 4.91 58 4.14 74 4.57 5712 5.29 5326 4.918 3971 3.65 YEREVAN
10 6.47 14 9.73 13 9.77 341 2.7 267 2.134 -205 -1.65 ARAGATSOTN
1 1.17 8 10.65 6 9.17 182 3.064 156 2.666 -183 -3.14 Ashtarak
1 4.67 1 4.39 3 14.35 21 0.986 80 3.774 -17 -0.66 Aparan
2 11.65 1 6.41 1 7.09 55 4.074 49 3.603 25 1.85 Aragats
6 16.65 4 13.20 3 9.20 83 2.586 -18 -0.566 -22 -1.05 Talin
25 7.63 21 6.45 26 10.09 1094 4.252 1106 4.31 -480 -1.87 ARARAT
7 6.10 5 4.18 9 10.38 297 3.352 403 4.58 -351 -4.0 Artashat
9 9.18 7 7.89 - - 443 6.392 363 5.246 - - Vedi
5 5.40 6 6.32 7 10.40 272 3.443 280 3.544 -233 -2.94 Masis
4 15.66 3 16.22 10 9.79 82 4.02 60 2.942 104 1.16 Ararat
17 5.55 16 5.22 23 8.86 937 3.545 909 3.445 -585 -2.21 ARMAVIR
4 3.17 5 4.08 12 10.76 444 4.306 393 3.816 -313 -2.81 Armavir
3 11.93 3 12.43 1 5.15 105 5.412 118 6.114 13 0.67 Baghramyan
10 6.88 8 5.27 10 7.80 352 2.643 380 2.855 -285 -2.14 Vagharshapat
0 0.00 0 0.00 - - 36 4.186 18 2.117 - - Metsamor
26 9.53 19 7.20 27 10.71 926 4.044 881 3.864 127 0.55 GEGHARKUNIK
7 17.33 3 7.37 2 5.14 70 1.862 134 3.573 -39 -1.05 Vardenis
2 3.34 9 16.94 6 11.69 177 3.59 93 1.906 -67 -1.38 Gavar
11 9.79 6 5.51 16 15.51 568 6.397 542 6.117 275 3.1 Martuni
0 0.00 0 0.00 1 8.85 -24 -1.804 -29 -2.197 -74 -5.65 Chambarak
6 12.56 1 2.04 2 4.26 135 3.375 141 3.534 32 0.8 Sevan
24 9.61 23 9.02 25 9.62 -82 -0.378 -24 -0.112 -574 -2.69 Lori
2 9.48 3 10.99 2 7.72 -19 -0.984 36 1.885 41 2.17 Gugark
4 8.57 3 6.50 7 14.61 158 4.438 135 3.802 60 1.69 Spitak
2 6.27 2 6.62 3 9.62 15 0.573 2 0.077 -78 -3.01 Stephanavan
3 12.17 4 16.64 3 11.78 18 0.989 24 1.349 28 1.59 Tashir
3 7.44 4 9.66 5 12.56 -95 -2.481 -88 -2.31 -186 -4.91 Tumanyan
10 11.74 7 8.09 5 5.73 -159 -2.018 -133 -1.709 -439 -5.7 Vanadzor
26 8.22 28 9.10 24 8.47 915 3.637 785 3.125 -604 -2.41 KOTAYK
13 9.17 12 8.60 9 6.91 450 4.05 401 3.609 -251 -2.25 Kotayk
4 6.67 5 8.50 9 18.92 135 2.356 93 1.626 -226 -3.95 Nairi
8 9.35 8 9.67 6 5.69 259 4.131 213 3.413 -127 -1.54 Hrazdan
1 3.55 3 11.24 - - 71 3.463 78 3.804 - - Charentsavan
36 12.35 19 6.69 26 9.41 536 2.287 389 1.675 -318 -1.38 SHIRAK
0 0.00 0 0.00 0 0.00 26 4.193 15 2.42 8 1.31 Amasia
4 16.67 1 4.63 0 0.00 92 4.894 72 3.85 32 1.71 Ani
8 13.58 1 1.72 4 7.62 175 3.616 167 3.494 10 0.21 Artik
10 16.84 8 14.92 6 11.41 229 6.091 163 4.37 75 2.01 Akhuryan
0 0.00 0 0.00 1 10.10 8 0.86 32 3.441 -31 -3.33 Ashotsk
14 10.44 9 6.73 15 11.46 6 0.053 -60 -0.531 -412 -3.67 Gyumri
18 12.43 9 6.70 13 9.96 273 1.978 150 1.091 -428 -3.14 SYUNIK
7 13.13 1 1.88 5 10.29 181 4.458 183 4.518 -67 -1.66 Goris
5 10.36 3 6.55 5 10.12 36 0.633 0 0.00 -163 -2.9 Kapan
0 0.00 1 12.99 0 0.00 7 0.649 -41 -3.832 -72 -6.86 Meghri
6 18.69 4 14.39 3 12.88 49 1.644 8 0.269 -126 -4.27 Sisian
3 5.28 4 7.74 2 4.64 143 2.9 25 0.513 -297 -6.15 VAYOTS DZOR
1 6.33 2 15.10 0 0.00 75 6.148 17 1.418 -118 6.98 Vayk
2 5.60 2 5.97 2 6.76 64 2.00 11 0.348 -179 -5.7 Yeghegnadzor
0 0.00 0 0.00 - - 4 0.784 -3 -0.588 - - Jermuk
6 4.61 8 6.06 14 11.73 28 0.228 41 0.337 -424 -3.51 TAVUSH
3 5.46 2 3.76 3 6.06 162 3.41 144 3.038 -26 -0.55 Ijevan
1 2.93 1 2.86 4 15.27 25 0.906 39 1.424 -105 -3.86 Noyemberyan
1 5.24 4 19.34 3 15.04 -161 -6.518 -119 -4.918 -212 -8.91 Tavush
1 4.50 1 4.35 4 16.74 2 0.087 -23 -1.008 -81 -3.57 Dilijan
17
NHIAC
NATURAL MOVEMENT OF POPULATION BY REGIONS AND BY SEX
Table 1.5
2019 2020
Number of Live Births Number of Deaths Number of Live Births Number of Deaths
Female Male Female Male Female Male Female Male
RA 17128 18913 12802 13384 17299 19054 16139 20031
YEREVAN 6693 7308 4282 4393 7841 8585 5670 6785
ARAGATSOTN 640 795 559 609 637 693 659 876
Ashtarak 331 417 272 320 317 337 359 478
Aparan 97 131 67 81 100 109 94 129
Aragats 63 93 50 57 72 69 55 61
Talin 149 154 170 151 148 178 151 208
ARARAT 1527 1728 1043 1106 1172 1384 1324 1712
Artashat 580 652 412 417 404 463 552 666
Vedi 412 475 235 289 - - - -
Masis 442 509 336 335 315 358 384 522
Ararat 93 92 60 65 453 563 388 524
ARMAVIR 1486 1585 1039 1123 1175 1315 1356 1719
Armavir 594 632 407 426 508 554 597 778
Baghramyan 122 118 65 57 82 112 82 99
Vagharshapat 723 795 539 599 585 649 677 842
Metsamor 47 40 28 41 - - - -
GEGHARKUNIK 1149 1487 849 906 1162 1339 1035 1339
Vardenis 178 229 120 153 176 213 176 252
Gavar 232 292 209 222 248 263 257 321
Martuni 457 632 272 275 459 560 338 406
Chambarak 59 66 75 79 49 64 81 106
Sevan 223 268 173 177 230 239 183 254
Lori 1263 1304 1319 1272 1275 1328 1536 1641
Gugark 121 152 119 118 129 152 115 125
Spitak 229 235 170 159 228 251 200 219
Stephanavan 158 144 157 143 169 143 184 206
Tashir 123 120 117 102 106 155 108 125
Tumanyan 214 204 262 244 211 187 295 289
Vanadzor 418 449 494 506 432 440 634 677
KOTAYK 1483 1592 1069 1221 1333 1456 1431 1962
Kotayk 680 713 469 523 620 671 662 880
Nairi 285 303 221 274 215 236 268 409
Hrazdan 389 438 296 318 498 549 501 673
Charentsavan 129 138 83 106 - - - -
SHIRAK 1376 1458 1213 1232 1306 1444 1402 1666
Amasia 24 26 14 21 29 35 11 45
Ani 102 114 70 74 103 132 90 113
Artik 269 312 218 196 257 268 254 261
Akhuryan 275 254 171 195 241 284 192 258
Ashotsk 51 71 45 45 45 54 46 84
Gyumri 655 681 695 701 631 671 809 905
SYUNIK 665 679 577 617 625 677 687 1043
Goris 254 277 173 175 242 244 200 353
Kapan 222 236 224 234 230 274 285 382
Meghri 42 35 54 64 30 49 65 86
Sisian 147 131 126 144 123 110 137 222
VAYOTS DZOR 232 270 243 234 211 220 283 445
Vayk 48 66 44 53 67 68 93 160
Yeghegnadzor 150 185 175 149 144 152 190 285
Jermuk 34 19 24 32 - - - -
TAVUSH 614 707 609 671 562 613 756 843
Ijevan 244 288 185 203 214 265 222 283
Noyemberyan 163 187 164 147 127 135 183 184
Tavush 96 113 151 177 91 104 194 213
Dilijan 111 119 109 144 130 109 157 163
18
NATURAL MOVEMENT OF POPULATION BY REGIONS AND BY SEX
Table 1.5
2019 2020
Including infants (under-1) Natural growth Including infants (under-1) Natural growth
Female Male Female Male Female Male Female Male
90 129 4326 5529 110 157 1160 -977 RA
26 32 2411 2915 35 39 2171 1800 YEREVAN
7 7 81 186 4 9 -22 -183 ARAGATSOTN
4 4 59 97 2 4 -42 -141 Ashtarak
0 1 30 50 0 3 6 -20 Aparan
1 0 13 36 1 0 17 8 Aragats
2 2 -21 3 1 2 -3 -30 Talin
6 15 484 622 6 20 -152 -328 ARARAT
0 5 168 235 3 6 -148 -203 Artashat
3 4 177 186 - - - - Vedi
2 4 106 174 0 7 -69 -164 Masis
1 2 33 27 3 7 65 39 Ararat
5 11 447 462 12 11 -181 -404 ARMAVIR
2 3 187 206 9 3 -89 -224 Armavir
0 3 57 61 0 1 0 13 Baghramyan
3 5 184 196 3 7 -92 -193 Vagharshapat
0 0 19 -1 - - - - Metsamor
10 9 300 581 9 18 127 0 GEGHARKUNIK
1 2 58 76 1 1 0 -39 Vardenis
5 4 23 70 3 3 -9 -58 Gavar
3 3 185 357 4 12 121 154 Martuni
0 0 -16 -13 0 1 -32 -42 Chambarak
1 0 50 91 1 1 47 -15 Sevan
11 12 -56 32 8 17 -261 -313 Lori
1 2 2 34 1 1 14 27 Gugark
3 0 59 76 1 6 28 32 Spitak
1 1 1 1 2 1 -15 -63 Stephanavan
1 3 6 18 1 2 -2 30 Tashir
2 2 -48 -40 1 4 -84 -102 Tumanyan
3 4 -76 -57 2 3 -202 -237 Vanadzor
14 14 414 371 9 15 -98 -506 KOTAYK
6 6 211 190 3 6 -42 -209 Kotayk
4 1 64 29 4 5 -53 -173 Nairi
3 5 93 120 2 4 -3 -124 Hrazdan
1 2 46 32 - - - - Charentsavan
2 17 163 226 12 14 -96 -222 SHIRAK
0 0 10 5 0 0 18 -10 Amasia
0 1 32 40 0 0 13 19 Ani
0 1 51 116 1 3 3 7 Artik
1 7 104 59 2 4 49 26 Akhuryan
0 0 6 26 0 1 -1 -30 Ashotsk
1 8 -40 -20 9 6 -178 -234 Gyumri
5 4 88 62 5 8 -62 -366 SYUNIK
1 0 81 102 1 4 42 -109 Goris
1 2 -2 2 2 3 -55 -108 Kapan
1 0 -12 -29 0 0 -35 -37 Meghri
2 2 21 -13 2 1 -14 -112 Sisian
1 3 -11 36 2 0 -72 -225 VAYOTS DZOR
0 2 4 13 0 0 -26 -92 Vayk
1 1 -25 36 2 0 -46 -133 Yeghegnadzor
0 0 10 -13 - - - - Jermuk
3 5 5 36 8 6 -194 -230 TAVUSH
2 0 59 85 2 1 -8 -18 Ijevan
0 1 -1 40 2 2 -56 -49 Noyemberyan
1 3 -55 -64 2 1 -103 -109 Tavush
0 1 2 -25 2 2 -27 -54 Dilijan
19
MORTALITY
WEEKLY MORTALITY BY ALL CAUSES OF DEATH, BY SEX, 2019

Table 1.6*
2018 2019 The difference between the
Week /
including including number of deaths in 2019
day, month Total Total
Male Female Male Female compared to 2018
W01/
144 73 71 114 53 61 -30
01.01-07.01
W02/
525 262 263 497 232 265 -28
08.01-14.01
W03/
552 257 295 577 304 273 25
15.01-21.01
W04/
562 280 282 597 283 314 35
22.01-28.01
W05/
530 258 272 580 305 275 50
29.01-04.02
W06/
592 276 316 555 277 278 -37
05.02-11.02
W07/
566 267 299 557 288 269 -9
12.02-18.02
W08/
562 280 282 567 292 275 5
19.02-25.02
W09/
500 261 239 548 272 276 48
26.02-04.03
W10/
404 204 200 506 242 264 102
05.03-11.03
W11/
658 349 309 590 299 291 -68
12.03-18.03
W12/
493 249 244 571 286 285 78
19.03-25.03
W13/
508 237 271 567 287 280 59
26.03-01.04
W14/
457 218 239 497 250 247 40
02.04-08.04
Շ15/
465 243 222 530 244 286 65
09.04-15.04
W16/
509 252 257 491 257 234 -18
16.04-22.04
W17/
504 234 270 453 243 210 -51
23.04-29.04
W18/
484 251 233 482 249 233 -2
30.04-06.05
W19/
503 266 237 503 270 233 0
07.05-13.05
W20/
481 245 236 578 290 288 97
14.05-20.05
W21/
449 226 223 514 245 269 65
21.05-27.05
W22/
416 209 207 483 261 222 67
28.05-03.06
W23/
483 255 228 486 222 264 3
04.06.-10.06
W24/
471 237 234 441 234 207 -30
11.06-17.06
W25/
443 220 223 462 243 219 19
18.06-24.06
W26/
430 219 211 497 235 262 67
25.06-01.07
W27/
542 246 296 361 179 182 -181
02.07-08.07
20
Table 1.6 continutation

2018 2019 The difference between the
Week /
including including number of deaths in 2019
day, month Total Total
Male Female Male Female compared to 2018
W28/
608 289 319 499 253 246 -109
09.07-15.07
W29/
576 294 282 473 234 239 -103
16.07-22.07
W30/
405 215 190 464 225 239 59
23.07-29.07
W31/
440 243 197 473 236 237 33
30.07-06.08
W32/
478 238 240 443 232 211 -35
07.08-12.08
W33/
437 232 205 430 219 211 -7
13.08-19.08
W34/
432 208 224 482 239 243 50
20.08-26.08
W35/
414 223 191 450 232 218 36
27.08-02.09
W36/
439 235 204 374 187 187 -65
03.09-09.09
W37/
435 211 224 391 209 182 -44
10.09-16.09
W38/
349 187 162 426 217 209 77
17.09-23.09
W39/
448 245 203 494 265 229 46
24.09-30.09
W40/
445 217 228 442 223 219 -3
01.10-07.10
W41/
337 171 166 464 265 199 127
08.10-14.10
W42/
537 291 246 417 213 204 -120
15.10-21.10
W43/
498 266 232 449 232 217 -49
22.10-28.10
Շ44/
485 256 229 455 232 223 -30
29.10-04.11
W45/
467 238 229 516 277 239 49
05.11-11.11
W46/
566 299 267 506 273 233 -60
12.11-18.11
W47/
555 290 265 504 263 241 -51
19.11-25.11
W48/
551 276 275 569 317 252 18
26.11-02.12
W49/
504 258 246 529 281 248 25
03.12-09.12
W50/
511 245 266 592 293 299 81
10.12-16.12
W51/
496 255 241 510 280 230 14
17.12-23.12
W52/
558 276 282 633 314 319 75
24.12.-30.12
TOTAL 25204 12732 12472 25589 13053 12536 385
*Source; Armastat, Data are presented on a weekly basis according to the deaths.
21
WEIGHT (%) OF DEATH OF RA POPULATION (%) BY CAUSES IN THE STRUCTURE OF ALL

DEATHS, 2020, 2019
Table 1.6*
The difference between the number
2020 2019
of deaths in 2020 compared to 2019
Week /
day, month including including including
Total
Total Total
Male Female Male Female Female Male Female
W01/
252 140 112 114 53 61 138 87 51
30.12.19-05.01.20
W02/
693 360 333 497 232 265 196 128 68
06.01-12.01
W03/
635 317 318 577 304 273 58 13 45
13.01-19.01
Շ04/
611 313 298 597 283 314 14 30 -16
20.01-26.01
W05/
579 297 282 580 305 275 -1 -8 7
27.01-02.02
W06/
590 284 306 555 277 278 35 7 28
03.02-09.02
W07/
595 308 287 557 288 269 38 20 18
10.02-16.02
W08/
575 288 287 567 292 275 8 -4 12
17.02-23.02
W09/
609 278 331 548 272 276 61 6 55
24.02-01.03
W10/
590 305 285 506 242 264 84 63 21
02.03-08.03
W11/
548 280 268 590 299 291 -42 -19 -23
09.03-15.03
W12/
524 259 265 571 286 285 -47 -27 -20
16.03-22.03
W13/
393 202 191 567 287 280 -174 -85 -89
23.03-29.03
W14/
448 218 230 497 250 247 -49 -32 -17
30.03-05.04
W15/
496 236 260 530 244 286 -34 -8 -26
06.04-12.04
W16/
521 261 260 491 257 234 30 4 26
13.04-19.04
Շ17/
458 238 220 453 243 210 5 -5 10
20.04-26.04
W18/
507 255 252 482 249 233 25 6 19
27.04-03.05
W19/
515 259 256 503 270 233 12 -11 23
04.05-10.05
W20/
559 292 267 578 290 288 -19 2 -21
11.05-17.05
W21/
564 291 273 514 245 269 50 46 4
18.05-24.05
W22/
398 199 199 483 261 222 -85 -62 -23
25.05-31.05
Շ23/
663 336 327 486 222 264 177 114 63
01.06.-07.06
W24/
634 318 316 441 234 207 193 84 109
08.06-14.06
W25/
631 311 320 462 243 219 169 68 101
15.06-21.06
W26/
652 331 321 497 235 262 155 96 59
22.06-28.06
W27/
635 334 301 361 179 182 274 155 119
29.06-05.07
22
Table 1.6 continutation

The difference between the
2020 2019 number of deaths in 2020
Week / compared to 2019
day, month
including including Total including
Total Total
Male Female Male Female Female Male Female
W28/
657 320 337 499 253 246 158 67 91
06.07-12.07
W29/
553 302 251 473 234 239 80 68 12
13.07-19.07
W30/
648 318 330 464 225 239 184 93 91
20.07-26.07
W31/
560 273 287 473 236 237 87 37 50
27.07-02.08
W32/
507 266 241 443 232 211 64 34 30
03.08-09.08
W33/
477 238 239 430 219 211 47 19 28
10.08-16.08
W34/
486 241 245 482 239 243 4 2 2
17.08-23.08
W35/
468 247 221 450 232 218 18 15 3
24.08-30.08
W36/
493 260 233 374 187 187 119 73 46
31.08-06.09
Շ37/
490 256 234 391 209 182 99 47 52
07.09-13.09
W38/
464 251 213 426 217 209 38 34 4
14.09-20.09
W39/
479 264 215 494 265 229 -15 -1 -14
21.09-27.09
W40/
424 224 200 442 223 219 -18 1 -19
28.09-04.10
W41/
509 275 234 464 265 199 45 10 35
05.10-11.10
W42/
591 344 247 417 213 204 174 131 43
12.10-18.10
W43/
1121 782 339 449 232 217 672 550 122
19.10-25.10
W44/
1273 849 424 455 232 223 818 617 201
26.10-01.11
W45/
1485 951 534 516 277 239 969 674 295
02.11-08.11
W46/
1372 831 541 506 273 233 866 558 308
09.11-15.11
W47/
1486 904 582 504 263 241 982 641 341
16.11-22.11
W48/
1386 823 563 569 317 252 817 506 311
23.11-29.12
W49/
1200 711 489 529 281 248 671 430 241
30.11-06.12
W50/
1022 579 443 592 293 299 430 286 144
07.12-13.12
W51/
965 529 436 510 280 230 455 249 206
14.12-20.12
W52/
950 533 417 633 314 319 317 219 98
21.12.-27.12
TOTAL 34941 19081 15860 25589 13053 12536 9352 6028 3324
Source; Armastat, Data are presented on a weekly basis according to the deaths.
23
NHIAC
WEIGHT (%) OF DEATH OF RA POPULATION (%) BY CAUSES IN THE STRUCTURE OF ALL
DEATHS
Table 1.6.1
Diseases 1990 1995 2000 2005 2010 2015 2017 2018 2019 2020
Certain infectious and parasitic diseases 2.1 1.4 1.2 0.9 1.1 1.1 0.7 0.6 0.6 0.4
Including tuberculosis – all forms 0.4 0.6 0.7 0.6 0.6 0.2 0.2 0.1 0.1 0.1
Neoplasms 16.1 13.9 16.5 17.7 19.8 21.9 20.6 20.4 20.9 15.0
Including malignant 15.8 13.6 16.5 17.7 19.7 21.8 20.4 20.2 20.8 14.8
Diseases of the blood and blood-forming organs and certain disorders involving
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
the immune mechanism
Endocrine, nutritional and metabolic diseases 2.6 4.0 5.5 6.1 5.2 4.7 3.1 2.3 2.1 1.4
Including diabetes mellitus 2.3 3.7 5.3 6.0 5.0 4.6 3.0 2.2 2.0 1.3
Mental and behavioral disorders 0.2 0.6 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0
Diseases of nervous system 0.6 0.7 0.7 0.5 0.6 0.4 0.6 0.7 0.9 0.7
Diseases of the circulatory system 49.3 54.2 54.9 55.3 48.9 46.0 55.6 55.2 53.7 47.3
Hypertensive diseases 9.2 11.1 12.2 2.0 3.9 2.5 4.8 4.0 3.7 3.2
Ischemic heart diseases, chronic and other forms 32.4 35.0 36.4 33.9 29.4 29.1 29.0 24.6 24.3 24.0
Including acute myocardial infarction 8.7 9.4 11.3 8.9 10.0 8.4 5.7 2.7 3.1 2.8
Cerebrovascular diseases 13.5 14.1 15.0 14.9 10.6 8.7 9.1 7.2 7.7 6.2
Diseases of the respiratory system 8.1 6.4 5.9 5.6 5.9 7.6 6.1 7.7 8.3 8.3
Diseases of the digestive system 3.4 3.6 3.3 4.1 5.8 5.9 5.7 4.7 4.7 3.7
Including stomach ulcer 0.4 0.3 0.3 0.4 0.4 0.4 0.4 0.5 0.5 0.4
Including Duodenum ulcer 0.2 0.3 0.2 0.2 0.3 0.4 0.5 0.5 0.6 0.4
Diseases of the skin and subcutaneous tissue 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Diseases of the musculoskeletal system and connective tissue 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1
Diseases of the genitourinary system 1.9 1.7 1.6 1.4 2.9 3.0 1.1 1.3 1.2 0.8
Pregnancy, childbirth and the puerperium 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Congenital malformations, deformations and chromosomal abnormalities 1.1 0.6 0.8 0.5 1.5 1.4 0.7 0.3 0.2 0.2
Certain conditions originating in the perinatal period 2.2 1.0 0.9 0.9 0.7 0.6 0.7 0.6 0.5 0.5
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere
3.0 4.7 3.5 2.1 2.9 2.0 0.8 1.6 2.3 0.9
classified
Injury, poisoning and certain other consequences of external causes 9.0 6.9 4.6 4.2 4.5 4.9 3.8 4.1 4.1 10.6
Covid-19 - - - - - - - - - 9.8
24
DEATHS BY MAIN CAUSES *
Table 1.6.2
Absolute value
Diseases 1990 1995 2000 2005 2010 2015 2017 2018 2019 2020
Certain infectious and parasitic diseases 462 354 287 247 304 309 194 163 165 161
Including tuberculosis – all forms 92 140 157 158 158 66 44 29 35 46
Neoplasms 3541 3454 3967 4679 5516 6103 5597 5258 5485 5420
Including malignant 3484 3384 3958 4665 5501 6069 5550 5199 5434 5367
Diseases of the blood and blood-forming organs and
22 14 22 23 20 15 28 25 31 31
certain disorders involving the immune mechanism
Endocrine, nutritional and metabolic diseases 565 986 1324 1615 1444 1323 853 598 543 495
Including diabetes mellitus 495 917 1266 1570 1395 1276 809 579 524 470
Mental and behavioral disorders 44 153 65 24 2 14 10 14 11 8
Diseases of nervous system 138 180 170 140 163 118 169 175 226 258
Diseases of the eye and adnexa - - - - 1 1 -
Diseases of the ear and mastoid process 1 3 2 3 1 2 2
Diseases of the circulatory system 10843 13456 13198 14578 13657 12817 15106 14209 14069 17114
Hypertensive diseases 2014 2748 2937 526 1102 700 1299 1028 970 1155
Ischemic heart diseases, chronic and other forms 7128 8698 8745 8946 8212 8118 7866 6334 6368 8674
Including acute myocardial infarction 1916 2342 2719 2343 2796 2337 1552 702 813 1002
Cerebrovascular diseases 2963 3515 3600 3927 2969 2428 2466 1848 2010 2236
Diseases of the respiratory system 1784 1600 1416 1484 1653 2126 1644 1978 2169 3015
Diseases of the digestive system 747 895 783 1070 1623 1652 1543 1217 1234 1350
Including stomach ulcer 92 86 73 109 113 119 122 121 137 154
Including Duodenum ulcer 48 70 52 55 83 123 126 122 167 161
Diseases of the skin and subcutaneous tissue 22 10 8 14 15 18 27 37 30 45
Diseases of the musculoskeletal system and connective
26 33 47 54 56 64 46 31 31 22
tissue
Diseases of the genitourinary system 424 412 383 382 797 842 308 346 312 278
Pregnancy, childbirth and the puerperium 32 17 18 7 4 7 4 8 12 8
Congenital malformations, deformations and
238 142 189 138 408 401 179 75 65 76
chromosomal abnormalities
Certain conditions originating in the perinatal period 481 259 211 249 199 155 189 154 130 172
Symptoms, signs and abnormal clinical and laboratory

652 1171 833 554 808 557 215 403 593 343
findings, not elsewhere classified
Injury, poisoning and certain other consequences of 1972 1706 1104 1120 1249 1355 1042 1058 1077 3827
external causes
Covid-19 - - - - - - - - - 3545
TOTAL 21993 24842 24025 26379 27921 27878 27157 25751 26186 36170
*Until 2003 including data presented in accordance with ICD 9
25
NHIAC
DEATHS BY MAIN CAUSES *
Table 1.6.2
per 100 000 population
Diseases
1990 1995 2000 2005 2010 2015 2017 2018 2019 2020
13.03 9.41 7.54 7.68 9.34 10.28 6.51 5.49 5.57 5.44 Certain infectious and parasitic diseases
Including tuberculosis
2.59 3.72 4.13 4.91 4.85 2.20 1.48 0.98 1.18 1.55
– all forms
99.89 91.86 104.31 145.42 169.41 203.12 187.86 177.10 185.15 183.02 Neoplasms
98.28 90.00 104.07 144.99 168.94 201.99 186.28 175.11 183.43 181.23 Including malignant
0.62 0.37 0.58 0.71 0.61 0.50 0.94 0.84 1.05 1.05
15.93 26.22 34.81 50.19 44.35 44.03 28.63 20.14 18.33 16.71 Endocrine, nutritional and metabolic diseases
13.96 24.39 33.29 48.8 42.84 42.47 27.15 19.50 17.69 15.87 Including diabetes mellitus
1.24 4.07 1.7 0.75 0.06 0.47 0.34 0.47 0.37 0.27 Mental and behavioral disorders
3.89 4.79 4.47 4.35 5.01 3.93 5.67 5.89 7.63 8.71 Diseases of nervous system
- - - - 0.03 0.03 - Diseases of the eye and adnexa
0.03 0.09 0.07 0.10 0.03 0.07 0.07 Diseases of the ear and mastoid process
305.89 357.88 347.05 453.08 419.43 426.58 507.01 478.58 474.90 577.88 Diseases of the circulatory system
56.81 73.08 77.23 16.35 33.84 23.30 43.60 34.62 32.74 39.00 Hypertensive diseases
201.08 231.33 229.95 278.04 252.20 270.19 264.01 213.34 214.95 292.89 Ischemic heart diseases, chronic and other forms
54.05 62.28 71.49 72.82 85.87 77.78 52.09 23.64 27.44 33.83 Including acute myocardial infarction
83.59 93.48 94.66 122.05 91.18 80.81 82.77 62.24 67.85 75.50 Cerebrovascular diseases
50.3 42.55 37.23 46.12 50.77 70.76 55.18 66.62 73.22 101.81 Diseases of the respiratory system
21.07 23.8 20.58 33.26 49.84 54.98 51.79 40.99 41.65 45.59 Diseases of the digestive system
2.59 2.29 1.92 3.39 3.47 3.96 4.09 4.08 4.62 5.20 Including stomach ulcer
1.35 1.86 1.36 1.71 2.55 4.09 4.23 4.11 5.64 5.44 Including Duodenum ulcer
0.62 0.26 0.21 0.44 0.46 0.60 0.91 1.25 1.01 1.52 Diseases of the skin and subcutaneous tissue
0.73 0.88 1.23 1.68 1.72 2.13 1.54 1.04 1.05 0.74
tissue
11.96 10.96 10.07 11.87 24.48 28.02 10.34 11.65 10.53 9.39 Diseases of the genitourinary system
3.54 1.91 1.96 0.76 0.44 0.90 0.53 1.06 1.61 1.07 Pregnancy, childbirth and the puerperium
Congenital malformations, deformations and chromosomal
6.71 3.78 4.97 4.29 12.53 13.35 6.01 2.53 2.19 2.57
abnormalities
44.43 24.10 23.52 36.61 33.50 26.46 31.62 25.67 21.67 28.71 Certain conditions originating in the perinatal period

18.39 31.14 21.9 17.22 24.81 18.54 7.22 13.57 20.02 11.58
55.63 45.37 29.03 34.81 38.36 45.10 34.97 35.63 36.35 129.23 Injury, poisoning and certain other consequences of
external causes
- - - - - - - - - 119.70 Covid-19
620.44 660.7 631.75 819.86 857.50 927.84 911.49 867.33 883.92 1221.34 TOTAL
26
MORTALITY BY CAUSES OF DEATH, BY REGIONS, 2020
Table 1.6.3
Yerevan Aragatsotn Ararat Armavir Gegharkunik Lori Kotayk Shirak Syunik Vayots Dzor Tavush RA
Diseases
a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. a.v. r.v.
Certain infectious and
68 6.3 7 5.6 10 3.9 10 3.8 11 4.8 7 3.3 24 9.6 7 3.0 3 2.2 4 8.3 10 8.3 161 5.4
parasitic diseases
Neoplasms 1870 171.9 221 177.4 405 157.8 404 153.1 374 164.4 579 271.8 448 178.5 473 204.7 234 171.3 91 188.4 268 221.5 5367 181.2
Diseases of the blood and

blood-forming organs and
23 2.1 0 0.0 1 0.4 4 1.5 2 0.9 3 1.4 8 3.2 8 3.5 0 0.0 3 6.2 1 0.8 53 1.8
certain disorders involving
Endocrine, nutritional and
6 0.6 0 0.0 0 0.0 10 3.8 3 1.3 6 2.8 1 0.4 1 0.4 0 0.0 1 2.1 3 2.5 31 1.0
metabolic diseases
Including diabetes
263 24.2 15 12.0 12 4.7 20 7.6 33 14.5 16 7.5 40 15.9 73 31.6 11 8.1 2 4.1 10 8.3 495 16.7
mellitus
Mental and behavioral

260 23.9 14 11.2 12 4.7 19 7.2 31 13.6 11 5.2 32 12.7 71 30.7 8 5.9 2 4.1 10 8.3 470 15.9
disorders
Diseases of nervous system 6 0.6 0 0.0 1 0.4 0 0.0 1 0.4 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 8 0.3
Diseases of the eye and

68 6.3 6 4.8 5 1.9 6 2.3 13 5.7 52 24.4 34 13.5 22 9.5 27 19.8 2 4.1 23 19.0 258 8.7
adnexa
Diseases of the circulatory
0 0.0 0 0.0 0 0.0 1 0.4 1 0.4 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 0.1
system
Hypertensive diseases 5731 526.8 829 665.3 1462 570.1 1580 598.7 1143 502.4 1602 752.1 1671 665.7 1486 643.0 559 409.2 246 509.3 805 665.3 17114 577.9
Аcute myocardial
719 66.1 82 65.8 14 5.5 39 14.8 60 26.4 47 22.1 52 20.7 90 38.9 12 8.8 2 4.1 38 31.4 1155 39.0
infarction
Ischemic heart diseases,
372 34.2 85 68.2 54 21.0 72 27.3 23 10.1 248 116.4 89 35.5 16 6.9 9 6.6 5 10.4 29 24.0 1002 33.8
chronic and other forms
Cerebrovascular diseases 2970 273.0 499 400.5 1177 458.7 759 287.6 199 87.5 642 301.4 980 390.4 701 303.3 339 248.2 166 343.7 242 200.0 8674 292.9
Diseases of the respiratory

490 45.0 85 68.2 189 73.7 190 72.0 300 131.9 376 176.5 182 72.5 206 89.1 61 44.7 54 111.8 103 85.1 2236 75.5
system
962 88.4 58 46.5 383 149.3 218 82.6 176 77.4 84 39.4 205 81.7 223 96.5 396 289.9 168 347.8 142 117.4 3015 101.8
system
280 25.7 18 14.4 16 6.2 7 2.7 13 5.7 5 2.3 17 6.8 65 28.1 4 2.9 3 6.2 5 4.1 433 14.6
parasitic diseases
27
NHIAC
MORTALITY BY CAUSES OF DEATH, BY REGIONS, 2020

Table 1.6.3 continutation
Yerevan Aragatsotn Ararat Armavir Gegharkunik Lori Kotayk Shirak Syunik Vayots Dzor Tavush RA
Diseases
a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
Diseases of the digestive
466 42.8 52 41.7 82 32.0 110 41.7 65 28.6 184 86.4 98 39.0 185 80.1 56 41.0 19 39.3 33 27.3 1350 45.6
system
Diseases of the skin and
14 1.3 1 0.8 2 0.8 1 0.4 5 2.2 13 6.1 3 1.2 2 0.9 2 1.5 0 0.0 2 1.7 45 1.5
subcutaneous tissue
Diseases of the
musculoskeletal system 14 1.3 0 0.0 1 0.4 2 0.8 1 0.4 0 0.0 1 0.4 2 0.9 1 0.7 0 0.0 0 0.0 22 0.7
and connective tissue
Diseases of the
94 8.6 6 4.8 10 3.9 21 8.0 20 8.8 48 22.5 26 10.4 27 11.7 8 5.9 3 6.2 15 12.4 278 9.4
genitourinary system
Pregnancy, childbirth
0 0.0 0 0.0 3 4.6 2 2.9 0 0.0 1 1.9 1 1.6 0 0.0 1 2.9 0 0.0 0 0.0 8 1.1
and the puerperium
Certain conditions
originating in the 50 23.2 8 30.0 16 29.7 11 20.8 20 43.1 16 35.6 16 30.0 17 34.7 8 33.5 0 0.0 10 43.1 172 28.7
perinatal period
Congenital
malformations,
deformations and 22 2.0 5 4.0 6 2.3 9 3.4 5 2.2 4 1.9 7 2.8 8 3.5 4 2.9 0 0.0 6 5.0 76 2.6
chromosomal
abnormalities
Symptoms, signs and
abnormal clinical and
86 7.9 15 12.0 30 11.7 26 9.9 47 20.7 43 20.2 32 12.7 23 10.0 19 13.9 9 18.6 13 10.7 343 11.6
laboratory findings, not
elsewhere classified
Injury, poisoning and
certain other
994 91.4 204 163.7 335 130.6 382 144.8 286 125.7 290 136.2 396 157.8 335 145.0 308 225.5 132 273.3 165 136.4 3827 129.2
consequences of external
causes
Covid - 19 1717 157.8 108 86.7 272 106.0 258 97.8 168 73.8 229 107.5 382 152.2 176 76.2 94 68.8 48 99.4 93 76.9 3545 119.7
TOTAL 12454 1144.8 1535 1231.9 3036 1183.2 3075 1165.2 2374 1043.5 3177 1491.5 3393 1351.8 3068 1327.6 1731 1267.2 728 1507.2 1599 1321.5 36170 1221.3
28
MORTALITY BY MAIN NCD'S DEATH, BY REGIONS, 2020
Table 1.6.4
Vayots
Yerevan Aragatsotn Ararat Armavir Gegharkunik Lori Kotayk Shirak Syunik Tavush
Diseases ICD 10 Dzor
a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
Diseases of the
I00-99 5731 526.8 829 665.3 1462 570.1 1580 598.7 1143 502.4 1602 752.1 1671 665.7 1486 643.0 559 409.2 246 509.3 805 665.3
circulatory system
Including
Hypertensive diseases I10-15 719 66.1 82 65.8 14 5.5 39 14.8 60 26.4 47 22.1 52 20.7 90 38.9 12 8.8 2 4.1 38 31.4
Ischemic heart
I20-25 2970 273.0 499 400.5 1177 458.7 759 287.6 199 87.5 642 301.4 980 390.4 701 303.3 339 248.2 166 343.7 242 200.0
diseases
Including аcute
I21 372 34.2 85 68.2 54 21.0 72 27.3 23 10.1 248 116.4 89 35.5 16 6.9 9 6.6 5 10.4 29 24.0
myocardial infarction
Cerebrovascular
I60-69 490 45.0 85 68.2 189 73.7 190 72.0 300 131.9 376 176.5 182 72.5 206 89.1 61 44.7 54 111.8 103 85.1
diseases
Malignant neoplasm C00-99 1870 171.9 221 177.4 405 157.8 404 153.1 374 164.4 579 271.8 448 178.5 473 204.7 234 171.3 91 188.4 268 221.5
Including
Stomach C16 116 10.7 7 5.6 36 14.0 33 12.5 31 13.6 23 10.8 31 12.4 48 20.8 14 10.2 10 20.7 18 14.9
Colorectal C17-20 235 21.6 16 12.8 23 9.0 23 8.7 34 14.9 31 14.6 37 14.7 52 22.5 9 6.6 7 14.5 33 27.3
Lung C34 371 34.1 38 30.5 129 50.3 117 44.3 73 32.1 137 64.3 105 41.8 83 35.9 112 82.0 26 53.8 55 45.5
Breast C50 204 18.8 13 10.4 22 8.6 32 12.1 23 10.1 24 11.3 41 16.3 41 17.7 8 5.9 7 14.5 22 18.2
Prostate C61 83 7.6 9 7.2 10 3.9 15 5.7 14 6.2 27 12.7 25 10.0 26 11.3 7 5.1 2 4.1 23 19.0
Endocrine,
nutritional and E00-90 263 24.2 15 12.0 12 4.7 20 7.6 33 14.5 16 7.5 40 15.9 73 31.6 11 8.1 2 4.1 10 8.3
metabolic diseases
Including
Diabetes mellitus E10-14 260 23.9 14 11.2 12 4.7 19 7.2 31 13.6 11 5.2 32 12.7 71 30.7 8 5.9 2 4.1 10 8.3
Diseases of the
J40-47 280 25.7 18 14.4 16 6.2 7 2.7 13 5.7 5 2.3 17 6.8 65 28.1 4 2.9 3 6.2 5 4.1
respiratory system
29
NHIAC
MORTALITY BY CAUSES OF DEATH, BY AGE GROUPS AND BY SEX, 2020

Table 1.6.5
Female Male Total
Premature mortality Premature mortality Premature mortality
Total in all age Total in all age Total in all age
35-65 age 0-70 age 35-65 age
groups 0-70 age group 35-65 age group groups 0-70 age group groups
Diseases group group group
ICD a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
10
Certain infectious and parasitic
A00-B99 51 3.3 33 2.3 15 2.4 110 7.9 89 6.8 76 14.5 161 5.4 122 4.5 91 7.8
diseases
C00-
Neoplasms 2426 155.1 1223 86.1 844 132.4 2941 210.4 1609 122.7 1065 203.1 5367 181.2 2832 103.7 1909 164.3
C97
Diseases of the blood and blood-
forming organs and certain D10-
29 1.9 14 1.0 9 1.4 24 1.7 6 0.5 4 0.8 53 1.8 20 0.7 13 1.1
disorders involving the immune D48
mechanism
Endocrine, nutritional and D50-
19 1.2 5 0.4 5 0.8 12 0.9 4 0.3 2 0.4 31 1.0 9 0.3 7 0.6
metabolic diseases D89
Mental and behavioral E00-
308 19.7 104 7.3 59 9.3 187 13.4 98 7.5 63 12.0 495 16.7 202 7.4 122 10.5
disorders E90
F00-
Diseases of nervous system 6 0.4 1 0.1 0 0.0 2 0.1 2 0.2 2 0.4 8 0.3 3 0.1 2 0.2
F99
Diseases of the eye and G00-
130 8.3 46 3.2 24 3.8 128 9.2 61 4.7 30 5.7 258 8.7 107 3.9 54 4.6
adnexa G99
Diseases of the circulatory H60-
0 0.0 0 0.0 0 0.0 2 0.1 2 0.2 2 0.4 2 0.1 2 0.1 2 0.2
system H95
I00-I99 8831 564.7 1468 103.4 773 121.4 8283 592.7 3090 235.7 2014 384.1 17114 577.9 4558 166.9 2787 240.0
system
Diseases of the digestive
J00-J99 1495 95.6 329 23.2 195 30.6 1520 108.8 531 40.5 315 60.1 3015 101.8 860 31.5 510 43.9
system
Diseases of the skin and K00-
632 40.4 155 10.9 93 14.6 718 51.4 382 29.1 283 54.0 1350 45.6 537 19.7 376 32.4
subcutaneous tissue K93
Certain infectious and parasitic L00-
33 2.1 11 0.8 5 0.8 12 0.9 5 0.4 2 0.4 45 1.5 16 0.6 7 0.6
diseases L99
30
NHIAC
MORTALITY BY CAUSES OF DEATH, BY AGE GROUPS AND BY SEX, 2020
Table 1.6.5 (continutation)

Female Male TOTAL
TOTAL in all TOTAL in all
Premature mortality Premature mortality Premature mortality
TOTAL in all age groups age groups
Diseases age groups 0-70 age 35-65 35-65 age 0-70 age 35-65 age
0-70 age group
group age group group group group
ICD
a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
10
Diseases of the musculoskeletal
M00-M99 15 1.0 6 0.4 3 0.5 7 0.5 4 0.3 3 0.6 22 0.7 10 0.4 6 0.5
system and connective tissue
Diseases of the genitourinary
N00-N99 132 8.4 43 3.0 32 5.0 146 10.4 65 5.0 42 8.0 278 9.4 108 4.0 74 6.4
system
Pregnancy, childbirth and the
O00-O99 8 1.1 8 1.1 4 0.5 0 0.0 0 0.0 0 0.0 8 1.1 8 1.1 4 0.5
puerperium
Certain conditions originating in
P00-P96 71 25.2 71 25.2 0 0.0 101 31.8 101 31.8 0 0.0 172 28.7 172 28.7 0 0.0
the perinatal period
Congenital malformations,
deformations and chromosomal Q00-Q99 26 1.7 21 1.5 5 0.8 50 3.6 49 3.7 6 1.1 76 2.6 70 2.6 11 0.9
abnormalities
Symptoms, signs and abnormal
clinical and laboratory findings, not R00-R99 144 9.2 44 3.1 23 3.6 199 14.2 130 9.9 77 14.7 343 11.6 174 6.4 100 8.6
Injury, poisoning and certain other
S00-T98 240 15.3 147 10.3 81 12.7 3587 256.7 3463 264.1 981 187.1 3827 129.2 3610 132.1 1062 91.4
consequences of external causes
U07.1,
Covid -19 1543 98.7 685 48.2 437 68.5 2002 143.2 923 70.4 565 107.8 3545 119.7 1608 58.9 1002 86.2
U07.2
TOTAL A00-T98 16139 1032.0 4414 310.7 2607 408.9 20031 1433.2 10614 809.5 5532 1055.1 36170 1221.3 15028 550.1 8139 700.5
31
NHIAC
MALE MORTALITY BY AGE, 2020

Table 1.7
Diseases TOTAL 0-4 5-14 15-19 20-29 30-39 40-49 50-59 60-69 70 և >
Certain infectious and parasitic diseases 110 3 1 2 12 26 27 18 21
Including tuberculosis – all forms 43 1 2 12 11 9 8
Neoplasms 2965 6 5 1 14 31 92 459 1007 1350
Including malignant 2941 6 5 1 14 31 89 459 1004 1332

12 1 3 8
Endocrine, nutritional and metabolic diseases 187 1 2 4 4 22 65 89
Including diabetes mellitus 174 4 3 20 62 85
Mental and behavioral disorders 2 2
Diseases of nervous system 128 2 6 4 3 2 9 9 26 67
Diseases of the eye and adnexa – – – – – – – – – –
Diseases of the ear and mastoid process 2 1 1
Diseases of the circulatory system 8283 1 1 5 18 50 268 826 1921 5193
Hypertensive diseases 482 1 4 18 67 136 256
Ischemic heart diseases, chronic and other forms 4605 3 12 26 158 530 1185 2691
Including acute myocardial infarction 525 2 14 63 154 292
Cerebrovascular diseases 997 1 1 3 10 39 94 255 594
Diseases of the digestive system 718 2 1 2 3 15 59 119 181 336
Including stomach ulcer 83 1 1 10 17 54
duodenum ulcer 90 5 6 15 64
Diseases of the skin and subcutaneous tissue 12 1 1 3 7

Diseases of the musculoskeletal system and
7 1 1 2 3
connective tissue
Diseases of the genitourinary system 146 2 1 3 3 9 15 32 81
50 36 2 1 2 3 1 3 1 1
Certain conditions originating in the perinatal period 101 101
Symptoms, signs and abnormal clinical and
199 5 9 5 12 6 14 40 39 69
laboratory findings, not elsewhere classified
Injury, poisoning and certain other consequences of
3587 4 16 1018 1044 649 384 228 120 124
external causes
Covid-19 2002 4 14 60 229 616 1079
TOTAL 20031 176 45 1038 1117 812 989 2081 4356 9417
32
FEMALE MORTALITY BY AGE, 2020

Table 1.8
Diseases TOTAL 0-4 5-14 15-19 20-29 30-39 40-49 50-59 60-69 70 և >
Certain infectious and parasitic diseases 51 6 1 2 2 8 14 18
Including tuberculosis – all forms 3 1 1 1
Neoplasm’s 2455 1 2 3 7 49 130 362 683 1218
Including malignant 2426 2 3 6 48 129 359 676 1203

19 1 1 3 14
Endocrine, nutritional and metabolic diseases 308 2 4 22 76 204
Including diabetes mellitus 296 2 2 22 71 199
Mental and behavioral disorders 6 1 5
Diseases of nervous system 130 5 1 1 5 2 12 20 84
Diseases of the eye and adnexa – – – – – – – – – –
Diseases of the ear and mastoid process – – – – – – – – – –
Diseases of the circulatory system 8831 1 1 7 13 65 285 1096 7363
Hypertensive diseases 673 1 3 20 86 563
Ischemic heart diseases, chronic and other forms 4069 3 3 38 145 564 3316
Including acute myocardial infarction 477 1 3 22 97 354
Cerebrovascular diseases 1239 1 4 11 61 208 954
Diseases of the digestive system 632 3 1 2 6 8 36 99 477
Including stomach ulcer 71 2 1 8 60
Duodenum ulcer 71 1 5 9 56
Diseases of the skin and subcutaneous tissue 33 3 2 6 22

15 2 4 9
connective tissue
Diseases of the genitourinary system 132 1 2 4 9 27 89
Pregnancy, childbirth and the puerperium 8 1 5 2

26 14 1 2 1 3 5
Certain conditions originating in the perinatal
71 71
period
144 2 4 2 2 9 9 16 100
240 3 7 1 18 18 15 28 57 93
external causes
Covid -19 1543 1 3 13 43 173 452 858
TOTAL 16139 123 24 14 54 131 317 1017 2734 11725
33
NHIAC
MORTALITY OF THE RA POPULATION DUE TO COVID-19, REGIONS, 2021

Table 1.8.1
Age Group
0-4 5-14 15-19 20-29 30-39 40-49 50-59 60-69 70 > TOTAL
Sex f m f m f m f m f m f m f m f m f m f m
Yerevan 0 0 0 0 0 0 2 2 3 8 16 19 53 97 200 294 461 562 735 982

Aragatsotn 0 0 0 0 0 0 1 0 1 0 4 3 7 8 15 17 20 32 48 60
Ararat 0 0 0 0 0 0 0 0 1 0 1 2 25 26 33 44 58 82 118 154
Armavir 0 0 0 0 0 0 0 0 3 2 5 3 23 23 39 41 56 63 126 132
Gegharkunik 0 0 0 0 0 0 0 0 0 1 1 8 6 11 19 41 37 44 63 105
Lori 0 0 0 0 1 0 0 0 1 0 2 4 14 13 37 41 62 54 117 112
Kotayk 0 0 0 0 0 0 0 1 1 2 8 7 23 20 55 66 74 125 161 221
Shirak 0 0 0 0 0 0 0 0 1 0 1 6 9 9 23 28 45 54 79 97
Syunik 0 0 0 0 0 0 0 1 0 0 1 4 4 9 13 15 19 28 37 57
Vayots Dzor 0 0 0 0 0 0 0 0 0 0 3 3 2 3 5 14 6 12 16 32
Tavush 0 0 0 0 0 0 0 0 2 1 1 1 7 10 13 15 20 23 43 50
RA 0 0 0 0 1 0 3 4 13 14 43 60 173 229 452 616 858 1079 1543 2002
34
NHIAC
NATURAL MOVEMENT OF POPULATION AND CHILD MORTALITY

Table 1.9
Number of still births
Number of live births* Natural growth
Total Including infants (0-1 y.o)
Years
per 1000
per 1000 per 1000
a.v. a.v a.v. per 1000 population a.v populatio
population population
n
1976 65065 22.7 15688 5.5 1996 31.0 49377 17.2
1980 70324 22.7 17124 5.5 1840 26.2 53200 17.2
1985 80306 24.1 19581 5.9 1987 24.8 60725 18.2
1986 81192 24.0 19410 5.7 1914 23.6 61782 18.3
1987 78492 22.9 19727 5.7 1790 22.6 58765 17.2
1988 74707 21.6 35567 10.3 1911 25.3 39140 11.3
1989 75250 21.6 20853 6.0 1534 20.4 54397 15.6
1990 79882 22.5 21993 6.2 1465 18.5 57889 16.3
1991 77825 21.6 23425 6.5 1404 17.9 54400 15.1
1992 70581 19.2 25824 7.0 1336 18.5 44757 12.2
1994 51143 13.7 24652 6.6 772 15.1 26556 7.1
1995 48960 13.0 24842 6.6 697 14.2 24118 6.4
1996 48134 12.8 24936 6.6 747 15.52 23198 6.2
1997 43929 11.6 23985 6.3 678 15.43 19944 5.3
1998 39366 10.4 23210 6.1 580 14.73 16156 4.3
1999 36502 9.6 24087 6.3 572 15.44 12415 3.3
2000 34276 9.01 24025 6.32 540 15.56 10251 2.7
2001 32065 8.44 24003 6.32 497 15.35 8062 2.12
2002 32229 10.04 25554 7.96 450 13.98 6675 2.08
2003 35793 11.15 26014 8.1 422 11.96 9779 3.04
2004 37520 11.67 25679 7.99 430 11.55 11841 3.68
2005 37499 11.66 26379 8.2 460 12.27 11120 3.46
2006 37639 11.69 27202 8.45 523 13.9 10437 3.24
2007 40105 12.43 26830 8.32 433 10.88 13275 4.11
2008 41185 12.73 27412 8.48 442 10.77 13773 4.26
2009 44413 13.69 27560 8.50 454 10.35 16853 5.20
2010 44825 13.77 27921 8.57 512 11.44 16904 5.19
2011 43340 13.26 27963 8.55 507 11.64 15377 4.71
2012 42480 14.05 27599 9.13 458 10.75 14881 4.92
2013 41790 13.83 27196 9.00 407 9.73 14594 4.83
2014 43031 14.28 27714 9.20 376 8.76 15317 5.08
2015 41763 13.90 27878 9.28 370 8.82 13885 4.62
2016 40592 13.565 28226 9.433 352 8.64 12366 4.132
2017 37700 12.654 27157 9.115 311 8.17 10543 3.539
2018 36574 12.319 25751 8.673 261 7.10 10823 3.646
2019 36041 12.166 26186 8.839 219 6.07 9855 3.327
2020 36353 12.28 36170 12.21 267 7.35 183 0.07
* Live birth is the complete expulsion or extraction from its mother of a product of conception, irrespective of the duration of the pregnancy, which, after
such separation, breathes or shows any other evidence of life, such as beating of the heart, pulsation of the umbilical cord, or definite movement of
voluntary muscles, whether or not the umbilical cord has been cut or the placenta is attached. Each product of such a birth is considered live-born.
35
NHIAC
MATERNAL MORTALITY
Table 1.10
NSS data*
Breakdown of deaths by causes (absolute number)
Number of Abortions done Other
Years
deaths per Extra- Artificial outside of Natal and complications of

All causes Obstetric Toxicities
100000 live uterine medical medical postnatal pregnancy,
bleeding of pregnancy
births pregnancy abortion facilities and sepsis delivery and
unspecified postnatal stage
1996 20.8 10 - 1 1 1 1 3 3
2000 52.5 18 2 - 2 8 - - 6
2003 22.4 8 - - 1 5 - 1 1
2004 26.7 10 - - - - 1 - 9
2005 18.7 7 - - 1 - - 1 5
2006 26.6 10 1 - - 3 - - 6
2007 15.0 6 - - - 2 - - 4
2008 38.8 16 - - 2 4 1 1 8
2009 27.0 12 - 1 - 2 1 3 5
2010 8.9 4 - - - 1 - - 3
2011 13.8 6 1 - - 2 1 - 2
2012 18.8 8 - - 1 2 - 1 4
2013 21.5 9 - - - 1 1 - 7
2014 18.6 8 - - - 2 1 - 5
2015 16.8 7 - - 1 - - - 6
2016 34.5 14 - - - 4 1 - 9
2017 10.6 4 - - - - - - 4
2018 21.9 8 - - - 1 - - 7
2019 33.3 12 - - - 1 - 2 9
2020 22.0 8 - - - - - - 8
MoH DATA **
1996 19.8 9 - - - 1 - 3 5
2000 71.1 25 2 - 3 6 3 1 10
2003 19.2 7 - - - 2 1 1 3
2004 37.2 14 - - 2 1 - - 11
2005 26.7 10 - - - - 1 3 6
2006 34.5 13 1 - - 3 2 2 5
2007 15.0 6 - - - - - 1 5
2008 36.4 15 - - 2 4 1 - 8
2009 33.8 15 - - - 1 - 4 10
2010 6.7 3 - - - - 1 - 2
2011 11.5 5 1 - - 1 1 - 2
2012 23.5 10 - - 2 1 - - 7
2013 19.1 8 - - - - - 1 7
2014 18.6 8 - - - 2 - - 6
2015 12.0 5 - - - - - - 5
2016 29.6 12 - - - 3 - - 9
2017 8.0 3 - - - - - - 3
2018 21.9 8 - - - 1 1 - 6
2019 36.1 13 - - - 1 - 2 10
2020 19.3 7 - - - - - - 7
* Source: Civil Acts Registration Office death registration certificates
** Source: Moh death registration certificates
MATERNAL MORTALITY (average triennial rate)
Table 1.11
2002–2004
2003-2005
2004-2006
2005-2007
2006-2008
2007-2009
2008-2010
2009-2011
2010-2012
2011-2013
2012-2014
2013-2015
2014-2016
2015-2017
2016-2018
2017-2019
2018-2020
Average
triennial 19.5 22.6 24.0 20.1 26.8 26.9 24.9 16.6 13.8 18.0 19.6 19.0 23.3 20.6 22.3 21.9 25.7
rate
36
HEALTH CHARACTERISTICS
HEALTH
CHARACTERISTICS
37
NHIAC
INCIDENCE OF DISEASES
(15 years and above)
Table 2.1.1
Registered diseases (absolute value)
Diseases ICD X *
1990 1995 2000 2005 2010 2015 2019 2020
TOTAL A00-T98 688868 416091 333332 425806 605395 636360 654542 786882
including:
Certain infectious and parasitic diseases A00-B99 19128 18888 27945 35234 48631 46403 41708 188317
including:
Covid- 19 U07.1,U07.2 - - - - - - - 151704
Neoplasms C00-D48 5434 4779 5755 6849 8463 9993 10705 10106
Diseases of the blood and blood-forming

organs and certain disorders involving the D50-D89 653 1342 1765 3655 5435 5591 6208 5910
immune mechanism
Endocrine, nutritional and metabolic E00-E90 8774 3524 4967 10003 11478 16087 18306 17113
disease
from which:
Thyrotoxicosis (hyperthyroidism) E05 644 331 441 384 396 426 504 545
Diabetes mellitus E10- E11 4546 1825 2792 5439 7052 8709 10015 10129
Mental and behavioral disorders F00-F99 7699 4024 3986 5249 8689 6545 6389 5402
Diseases of nervous system G00-G99 46668 24466 17465 11607 18284 22422 24520 22231
Diseases of the eye and adnexa H00-H59 - - - 26578 37952 42364 50235 40319
from which:
Glaucoma H40 425 463 384 850 1695 1747 2640 1646
Diseases of the ear and mastoid process H60-H95 - - - 8685 17626 23925 26732 23344
Diseases of the circulatory system** I00-I99 32484 19730 19767 34717 49905 55468 54511 45481
from which:
Hypertensive diseases I10-I15 12037 3231 5026 15936 22499 25038 26177 22395
Ischaemic heart diseases I20-I25 9322 7654 7380 11303 14891 15990 16187 12017
Acute myocardial infarction I21 1118 1006 1310 1876 2189 2150 1728 1547
Angina pectoris I20 2448 2014 2010 4494 5026 5344 4628 3856
Cerebrovascular diseases I60-I69 3661 3023 2983 3200 4556 6419 5782 5420
Diseases of the respiratory system J00-J99 296584 163387 134554 161045 213865 189841 183242 221711
** Data are presented according to ICD IX before 2003 inclusive

* *The ischaemic heart disease and cerebrovascular diseases are presented together with hypertensive disease before 2003 inclusive
38
Table 2.1.1
Registered diseases (per 100 000 population) Diseases
1990 1995 2000 2005 2010 2015 2019 2020
27827.4 15496.9 11470.9 16781.9 22742.1 26307.8 27703.1 33307.2 TOTAL
including:
772.7 703.5 961.7 1388.6 1826.9 1918.4 1765.3 7971.1 Certain infectious and parasitic diseases
including:
- - - - - - - 6421.3 Covid -19
219.7 178.0 198.0 269.9 317.9 413.1 453.1 427.8 Neoplasms

26.4 50.0 60.7 144.1 204.2 231.1 262.8 250.2 organs and certain disorders involving the
immune mechanism
Endocrine, nutritional and metabolic
354.4 131.2 170.9 394.2 431.2 665.1 774.8 724.4
diseases
from which:
26.0 12.3 15.2 15.1 14.9 17.6 21.3 23.1 Thyrotoxicosis (hyperthyroidism)
183.6 68.0 96.1 214.4 264.9 360.0 423.9 428.7 Diabetes mellitus
311.0 149.9 137.2 206.9 326.4 270.6 270.4 228.7 Mental and behavioral disorders
1885.2 911.2 601.0 457.5 686.9 927.0 1037.8 941.0 Diseases of nervous system
- - - 751.0 1425.7 1751.4 2126.2 1706.6 Diseases of the eye and adnexa
from which:
17.2 17.2 13.2 33.5 63.7 72.2 111.7 69.7 Glaucoma
- - - 342.3 662.1 989.1 1131.4 988.1 Diseases of the ear and mastoid process
1312.2 734.8 680.2 1368.3 1874.7 2293.1 2307.1 1925.1 Diseases of the circulatory system**
from which:
486.2 120.3 173.0 628.1 845.2 1035.1 1107.9 947.9 Hypertensive diseases
376.6 285.1 254.0 445.5 559.4 661.0 685.1 508.7 Ischaemic heart diseases
45.2 37.5 45.1 73.9 82.2 88.9 73.1 65.5 Acute myocardial infarction
98.9 75.0 69.2 177.1 188.8 220.9 195.9 163.2 Angina pectoris
147.9 112.6 102.7 126.1 171.1 265.4 244.7 229.4 Cerebrovascular diseases
11980.7 6085.1 4630.4 6347.1 8034.0 7848.2 7755.6 9384.6 Diseases of the respiratory system
39
NHIAC
continutation 2.1.1
Diseases ICD10*
1990 1995 2000 2005 2010 2015 2019 2020
Diseases of the digestive system K00-K93 78034 32183 19393 24084 30640 36326 34980 33306
from which:
Gastric and duodenal ulcer K25-K26 2865 2064 1909 2286 2246 2609 2653 2347
Disorders of gallbladder, biliary tract K80-K83 3546 2090 2159 3423 4171 5160 5534 5183
Diseases of the skin and subcutaneous tissue L00-L99 21633 26837 13191 19002 30987 37110 46022 37210

M00-M99 11775 5905 5391 9347 19012 22944 26093 25202
tissue
Diseases of the genitourinary system N00-N99 27430 20398 14247 25823 43577 52089 56123 51001
from which:
glomerular diseases, renal tubulo-interstitial diseases, N00-N16

- - - 2371 3655 4129 3703 3434
other disorders of kidney and ureter N25-N28
Urolithiasis N20-N23 1302 1259 1516 3238 4363 5261 5661 5213
O00-
Pregnancy, childbirth and the puerperium and other
O75.O81- 17332 9592 13307 15222 13254 16615 12708 14536
obstretic conditions*
O99

Q00-Q99 153 132 177 575 750 793 826 549

R00-R99 164 2041 550 1000 3671 4738 4899 4407

S00-T98 114918 78863 47872 34653 43176 47106 50335 40737
external causes
* *The indicators are calculated for fertile age women
40
continutation 2.1.1
Registered diseases (per 100 000 population)
Diseases
1990 1995 2000 2005 2010 2015 2019 2020
3152.3 1198.6 667.4 949.2 1151.0 1501.8 1480.5 1409.8 Diseases of the digestive system,
from which:
115.4 76.9 65.7 90.1 84.4 107.9 112.3 99.3 Gastric and duodenal ulcer
142.2 77.8 74.3 134.9 156.7 213.3 234.2 219.4 Disorders of gallbladder, biliary tract
873.9 999.5 453.9 748.9 1164.0 1534.2 1947.9 1575.0 Diseases of the skin and subcutaneous tissue

475.7 220.1 185.5 368.4 714.2 948.5 1104.4 1066.8
tissue
1108.1 759.7 593.5 1017.8 1637.0 2153.4 2375.4 2158.8 Diseases of the genitourinary system
from which:
glomerular diseases, renal tubulo-interstitial diseases,

- - - 93.4 137.3 170.7 156.7 145.4
other disorders of kidney and ureter
52.6 46.9 52.2 127.6 163.9 217.5 239.6 220.7 Urolithiasis
Pregnancy, childbirth and the puerperium and other

1906.7 951.0 1230.9 1654.9 1457.4 2125.8 1700.1 1950.9
obstretic conditions*

6.2 4.9 6.1 22.7 28.2 32.8 35.0 23.2

6.6 76.0 18.9 39.4 137.9 195.9 207.3 186.5

4642.2 2937.2 1647.4 1365.7 1621.9 1947.4 2130.4 1724.3
external causes
41
NHIAC
(0-14 years old)
Table 2.1.2
Diseases ICD X Registered diseases (absolute value)
1990 1995 2000 2005 2010 2015 2019 2020
TOTAL A00-T98 542012 328221 260683 211728 305729 293468 306725 253652
including:
Certain infectious and parasitic A00-B99

37314 30430 37426 22552 32776 28758 32512 25560
diseases
from which:
Covid -19 U07.1,U07.2 - - - - - - - 2928
Neoplasms C00-D48 189 143 172 124 268 341 336 349

forming organs and certain disorders D50-D89 3058 3073 3801 4320 5372 5855 5386 4685
involving the immune mechanism

diseases E00-E90 24995 10486 4544 2957 2579 2016 1926 2004
from which:
Diseases of the eye and adnexa

H00-H59 - - - 11179 17368 19968 17865 15938
Diseases of the ear and mastoid

H60-H95 - - - 5917 12006 13559 13679 10597
process
Diseases of the circulatory system I00-I99 1159 517 381 447 614 344 508 266
from which:
Hypertensive diseases
I10-I15 9 1 3 29 24 26 28 19
Diseases of the respiratory system

J00-J99 305433 171560 132105 118720 174030 154574 165633 133277
*The data are presented according to ICD IX before 2003 inclusive
42
(0-14 years old)
Table 2.1.2
1990 1995 2000 2005 2010 2015 2019 2020
50061.1 30535.0 29061.6 31127.3 51460.9 50105.5 51137.9 42345.9 TOTAL
including:
including:
- - - - - - - 488.8 Covid - 19
17.5 13.3 19.2 18.2 45.1 58.2 56.0 58.3 Neoplasms

282.4 285.9 423.7 635.1 904.2 999.7 898.0 782.1 organs and certain disorders involving the
immune mechanism

2308.6 975.5 506.6 434.7 434.1 344.2 321.1 334.6
diseases
from which:
106.9 48.1 42.5 65.7 103.3 58.7 84.7 44.4 Diseases of the circulatory system
from which:
43
NHIAC
(0-14 years old)
continutation 2.1.2
Diseases ICD X
1990 1995 2000 2005 2010 2015 2019 2020
Diseases of the skin and subcutaneous

L00-L99 18402 18714 8349 6968 14065 17160 18911 16847
tissue
Diseases of the musculoskeletal system

M00-M99 3728 1642 883 948 1466 2249 3039 2695
from which:
glomerular diseases, renal tubulo-

N00-N16
interstitial diseases, other disorders of - - - 781 789 989 775 765
N25-N28
kidney and ureter
Congenital malformations, deformations

Q00-Q99 1304 996 972 855 1398 1405 1267 1142
and chromosomal abnormalities
O00-
Complications of labour and delivery O75.O81- - - - - - - - -
O99
Certain conditions originating in the

P00-P96 - 2588 3319 3181 2878 2413 2146 2394
perinatal period
Symptoms, signs and abnormal clinical

and laboratory findings, not elsewhere R00-R99 - 989 1285 988 1788 3519 3590 3067
classified

S00-T98 58451 37437 23076 12634 13120 13279 11770 10434
44
(0-14 years old)
continutation 2.1.2
1990 1995 2000 2005 2010 2015 2019 2020
4662.2 1582.5 2641.1 2046.5 2738.3 3014.5 2868.3 2568.4 Diseases of the digestive system

344.3 152.8 98.4 139.4 246.8 384.0 506.7 449.9
tissue
from which:
- - - 114.8 132.8 168.9 129.2 127.7 glomerular diseases, renal tubulo-interstitial diseases,
other disorders of kidney and ureter

120.4 92.7 108.4 125.7 235.3 239.9 211.2 190.7
- - - - - - - - Complications of labour and delivery
- 240.8 370.0 467.7 484.4 412.0 357.8 399.7 Certain conditions originating in the perinatal period

- 92.0 143.3 145.3 301.0 600.8 598.5 512.0

5398.6 3482.8 2572.6 1857.4 2208.4 2267.2 1962.3 1741.9
external causes
45
NHIAC
PREVALENCE OF DISEASES
Table 2.1.3

Diseases ICD X *
1990 1995 2000 2005 2010 2015 2019 2020
TOTAL A00-T98 1551289 965099 742074 811024 1117203 1272457 1373163 1513836
including:
including:
Covid -19
U07.1,U07.2 - - - - - - - 151704
Neoplasms C00-D48 28528 29122 27056 30926 38148 51135 62942 60520

organs and certain disorders involving D50-D89 1742 2873 3622 6013 8652 11400 13449 13321
diseases
E00-E90 49595 47406 49492 56749 73919 106497 132892 142937
from which:
Thyrotoxicosis (hyperthyroidism)
E05 3438 2668 1993 2195 2372 2764 2841 3182
from which:
Glaucoma
H40 3443 3233 2932 3603 7050 8530 10188 9416
Diseases of the circulatory system **
I00-I99 215594 150035 117586 112399 175651 235210 261070 252877
from which:
Hypertensive diseases
I10-I15 87467 32185 32831 48010 84639 123180 142642 141049
Ischaemic heart diseases I20-I25 74406 66918 48925 37663 55678 71391 77565 73733
Acute myocardial infarction
I21 1757 1458 1725 2178 2286 2439 1747 1641
Angina pectoris I20 14840 12226 11078 13273 18014 24306 23615 23775
Cerebrovascular diseases I60-I69 16895 14706 12991 11509 15036 18588 19572 18684
**The data are presented according to ICD IX before 2003 inclusive

*The ischaemic heart disease and cerebrovascular diseases presented together with hypertensive disease before 2003 inclusive
46
Table 2.1.3
1990 1995 2000 2005 2010 2015 2019 2020

62665.0 35944.1 25536.8 31964.1 41968.6 52604.8 58118.4 64077.7 TOTAL
including:
including:
- - - - - - - 6421.3 Covid -19
1152.4 1084.6 931.1 1218.9 1433.1 2114.0 2664.0 2561.7 Neoplasms

Diseases of the blood and blood-forming organs
70.4 107.0 124.6 237.0 325.0 471.3 569.2 563.9 and certain disorders involving the immune
mechanism
2003.4 1765.6 1703.2 2236.6 2776.8 4402.7 5624.6 6050.2 Endocrine, nutritional and metabolic diseases
from which:
from which:
139.1 120.4 100.9 142.0 264.8 352.6 431.2 398.6 Glaucoma
8709.1 5587.9 4046.5 4429.9 6598.5 9723.8 11049.6 10703.8 Diseases of the circulatory system **
from which:
3005.7 2492.3 1683.6 1484.4 2091.6 2951.4 3282.9 3121.0 Ischaemic heart diseases
71.0 54.3 59.4 85.8 85.9 100.8 73.9 69.5 Acute myocardial infarction
599.5 455.3 381.2 523.1 676.7 1004.8 999.5 1006.3 Angina pectoris
682.5 547.7 447.1 453.6 564.8 768.4 828.4 790.9 Cerebrovascular diseases
47
NHIAC
continutation 2.1.3

Diseases ICD X
1990 1995 2000 2005 2010 2015 2019 2020

from which:
Gastric and duodenal ulcer K25-K26 26537 21417 16324 13389 11603 11276 10635 9893
Disorders of gallbladder, biliary tract K80-K83 27968 19932 13876 12117 12277 13037 13307 12429

L00-L99 48654 40375 19151 26321 41024 48620 58635 49163
tissue
M00-M99 48647 25816 21024 23880 38928 50384 55824 55468
from which:
Glomerular diseases, renal tubulo-

N00-N16
N25-N28
kidney and ureter
Urolithiasis N20-N23 6241 4873 6071 8219 11519 13204 14937 14038
O00-O75.
puerperium and other obstretic 22915 12845 16541 18795 17714 21523 15999 17990
O81-O99
conditions*

Q00-Q99 1425 1271 1241 1962 2532 2340 2279 1873

and laboratory findings, not elsewhere R00-R99 286 2131 595 1093 3890 5491 6345 6094
classified

S00-T98 122416 82284 49066 37943 44669 47187 50335 40737
* The indicators are calculated for fertile age women
48
continutation 2.1.3
1990 1995 2000 2005 2010 2015 2019 2020
from which:
1072.0 797.7 561.8 527.7 435.9 466.2 450.1 418.8 Gastric and duodenal ulcer
1129.8 742.3 477.5 477.6 461.2 539.0 563.2 526.1 Disorders of gallbladder, biliary tract

1965.1 961.5 723.5 941.2 1462.4 2082.9 2362.7 2347.9
connective tissue
from which:
glomerular diseases, renal tubulo-interstitial

- - - 269.5 339.1 389.8 376.9 364.4
diseases, other disorders of kidney and ureter
252.1 181.5 208.9 323.9 432.7 545.9 632.2 594.2 Urolithiasis

Pregnancy, childbirth and the puerperium and
2520.9 1273.5 1530.0 2043.4 1947.9 2753.7 2140.3 2414.4
other obstretic conditions*

57.6 47.3 42.7 77.3 95.1 96.7 96.5 79.3

11.6 79.4 20.5 43.1 146.1 227.0 268.5 257.9

4945.1 3064.6 1688.5 1495.4 1678.0 1950.8 2130.4 1724.3
49
NHIAC
(0-14 years old)
Table 2.1.4
Diseases ICD X *
1990 1995 2000 2005 2010 2015 2019 2020
TOTAL A00-T98 850249 463694 317721 264191 364396 352279 361636 312653
including:
from which:
Covid- 19 U07.1,U07.2 - - - - - - - 2928
Neoplasms C00-D48 528 372 408 364 624 917 1133 1223

forming organs and certain disorders D50-D89 7263 5552 6836 6710 8123 9323 9164 8303

diseases
E00-E90 60033 24506 9136 5440 5548 4840 5395 5946
from which:
Diseases of the circulatory system I00-I99 6767 3040 1765 1136 1303 845 982 811
from which:
Hypertensive diseases I10-I15

28 5 11 49 56 63 71 52
*The data are presented according to ICD IX before 2003 inclusive
50
NHIAC
(0-14 years old)
Table 2.1.4
Registered diseases (per 100 000 population)
Diseases
1990 1995 2000 2005 2010 2015 2019 2020
78530.4 43138.3 35420.4 38840.2 61335.8 60146.7 60292.8 52195.8 TOTAL
including:
including:
- - - - - - - 488.8 Covid -19
48.8 34.6 45.5 53.5 105.0 156.6 188.9 204.2 Neoplasms
Diseases of the blood and blood-forming organs and certain

670.8 516.5 762.1 986.5 1367.3 1591.8 1527.8 1386.1
disorders involving the immune mechanism
5544.7 2279.8 1018.5 799.8 933.8 826.4 899.5 992.7 Endocrine, nutritional and metabolic diseases
from which:
625.0 282.8 196.8 167.0 219.3 144.3 163.7 135.4 Diseases of the circulatory system
from which:
51
(0-14 years old)
continutation 2.1.4
Diseases ICD X
1990 1995 2000 2005 2010 2015 2019 2020
Diseases of the skin and subcutaneous tissue L00-L99 30549 25609 11073 8742 16845 20177 22575 19994

M00-M99 12945 4431 2258 2157 2610 3803 4372 4401
connective tissue
from which:
glomerular diseases, renal tubulo-

N00-N16
N25-N28
kidney and ureter

Q00-Q99 6230 4523 3760 2922 4188 4447 4205 4338
O00-
Complications of labour and delivery O75.O81- - - - - - - - -
O99

P00-P96 - 2927 3562 3618 3279 2569 2243 2536
perinatal period

R00-R99 - 1098 1521 1094 1919 3647 3764 3252

S00-T98 62836 37616 23122 12687 13212 13306 11770 10434
52
NHIAC
(0-14 years old)
continutation 2.1.4
1990 1995 2000 2005 2010 2015 2019 2020
1195.6 412.2 251.7 317.1 439.3 649.3 728.9 734.7 Diseases of the musculoskeletal system and connective tissue
from which:
glomerular diseases, renal tubulo-interstitial diseases, other

- - - 244.5 266.8 344.2 294.1 254.3
disorders of kidney and ureter
Congenital malformations, deformations and chromosomal

575.4 420.8 419.2 429.5 704.9 759.3 701.1 724.2
abnormalities
- - - - - - - - Complications of labour and delivery
- 272.3 397.1 531.9 551.9 438.6 374.0 423.4 Certain conditions originating in the perinatal period
Symptoms, signs and abnormal clinical and laboratory findings,

- 102.1 169.6 160.8 323.0 622.7 627.5 542.9
not elsewhere classified
Injury, poisoning and certain other consequences of external

5803.6 3499.5 2577.7 1865.2 2223.9 2271.8 1962.3 1741.9 causes
53
INCIDENCE OF DISEASES BY REGIONS

(18 years and above) 2020
Table 2.2.1
Yerevan Aragatsotn Ararat Armavir Gegharkunik Lori
ICD X a.v. r.v.* a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
TOTAL A00-
251574 30011.1 33279 35762.0 64282 33282.8 61731 30691.8 48475 28190.0 64328 40312.3
T98
including:
Certain infectious and parasitic A00-
84791 10115.0 5275 5668.6 11195 5796.3 11012 5475,0 8793 5113.5 10709 6711.0
diseases B99
U07.1.
from which: Covid -19 68245 8141.2 4512 4848.6 9386 4859.7 9362 4654.7 7298 4244.1 8173 5121.8
U07.2
Neoplasms
C00-
4117 491.1 232 249.3 527 272.9 856 425.6 402 233.8 728 456.2
D48

forming organs and certain D50-
disorders involving the immune D89 1055 125.9 310 333.1 984 509.5 495 246.1 370 215.2 649 406.7
mechanism

E00-
metabolic diseases 5565 663.9 901 968.2 1472 762.1 1715 852.7 790 459.4 1464 917.4
E90
Mental and behavioral disorders F00-

F99 1956 233.3 108 116.1 199 103.0 795 395.3 212 123.3 254 159.2
Diseases of nervous system G00-

5782 689.8 1006 1081.1 1960 1014.8 2371 1178.8 2425 1410.2 2043 1280.3
G99
from which:
Parkinson disease G20-
48 5.7 8 8.6 20 10.4 44 21.9 5 2.9 9 5.6
G21
Alzheimer disease G30 21 2.5 3 3.2 6 3.1 21 10.4 2 1.2 1 0.6
Epilepsy, status epilepticus G40-

90 10.7 17 18.3 23 11.9 66 32.8 41 23.8 32 20.1
G41
Diseases of the eye and adnexa H00-
10190 1215.6 1773 1905.3 3390 1755.2 2469 1227.6 3323 1932.4 3878 2430.2
H59
from which:
Glaucoma H40 545 65.0 63 67.7 86 44.5 187 93.0 104 60.5 130 81.5
Diseases of the ear and mastoid H60-
7176 856.0 857 920.9 1896 981.7 1515 753.2 831 483.3 4667 2924.7
process H95
Diseases of the circulatory system I00-
I99 12081 1441.2 3620 3890.1 3453 1787.8 4989 2480.5 2967 1725.4 4093 2565.0
Diseases of the respiratory system J00-

57424 6850.3 9841 10575.2 23381 12105.8 13719 6820.9 16626 9668.6 16764 10505.5
J99
from which:
J40-
Diseases of the respiratory system 1737 207.2 861 925.2 753 389.9 732 363.9 513 298.3 883 553.3
J42
Emphysema J43 51 6.1 46 49.4 26 13.5 23 11.4 43 25.0 37 23.2
* per 100 000 population
54
NHIAC

continutation
Vayots
Kotayk Shirak Syunik Tavush Total
Dzor
Diseases
67761 36052.7 69477 40031.9 30932 28750.2 12894 34575.8 28016 30157.8 732749 32474.0 TOTAL
including:
14499 7714.3 14134 8143.9 11778 10947.2 3861 10353.4 8286 8919.5 184333 8169.3 Certain infectious and parasitic diseases
12856 6840.1 10600 6107.6 9389 8726.7 3615 9693.8 7365 7928.1 150801 6683.2 from which: Covid -19
1524 810.9 980 564.7 219 203.6 122 327.1 278 299.3 9985 442.5 Neoplasms

forming organs and certain
389 207.0 327 188.4 297 276.1 76 203.8 325 349.8 5277 233.9
disorders involving the immune
mechanism
1391 740.1 1421 818.8 538 500.1 204 547.0 678 729.8 16139 715.2 metabolic diseases
483 257.0 829 477.7 184 171.0 24 64.4 120 129.2 5164 228.9 Mental and behavioral disorders
997 530.5 2433 1401.9 822 764.0 347 930.5 1084 1166.9 21270 942.6 Diseases of nervous system
from which:
10 5.3 9 5.2 12 11.2 1 2.7 16 17.2 182 8.1 Parkinson disease
10 5.3 2 1.2 11 10.2 2 5.4 8 8.6 87 3.9 Alzheimer disease
29 15.4 26 15.0 34 31.6 8 21.5 13 14.0 379 16.8
Epilepsy, status epilepticus
3834 2039.9 3826 2204.5 792 736.1 825 2212.3 1476 1588.8 35776 1585.5 Diseases of the eye and adnexa
from which:
187 99.5 137 78.9 63 58.6 79 211.8 65 70.0 1646 72.9 Glaucoma
1004 534.2 2053 1182.9 359 333.7 246 659.7 724 779.3 21328 945.2
process
3214 1710.0 5905 3402.4 1406 1306.8 1507 4041.1 1859 2001.1 45094 1998.5 Diseases of the circulatory system
22655 12053.7 20030 11541.1 7767 7219.1 2862 7674.6 6824 7345.7 197893 8770.2 Diseases of the respiratory system
from which:
Bronchitis, not specified as acute or
567 301.7 747 430.4 217 201.7 186 498.8 252 271.3 7448 330.1 chronic Simple and mucopurulent
chronic bronchitis
36 19.2 70 40.3 11 10.2 8 21.5 27 29.1 378 16.8 Emphysema
55
continutation 2.2.1
ICD X
J45-
Asthma, status asthmaticus 46
92 11.0 38 40.8 45 23.3 52 25.9 102 59.3 96 60.2
K00-
Diseases of the digestive system K93
5736 684.3 1744 1874.1 3215 1664.6 3701 1840.1 2659 1546.3 3769 2361.9
from which:
Gastric ulcer K25 184 21.9 80 86.0 116 60.1 86 42.8 131 76.2 127 79.6
Duodenal ulcer K26 206 24.6 83 89.2 160 82.8 154 76.6 108 62.8 133 83.3
K80-
Disorders of gallbladder, biliary tract K83
1331 158.8 274 294.4 429 222.1 848 421.6 418 243.1 460 288.3
Diseases of the skin and subcutaneous L00-

10220 1219.2 3026 3251.8 3194 1653.7 2114 1051.1 1628 946.7 4324 2709.7
tissue, L99
Diseases of the musculoskeletal system M00-
6781 808.9 1080 1160.6 2729 1413.0 2714 1349.4 1233 717.0 3020 1892.5
and connective tissue M99
N00-
Diseases of the genitourinary system N99
17009 2029.1 1830 1966.5 4221 2185.5 5274 2622.2 2858 1662.0 3861 2419.6
from which:
N17-
Renal failure N19
96 11.5 57 61.3 49 25.4 50 24.9 25 14.5 41 25.7
Pregnancy, childbirth and the O00-

O75.
puerperium and other obstretic O81-
8339 3252.4 79 272.2 98 161.2 2724 4285.2 1019 1896.2 748 1535.6
conditions O99
Congenital malformations, deformations Q00-

297 35.4 0 0.0 13 6.7 28 13.9 8 4.7 8 5.0
and chromosomal abnormalities Q99
from which:
Congenital malformations o the Q20-
189 22.5 0 0.0 0 0.0 17 8.5 4 2.3 0 0.0
circulatory system Q28

R00-
and laboratory findings, not elsewhere R99
528 63.0 154 165.5 184 95.3 725 360.5 145 84.3 856 536.4
classified
Injury, poisoning and certain other S00-

12527 1494.4 1443 1550.7 2171 1124.1 4515 2244.8 2186 1271.2 2493 1562.3
consequences of external causes T98
56
NHIAC
continutation
Kotayk Shirak Syunik Vayots Dzor Tavush Total
36 19.2 117 67.4 27 25.1 18 48.3 59 63.5 682 30.2 Asthma, status asthmaticus
2434 1295.0 2604 1500.4 1214 1128.4 673 1804.7 1356 1459.7 29105 1289.9 Diseases of the digestive system
from which:
122 64.9 86 49.6 77 71.6 26 69.7 48 51.7 1083 48.0 Gastric ulcer
127 67.6 81 46.7 82 76.2 39 104.6 44 47.4 1217 53.9 Duodenal ulcer
278 147.9 552 318.1 152 141.3 105 281.6 207 222.8 5054 224.0 Disorders of gallbladder, biliary tract

2728 1451.4 3080 1774.7 1272 1182.3 431 1155.7 1139 1226.1 33156 1469.4
tissue,
1868 993.9 2556 1472.7 609 566.0 435 1166.5 874 940.8 23899 1059.2
5588 2973.1 4475 2578.4 1543 1434.2 820 2198.9 1381 1486.6 48860 2165.4 Diseases of the genitourinary system
from which:
44 23.4 92 53.0 25 23.2 13 34.9 30 32.3 522 23.1 Renal failure
492 835.6 504 922.5 194 614.6 108 971.6 231 842.4 14536 2089.0 puerperium and other obstretic
conditions
24 12.8 12 6.9 8 7.4 4 10.7 8 8.6 410 18.2
from which:
Congenital malformations o the
15 8.0 6 3.5 2 1.9 2 5.4 0 0.0 235 10.4
circulatory system

455 242.1 308 177.5 32 29.7 8 21.5 241 259.4 3636 161.1 and laboratory findings, not elsewhere
classified

4182 2225.1 4000 2304.8 1898 1764.1 341 914.4 1132 1218.5 36888 1634.8
57

(15-17 years old) 2020
Table 2.2.2
ICD
X a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
A00-
TOTAL 11263 32969.4 3341 68971.9 6224 65241.1 3752 37815.0 4527 50005.5 5335 62823.8
T98
including:
Certain infectious and A00-
1175 3439.5 214 4417.8 291 3050.3 256 2580.1 399 4407.4 340 4003.8
parasitic diseases B99
from which: Covid -19 451 1320.2 37 763.8 24 251.6 65 655.1 59 651.7 30 353.3
C00-
Neoplasms 63 184.4 1 20.6 4 41.9 6 60.5 3 33.1 4 47.1
D48
Diseases of the
blood and blood-
forming organs
and certain
D50- 50 146.4 59 1218.0 104 1090.1 61 614.8 45 497.1 106 1248.2
disorders D89
involving the
immune
mechanism
Endocrine,
nutritional and E00-
372 1088.9 41 846.4 66 691.8 155 1562.2 25 276.2 105 1236.5
E90
metabolic diseases
Diseases of nervous F00-

85 248.8 5 103.2 4 41.9 30 302.4 4 44.2 38 447.5
system F99
Diseases of nervous G00-
279 816.7 39 805.1 93 974.8 132 1330.4 46 508.1 103 1212.9
system G99
from which:
Epilepsy, status
G40-
epilepticus 14 41.0 4 82.6 0 0.0 19 191.5 4 44.2 1 11.8
G41
Cerebral palsy G80 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Diseases of the eye H00-

755 2210.1 235 4851.4 408 4276.7 294 2963.1 336 3711.5 349 4109.8
and adnexa H59
Diseases of the ear H60

and mastoid - 328 960.1 143 2952.1 290 3039.8 109 1098.6 134 1480.2 403 4745.6
H95
process
Diseases of the I00-
103 301.5 4 82.6 18 188.7 47 473.7 28 309.3 66 777.2
circulatory system I99
Diseases of the J00-

4782 13998.0 1401 28922.4 3074 32222.2 1256 12658.7 2371 26190.2 2021 23798.9
respiratory system J99
58
NHIAC
(15-17 years old) 2020
continutation
5578 57410.5 7387 85349.5 2512 49361.4 1318 76097.0 2895 59851.1 54132 51047.7 TOTAL
including:
108 1111.6 22 254.2 55 1080.8 26 1501.2 24 496.2 900 848.7 from which: Covid -19
30 308.8 4 46.2 1 19.7 1 57.7 4 82.7 121 114.1 Neoplasms

32 329.4 98 1132.3 31 609.2 0 0.0 47 971.7 633 596.9 organs and certain disorders involving the
immune mechanism

76 782.2 70 808.8 24 471.6 0 0.0 40 827.0 974 918.5 diseases
from which:

7 72.0 12 138.6 8 157.2 0 0.0 3 62.0 72 67.9
0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 Cerebral palsy
156 1605.6 281 3246.7 76 1493.4 40 2309.5 56 1157.7 2016 1901.1 Diseases of the ear and mastoid process
59
continutation 2.2.2

ICD X
from which:
Asthma, status J45-
10 29.3 8 165.2 0 0.0 3 30.2 13 143.6 4 47.1
asthmaticus 4646
Diseases of the digestive K00-
235 687.9 381 7865.4 754 7903.6 314 3164.7 458 5059.1 507 5970.3
system K93
Diseases of the skin and L00-

1038 3038.5 214 4417.8 461 4832.3 189 1904.9 157 1734.2 636 7489.4
subcutaneous tissue, L99
Diseases of the
M00-
musculoskeletal system M99
443 1296.8 28 578.0 79 828.1 150 1511.8 60 662.8 88 1036.3
Diseases of the N00-
437 1279.2 186 3839.8 193 2023.1 202 2035.9 169 1866.8 240 2826.2
genitourinary system N99
from which:
N17-
Renal failure N19
1 2.9 0 0.0 0 0.0 0 0.0 2 22.1 0 0.0
Pregnancy, childbirth and O00-

O75.
the puerperium and other O81-
0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
obstretic conditions O99
Congenital
malformations,
Q00-
deformations and Q99
30 87.8 1 20.6 1 10.5 37 372.9 8 88.4 4 47.1
chromosomal
abnormalities
from which:
Congenital malformations Q20-
3 8.8 1 20.6 0 0.0 2 20.2 1 11.0 2 23.6
o the circulatory system Q28
Symptoms, signs and

abnormal clinical and R00-
399 1168.0 9 185.8 46 482.2 37 372.9 76 839.5 56 659.4
laboratory findings, not R99

certain other S00-
689 2016.9 380 7844.8 338 3543.0 477 4807.5 208 2297.6 269 3167.7
consequences of external T98
causes
60
NHIAC
continutation
from which:

568 5846.0 404 4667.8 182 3576.3 30 1732.1 175 3617.9 4054 3823.0
subcutaneous tissue,

158 1626.2 160 1848.6 53 1041.5 26 1501.2 58 1199.1 1303 1228.8
Diseases of the genitourinary

206 2120.2 291 3362.2 70 1375.5 31 1789.8 116 2398.2 2141 2019.0
system
from which:
0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 3 2.8 Renal failure
conditions
41 422.0 10 115.5 4 78.6 0 0.0 3 62.0 139 131.1 deformations and chromosomal
abnormalities
from which:
4 41.2 3 34.7 1 19.7 0 0.0 1 20.7 18 17.0
circulatory system

27 277.9 99 1143.8 22 432.3 0 0.0 0 0.0 771 727.1 clinical and laboratory findings, not
Injury, poisoning and certain

544 5599.0 603 6967.1 158 3104.7 21 1212.5 162 3349.2 3849 3629.7 other consequences of external
causes
61

(0-14 years old) 2020
Table 2.2.3
ICD
X
a.v. r.v.* a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
A00-
TOTAL T98
67290 31231.9 14250 53406.8 31515 58446.6 22288 42173.0 16356 35219.6 27555 61403.9
including:
9026 4189.3 1084 4062.7 1992 3694.3 1868 3534.6 1750 3768.3 2733 6090.3
from which: Covid -19 1707 792.3 80 299.8 115 213.3 99 187.3 190 409.1 72 160.4
C00-
Neoplasms D48
233 108.1 1 3.7 8 14.8 39 73.8 8 17.2 8 17.8
Diseases of the blood

and blood-forming
organs and certain D50- 870 403.8 463 1735.3 526 975.5 527 997.2 319 686.9 537 1196.7
D89
disorders involving the
immune mechanism
Endocrine, nutritional E00-
675 313.3 167 625.9 203 376.5 232 439.0 44 94.7 242 539.3
and metabolic diseases E90
Mental and behavioral F00-

731 339.3 6 22.5 52 96.4 67 126.8 12 25.8 176 392.2
disorders F99
904 419.6 95 356.0 289 536.0 361 683.1 114 245.5 165 367.7
system G99
from which:
Epilepsy, status
G40-
epilepticus 84 39.0 17 63.7 15 27.8 24 45.4 19 40.9 16 35.7
G41
Cerebral palsy G80 41 19.0 13 48.7 7 13.0 12 22.7 4 8.6 4 8.9

Diseases of the eye and H00-
4477 2077.9 594 2226.2 1953 3622.0 1303 2465.5 742 1597.8 1523 3393.9
adnexa H59
Diseases of the ear and H60-

2481 1151.5 607 2274.9 1178 2184.7 878 1661.3 453 975.5 1956 4358.8
mastoid process H95

119 55.2 2 7.5 15 27.8 47 88.9 6 12.9 20 44.6

33964 15764.0 7753 29057.0 18637 34563.5 10749 20339.1 9615 20704.1 13610 30328.7
* per 100 000 residents
62
NHIAC

(0-14 years old), 2020
25336 47467.0 23756 485262.0 8533 35697.0 3280 35299.2 13493 57984.5 253652 42344.7 TOTAL
including:
427 800.0 52 1062.2 105 439.3 42 452.0 39 167.6 2924 488.1 from which:` Covid -19
18 33.7 22 449.4 0 0.0 4 43.0 8 34.4 349 58.3 Neoplasms

369 691.3 395 8068.6 309 1292.7 57 613.4 313 1345.1 4685 782.1
disorders involving the immune
mechanism

213 399.1 149 3043.6 11 46.0 1 10.8 67 287.9 2004 334.5 metabolic diseases
from which:
29 54.3 16 326.8 8 33.5 4 43.0 9 38.7 241 40.2
1 1.9 7 143.0 4 16.7 5 53.8 0 0.0 98 16.4 Cerebral palsy


650 1217.8 1626 33214.2 172 719.5 80 861.0 516 2217.4 10597 1769.1
process
63
continutation 2.2.3
ICD X
from which:
Asthma, status asthmaticus J45-46 73 33.9 7 26.2 7 13.0 9 17.0 9 19.4 14 31.2

1850 858.7 1418 5314.4 2181 4044.8 1370 2592.3 1246 2683.0 1886 4202.8
system K93

4347 2017.6 835 3129.5 2329 4319.3 1479 2798.5 722 1554.7 2717 6054.6
Diseases of the
M00-
musculoskeletal system and M99
831 385.7 66 247.4 144 267.1 302 571.4 81 174.4 147 327.6
connective tissue
Diseases of the N00-
1221 566.7 316 1184.3 723 1340.9 666 1260.2 354 762.3 496 1105.3
genitourinary system N99
from which:
N17-
Renal failure N19
3 1.4 0 0.0 0 0.0 0 0.0 6 12.9 0 0.0
Pregnancy, childbirth and O00-

O75.
the puerperium and other O81-
0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Certain conditions
P00-P-
originating in the perinatal 96
1167 541.6 184 689.6 132 244.8 198 374.7 88 189.5 259 577.2
period
Q00-
497 230.7 19 71.2 72 133.5 218 412.5 38 81.8 72 160.4
from which:
Congenital malformations o Q20-
159 73.8 7 26.2 38 70.5 52 98.4 20 43.1 41 91.4
the circulatory system Q28
Symptoms, signs and

1524 707.3 23 86.2 190 352.4 289 546.8 227 488.8 193 430.1

S00-
certain other consequences T98
2373 1101.4 617 2312.4 891 1652.4 1695 3207.3 537 1156.3 815 1816.2
of external causes
64
NHIAC
continutation
from which:
1347 2523.6 1556 31784.3 460 1924.4 160 1721.9 895 3846.2 16847 2812.4 Diseases of the skin and subcutaneous tissue,

517 968.6 409 8354.6 39 163.2 19 204.5 140 601.6 2695 449.9
connective tissue
from which:
0 0.0 0 0.0 2 8.4 0 0.0 0 0.0 11 1.8 Renal failure

0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
other obstretic conditions
Certain conditions originating in the perinatal

151 282.9 132 2696.4 26 108.8 8 86.1 49 210.6 2394 399.7
period

70 131.1 75 1532.0 30 125.5 8 86.1 43 184.8 1142 190.6
from which:
Congenital malformations o the circulatory

26 48.7 23 469.8 20 83.7 3 32.3 18 77.4 407 67.9
system

86 161.1 435 8885.7 10 41.8 0 0.0 90 386.8 3067 512.0

1419 2658.5 1351 27596.8 249 1041.7 83 893.2 404 1736.1 10434 1741.9
65
PREVALENCE OF DISEASES BY REGIONS
Table 2.2.4
ICD X
Yerevan Aragatsotn Ararat Armavir Gegharkunik Yerevan
A00-
TOTAL 515873 61540.1 59743 64200.4 119492 61868.4 117137 58238.9 106241 61783.1 118437 74220.7
T98
including:

86394 10306.2 5351 5750.2 11746 6081.6 12103 6017.4 9321 5420.5 10882 6819.4
diseases B99
from which:` Covid -19 68245 8141.2 4512 4848.6 9386 4859.7 9362 4654.7 7298 4244.1 8173 5121.8
C00-
Neoplasms D48
27443 3273.8 1962 2108.4 3743 1938.0 4165 2070.8 2756 1602.7 5019 3145.2

D50- 4454 531.3 488 524.4 1397 723.3 807 401.2 667 387.9 1328 832.2
disorders involving the immune D89
mechanism
E00-
diseases E90
54636 6517.7 5803 6236.0 12206 6319.8 12589 6259.1 8548 4971.0 10758 6741.7
F00-
Mental and behavioral disorders 18540 2211.7 2319 2492.0 4594 2378.6 5708 2837.9 4107 2388.4 4830 3026.8
F99
G00-
Diseases of nervous system 13728 1637.7 2336 2510.3 4056 2100.0 4709 2341.2 7674 4462.7 4201 2632.6
G99
from which:
G20-
Parkinson disease G21
334 39.8 34 36.5 125 64.7 163 81.0 86 50.0 96 60.2
Alzheimer disease G30 78 9.3 6 6.4 43 22.3 66 32.8 15 8.7 20 12.5

1249 149.0 287 308.4 435 225.2 608 302.3 953 554.2 503 315.2
G41
H00-
Diseases of the eye and adnexa H59
33924 4046.9 5177 5563.3 7043 3646.6 4546 2260.2 7758 4511.6 7695 4822.2
from which:
Glaucoma H40 3095 369.2 408 438.4 766 396.6 565 280.9 724 421.0 916 574.0
H60-
Diseases of the ear and mastoid process H95
12148 1449.2 1031 1107.9 2758 1428.0 2185 1086.4 1465 852.0 5894 3693.6
I00-
Diseases of the circulatory system I99
90531 10799.7 10237 11000.8 18737 9701.3 24687 12274.0 21931 12753.7 20228 12676.3
J00-
Diseases of the respiratory system J99
70383 8396.2 11001 11821.8 26769 13860.0 16209 8058.9 20225 11761.6 19362 12133.6
from which:
Bronchitis, not specified as acute or
J40-
chronic Simple and mucopurulent J42
4839 577.3 1315 1413.1 1698 879.2 1682 836.3 1627 946.2 1657 1038.4
chronic bronchitis
Emphysema J43 470 56.1 91 97.8 144 74.6 95 47.2 199 115.7 145 90.9
* per 100 000 residents
66
NHIAC

138984 73947.3 121051 69748.3 62043 57666.7 28562 76590.2 54365 58521.2 1441928 63903.5 TOTAL
including:
12856 6840.1 10600 6107.6 9389 8726.7 3615 9693.8 7365 7928.1 150801 6683.2 from which:` Covid -19
5714 3040.2 5219 3007.1 1730 1608.0 667 1788.6 1800 1937.6 60218 2668.7 Neoplasms
Diseases of the blood and blood-forming organs and certain

986 524.6 620 357.2 525 488.0 261 699.9 598 643.7 12131 537.6
disorders involving the immune mechanism
Endocrine, nutritional and metabolic diseases

12719 6767.2 9688 5582.1 5785 5376.9 2254 6044.2 5382 5793.5 140368 6220.8
from which:
83 44.2 48 27.7 51 47.4 22 59.0 57 61.4 1099 48.7 Parkinson disease
37 19.7 15 8.6 27 25.1 7 18.8 28 30.1 342 15.2 Alzheimer disease

487 259.1 685 394.7 317 294.6 149 399.5 244 262.7 5917 262.2
from which:
1354 720.4 703 405.1 391 363.4 181 485.4 313 336.9 9416 417.3 Glaucoma
2101 1117.9 3018 1738.9 812 754.7 523 1402.4 1015 1092.6 32950 1460.3 Diseases of the ear and mastoid process
from which:
Bronchitis, not specified as acute or chronic Simple and

1413 751.8 1374 791.7 810 752.9 509 1364.9 565 608.2 17489 775.1
mucopurulent chronic bronchitis
177 94.2 161 92.8 127 118.0 31 83.1 64 68.9 1704 75.5 Emphysema
67
continutation 2.2.4
ICD X
Diseases of the digestive system K00-K93 16608 1981.2 3369 3620.4 6275 3249.0 6604 3283.4 6201 3606.1 6325 3963.7
from which:
Gastric ulcer K25 1000 119.3 271 291.2 470 243.3 330 164.1 438 254.7 387 242.5
Duodenal ulcer K26 1201 143.3 257 276.2 605 313.2 558 277.4 432 251.2 448 280.7
Disorders of gallbladder, biliary tract K80-K83 3582 427.3 609 654.4 995 515.2 1633 811.9 1193 693.8 938 587.8
L00-L99 13695 1633.7 3257 3500.0 4220 2185.0 2704 1344.4 2843 1653.3 5584 3499.3
Diseases of the musculoskeletal M00-
16846 2009.6 2507 2694.0 6451 3340.1 4397 2186.1 3360 1954.0 5055 3167.8
system and connective tissue M99
Diseases of the genitourinary system N00-N99 31176 3719.1 3203 3442.0 6933 3589.6 7442 3700.1 5879 3418.9 6829 4279.5
from which:
Renal failure N17-N19 444 53.0 154 165.5 161 83.4 163 81.0 160 93.0 153 95.9

puerperium and other obstretic O75. 10598 4133.5 79 272.2 137 225.4 2879 4529.1 1114 2073.0 1033 2120.7
conditions O81-O99
deformations and chromosomal Q00-Q99 522 62.3 23 24.7 55 28.5 158 78.6 61 35.5 65 40.7
abnormalities
from which:

Q20-Q28 292 34.8 13 14.0 24 12.4 84 41.8 29 16.9 24 15.0
circulatory system
clinical and laboratory findings, not R00-R99 1720 205.2 157 168.7 201 104.1 730 362.9 145 84.3 856 536.4

S00-T98 12527 1494.4 1443 1550.7 2171 1124.1 4515 2244.8 2186 1271.2 2493 1562.3
68
NHIAC
continutation
from which:
564 300.1 246 141.7 314 291.9 207 555.1 180 193.8 4407 195.3 from which:
586 311.8 231 133.1 476 442.4 378 1013.6 195 209.9 5367 237.9 Duodenal ulcer
1034 550.1 993 572.2 444 412.7 284 761.6 484 521.0 12189 540.2 Disorders of gallbladder, biliary tract
4008 2132.5 3961 2282.3 1707 1586.6 757 2029.9 1276 1373.5 44012 1950.5 Diseases of the skin and subcutaneous tissue,

5216 2775.2 4365 2515.1 2020 1877.5 1314 3523.5 1751 1884.9 53282 2361.4
connective tissue
from which:
221 117.6 258 148.7 101 93.9 65 174.3 92 99.0 1972 87.4 from which:

679 1153.2 873 1597.8 216 684.3 113 1016.6 269 981.0 17990 2585.4
other obstretic conditions

171 91.0 72 41.5 81 75.3 15 40.2 35 37.7 1258 55.8
from which:
56 29.8 44 25.4 21 19.5 6 16.1 10 10.8 603 26.7 from which:

560 298.0 360 207.4 54 50.2 8 21.5 241 259.4 5032 223.0

4182 2225.1 4000 2304.8 1898 1764.1 341 914.4 1132 1218.5 36888 1634.8
69

(15-17 years old) 2020
Table 2.2.5
ICD
X
A00-
TOTAL 16738 48996.0 4103 84702.7 7433 77914.0 4970 50090.7 5747 63481.7 7467 87929.8
T98
including:

1184 3465.8 215 4438.5 321 3364.8 267 2691.0 425 4694.6 401 4722.1
from which:` Covid -19 451 1320.2 37 763.8 24 251.6 67 675.3 59 651.7 30 353.3
C00-
Neoplasms 197 576.7 4 82.6 8 83.9 10 100.8 4 44.2 17 200.2
D48
and blood-forming
organs and certain
D50- 339 992.3 68 1403.8 139 1457.0 86 866.8 69 762.2 185 2178.5
disorders involving D89
the immune
mechanism
Endocrine, nutritional
E00-
and metabolic diseases 1086 3179.0 104 2147.0 166 1740.0 278 2801.9 161 1778.4 244 2873.3
E90
Diseases of nervous F00-

205 600.1 16 330.3 53 555.6 77 776.1 118 1303.4 101 1189.4
system F99
675 1975.9 95 1961.2 205 2148.8 266 2680.9 110 1215.1 257 3026.4
system G99
from which:
Epilepsy, status
G40-
epilepticus G41
166 485.9 29 598.7 19 199.2 62 624.9 20 220.9 36 423.9
Cerebral palsy G80 70 204.9 13 268.4 18 188.7 18 181.4 26 287.2 31 365.0

Diseases of the eye H00-
H59
2101 6150.1 530 10941.4 724 7589.1 622 6268.9 622 6870.7 844 9938.8
and adnexa
495 1449.0 198 4087.5 351 3679.2 157 1582.3 174 1922.0 647 7618.9
mastoid process H95

167 488.8 13 268.4 39 408.8 157 1582.3 136 1502.3 162 1907.7

5406 15824.6 1523 31441.0 3270 34276.7 1356 13666.6 2562 28300.0 2262 26636.8
70
NHIAC

(15-17 years old) 2020
7526 77459.9 9658 111588.7 3276 64374.1 1524 87990.8 3466 71656.0 71908 67810.9 TOTAL
including:

301 3098.0 658 7602.5 191 3753.2 120 6928.4 183 3783.3 4266 4022.9
diseases
108 1111.6 22 254.2 55 1080.8 26 1501.2 24 496.2 903 851.5 from which: Covid -19
39 401.4 12 138.6 4 78.6 1 57.7 6 124.0 302 284.8 Neoplasms

50 514.6 127 1467.4 53 1041.5 5 288.7 69 1426.5 1190 1122.2
certain disorders involving

165 1698.2 199 2299.2 61 1198.7 17 981.5 88 1819.3 2569 2422.6
metabolic diseases
from which:
48 494.0 42 485.3 21 412.7 14 808.3 11 227.4 468 441.3

39 401.4 25 288.9 15 294.8 7 404.2 11 227.4 273 257.4 Cerebral palsy

Diseases of the eye and
1407 14481.3 1473 17019.1 398 7820.8 144 8314.1 685 14161.7 9550 9005.9
adnexa
Diseases of the ear and
274 2820.1 412 4760.3 108 2122.2 51 2944.6 84 1736.6 2951 2782.9
mastoid process
Diseases of the circulatory
104 1070.4 70 808.8 32 628.8 0 0.0 31 640.9 911 859.1
system
2490 25627.8 3659 42276.1 1436 28217.7 933 53868.4 1164 24064.5 26061 24576.1
system
71
continutation 2.2.5
ICD X
from which:

428 1252.9 427 8815.0 851 8920.3 363 3658.5 513 5666.6 682 8031.1
system K93

1351 3954.7 258 5326.2 536 5618.4 248 2499.5 212 2341.8 799 9408.9
Diseases of the
M00-
musculoskeletal system and M99
768 2248.1 50 1032.2 120 1257.9 242 2439.0 127 1402.8 160 1884.1
connective tissue
Diseases of the genitourinary N00-
738 2160.3 202 4170.1 247 2589.1 253 2549.9 182 2010.4 334 3933.1
system N99
from which:
N17-
Renal failure N19
1 2.9 0 0.0 0 0.0 1 10.1 2 22.1 0 0.0

O75.
puerperium and other O81-
0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Q00-
234 685.0 11 227.1 14 146.8 73 735.7 48 530.2 47 553.5
from which:
Congenital malformations o Q20-
94 275.2 7 144.5 7 73.4 25 252.0 8 88.4 22 259.1
the circulatory system Q28
Symptoms, signs and

675 1975.9 9 185.8 51 534.6 38 383.0 76 839.5 56 659.4

S00-
other consequences of T98
689 2016.9 380 7844.8 338 3543.0 477 4807.5 208 2297.6 269 3167.7
external causes
72
NHIAC
continutation
from which:
641 6597.4 605 6990.2 265 5207.3 35 2020.8 201 4155.5 5151 4857.5

297 3056.8 225 2599.7 65 1277.3 35 2020.8 97 2005.4 2186 2061.4
from which:
0 0.0 0 0.0 0 0.0 0 0.0 1 20.7 5 4.7 Renal failure
conditions
106 1091.0 35 404.4 40 786.0 0 0.0 7 144.7 615 580.0 deformations and chromosomal
abnormalities
from which:
18 185.3 15 173.3 17 334.1 0 0.0 4 82.7 217 204.6
circulatory system

27 277.9 108 1247.8 22 432.3 0 0.0 0 0.0 1062 1001.5 clinical and laboratory findings, not

544 5599.0 603 6967.1 158 3104.7 21 1212.5 162 3349.2 3849 3629.7
73

(0-14 years old) 2020
Table 2.2.6
ICD Yerevan Aragatsotn Ararat Armavir Gegharkunik Lori
X a.v. r.v.* a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
A00-
TOTAL 90053 41797.1 16287 61041.2 35633 66083.7 26734 50585.6 19630 42269.6 33479 74605.0
T98
including:

9311 4321.6 1091 4088.9 2079 3855.6 2055 3888.4 1926 4147.3 2823 6290.8
diseases B99
from which:` Covid -19 1707 792.3 80 299.8 115 213.3 99 187.3 190 409.1 72 160.4
C00-
Neoplasms D48
857 397.8 9 33.7 42 77.9 64 121.1 23 49.5 51 113.6

certain disorders D50- 2539 1178.4 573 2147.5 780 1446.6 771 1458.9 444 956.1 1030 2295.3
involving the immune D89
mechanism
Endocrine, nutritional and E00-

2389 1108.8 303 1135.6 586 1086.8 523 989.6 240 516.8 533 1187.7
metabolic diseases E90
Mental and behavioral F00-

1407 653.0 37 138.7 221 409.9 164 310.3 113 243.3 448 998.3
disorders F99
G00-
Diseases of nervous system G99
2457 1140.4 365 1368.0 767 1422.5 965 1826.0 424 913.0 611 1361.6
from which:
564 261.8 134 502.2 134 248.5 187 353.8 126 271.3 174 387.7
G41
Cerebral palsy G80 442 205.1 103 386.0 144 267.1 133 251.7 110 236.9 103 229.5
Diseases of the eye and H00-
11223 5209.0 1079 4043.9 2866 5315.2 2124 4019.0 1426 3070.6 2761 6152.6
adnexa H59
3077 1428.2 750 2810.9 1372 2544.5 1033 1954.6 634 1365.2 2760 6150.4
mastoid process H95
Diseases of the circulatory I00-

303 140.6 8 30.0 35 64.9 206 389.8 23 49.5 59 131.5
system I99
Diseases of the respiratory J00-

37469 17390.8 8167 30608.7 19396 35971.1 11505 21769.6 10329 22241.6 14682 32717.5
system J99
74
NHIAC
(0-14 years old) 2020

31801 59579.2 28708 58641.6 10641 44515.6 4209 45297.0 15478 66514.8 312653 52194.3 TOTAL
including:
2900 5433.2 2130 4350.9 795 3325.8 574 6177.4 1490 6403.1 27174 4536.4
parasitic diseases
427 800.0 52 106.2 105 439.3 42 452.0 39 167.6 2928 488.8 from which:` Covid- 19
63 118.0 71 145.0 12 50.2 12 129.1 19 81.7 1223 204.2 Neoplasms

and blood-forming
organs and certain
715 1339.6 561 1146.0 411 1719.4 86 925.5 393 1688.9 8303 1386.1
disorders involving
the immune
mechanism
Endocrine, nutritional
536 1004.2 551 1125.5 61 255.2 22 236.8 202 868.1 5946 992.6 and metabolic diseases
Mental and behavioral

66 123.7 458 935.6 31 129.7 23 247.5 58 249.2 3026 505.2
disorders
Diseases of nervous
720 1348.9 544 1111.2 230 962.2 118 1269.9 249 1070.0 7450 1243.7
system
from which:
Epilepsy, status
194 363.5 111 226.7 87 364.0 33 355.1 63 270.7 1807 301.7 epilepticus
141 264.2 120 245.1 55 230.1 20 215.2 47 202.0 1418 236.7 Cerebral palsy
Diseases of the eye
4412 8265.9 3094 6320.1 1131 4731.4 211 2270.8 1490 6403.1 31817 5311.5
and adnexa
Diseases of the ear and
999 1871.6 1850 3779.0 238 995.6 133 1431.3 607 2608.5 13453 2245.8
mastoid process
Diseases of the
58 108.7 68 138.9 35 146.4 0 0.0 16 68.8 811 135.4
circulatory system
Diseases of the
14035 26294.6 12579 25695.0 5826 24372.5 2281 24548.0 7139 30679.0 143408 23940.6
respiratory system
75
continutation 2.2.6
ICD X
from which:
K00-
Diseases of the digestive system K93
2542 1179.8 1523 5708.0 2387 4426.8 1501 2840.2 1469 3163.2 2043 4552.6

5400 2506.3 919 3444.3 2489 4616.0 1708 3231.8 974 2097.3 3130 6974.9
Diseases of the musculoskeletal M00-

1761 817.3 110 412.3 231 428.4 445 842.0 157 338.1 292 650.7
system and connective tissue M99
Diseases of the genitourinary N00-

2174 1009.0 424 1589.1 878 1628.3 843 1595.1 434 934.5 639 1424.0
system N99
from which:
N17-
Renal failure N19
7 3.2 2 7.5 4 7.4 2 3.8 17 36.6 4 8.9

O75.
puerperium and other obstretic O81-
0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
conditions O99
Certain conditions originating P00-
1174 544.9 185 693.4 155 287.5 199 376.5 112 241.2 295 657.4
in the perinatal period P-96
Q00-
deformations and chromosomal Q99
1941 900.9 104 389.8 268 497.0 636 1203.4 134 288.5 314 699.7
abnormalities
from which:
Congenital malformations o the Q20-
972 451.1 51 191.1 143 265.2 302 571.4 74 159.3 185 412.3
circulatory system Q28

R00-
clinical and laboratory findings, R99
1656 768.6 23 86.2 190 352.4 297 562.0 231 497.4 193 430.1

S00-
other consequences of external T98
2373 1101.4 617 2312.4 891 1652.4 1695 3207.3 537 1156.3 815 1816.2
causes
76
NHIAC
continutation
Vayots
Kotayk Shirak Syunik Tavush Total
Dzor
from which:
1654 3098.8 1923 3928.1 618 2585.3 199 2141.6 980 4211.4 19994 3337.8
tissue,

654 1225.3 494 1009.1 52 217.5 31 333.6 174 747.7 4401 734.7
from which:
2 3.7 0 0.0 3 12.6 1 10.8 0 0.0 42 7.0 Renal failure

conditions
194 363.5 137 279.8 26 108.8 10 107.6 49 210.6 2536 423.4
perinatal period

402 753.1 200 408.5 170 711.2 19 204.5 150 644.6 4338 724.2
from which:

177 331.6 101 206.3 67 280.3 6 64.6 79 339.5 2157 360.1
circulatory system

124 232.3 437 892.7 11 46.0 0 0.0 90 386.8 3252 542.9 and laboratory findings, not elsewhere
classified

1419 2658.5 1351 2759.7 249 1041.7 83 893.2 404 1736.1 10434 1741.9
77
PREVALENCE OF DISEASES IN CHILDREN AGED 0-14 YEARS
BY SPECIFIC DISEASES
Table 2.2.7
1990 1995 2000 2005 2010 2015 2019 2020
Diseases
a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
Number of patients under dispensary control diagnosed for the first time in life
Mental disorders 1923 177.6 214 19.9 225 25.1 83 12.2 305 51.3 103 17.6 133 22.2 152 25.4
Malignant neoplasms 102 9.4 81 7.5 96 10.7 67 9.9 58 9.8 57 9.7 77 12.8 60 10.0
Active tuberculosis 52 4.8 97 9.0 62 6.9 107 15.7 61 10.3 27 4.6 36 6.0 23 3.8
Syphilis 1 0.09 8 0.74 6 0.7 - - - - - - 1 0.2 7 1.2
Number of dispensary follow up patients at the end of the year
Malignant
285 26.3 190 17.9 405 46.4 256 38.5 143 24.1 193 32.8 209 34.9 338 56.5
neoplasms
Active
225 20.8 279 26.2 343 39.3 258 38.8 105 17.7 143 24.3 124 20.7 127 21.2
tuberculosis
r.v. – per 100 000 0-14 y, o children
78
NHIAC
PREVALENCE OF DISEASES IN CHILDREN AGED 15-17 YEARS
BY SPECIFIC DISEASES
Table 2.2.8
1990 1995 2000 2005 2010 2015* 2019 2020
Diseases
Malignant neoplasms 8 5.5 23 18.2 26 21.1 56 29.5 20 13.0 17 16.1 19 18.6 9 8.5
Active tuberculosis 5 3.4 10 7.9 4 3.2 - - - - - - 1 1.0 - -
Syphilis 28 19.2 65 51.5 16 13.0 5 2.6 6 3.9 - - - - - -
Number of
dispensary follow
Missing data 30 15.8 21 13.6 15 14.2 12 11.8 10 9.4
up patients at the
end of the year
Mental disorders
Malignant
1058 727.2 594 470.5 588 490.6 405 211.7 1061 717.4 306 296.2 367 354.2 151 139.2
neoplasms
Active tuberculosis 30 20.6 34 26.9 38 31.7 125 65.3 65 43.9 141 136.5 72 69.5 130 119.8
Mental disorders Missing data 118 61.7 68 46.0 52 50.3 65 62.7 113 104.1
r.v. – per 100 000 15-17 y, o
79
INCIDENCE OF WOMEN’S DISEASES BY SPECIFIC DISEASES
Table 2.2.9
Female (absolute value)
Diseases
ICD X 1990 1995 2000 2005 2010 2015 2019 2020
Malignant neoplasms 2516 2175 2599 3069 3687 4081 4072 3588
Including `
Breast C50 663 619 686 927 982 1093 1324 1116
Uterine neck C53 262 192 238 207 278 257 274 206
Uterine body C54 82 74 102 162 191 260 248 173
Ovary C56 145 109 148 181 184 201 188 192
Active tuberculosis A15-A19 126 268 224 384 397 225 129 104
Alcoholism and alcoholic psychosis F10 10 - - 3 7 4 4 4
Syphilis A50-A53 54 251 139 43 41 17 31 41
Salpingitis and oophoritis N70 4689 2868 3044 2858 4912 5116 4654 4261
Erosion and ectropion of cervix uteri N86 4664 3055 2148 2735 4293 4696 5006 4538
Endometriosis N80 146 96 161 296 482 540 827 685
Absent, scanty and rare menstruation, Pain
and other conditions associated with female N91- N94 1825 1301 1612 2163 4822 5369 6049 5346
genital organs and menstrual cycle*
Menopausal and other perimenopausal
N95 1014 448 877 1203 3179 4013 4352 3909
disorders
Female infertility* N97 799 565 943 607 1682 1285 1325 1225
Ectopic pregnancy, Other complications of
labour and delivery, not elsewhere classified,
Single delivery by forceps and vacuum O00-O75.
17332 9592 13307 15222 13254 16615 12708 14536
extractor, Other maternal diseases O81-O99
classifiable elsewhere but complicating
pregnancy, childbirth and the puerperium *
INCIDENCE OF WOMEN’S DISEASES BY SPECIFIC DISEASES

Table 2.2.10
Female (relative value)**
Diseases
1990 1995 2000 2005 2010 2015 2019 2020
Malignant neoplasms 137.8 112.1 133.0 184.3 219.9 259.9 260.5 229.4
Including `
Breast 36.3 31.9 35.1 55.7 58.6 69.6 84.7 71.4
Uterine neck 14.3 9.8 12.2 12.4 16.6 16.4 17.5 13.2
Uterine body 4.4 3.8 5.2 9.7 11.4 16.6 15.9 11.1
Ovary 7.9 5.6 7.6 10.9 11.0 12.8 12.0 12.3
Active tuberculosis 6.9 13.8 11.5 23.1 23.7 14.3 8.3 6.7
Alcoholism and alcoholic psychosis 0.5 - - 0.2 0.4 0.3 0.3 0.3
Syphilis 2.9 12.9 7.1 2.6 2.4 1.1 2.0 2.6
Salpingitis and oophoritis 256.8 147.8 155.8 171.6 293.0 325.8 297.7 272.5
Erosion and ectropion of cervix uteri 255.5 157.4 109.9 164.2 256.1 299.0 320.3 290.2
Endometriosis 7.9 4.9 8.2 17.8 28.8 34.4 52.9 43.8
Absent, scanty and rare menstruation, Pain and other
conditions associated with female genital organs and 200.7 128.9 149.1 235.2 530.2 686.9 809.2 717.5
menstrual cycle*
Menopausal and other perimenopausal disorders 55.6 23.1 44.9 72.2 189.6 255.5 278.4 250.0
Female infertility* 87.8 56.0 87.2 66.0 185.0 164.4 177.3 164.4
Ectopic pregnancy, Other complications of labour and
delivery, not elsewhere classified, Single delivery by
forceps and vacuum extractor, Other maternal diseases 1906.7 951.0 1230.9 1654.9 1457.4 2125.8 1700.1 1950.9
classifiable elsewhere but complicating pregnancy,
childbirth and the puerperium *
* * The indicators are calculated from the number of fertile age women
** r.v.– per 100000 women
80
NHIAC
PREVALENCE OF MENTAL/PSYCHIC DISORDERS

(excluding alcoholic pshychosis, alcoholism, narcomania and toxicomania)
Table 2.3. 1
1990 1995 2000 2005 2010 2015 2019 2020
Diseases
a.v. r.v.* a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
Total incidence of
mental/psychic 3118 87.6 1244 33.1 1285 33.8 2501 77.7 3548 109.0 1961 65.3 2188 73.9 1959 66.1
disorders
including ՝
Total number of
patients on dispensary 1169 32.8 887 23.6 1170 30.8 2042 63.4 2722 83.6 1926 64.1 2353 79.4 2349 79.3
follow-up
Total number of patients
on consultative follow- 1949 54.8 357 9.5 115 3.0 459 14.3 826 25.4 941 31.3 1340 45.2 8042 271.6
up
Total number of
registered patients at the 37116 1043.1 35280 936.7 32717 860.4 38004 1180.5 46157 1414.7 51167 1706.4 57164 1931.4 58461 1972.8
end of the year
including:
Total number of
patients on dispensary
28878 811.6 31789 844.0 28181 7414.1 34157 1061.0 40093 1228.9 22489 750.0 25162 850.2 25985 876.9
control at the end of
the year
Total number of patients
on consultative control 8238 231.5 3491 92.7 4536 119.3 3847 119.5 6064 185.9 7181 239.5 7428 251.0 14260 481.2
at the end of the year
REGISTERED NUMBER OF PATIENTS WITH MENTAL/PSYCHIC DISORDERS

AT THE END OF THE YEAR BY AGE GROUP
Table 2.3.2
2012 2013 2015 2016 2017 2019 2020
TOTAL 45239 46048 51167 52129 54025 57164 58461
including:
0-14 y.o. 1360 1054 979 993 889 768 962
15-17 y.o. 580 813 654 550 546 540 384
81
INCIDENCE OF MENTAL/PSYCHIC DISORDERS BY AGE GROUP, 2019
Table 2.3.3
Diseases ICD X Total 0-14 15-17 18-19 20-39 40-64 65 և >
FOO-
Mental and behavioral disorders` Total 2188 133 92 472 794 453 244
F99
including:
FOO-
Organic, including symptomatic, mental disroders 462 9 4 53 104 121 171
F09
Mental and behavioural disorders due to F1O-
125 1 53 65 6
pshychoactive substance use F19
F2O-
Schizophrenia, schizotypal and delusional disorders 347 3 13 180 133 18
F29
F3O-
Mood disorders 108 2 13 38 49 6
F39
F4O-
Neurotic, stress-relaties and somatoform disorders 202 1 6 66 89 36 4
F48
Behavioural syndromes associated with F5O-
17 2 1 14
physiological disturbance and phsyical factors F59
F6O-
Disorders of adult personality and behaviour 135 1 23 65 21 25
F69
F7O-
Mental retardation 673 71 69 263 245 25
F79
F8O-
Disorders and pshychological development 52 45 2 4 1
F89
Behavioural and emotional disorders with onset F9O-
67 7 5 36 17 2
usually occurring in childhood and adolescence F98
NUMBER OF INTENTIONAL SUICIDES BY AGE GROUP, 2019
Table 2.3.4
TOTAL 0-4 5-14 15-19 20-29 30-39 40-49 50-59 60-69 70 և >
Male 43 1 2 5 7 7 3 18
Female 6 1 1 1 1 2
NUMBER OF DIAGNOSED PATIENTS WITH MENTAL/ PSYCHIC DISORDERS

ON FOLLOW-UP DURING,2019
Suicide attempts - 48
of which suicidal deaths -16
82
NHIAC
INCIDENCE OF MENTAL/PSYCHIC DISORDERS BY AGE GROUP, 2020
Table 2.3.5
Diseases ICD X Total 0-14 15-17 18-19 20-39 40-64 65 և >
FOO-
Mental and behavioral disorders` Total 1959 152 96 321 633 520 237
F99
including:
FOO-
Organic, including symptomatic, mental disroders 398 6 3 41 87 101 160
F09
Mental and behavioural disorders due to F1O-
110 39 64 7
pshychoactive substance use F19
F2O-
Schizophrenia, schizotypal and delusional disorders 379 3 17 200 140 19
F29
F3O-
Mood disorders 105 4 4 8 30 51 8
F39
F4O-
Neurotic, stress-relaties and somatoform disorders 264 5 8 44 79 114 14
F48
Behavioural syndromes associated with F5O-
23 2 4 3 6 8
physiological disturbance and phsyical factors F59
F6O-
Disorders of adult personality and behaviour 165 42 78 24 21
F69
F7O-
Mental retardation 368 80 45 130 94 19
F79
F8O-
Disorders and pshychological development 83 45 24 6 8
F89
Behavioural and emotional disorders with onset F9O-
64 10 5 33 15 1
usually occurring in childhood and adolescence F98
NUMBER OF INTENTIONAL SUICIDES BY AGE GROUP, 2020
Table 2.3.6
TOTAL 0-4 5-14 15-19 20-29 30-39 40-49 50-59 60-69 70 և >
Male 34 4 4 4 7 5 10
Female 7 2 1 3 1
NUMBER OF DIAGNOSED PATIENTS WITH MENTAL/ PSYCHIC DISORDERS

ON FOLLOW-UP DURING, 2019
Suicide attempts - 34
of which suicidal death -20
83
PREVALENCE OF ALCOHOLIC PSYCHOSIS, ALCOHOLISM,
NARCOMANIA AND TOXICOMANIA
Table 2.4.1
1990 1995 2000 2005 2010 2015* 2019 2020
Diseases
Total 461 13.0 498 13.3 262 6.9 473 14.7 616 18.9 958 31.9 830 28.0 643 21.7
Including diagnosed with:
Alcoholic psychosis 29 0.8 49 1.3 52 1.37 62 1.9 39 1.2 25 0.8 30 1.0 18 0.6
Chronic alcoholism 402 11.3 401 10.7 195 5.1 354 11.0 328 10.1 354 11.8 285 9.6 220 7.4
Narcomania 77 2.1 41 1.1 8 0.21 53 1.6 235 7.2 579 19.3 486 16.4 387 13.1
Toxicomania 3 0.08 7 0.19 7 0.18 4 0.12 14 0.43 - - 26 0.9 18 0.6
Behavioral disorders
caused by drugs and
psychotropic
- - - - - - - - - - - - 3 0.1 - -
substances not
included in the
lists,**
*Individuals, previously detected by preventive surveillance due to substance abuse are included in the census of patients since 2012,
**- The data are calculated from 2012
r,v – per 100 000 population
a.v. - absolute value
INCIDENCE OF ALCOHOLIC PSYCHOSIS, ALCOHOLISM, NARCOMANIA

AND TOXICOMANIA BY SEX AND AGE GROUP, 2020
Table 2.4.2
Diseases TOTAL 0-14 15 16-17 18 19-27 28-49 50-64 65 և >
Male
Mental and behavioral disorders due to use of
234 6 120 92 16
alcohol
Including alcoholic psychosis 17 8 7 2
377 5 1 110 199 56 6
drug
18 6 12
psychotropic substances
Mental and behavioral disorders caused by
drugs and psychotropic substances not
included in the lists
Total 629 5 1 122 331 148 22
Female
4 3 1
alcohol
Including alcoholic psychosis 1 1
10 8 1 1
drug
psychotropic substances
Mental and behavioral disorders caused by
drugs and psychotropic substances not
included in the lists
Total 14 11 2 1
84
NHIAC
NUMBER OF ALCOHOLIC PSYCHOSIS, ALCOHOLISM, NARCOMANIA
AND TOXICOMANIA PATIENTS UNDER DISPENSARY
CONTROLAT THE END OF THE YEAR, 2020
Table 2.5.1
Diseases TOTAL 0-14 15 16-17 18 19-27 28-49 50-64 65 և >
Male
Mental and behavioral disorders due
6100 297 3057 2281 465
to use of an alcohol
including:Alcoholic psychosis 511 12 229 211 59
7251 1 5 6 1438 4152 1480 169
to use of drug
157 33 88 31 5
to use of psychotropic substances
Mental and behavioral disorders
caused by drugs and psychotropic 12 2 10
substances not included in the lists,
Total 13520 1 5 6 1770 7307 3792 639
Female
106 5 46 43 12
to use of an alcohol
including:Alcoholic psychosis 13 8 4 1
141 40 78 20 3
to use of drug
18 3 10 3 2
to use of psychotropic substances
Mental and behavioral disorders
caused by drugs and psychotropic 1 1
substances not included in the lists,
Total 266 49 134 66 17
85
NUMBER OF NARCOLOGICAL PATIENTS UNDER THE

DISPENSARY CONTROL AT THE END OF YEAR
Table 2.5.2
1990 1995 2000 2005 2010 2015* 2019 2020
Diseases
Total 5401 150.6 4697 124.7 4033 106.0 3820 118.7 5579 171.0 11577 386.1 13550 457.8 13786 465.2
Including diagnosed with:
Alcoholic psychosis 122 3.4 130 3.5 176 4.6 176 5.5 432 13.2 500 16.7 538 18.2 524 17.7
Chronic alcoholism 5056 140.9 4277 113.5 3652 96 3401 105.6 4173 127.9 5152 171.8 5630 190.2 5682 191.7
Narcomania 209 5.9 283 7.5 193 5.1 219 6.8 912 28.0 5828 194.4 7209 243.6 7392 249.5
Toxicomania 14 0.39 7 0.18 12 0.3 24 0.7 62 1.9 86 2.9 160 5.4 175 5.9
Mental and - - - - - - - - - - 11 0.37 13 0.44 13 0.44

behavioral disorders
caused by drugs and
psychotropic
substances, which are
not included in the
lists**
**Individuals, previously detected by preventive surveillance due to substance abuse, are included in the census of patients from 2012
r.v. – per 100 000 population
86
NHIAC
PREVALENCE OF INFECTIOUS DISEASES

Table 2.6
Years
Diseases 1990 1995 2000 2005 2010 2015 2019 2020
Abdominal typhus 38 1.06 30 0.8 14 0.4 1 0.03 - - 1 0.03 - - - -
Paratyphoid A B C 7 0.2 9 0.2 - - 2 0.06 - - - - - - - -
Acute intentional
7191 202.1 3744 99.6 3683 96.8 4743 147.4 7506 230.5 12268 408.3 10416 351.6 4612 155.7
infectious diseases
including:
Bacterial dysentery 1468 41.3 1071 28.5 771 20.3 792 24.6 1241 38.1 1881 62.6 422 14.2 202 6.8
Other bacterial
intestinal infections
1913 53.8 452 12.0 710 18.7 874 27.2 2476 76.0 3749 124.8 4158 140.4 1542 52.1
and intoxications with
confirmed pathogens
Other bacterial
intestinal infections
and intoxications 3810 107.1 2221 59.1 2202 57.9 3077 95.6 3789 116.4 6638 220.9 5836 197.0 2868 96.8
without confirmed
pathogens
Acute viral hepatitis 7196 202.2 2986 79.5 1723 45.3 749 23.3 548 16.8 250 8.3 59 2.0 17 0.6
including:
Acute viral hepatitis B 793 22.3 360 9.6 122 3.2 86 2.7 74 2.3 69 2.3 25 0.8 7 0.24
Acute viral hepatitis A 6163 173.2 2608 69.4 1597 42.0 581 18.1 379 11.6 88 2.9 6 0.2 4 0.14
Acute viral hepatitis
19 0.6 4 0.14
C**
Brucellosis- incidence
( diagnosed for the 183 5.1 297 7.9 110 2.9 151 4.7 295 9.1 309 10.3 246 8.3 132 4.5
first time )
Diphtheria 7 0.2 29 0.8 - - - - - - - - - - - -
Measles 879 24.7 187 5.0 15 0.4 2281 70.9 2 0.06 33 1.1 7 0.24 - -
Whooping cough 469 13.2 12 0.3 10 0.26 6 0.19 4 0.12 27 0.9 46 1.6 14 0.5
Scarlet fever 570 16.0 39 1.0 440 11.6 370 11.5 632 19.4 715 23.8 1451 49.0 231 7.8
Meningococcal
34 0.95 14 0.4 15 0.39 18 0.56 14 0.43 6 0.20 7 0.24 5 0.17
infection
including
Widespread
- - 1 0.03 3 0.08 - - 3 0.09 - - - - - -
(generalized) forms
Acute poliomyelitis - - - - - - - - - - - -
Acute poliomyelitis
(acute flaccid 12 0.33 3 0.08 22 0.57 10 0.3 13 0.4 17 0.57 16 0.54 9 0.3
paralysis)
Malaria-incidence
(diagnosed for the first - - 502 13.4 141 3.7 7 0.22 1 0.03 2 0.07 3 0.10 3 0.1
time )
Human
immunodeficiency - - - - 1 0.03 41 1.27 95 2.9 161 5.4 173 5.8 153 5.2
virus disease (AIDS) *
Human
immunodeficiency - - - - 14 0.37 75 2.33 148 4.5 294 9.8 448 15.1 369 12.5
virus [HIV]*
Acute respiratory
396187 11134.5 195718 5207.8 169348 4453.1 118460 3681.7 108229 3323.9 124088 4129.9 175571 5926.4 167325 5650.0
infections
Grippus 69059 1940.8 54554 1451.6 40284 1059.3 7485 232.6 55 1.7 36 1.2 321 10.8 398 13.4
**The indicator is included in reporting forms from 2016
r.v.– per 100 000 popluation
a.v.- absolute number
87
PREVALENCE OF ACTIVE TUBERCULOSIS
Table 2.7.1
Number of patients with active tuberculosis
Number of patients on dispensary follow up by tuberculosis
recorded by tuberculosis facilities diagnosed for the
Years facilities at the end of the year
first time in life
a.v. r.v. a.v. r.v.
1986 809 23.8 3587 104.9
1987 742 21.6 3485 100.6
1988 642 18.6 3205 92.8
1989 630 18.0 3150 89.3
1990 590 16.6 3069 85.5
1993 590 15.8 3082 82.4
1994 730 19.5 3362 89.6
1995 811 21.6 3534 93.8
1996 904 24.0 3692 97.7
1997 1047 27.6 3909 103.1
1998 1420 37.4 4652 122.5
1999 1434 37.4 5280 138.8
2000 1284 33.8 5458 143.5
2001 1343 35.4 5786 152.3
2002 1393 43.4 6050 188.5
2003 1437 44.7 6068 188.9
2004 1558 48.5 6165 191.7
2005 2006 62.3 6455 200.5
2006 1579 49.0 5673 176.0
2007 1518 47.0 3867 119.7
2008 1486 45.9 3489 107.8
2009 1431 44.1 3446 106.0
2010 1322 40.6 3707 113.6
2011 1185 36.3 3694 112.8
2012 1131 37.4 3437 113.5
2013 1047 34.6 3760 124.6
2014 1046 34.7 3930 130.5
2015 842 28.0 3681 122.8
2016 812 27.1 3495 117.0
2017 685 23.0 3205 107.8
2018 626 21.1 2852 96.2
2019 543 18.3 2579 87.1
2020 374 12.6 2350 79.3
r.v.-per 100 000 population
INCIDENCE OF ACTIVE TUBERCULOSIS BY SEX AND AGE GROUP, 2018
Table 2.7.2
Active tuberculosis- Total Including `tuberculosis of lung
Age TOTAL male female TOTAL male female
0-4 14 7.0 7 6.6 7 7.4 7 3.5 4 3.8 3 3.2
5-14 23 5.8 16 9.1 7 3.1 12 3.0 7 4.0 5 2.2
15-24 87 24.5 77 42.1 10 5.8 52 14.6 43 23.5 9 5.2
25-34 109 20.9 77 31.1 32 11.7 91 17.5 62 25.1 29 10.6
35-44 96 23.4 70 36.3 26 12.0 78 19.0 62 32.2 16 7.4
45-54 93 27.2 72 47.1 21 11.1 78 22.8 61 39.9 17 9.0
55-64 142 36.2 108 62.6 34 15.5 110 28.0 88 51.0 22 10.0
65 և > 62 17.8 45 32.8 17 8.0 40 11.5 32 23.3 8 3.8
TOTAL 626 21.1 472 33.6 154 9.8 468 15.8 359 25.6 109 7.0
88
NHIAC
INCIDENCE OF ACTIVE TUBERCULOSIS BY SEX AND AGE GROUP, 2019
Table 2.7.3
0-4 15 7.7 6 5.8 9 9.8 5 2.6 3 2.9 2 2.2
5-14 21 5.2 11 5.1 10 5.3 7 1.7 3 1.4 4 2.1
15-24 58 16.8 45 25.1 13 7.8 35 10.1 25 13.9 10 6.0
25-34 98 19.3 69 28.8 29 10.9 78 15.4 58 24.2 20 7.5
35-44 101 23.9 79 39.7 22 9.8 82 19.4 63 31.7 19 8.5
45-54 83 25.0 67 45.3 16 8.7 61 18.4 53 35.8 8 4.3
55-64 114 28.8 100 57.8 14 6.3 83 21.0 77 44.5 6 2.7
65 և > 53 14.8 37 26.2 16 7.3 32 8.9 23 16.3 9 4.1
TOTAL 543 18.3 414 29.6 129 8.3 383 12.9 305 21.8 78 5.0
INCIDENCE OF ACTIVE TUBERCULOSIS BY SEX AND AGE GROUP , 2020
Table 2.7.4
0-4 18 9.5 15 15.1 3 3.4 6 3.2 5 5.0 1 1.1
5-14 5 1.2 4 1.8 1 0.5 1 0.2 1 0.5 - -
15-24 40 11.7 25 14.0 15 9.2 31 9.1 19 10.7 12 7.4
25-34 65 13.2 39 16.7 26 10.1 48 9.8 31 13.3 17 6.6
35-44 63 14.3 39 18.9 24 10.3 50 11.4 33 16.0 17 7.3
45-54 62 18.9 56 38.2 6 3.3 52 15.8 49 33.4 3 1.6
55-64 76 19.3 61 35.5 15 6.7 56 14.2 47 27.4 9 4.0
65 և > 45 12.2 31 21.4 14 6.2 24 6.5 18 12.4 6 2.7
TOTAL 374 12.6 270 19.3 104 6.7 268 9.0 203 14.5 65 4.2
89
PREVALENCE OF SEXUALLY TRANSMITTED DISEASES, RA
Table 2.8.1
Number of patients with confirmed
End of the year number of patients on dispensary
acute and chronic syphilis diagnosed
Years follow up with acute and chronic syphilis
for the first time in life
a.v. r.v. a.v. r.v.
1986 290 8.5 1926 56.7
1987 203 5.9 1177 34.2
1988 142 4.1 941 27.2
1989 108 3.1 685 19.6
1990 125 3.5 515 14.5
1995 448 11.9 797 21.2
1996 657 17.4 944 25
1997 621 16.4 1130 29.8
1998 497 13.1 1228 32.3
1999 440 11.6 1314 34.5
2000 262 6.9 1311 34.5
2001 221 5.8 1054 27.7
2002 134 4.2 899 28.0
2003 136 4.2 804 25.0
2004 138 4.3 388 12.1
2005 85 2.6 371 11.5
2006 157 4.9 544 16.9
2007 155 4.8 378 11.7
2008 147 4.5 293 9.0
2009 140 4.3 282 8.7
2010 98 3.0 277 8.5
2011 89 2.7 272 8.3
2012 72 2.4 256 8.5
2013 55 1.8 215 7.1
2014 50 1.7 142 4.7
2015 36 1.2 171 5.7
2016 51 1.7 128 4.3
2017 55 1.8 2 0.1
2018 69 2.3 10 0.3
2019 110 3.7 10 0.3
2020 141 4.8 18 0.6
INCIDENCE OF SYPHILIS BY SEX AND AGE GROUP, 2018
Table 2.8.2
Syphilis
Age TOTAL male female
a.v. r.v. a.v. r.v. a.v. r.v.
0-14
15-17
18-24 16 6.3 11 8.5 5 4.0
25-49 35 3.2 19 3.7 16 2.8
50 և > 18 2.0 12 3.1 6 1.1
TOTAL 69 2.3 42 3.0 27 1.7
90
NHIAC
Table 2.8.3
Syphilis
0-14 1 0.2 - - 1 0.4
15-17 1 1.0 1 1.8 - -
18-24 19 7.8 12 9.6 7 5.9
25-49 69 6.3 52 10.1 17 2.9
50 և > 20 2.2 14 3.6 6 1.1
TOTAL 110 3.7 79 5.6 31 2.0
Table 2.8.4
Syphilis
0-14 7 1.2 5 1.6 2 0.7
15-17
18-24 50 21.3 35 28.9 15 13.2
25-49 43 3.9 27 5.2 16 2.7
50 և > 41 4.4 33 8.5 8 1.5
TOTAL 141 4.8 100 7.2 41 2.6
NUMBER OF TESTED RESIDENCE FOR THE HIV/AIDS DETECTION BY SEX

Table 2.9.1
2005 2010 2015 2018 2019 2020
Diseases
f m f m f m f m f m f m
Absolute value
Tested citizens 34858 14403 55379 16503 83628 36868 95541 49020 108683 50428 90468 47276
Seropositive 31 117 82 184 148 301 305 631 346 624 511 606
HIV- infected 15 60 51 97 89 205 136 293 135 313 118 251
Total 36067 15369 57022 18451 92365 40455 97189 50639 111637 51888 91979 48762
Relative value ( per 100 000 population)
Tested citizens 2093.3 927.8 3303.4 1044.7 5324.9 2570.8 6108.8 3489.0 6953.0 3603.5 5784.8 3382.7
Seropositive 1.9 7.5 4.9 11.6 9.4 21.0 19.5 44.9 22.1 44.6 32.7 43.4
HIV- infected 0.9 3.9 3.0 6.1 5.7 14.3 8.7 20.9 8.6 22.4 7.5 18.0
Total 2165.9 990.1 3401.5 1168.0 5881.2 2820.9 6214.1 3604.2 7142.0 3707.9 5881.4 3489.0
91
HIV/AIDS TEST RESULTS
Table 2.9.2
2005 2010 2015 2018 2019 2020
Diseases
Persons who have had sexual
contacts with AIDS patients or 42 1.3 65 2.0 526 17.5 548 18.5 516 17.4 471 15.9
seropositives
Children born to women with
6 0.7 31 3.4 120 15.4 222 29.5 226 30.2 910 122.1
HIV**
Injective drug users 532 16.5 856 26.3 3997 133.0 1419 47.8 111 3.7 49 1.7
Donors 12449 386.9 14818 455.1 16194 539.0 16533 556.9 19924 672.5 24494 827.0
Pregnant women** 21720 2361.4 41638 4578.6 46364 5931.9 45673 6063.1 45024 6023.3 42680 5728.1
including 15 – 24 years of age* 11812 1284.2 20423 2245.8 18327 2344.8 14795 1964.0 13751 1839.6 11823 1586.8
Persons infected by sexually
462 14.4 381 11.7 490 16.3 428 14.4 270 9.1 147 5.0
transmitted infections
Servicemen 577 17.9 428 13.1 247 8.2 1019 34.3 489 16.5 955 32.2
Prisoners 1019 31.7 611 18.8 423 14.1 2583 87.0 1505 50.8 435 14.7
**- The data are presented from 2005
* *- The indicators are calculated from the number of fertile age women
r.v.– per 100 000 population
NUMBER OF HIV/AIDS TESTED CITIZENS BY SEX, AGE AND RESIDENCE

(absolute value), 2018
Table 2.9.3
including: by residence
Age TOTAL Yerevan Other cities of RA Villages (RA)
female male female male female male
0-4 - - - - - - -
0-14 4389 966 1363 609 876 238 337
15-24 28427 6732 5355 6657 1778 6751 1154
25-34 50179 17412 6079 12720 2956 9051 1961
35-44 23963 7772 4974 4112 2320 3331 1454
45-54 14158 3565 3482 1768 1846 2165 1332
55-59 7733 1795 1730 909 1056 1187 1056
60 և > 15712 3502 3730 2001 2042 2298 2139
TOTAL 144561 41744 26713 28776 12874 25021 9433
92
NHIAC

Table 2.9.4
Age TOTAL Yerevan Other cities of RA RA villages
0-4 - - - - - - -
0-14 4863 1182 1496 720 934 226 305
15-24 27350 7431 4172 6073 1719 6707 1248
25-34 54693 19595 6024 12937 2626 11180 2331
35-44 27440 9117 5227 4373 2217 4799 1707
45-54 16023 4678 3699 1787 1434 2946 1479
55-59 9225 2396 1900 980 1042 1691 1216
60 և > 19517 4922 4812 2336 2551 2607 2289
TOTAL 159111 49321 27330 29206 12523 30156 10575

Table 2.9.5
Age TOTAL Yerevan Other cities of RA RA villages
0-4 - - - - - - -
0-14 3774 950 1277 426 675 189 257
15-24 24593 7107 4520 4952 1551 5414 1049
25-34 45969 18284 5399 10056 2423 7996 1811
35-44 24537 8983 5358 4337 2066 2586 1207
45-54 13253 4297 3948 1595 1417 1119 877
55-59 6515 2141 1681 796 756 536 605
60 և > 19103 5231 6213 2074 2382 1399 1804
TOTAL 137744 46993 28396 24236 11270 19239 7610
93
NUMBER OF POISONINGS, 2018
Table 2.10
including:
of them rural Of them

Name of infectious diseases/ food poisoning ICD X Patients 0-18
female fatal
y.o. 3-6 0-18
0 -2 y.o. TOTAL
y.o. y.o.
Intoxications/ poisonings
Other bacterial foodborne intoxications,

A05 47 27 13 3 2 28 6 0
Foodborne staphylococcal intoxication A05.0 6 4 4 0 2 0 0 0
Botulism A05.1 25 16 2 0 0 19 2 0
Other specified bacterial foodborne
A05.8 6 3 4 2 1 3 2 0
intoxications
Bacterial foodborne intoxication,
A05.9 10 4 3 1 0 5 2 0
unspecified
Toxic effects of substances chiefly
T51-T 65 1791 738 546 132 154 738 245 18
nonmedicinal as to source including՝
T51-
Toxic effect of alcohol 459 59 53 3 4 90 18 1
T51.8
Toxic effect of organic solvents, halogen

T52, T53,
derivatives of aliphatic and aromatic
T54, 551 336 221 47 69 222 89 11
hydrocarbons, corrosive substances, metals
T56,T59
and other gases, fumes and vapours
Toxic effect of soaps and detergents T55 112 57 70 38 24 33 23 0
Toxic effect of pesticides T60 81 27 22 4 13 70 17 5
fish and shellfish poisoning T61 3 3 0 0 0 3 0 0
Toxic effect of other noxious substances

T62 73 38 20 7 5 31 8 0
eaten as food
Ingested mushrooms T62.0 62 36 10 1 2 27 4 0
Other ingested (parts of) plant(s) T62.2 8 2 7 5 1 3 3 0
Other specified noxious substances eaten as

T62.8 3 0 3 1 2 1 1 0
food
Toxic effect of contact with venomous
T63 425 185 127 14 29 242 72 0
animals
Toxic effect of other and unspecified
T65 87 33 33 19 10 47 18 1
substances
Poisoning by drugs, medicaments and
T36-T50 551 328 216 83 80 142 77 2
biological substances
Poisoning by narcotics and

T40 3 0 0 0 0 0 0 0
psychodysleptics [hallucinogens]
Termal and chemical burns
Termal burns T20-T31 4 1 4 3 1 2 2 0
Source՝ National Center for Disease Control and Prevention SNCO
94
NHIAC
NUMBER OF POISONINGS, BURNS AND CORROSIONS, 2019
Table 2.11
including:
of them rural
Of them
female fatal
y.o. 3-6 0-18
0 -2 y.o. TOTAL
y.o. y.o.
INTOXICATIONS/ POISONINGS

A05 84 47 16 0 1 50 8 0
Botulism A05.1 23 13 2 0 0 18 2 0
A05.8 25 14 6 0 0 21 5 0
intoxications
A05.9 5 2 2 0 0 3 1 0
unspecified
T51-T 65 2209 940 697 170 195 936 347 21
T51-
T51.8

T52, T53,
T54, 819 506 319 68 88 401 168 13
T56,T59

T62 64 30 30 9 6 33 17 0
eaten as food

T62.8 0 0 0 0 0 0 0 0
food
T63 402 195 99 12 26 207 51 0
animals
T65 75 31 34 18 12 41 22 2
substances
T36-T50 633 362 278 112 97 150 77 1

T40 5 0 2 1 0 0 0 1
TERMAL AND CHEMICAL BURNS
Termal burns T20-T31 4 2 4 3 1 3 3 0
95
NUMBER OF POISONINGS, BURNS AND CORROSIONS, 2020
Table 2.12
including:
of them rural
Of them
female fatal
y.o. 3-6 0-18
0 -2 y.o. TOTAL
y.o. y.o.
INTOXICATIONS/ POISONINGS

A05 53 31 14 3 1 26 9 0
Botulism A05.1 20 11 2 0 0 11 2 0
A05.8 17 11 5 1 1 3 0 0
intoxications
A05.9 10 7 2 1 0 6 2 0
unspecified
T51-T 65 1899 766 620 168 146 717 270 42
T51-
T51.8

T52, T53,
T54, 647 379 258 54 68 273 115 10
T56,T59

T62 79 47 24 6 5 28 10 1
eaten as food

T62.8 3 1 1 0 1 2 1 0
food
T63 416 177 109 8 19 192 63 0
animals
T65 74 30 37 24 9 32 19 2
substances
T36-T50 629 380 254 88 95 156 84 2

T40 7 0 2 0 0 0 0 1
TERMAL AND CHEMICAL BURNS
Termal burns T20-T31 0 0 0 0 0 0 0 0
96
NHIAC
REGISTERED NUMBER OF TRAUMAS AND POISONINGS IN PHC
Table 2.12.1
Incidence of registered injuries and poisonings
including:
Years TOTAL
15 years and above 0 – 14 years inclusive
1980 133497 43 98903 45.7 34597 36.8
1985 160900 48.8 108774 46.9 52126 53.3
1990 185252 52.1 122416 49.5 62836 58
1991 186102 51.5 118607 47.8 67495 61.2
1992 162261 44 104983 41 57278 50.9
1993 145635 39 92900 35.6 52735 47
1994 125694 33.5 83289 32.3 42405 36.4
1995 116300 30.9 78863 29.4 37437 34.8
1996 110796 29.4 75298 27.6 35498 33.8
1997 90887 24 60594 21.9 30293 29.8
1998 75991 20 49192 17.2 26799 27.2
1999 75048 19.7 48959 17.1 26089 27.6
2000 70948 18.7 47872 16.5 23076 25.7
2001 59501 15.7 40266 13.3 19235 22.7
2002 59537 18.5 42409 16.9 17128 24.3
2003 59757 18.6 43847 17.7 15910 21.6
2004 45450 14.1 33136 13.2 12314 17.4
2005 47287 14.7 34653 13.7 12634 18.6
2006 51717 16.1 38072 14.8 13645 21
2007 51943 16.1 39180 15.1 12763 20.4
2008 55031 17 41795 15.9 13236 21.8
2009 56721 17.5 43420 16.4 13301 22.2
2010 56296 17.3 43176 16.2 13120 22.1
2011 57479 17.6 43638 16.3 13841 23.4
2012 57256 18.9 43739 17.8 13517 23.7
2013 57815 19.1 43528 17.8 14287 24.9
2014 59290 19.7 45655 18.8 13635 23.5
2015 60385 20.1 47106 19.5 13279 22.7
2016 58864 19.7 46251 19.3 12613 21.3
2017 56418 18.9 43889 18.4 12529 21.0
2018 59829 20.2 47770 20.2 12059 20.1
2019 62105 21.0 50335 21.3 11770 19.6
2020* 51171 17.3 40737 17.2 10434 17.4
r.v.- per 1000 population
97
NUMBER OF REGISTERED POISONINGS, 2018-2020
Table 2.12.2
TOTAL Adults 15-17 years old 0-14 years old
Diseases
2018 2019 2020 2018 2019 2020 2018 2019 2020 2018 2019 2020
Number of recorded inpatient
poisonings of medecines, biological
309 424 437 229 334 322 17 17 31 63 73 84
substances and mainly non-medical
substances in PHC
Number of recorded inpatient
poisonings of medecines, biological
3275 2787 2186 2532 1981 1391 82 105 76 661 701 719
substances and mainly non-medical
substances in hospitals
Number of recorded outpatient toxic
47 50 54 43 50 52 3 - - 1 - 2
effects of snake bite
Number of recorded inpatient toxic
138 113 123 121 99 114 7 2 3 10 12 6
effects of snake bite
98
CIRCULATORY SYSTEM DISEASES
ENDOCRINE SYSTEM DISEASES
MALIGNANT NEOPLASM
99
\
NHIAC
ABBREVIATIONS
CSD - Diseases of the circulatory system
HD - Hypertensive and heart diseases
ED - Endocrine diseases
IHD - Ichemic heart diseases
AMI - Acute myocardial infarction
CRHD - Chronic rheumatic heart diseases
SMI - Subsequent myocardial infarction
DM - Diabetes mellitus
CERVD - Cerebrovascular diseases
CI - Cerebral infarction
BH - Brain haemorrhage
AP - Angina pectoris
r.v. - per 100 000 population
100
\
NHIAC
CIRCULATORY SYSTEM DISEASES
INCIDENCE OF CSD AMONG ADULT POPULATION IN REGIONS, 2020
Table 2a.1
Yerevan Aragatsotn Ararat Armavir Gegharkunik

Diseases
ICD X
a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
CSD Total I00-I99 12081 1441.2 3620 3890.1 3453 1787.8 4989 2480.5 2967 1725.4
including:HD I10-I13 4434 528.9 1822 1957.9 1488 770.4 2548 1266.8 1608 935.1
IHD I20-I25 4303 513.3 893 959.6 835 432.3 1386 689.1 760 442.0
AMI I21 437 52.1 56 60.2 154 79.7 246 122.3 81 47.1
AP I20 1120 133.6 213 228.9 344 178.1 447 222.2 214 124.4
CERVD I60-I69 1235 147.3 484 520.1 733 379.5 620 308.3 311 180.9
INCIDENCE OF CSD AMONG ADOLESCENTS AGED 15-17 YEARS IN REGIONS, 2020
Table 2a.2
Diseases
ICD X a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
CSD Total I00-I99 103 301.5 4 82.6 18 188.7 47 473.7 28 309.3
including: CRHD I05-I09 1 2.9 0 0.0 2 21.0 0 0.0 1 11.0
HD I10-I13 2 5.9 4 82.6 8 83.9 14 141.1 3 33.1
INCIDENCE OF CSD AMONG CHILDREN AGED 0-14 YEARS IN REGIONS, 2020

Table 2a.3
Diseases
ICD X a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
CSD Total I00-I99 119 55.2 2 7.5 15 27.8 47 88.9 6 12.9
including: CRHD I05-I09 1 0.5 0 0.0 2 3.7 1 1.9 2 4.3
HD I10-I13 1 0.5 0 0.0 0 0.0 1 1.9 2 4.3
101
NHIAC
INCIDENCE OF CSD AMONG ADULT POPULATION IN REGIONS, 2020

continutation 2a.1
Lori Kotayk Shirak Syunik Vayots Dzor Tavush RA

Diseases
a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
4093 2565.0 3214 1710.0 5905 3402.4 1406 1306.8 1507 4041.1 1859 2001.1 45094 1998.5 CSD Total
1912 1198.2 1696 902.4 4362 2513.3 760 706.4 806 2161.3 864 930.1 22300 988.3 including:HD
1219 763.9 812 432.0 773 445.4 309 287.2 255 683.8 472 508.1 12017 532.6 IHD
76 47.6 161 85.7 91 52.4 138 128.3 30 80.4 77 82.9 1547 68.6 AMI
389 243.8 241 128.2 408 235.1 89 82.7 151 404.9 240 258.3 3856 170.9 AP
433 271.3 400 212.8 361 208.0 276 256.5 250 670.4 316 340.2 5419 240.2 CERVD
INCIDENCE OF CSD AMONG ADOLESCENTS AGED 15-17 YEARS IN REGIONS, 2020
continutation 2a.2
Diseases
66 777.2 55 566.1 37 427.5 14 275.1 0 0.0 15 310.1 387 364.9 CSD Total
1 11.8 0 0.0 0 0.0 2 39.3 0 0.0 0 0.0 7 6.6 including: CRHD
25 294.4 18 185.3 14 161.8 2 39.3 0 0.0 5 103.4 95 89.6 HD
INCIDENCE OF CSD AMONG CHILDREN AGED 0-14 YEARS IN REGIONS, 2020

continutation 2a.3
Diseases
20 44.6 22 41.2 16 32.7 11 46.0 0 0.0 8 34.4 266 44.4 CSD Total
0 0.0 0 0.0 1 2.0 0 0.0 0 0.0 0 0.0 7 1.2 including: CRHD
0 0.0 10 18.7 2 4.1 1 4.2 0 0.0 2 8.6 19 3.2 HD
102
\NON COMMUNICABLE DISEASES
PREVALENCE OF CSD AMONG ADULT POPULATION IN REGIONS

(total number of patients), 2020
Table 2a.4

Diseases ICD X
CSD Total I00-I99 90531 10799.7 10237 11000.8 18737 9701.3 24687 12274.0 21931 12753.7
including:HD I10-I13 46051 5493.6 6282 6750.7 10258 5311.2 15032 7473.7 13410 7798.4
IHD I20-I25 31572 3766.3 2335 2509.2 5369 2779.9 6798 3379.9 5412 3147.3
AMI I21 438 52.3 65 69.8 198 102.5 246 122.3 121 70.4
AP I20 8763 1045.4 663 712.5 1475 763.7 2070 1029.2 2427 1411.4
CERVD I60-I69 5720 682.4 875 940.3 1967 1018.4 1627 808.9 1506 875.8
PREVALENCE OF CSD AMONG ADOLESCENTS AGED 15-17 YEARS IN REGIONS

Table 2a.5

Diseases
ICD X
CSD Total I00-I99 167 488.8 13 268.4 39 408.8 157 1582.3 136 1502.3
including:
I05-I09 1 2.9 2 41.3 3 31.4 6 60.5 2 22.1
CRHD
HD I10-I13 13 38.1 7 144.5 24 251.6 52 524.1 4 44.2

Table 2a.6

Diseases
ICD X
CSD Total I00-I99 303 140.6 8 30.0 35 64.9 206 389.8 23 49.5
including:
I05-I09 3 1.4 5 18.7 8 14.8 4 7.6 7 15.1
CRHD
HD I10-I13 5 2.3 0 0.0 0 0.0 6 11.4 4 8.6
103
NHIAC
PREVALENCE OF CSD AMONG ADULT POPULATION IN REGIONS

continutation 2a.4

Diseases
20228 12676.3 18729 9964.9 18448 10629.5 10048 9339.2 6339 16998.3 12051 12972.3 251966 11166.7 CSD Total
10781 6756.1 10268 5463.2 11497 6624.5 6384 5933.7 3578 9594.6 7281 7837.6 140822 6241.0 including:HD
6233 3906.0 5299 2819.4 4190 2414.2 2224 2067.1 1531 4105.4 2770 2981.8 73733 3267.7 IHD
76 47.6 161 85.7 91 52.4 138 128.3 30 80.4 77 82.9 1641 72.7 AMI
1772 1110.5 1789 951.8 1470 847.0 1344 1249.2 937 2512.6 1065 1146.4 23775 1053.7 AP
1674 1049.0 1457 775.2 1262 727.2 866 804.9 662 1775.2 1066 1147.5 18682 828.0 CERVD

continutation 2a.5
Diseases
162 1907.7 104 1070.4 70 808.8 32 628.8 0 0.0 31 640.9 911 859.1 CSD Total
1 11.8 1 10.3 4 46.2 9 176.9 0 0.0 0 0.0 29 27.3 including: CRHD
51 600.6 26 267.6 29 335.1 7 137.6 0 0.0 14 289.4 227 214.1 HD

continutation 2a.6

Diseases
59 131.5 58 108.7 68 138.9 35 146.4 0 0.0 16 68.8 811 135.4 CSD Total
4 8.9 3 5.6 7 14.3 7 29.3 0 0.0 1 4.3 49 8.2 including: CRHD
2 4.5 19 35.6 3 6.1 6 25.1 0 0.0 7 30.1 52 8.7 HD
104
\
NHIAC
PREVALENCE OF CSD AMONG RA POPULATION

(total number of registered patients) 2020
Table 2a.7
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
CSD Total I00-I99 251966 11166.7 811 135.4 911 859.1

CRHD I05-I09 3151 139.6 49 8.2 29 27.3
HD I10-I13 140822 6241.0 52 8.7 227 214.1
IHD I20-I25 73733 3267.7 0 0.0 0 0.0
including: AP I20 23775 1053.7 0 0.0 0 0.0
AMI I21 1641 72.7 0 0.0 0 0.0
SMI I22 406 18.0 0 0.0 0 0.0
CERVD I60-I69 18682 828.0 3 0.5 2 1.9
including: SH I60-I62 2088 92.5 0 0.0 0 0.0
CI I63 2463 109.2 1 0.2 0 0.0
Stroke, not specified as haemorrhage or
I64 2010 89.1 0 0.0 0 0.0
infarction
Occlusion and stenosis of precerebral
arteries, not resulting in cerebral I65-I66 5224 231.5 0 0.0 1 0.9
infarction
NCIDENCE OF CSD AMONG RA POPULATION BY SEX AND AGE GROUP, 2020

Table 2a.8
Adults
Diseases ICD X Sex 0-14 15-17
Total 18-24 25-39 40-49 50-59 60-65 65 & >
CSD Total I00-I99 266 387 45094
m 2 3 177 1 11 40 47 53 25
CRHD I05-I09
f 5 4 140 1 16 27 51 29 16
m 13 73 10978 98 523 2026 3352 2861 2118
HD I10-I13
f 6 22 11322 53 498 2167 3288 2925 2391
m 0 0 7376 6 171 1122 2092 2209 1776
IHD I20-I25
f 0 0 4641 5 88 578 1327 1477 1166
m 0 0 2328 4 72 404 683 687 478
including: AP I20
f 0 0 1528 1 25 225 469 480 328
m 0 0 1159 0 13 161 392 326 267
AMI I21
f 0 0 388 0 5 25 91 146 121
m 0 0 295 0 1 21 78 119 76
SMI I22
f 0 0 77 0 1 4 19 29 24
m 0 0 2841 8 57 286 653 874 963
CERVD I60-I69
f 1 1 2578 3 31 229 605 812 898
m 0 0 476 1 8 49 105 174 139
including: SH I60-I62
f 0 0 349 0 4 25 83 106 131
m 0 0 463 2 10 36 117 139 159
CI I63
f 1 0 343 1 3 29 76 142 92
Stroke, not specified as m 0 0 471 0 9 34 103 141 184
I64
haemorrhage or infarction f 0 0 379 0 7 20 80 107 165
Occlusion and stenosis of m 0 0 630 2 14 67 128 203 216
precerebral arteries, not I65-I66
resulting in cerebral infarction f 0 0 748 2 10 91 174 239 232
105
\
NHIAC
PREVALENCE OF CSD AMONG YEREVAN POPULATION

(total number of registered patients) 2020
Table 2a.9
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
CSD Total I00-I99 90531 10799.7 303 140.6 167 488.8
CRHD I05-I09 612 73.0 3 1.4 1 2.9
HD I10-I13 46051 5493.6 5 2.3 13 38.1
IHD I20-I25 31572 3766.3 0 0.0 0 0.0
including: AP I20 8763 1045.4 0 0.0 0 0.0
AMI I21 438 52.3 0 0.0 0 0.0
ՍF I22 89 10.6 0 0.0 0 0.0
CERVD I60-I69 5720 682.4 1 0.5 0 0.0
including:SH I60-I62 573 68.4 0 0.0 0 0.0
CI I63 895 106.8 0 0.0 0 0.0
Stroke, not specified as
I64 304 36.3 0 0.0 0 0.0
haemorrhage or infarction
infarction
INCIDENCE OF CSD AMONG YEREVAN POPULATION BY SEX AND AGE GROUP, 2020
Table 2a.10
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
CSD Total I00-I99 119 103 12081
m 1 1 25 0 2 6 7 5 5
CRHD I05-I09
f 0 0 24 1 1 7 8 4 3
m 1 2 2038 5 80 302 586 620 445
HD I10-I13
f 0 0 2396 3 88 359 622 687 637
m 0 0 2523 1 43 293 565 889 732
IHD I20-I25
f 0 0 1780 0 18 177 455 607 523
m 0 0 636 0 15 110 154 203 154
including: AP I20
f 0 0 484 0 5 59 121 159 140
m 0 0 341 0 2 19 99 111 110
AMI I21
f 0 0 96 0 0 6 17 33 40
m 0 0 76 0 0 4 13 29 30
SMI I22
f 0 0 13 0 0 2 0 5 6
m 0 0 671 4 13 81 135 173 265
CERVD I60-I69
f 0 0 564 1 7 62 114 153 227
m 0 0 118 1 4 16 24 38 35
f 0 0 88 0 3 11 17 27 30
m 0 0 148 2 4 15 42 37 48
CI I63
f 0 0 84 1 2 14 17 28 22
I64
Occlusion and stenosis of precerebral m 0 0 89 0 1 10 14 21 43
arteries, not resulting in cerebral I65-I66
infarction f 0 0 91 0 0 15 15 27 34
106
ARAGATSOTN REGION
PREVALENCE OF CSD AMONG POPULATION
(TOTAL NUMBER OF REGISTERED PATIENTS), 2020
Table 2a.11
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
CSD Total I00-I99 10237 11000.8 8 30.0 13 268.4
CRHD I05-I09 77 82.7 5 18.7 2 41.3
HD I10-I13 6282 6750.7 0 0.0 7 144.5
IHD I20-I25 2335 2509.2 0 0.0 0 0.0
including: AP I20 663 712.5 0 0.0 0 0.0
AMI I21 65 69.8 0 0.0 0 0.0
SMI I22 14 15.0 0 0.0 0 0.0
CERVD I60-I69 875 940.3 0 0.0 1 20.6
including: SH I60-I62 90 96.7 0 0.0 0 0.0
CI I63 133 142.9 0 0.0 0 0.0
I64 118 126.8 0 0.0 0 0.0
Occlusion and stenosis of
precerebral arteries, not resulting I65-I66 192 206.3 0 0.0 0 0.0
in cerebral infarction
INCIDENCE OF CSD AMONG POPULATION ,

BY SEX AND AGE GROUP , 2020
Table 2a.12
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
CSD Total I00-I99 2 4 3620
m 0 0 4 0 1 3 0 0 0
CRHD I05-I09
f 0 0 5 0 1 2 0 2 0
m 0 4 756 15 52 137 221 185 146
HD I10-I13
f 0 0 1066 6 31 157 365 273 234
m 0 0 625 1 22 84 191 167 160
IHD I20-I25
f 0 0 268 0 8 31 88 85 56
m 0 0 137 1 12 13 50 36 25
including: AP I20
f 0 0 76 0 6 14 23 21 12
m 0 0 48 0 1 7 24 9 7
AMI I21
f 0 0 8 0 0 1 2 2 3
m 0 0 11 0 1 2 4 3 1
SMI I22
f 0 0 3 0 0 0 1 0 2
m 0 0 245 0 12 28 52 71 82
CERVD I60-I69
f 0 0 239 0 10 19 39 93 78
m 0 0 32 0 2 4 4 11 11
f 0 0 16 0 0 1 5 4 6
m 0 0 56 0 3 2 3 24 24
CI I63
f 0 0 44 0 1 3 0 33 7
I64

107
NHIAC
ARARAT REGION
Table 2a.13
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
CSD Total I00-I99 18737 9701.3 35 64.9 39 408.8
CRHD I05-I09 226 117.0 8 14.8 3 31.4
HD I10-I13 10258 5311.2 0 0.0 24 251.6
IHD I20-I25 5369 2779.9 0 0.0 0 0.0
including: AP I20 1475 763.7 0 0.0 0 0.0
AMI I21 198 102.5 0 0.0 0 0.0
SMI I22 51 26.4 0 0.0 0 0.0
CERVD I60-I69 1967 1018.4 1 1.9 0 0.0
including:SH I60-I62 253 131.0 0 0.0 0 0.0
CI I63 222 114.9 0 0.0 0 0.0
Stroke, not specified as haemorrhage
I64 365 189.0 0 0.0 0 0.0
or infarction
infarction

Table 2a.14
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
CSD Total I00-I99 15 18 3453
m 0 0 11 0 0 1 3 2 5
CRHD I05-I09
f 2 2 11 0 1 1 4 3 2
m 0 4 772 7 27 168 227 192 151
HD I10-I13
f 0 4 716 2 34 153 198 186 143
m 0 0 512 0 14 80 169 150 99
IHD I20-I25
f 0 0 323 0 3 47 108 101 64
m 0 0 196 0 5 34 67 56 34
including: AP I20
f 0 0 148 0 2 27 51 42 26
m 0 0 116 0 2 17 40 33 24
AMI I21
f 0 0 38 0 0 3 9 14 12
m 0 0 26 0 0 0 10 10 6
SMI I22
f 0 0 9 0 0 0 5 2 2
m 0 0 363 2 9 32 90 122 108
CERVD I60-I69
f 0 0 370 2 4 31 112 119 102
m 0 0 64 0 0 3 13 25 23
f 0 0 51 0 0 1 11 21 18
m 0 0 44 0 0 1 11 11 21
CI I63
f 0 0 40 0 0 1 15 14 10
I64

108
ARMAVIR REGION
Table 2a.15
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
CSD Total I00-I99 24687 12274.0 206 389.8 157 1582.3
CRHD I05-I09 278 138.2 4 7.6 6 60.5
HD I10-I13 15032 7473.7 6 11.4 52 524.1
IHD I20-I25 6798 3379.9 0 0.0 0 0.0
including: AP I20 2070 1029.2 0 0.0 0 0.0
AMI I21 246 122.3 0 0.0 0 0.0
SMI I22 64 31.8 0 0.0 0 0.0
CERVD I60-I69 1627 808.9 0 0.0 0 0.0
including: SH I60-I62 140 69.6 0 0.0 0 0.0
CI I63 76 37.8 0 0.0 0 0.0
I64 274 136.2 0 0.0 0 0.0

Table 2a.16
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
CSD Total I00-I99 47 47 4989
m 0 0 7 0 1 2 3 1 0
CRHD I05-I09
f 1 0 12 0 4 3 4 1 0
m 1 11 1347 2 58 266 428 404 189
HD I10-I13
f 0 3 1201 1 46 243 366 331 214
m 0 0 828 1 9 145 255 256 162
IHD I20-I25
f 0 0 558 1 16 65 164 195 117
m 0 0 267 0 1 50 82 86 48
including: AP I20
f 0 0 180 0 1 26 59 65 29
m 0 0 157 0 0 28 43 56 30
AMI I21
f 0 0 89 0 2 4 27 41 15
m 0 0 48 0 0 2 12 21 13
SMI I22
f 0 0 15 0 0 0 1 11 3
m 0 0 328 0 4 22 73 126 103
CERVD I60-I69
f 0 0 292 0 3 29 71 99 90
m 0 0 45 0 0 4 11 22 8
f 0 0 35 0 1 3 7 14 10
m 0 0 37 0 2 3 5 17 10
CI I63
f 0 0 19 0 0 2 3 5 9
I64
precerebral arteries, not
I65-I66
resulting in cerebral f 0 0 122 0 0 13 26 42 41
infarction
109
\
NHIAC
GEGHARKUNIK REGION
Table 2a.17
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
CSD Total I00-I99 21931 12753.7 23 49.5 136 1502.3
CRHD I05-I09 292 169.8 7 15.1 2 22.1
HD I10-I13 13410 7798.4 4 8.6 4 44.2
IHD I20-I25 5412 3147.3 0 0.0 0 0.0
including: AP I20 2427 1411.4 0 0.0 0 0.0
AMI I21 121 70.4 0 0.0 0 0.0
SMI I22 45 26.2 0 0.0 0 0.0
CERVD I60-I69 1506 875.8 0 0.0 0 0.0
including:SH I60-I62 105 61.1 0 0.0 0 0.0
CI I63 83 48.3 0 0.0 0 0.0
I64 173 100.6 0 0.0 0 0.0
precerebral arteries, not I65-I66 263 152.9 0 0.0 0 0.0
resulting in cerebral infarction

Table 2a.18
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
CSD Total I00-I99 6 28 2967
m 1 1 9 0 1 2 3 3 0
CRHD I05-I09
f 1 0 6 0 0 1 3 1 1
m 2 3 784 10 29 154 254 194 143
HD I10-I13
f 0 0 824 8 26 185 271 192 142
m 0 0 470 2 15 62 149 139 103
IHD I20-I25
f 0 0 290 0 11 34 96 81 68
m 0 0 131 2 2 21 42 41 23
Including: AP I20
f 0 0 83 0 2 11 28 25 17
m 0 0 65 0 1 5 25 18 16
AMI I21
f 0 0 16 0 0 0 4 6 6
m 0 0 27 0 0 3 10 8 6
SMI I22
f 0 0 6 0 0 0 3 2 1
m 0 0 175 0 7 16 46 61 45
CERVD I60-I69
f 0 0 136 0 3 7 36 44 46
m 0 0 18 0 0 0 8 6 4
f 0 0 15 0 0 0 6 4 5
m 0 0 10 0 1 0 5 2 2
CI I63
f 0 0 9 0 0 0 2 4 3
I64
I65-I66
infarction
110
LORI REGION
Table 2a.19
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
CSD Total I00-I99 20228 12676.3 59 131.5 162 1907.7
CRHD I05-I09 324 203.0 4 8.9 1 11.8
HD I10-I13 10781 6756.1 2 4.5 51 600.6
IHD I20-I25 6233 3906.0 0 0.0 0 0.0
including: AP I20 1772 1110.5 0 0.0 0 0.0
AMI I21 76 47.6 0 0.0 0 0.0
SMI I22 13 8.1 0 0.0 0 0.0
CERVD I60-I69 1674 1049.0 1 2.2 0 0.0
including: SH I60-I62 233 146.0 0 0.0 0 0.0
CI I63 135 84.6 1 2.2 0 0.0
I64 128 80.2 0 0.0 0 0.0
or infarction
infarction
INCIDENCE OF CSD AMONG POPULATION,

BY SEX AND AGE GROUP, 2020
Table 2a.20
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
CSD Total I00-I99 20 66 4093
m 0 0 23 0 0 7 10 5 1
CRHD I05-I09
f 0 1 20 0 1 5 8 5 1
m 0 18 1008 16 34 224 294 259 181
HD I10-I13
f 0 7 904 11 37 167 235 262 192
m 0 0 726 0 17 123 216 182 188
IHD I20-I25
f 0 0 493 3 13 85 137 134 121
m 0 0 246 0 7 41 77 76 45
including: AP I20
f 0 0 143 0 2 24 50 44 23
m 0 0 56 0 1 6 20 16 13
AMI I21
f 0 0 20 0 1 1 3 5 10
m 0 0 10 0 0 0 2 5 3
SMI I22
f 0 0 3 0 0 0 0 0 3
m 0 0 218 0 2 26 47 69 74
CERVD I60-I69
f 1 0 215 0 2 21 45 75 72
m 0 0 45 0 0 7 8 17 13
f 0 0 34 0 0 2 8 7 17
m 0 0 14 0 0 3 4 1 6
CI I63
f 1 0 22 0 0 1 5 8 8
I64
I65-I66
infarction
111
NHIAC
KOTAYK REGION
Table 2a.21
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
CSD Total I00-I99 18729 9964.9 58 108.7 104 1070.4
CRHD I05-I09 311 165.5 3 5.6 1 10.3
HD I10-I13 10268 5463.2 19 35.6 26 267.6
IHD I20-I25 5299 2819.4 0 0.0 0 0.0
including: AP I20 1789 951.8 0 0.0 0 0.0
AMI I21 161 85.7 0 0.0 0 0.0
SMI I22 33 17.6 0 0.0 0 0.0
CERVD I60-I69 1457 775.2 0 0.0 0 0.0
including: SH I60-I62 255 135.7 0 0.0 0 0.0
CI I63 371 197.4 0 0.0 0 0.0
I64 142 75.6 0 0.0 0 0.0

Table 2a.22
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
CSD Total I00-I99 22 55 3214
m 0 0 21 1 1 5 3 8 3
CRHD I05-I09
f 0 0 11 0 1 1 5 2 2
m 5 13 785 12 46 136 245 195 151
HD I10-I15
f 5 5 911 4 53 162 301 246 145
m 0 0 542 1 13 120 200 121 87
IHD I20-I25
f 0 0 270 0 4 43 100 72 51
m 0 0 168 1 6 38 52 43 28
including: AP I20
f 0 0 73 0 1 10 27 21 14
m 0 0 122 0 2 26 49 25 20
AMI I21
f 0 0 39 0 0 4 9 17 9
m 0 0 26 0 0 3 5 15 3
SMI I22
f 0 0 4 0 0 0 3 1 0
m 0 0 218 0 2 22 75 66 53
CERVD I60-I69
f 0 0 182 0 0 11 57 62 52
m 0 0 44 0 1 2 12 18 11
f 0 0 28 0 0 1 7 8 12
m 0 0 66 0 0 9 27 16 14
CI I63
f 0 0 38 0 0 2 13 15 8
I64
I65-I66
infarction
112
SHIRAK REGION
Table2a.23
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
CSD Total I00-I99 18448 10629.5 68 138.9 70 808.8
CRHD I05-I09 369 212.6 7 14.3 4 46.2
HD I10-I15 11497 6624.5 3 6.1 29 335.1
IHD I20-I25 4190 2414.2 0 0.0 0 0.0
including: AP I20 1470 847.0 0 0.0 0 0.0
AMI I21 91 52.4 0 0.0 0 0.0
SMI I22 46 26.5 0 0.0 0 0.0
CERVD I60-I69 1262 727.2 0 0.0 0 0.0
including: SH I60-I62 184 106.0 0 0.0 0 0.0
CI I63 89 51.3 0 0.0 0 0.0
I64 173 99.7 0 0.0 0 0.0

Table 2a.24
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 &>
CSD Total I00-I99 16 37 5905
m 0 0 49 0 1 7 10 21 10
CRHD I05-I09
f 1 0 23 0 2 2 9 6 4
m 2 12 2292 3 75 383 735 566 530
HD I10-I13
f 0 2 2070 0 70 444 564 483 509
m 0 0 474 0 12 71 142 148 101
IHD I20-I25
f 0 0 299 1 7 39 81 102 69
m 0 0 259 0 6 36 75 76 66
including: AP I20
f 0 0 149 1 2 20 56 49 21
m 0 0 73 0 1 22 23 19 8
AMI I21
f 0 0 18 0 0 3 5 7 3
m 0 0 36 0 0 2 14 14 6
SMI I22
f 0 0 10 0 0 0 5 3 2
m 0 0 200 0 3 23 47 68 59
CERVD I60-I69
f 0 0 161 0 1 14 43 58 45
m 0 0 28 0 0 2 5 12 9
f 0 0 22 0 0 0 9 7 6
m 0 0 18 0 0 0 1 10 7
CI I63
f 0 0 11 0 0 0 0 8 3
I64
I65-I66
infarction
113
NHIAC
SYUNIK REGION
Table 2a.25
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
CSD Total I00-I99 10048 9339.2 35 146.4 32 628.8
CRHD I05-I09 246 228.6 7 29.3 9 176.9
HD I10-I13 6384 5933.7 6 25.1 7 137.6
IHD I20-I25 2224 2067.1 0 0.0 0 0.0
including: AP I20 1344 1249.2 0 0.0 0 0.0
AMI I21 138 128.3 0 0.0 0 0.0
SMI I22 18 16.7 0 0.0 0 0.0
CERVD I60-I69 866 804.9 0 0.0 0 0.0
including: SH I60-I62 89 82.7 0 0.0 0 0.0
CI I63 319 296.5 0 0.0 0 0.0
I64 80 74.4 0 0.0 0 0.0
precerebral arteries, not I65-I66 218 202.6 0 0.0 0 0.0
resulting in cerebral infarction

Table 2a.26
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
CSD Total I00-I99 11 14 1406
m 0 1 2 0 2 0 0 0 0
CRHD I05-I09
f 0 1 1 0 0 1 0 0 0
m 1 2 355 12 41 80 115 69 38
HD I10-I13
f 0 0 405 8 49 101 123 81 43
m 0 0 218 0 5 45 82 43 43
IHD I20-I25
f 0 0 91 0 2 14 27 25 23
m 0 0 56 0 3 17 16 9 11
including: AP I20
f 0 0 33 0 1 7 12 8 5
m 0 0 107 0 2 19 50 19 17
AMI I21
f 0 0 31 0 1 1 8 11 10
m 0 0 13 0 0 1 5 4 3
SMI I22
f 0 0 5 0 0 1 0 2 2
m 0 0 132 0 1 8 34 48 41
CERVD I60-I69
f 0 0 144 0 0 8 32 50 54
m 0 0 24 0 0 1 6 9 8
f 0 0 22 0 0 1 3 7 11
m 0 0 37 0 0 0 14 14 9
CI I63
f 0 0 55 0 0 2 18 23 12
I64

114
VAYOTS DZOR REGION

Table 2a.27
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
CSD Total I00-I99 6339 16998.3 0 0.0 0 0.0
CRHD I05-I09 209 560.4 0 0.0 0 0.0
HD I10-I13 3578 9594.6 0 0.0 0 0.0
IHD I20-I25 1531 4105.4 0 0.0 0 0.0
including: AP I20 937 2512.6 0 0.0 0 0.0
AMI I21 30 80.4 0 0.0 0 0.0
SMI I22 11 29.5 0 0.0 0 0.0
CERVD I60-I69 662 1775.2 0 0.0 0 0.0
including:SH I60-I62 55 147.5 0 0.0 0 0.0
CI I63 10 26.8 0 0.0 0 0.0
I64 126 337.9 0 0.0 0 0.0
or infarction
infarction
INCIDENCE OF CSD AMONG POPULATION,

Table2a.28
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
CSD Total I00-I99 0 0 1507
m 0 0 11 0 2 5 2 2 0
CRHD I05-I09
f 0 0 10 0 3 1 5 1 0
m 0 0 402 6 45 80 118 84 69
HD I10-I13
f 0 0 404 2 29 95 129 88 61
m 0 0 177 0 3 50 52 46 26
IHD I20-I25
f 0 0 78 0 0 10 22 25 21
m 0 0 88 0 2 13 35 26 12
including: AP I20
f 0 0 63 0 0 10 18 21 14
m 0 0 23 0 1 8 4 5 5
AMI I21
f 0 0 7 0 0 0 2 2 3
m 0 0 11 0 0 2 0 7 2
SMI I22
f 0 0 0 0 0 0 0 0 0
m 0 0 128 0 1 13 23 30 61
CERVD I60-I69
f 0 0 122 0 0 16 18 25 63
m 0 0 23 0 1 7 5 4 6
f 0 0 15 0 0 4 2 2 7
m 0 0 6 0 0 0 1 0 5
CI I63
f 0 0 4 0 0 1 1 0 2
I64

115
NHIAC
TAVUSH REGION
Table 2a.29
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
CSD Total I00-I99 12051 12972.3 16 68.8 31 640.9
CRHD I05-I09 207 222.8 1 4.3 0 0.0
HD I10-I13 7281 7837.6 7 30.1 14 289.4
IHD I20-I25 2770 2981.8 0 0.0 0 0.0
including: AP I20 1065 1146.4 0 0.0 0 0.0
AMI I21 77 82.9 0 0.0 0 0.0
SMI I22 22 23.7 0 0.0 0 0.0
CERVD I60-I69 1066 1147.5 0 0.0 1 20.7
including:SH I60-I62 111 119.5 0 0.0 0 0.0
CI I63 130 139.9 0 0.0 0 0.0
I64 127 136.7 0 0.0 0 0.0
or infarction
infarction

Table 2a.30
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
CSD Total I00-I99 8 15 1859
m 0 0 15 0 0 2 6 6 1
CRHD I05-I09
f 0 0 17 0 2 3 5 4 3
m 1 4 439 10 36 96 129 93 75
HD I10-I13
f 1 1 425 8 35 101 114 96 71
m 0 0 281 0 18 49 71 68 75
IHD I20-I25
f 0 0 191 0 6 33 49 50 53
m 0 0 144 0 13 31 33 35 32
including: AP I20
f 0 0 96 0 3 17 24 25 27
m 0 0 51 0 0 4 15 15 17
AMI I21
f 0 0 26 0 1 2 5 8 10
m 0 0 11 0 0 2 3 3 3
SMI I22
f 0 0 9 0 1 1 1 3 3
m 0 0 163 2 3 15 31 40 72
CERVD I60-I69
f 0 1 153 0 1 11 38 34 69
m 0 0 35 0 0 3 9 12 11
f 0 0 23 0 0 1 8 5 9
m 0 0 27 0 0 3 4 7 13
CI I63
f 0 0 17 0 0 3 2 4 8
m 0 0 33 0 0 2 6 3 22
I64

precerebral arteries, not resulting I65-I66
in cerebral infarction f 0 0 50 0 0 5 7 11 27
116
ENDOCRINE SYSTEM DISEASES

INCIDENCE OF ED AMONG RA POPULATION, 2020
Table 2e.1
Diseases ICD X
EMD, endocrine, nutritional and metabolic

E00-E90 5565 663.9 901 968.2 1472 762.1 1715 852.7 790 459.4
diseases
Other nontoxic goitre E04 810 96.6 74 79.5 212 109.8 205 101.9 117 68.0
Thyrotoxicosis E05 172 20.5 37 39.8 68 35.2 59 29.3 43 25.0

Autoimmune thyroiditis E06.3 631 75.3 56 60.2 83 43.0 233 115.8 69 40.1
Type 1 diabetes mellitus E10 440 52.5 109 117.1 286 148.1 120 59.7 83 48.3
Amyloidosis E85.0 62 7.4 29 31.2 22 11.4 14 7.0 14 8.1
INCIDENCE OF ED AMONG ADOLESCENTS AGED 15-17 YEARS, 2020

Table 2e.2
Diseases ICD X
EMD, endocrine, nutritional and metabolic E00-

372 1088.9 41 846.4 66 691.8 155 1562.2 25 276.2
diseases E90

Amyloidosis E85.0 9 26.3 3 61.9 5 52.4 2 20.2 4 44.2
INCIDENCE OF ED AMONG CHILDREN AGED 0-14 YEARS, 2020
Table 2e.3
Diseases ICD X
EMD, endocrine, nutritional and metabolic

E00-E90 675 313.3 167 625.9 203 376.5 232 439.0 44 94.7
diseases

Amyloidosis E85.0 59 27.4 4 15.0 16 29.7 13 24.6 4 8.6
117
NHIAC
INCIDENCE OF ED AMONG RA POPULATION, 2020
continutation 2e.1
Vayots
Lori Kotayk Shirak Syunik Tavush RA Diseases
Dzor
EMD, endocrine,
1464 917.4 1391 740.1 1421 818.8 538 500.1 204 547.0 678 729.8 16139 715.2 nutritional and metabolic
diseases
111 69.6 185 98.4 259 149.2 52 48.3 35 93.9 92 99.0 2152 95.4 Other nontoxic goitre .
31 19.4 36 19.2 40 23.0 3 2.8 23 61.7 33 35.5 545 24.2 Thyrotoxicosis
72 45.1 75 39.9 83 47.8 31 28.8 11 29.5 28 30.1 1372 60.8 Autoimmune thyroiditis
173 108.4 163 86.7 187 107.7 44 40.9 7 18.8 66 71.0 1678 74.4 Type 1 diabetes mellitus
21 13.2 34 18.1 22 12.7 8 7.4 2 5.4 8 8.6 236 10.5 Amyloidosis
INCIDENCE OF ED AMONG ADOLESCENTS AGED 15-17, 2020

continutation 2e 2
Lori Kotayk Shirak Syunik Vayots Dzor Tavush RA Diseases
EMD, endocrine, nutritional

105 1236.5 76 782.2 70 808.8 24 471.6 0 0.0 40 827.0 974 918.5
and metabolic diseases
0 0.0 0 0.0 0 0.0 1 19.7 0 0.0 0 0.0 64 60.4 Other nontoxic goitre
0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 Thyrotoxicosis

1 11.8 4 41.2 7 80.9 0 0.0 0 0.0 4 82.7 39 36.8 Amyloidosis
INCIDENCE OF ED AMONG CHILDREN AGED 0-14, 2020

continutation 2e. 3
Vayots
Lori Kotayk Shirak Syunik Tavush RA
Dzor Diseases

242 539.3 213 399.1 149 304.4 11 46.0 1 10.8 67 287.9 2004 334.5
0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 4.3 1 0.2 Thyrotoxicosis
14 31.2 15 28.1 8 16.3 2 8.4 1 10.8 0 0.0 136 22.7 Amyloidosis
118
PREVALENCE OF ED AMONG ADULT POPULATION IN REGIONS
(total number of patients) 2020
Table 2e.4
Diseases ICD
X
EMD, endocrine, nutritional and E00-

54636 6517.7 5803 6236.0 12206 6319.8 12589 6259.1 8548 4971.0
Amyloidosis E85.0 1605 191.5 235 252.5 389 201.4 283 140.7 506 294.3
PREVALENCE OF ED AMONG ADOLESCENTS AGED 15-17 YEARS IN REGIONS

Table 2e.5
Diseases ICD
X
1086 3179.0 104 2147.0 166 1740.0 278 2801.9 161 1778.4
Amyloidosis E85.0 124 363.0 28 578.0 27 283.0 16 161.3 41 452.9

Table 2e.6
ICD Yerevan Aragatsotn Ararat Armavir Gegharkunik
Diseases
X a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v. a.v. r.v.
2389 1108.8 303 1135.6 586 1086.8 523 989.6 240 516.8
Amyloidosis E85.0 449 208.4 64 239.9 83 153.9 78 147.6 115 247.6
119
NHIAC
PREVALENCE OF ED AMONG ADULT POPULATION IN REGIONS
continutation 2e.4
EMD, endocrine,
10758 6741.7 12719 6767.2 9688 5582.1 5785 5376.9 2254 6044.2 5382 5793.5 140368 6220.8 nutritional and
metabolic diseases
240 150.4 393 209.1 201 115.8 87 80.9 146 391.5 139 149.6 3176 140.8 Thyrotoxicosis
Autoimmune
502 314.6 440 234.1 301 173.4 259 240.7 54 144.8 134 144.2 6187 274.2
thyroiditis
Type 1 diabetes
1330 833.5 1516 806.6 1659 955.9 419 389.4 202 541.7 572 615.7 15155 671.6
mellitus
Type 2 diabetes
6298 3946.8 7744 4120.2 5997 3455.4 4005 3722.5 1405 3767.6 3578 3851.5 90294 4001.7
mellitus
441 276.4 607 323.0 537 309.4 101 93.9 95 254.7 89 95.8 4888 216.6 Amyloidosis

continutation 2e.5
244 2873.3 165 1698.2 199 2299.2 61 1198.7 17 981.5 88 1819.3 2569 2422.6
3 35.3 0 0.0 0 0.0 1 19.7 0 0.0 0 0.0 6 5.7 Thyrotoxicosis
31 365.0 32 329.4 20 231.1 4 78.6 3 173.2 5 103.4 331 312.1 Amyloidosis

continutation 2e.6
EMD, endocrine, nutritional and
533 1187.7 536 1004.2 551 1125.5 61 255.2 22 236.8 202 868.1 5946 992.6
metabolic diseases
3 6.7 1 1.9 5 10.2 0 0.0 0 0.0 0 0.0 21 3.5 Thyrotoxicosis
83 185.0 149 279.2 46 94.0 17 71.1 5 53.8 14 60.2 1103 184.1 Amyloidosis
120
RA PREVALENCE OF ED AMONG POPULATION
Table 2e.7
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
ED Total 140368 6220.8 5946 992.6 2569 2422.6

Other nontoxic goitre E04 13067 579.1 133 22.2 138 130.1
Thyrotoxicosis E05 3176 140.8 21 3.5 6 5.7
Autoimmune thyroiditis E06.3 6187 274.2 226 37.7 119 112.2
Type 1 diabetes mellitus E10 15155 671.6 488 81.5 169 159.4
Amyloidosis E85.0 4888 216.6 1103 184.1 331 312.1
INCIDENCE OF ED AMONG POPULATION

Table 2e.8
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
ED Total 2004 974 16139
m 16 15 523 16 116 143 139 68 41
Other nontoxic goitre E04
f 36 49 1629 79 340 449 393 208 160
m 1 0 169 8 27 65 36 18 15
Thyrotoxicosis E05
f 0 0 376 19 96 108 90 36 27
m 22 15 343 15 60 115 90 46 17
Autoimmune thyroiditis E06.3
f 52 24 1029 67 245 278 234 135 70
m 11 9 729 32 79 136 193 159 130
Type 1 diabetes mellitus E10
f 11 4 949 26 83 176 262 225 177
m 0 0 3762 12 230 784 1108 873 755
f 0 0 4689 20 227 815 1391 1196 1040
m 77 25 129 35 37 28 22 5 2
Amyloidosis E85.0
f 59 14 107 19 35 27 17 3 6
121
NHIAC
YEREVAN
PREVALENCE OF ED AMONG POPULATION
Table 2e.9
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
ED Total 54636 6517.7 2389 1108.8 1086 3179.0

Amyloidosis E85.0 1605 191.5 449 208.4 124 363.0
INCIDENCE OF ED AMONG POPULATION

Table 2e.10
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 &>
ED Total 675 372 5565
m 3 9 194 7 38 44 44 33 28
f 27 42 616 7 101 124 158 114 112
m 0 0 59 1 8 19 12 6 13
Thyrotoxicosis E05
f 0 0 113 4 17 30 27 17 18
m 15 12 224 7 36 72 55 38 16
f 44 15 407 14 75 101 88 81 48
m 11 9 192 13 21 47 37 34 40
f 11 4 248 14 21 61 62 47 43
m 0 0 1338 8 100 304 342 285 299
f 0 0 1799 15 108 355 472 431 418
m 40 6 33 7 9 10 7 0 0
Amyloidosis E85.0
f 19 3 29 2 9 9 3 3 3
122
ARAGATSOTNF REGION
Table 2e.11
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
ED Total 5803 6236.0 303 1135.6 104 2147.0

Amyloidosis E85.0 235 252.5 64 239.9 28 578.0
INCIDENCE OF ED AMONG POPULATION ,

Table 2e.12
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 &>
ED Total 167 41 901
m 1 1 21 1 7 3 8 1 1
f 0 0 53 10 6 28 7 2 0
m 0 0 16 0 2 12 1 1 0
Thyrotoxicosis E05
f 0 0 21 7 6 6 0 2 0
m 0 0 7 0 1 2 3 1 0
f 0 0 49 21 12 8 5 2 1
m 0 0 42 2 6 16 13 2 3
f 0 0 67 1 9 26 21 4 6
m 0 0 225 3 19 48 81 47 27
f 0 0 227 3 18 38 82 52 34
m 3 0 16 3 2 7 4 0 0
Amyloidosis E85.0
f 1 3 13 3 2 7 1 0 0
123
NHIAC
ARARAT REGION
Table 2e.13
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
ED Total 12206 6319.8 586 1086.8 166 1740.0
Amyloidosis E85.0 389 201.4 83 153.9 27 283.0

Table 2e.14
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
ED Total 203 66 1472
m 0 0 76 4 17 21 18 12 4
f 0 2 136 7 29 52 29 10 9
m 0 0 21 2 7 4 8 0 0
Thyrotoxicosis E05
f 0 0 47 0 15 16 12 2 2
m 4 0 21 4 1 11 5 0 0
f 6 3 62 2 22 18 16 2 2
m 0 0 137 0 33 23 38 31 12
f 0 0 149 4 26 24 30 51 14
m 0 0 336 0 9 74 107 109 37

f 0 0 367 0 10 66 131 116 44
m 4 2 11 2 4 2 1 1 1
Amyloidosis E85.0
f 12 3 11 3 5 1 1 0 1
124
ARMAVIR REGION
Table 2e.15
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
ED Total 12589 6259.1 523 989.6 278 2801.9
Amyloidosis E85.0 283 140.7 78 147.6 16 161.3

Table 2e.16
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
ED Total 232 155 1715
m 8 5 55 1 14 19 14 7 0
f 4 4 150 8 48 45 34 9 6
m 0 0 18 0 3 8 6 0 1
Thyrotoxicosis E05
f 0 0 41 1 8 12 16 3 1
m 2 2 40 3 13 13 7 4 0
f 2 2 193 17 50 51 43 22 10
m 0 0 49 0 5 11 19 10 4
f 0 0 71 0 7 11 25 19 9
m 0 0 338 0 27 61 109 84 57
f 0 0 424 0 22 73 133 117 79
m 7 1 10 4 3 1 1 0 1
Amyloidosis E85.0
f 6 1 4 0 3 0 0 0 1
GEGHARKUNIK REGION
125
NHIAC
Table 2e.17
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
ED Total 8548 4971.0 240 516.8 161 1778.4
Amyloidosis E85.0 506 294.3 115 247.6 41 452.9

Table 2e.18
Adults
Diseases ICD X Sex 0-14 15-17 18- 60-
Total 25-39 40-49 50-59 65 & >
24 65
ED Total 44 25 790
m 0 0 18 1 3 4 8 1 1
f 0 0 99 4 30 36 19 9 1
m 0 0 5 0 2 3 0 0 0
Thyrotoxicosis E05
f 0 0 38 0 19 11 6 1 1
m 0 0 12 0 2 4 5 1 0
f 0 4 57 2 19 18 11 6 1
m 0 0 40 1 3 5 13 11 7
f 0 0 43 1 1 3 11 19 8
m 0 0 211 0 2 31 80 55 43
f 0 0 206 0 2 28 71 64 41
m 2 3 11 5 3 1 1 1 0
Amyloidosis E85.0
f 2 1 3 0 1 0 1 0 1
126
LORI REGION
Table 2e.19
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
ED Total 10758 6741.7 533 1187.7 244 2873.3
Amyloidosis E85.0 441 276.4 83 185.0 31 365.0

Table 2e.20
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
ED Total 242 105 1464
m 0 0 12 0 1 5 6 0 0
f 1 0 99 8 24 19 27 12 9
m 0 0 4 0 1 1 1 1 0
Thyrotoxicosis E05
f 0 0 27 0 7 4 10 3 3
m 0 0 10 0 2 2 5 0 1
f 0 0 62 3 16 14 21 4 4
m 0 0 67 0 4 1 16 20 26
f 0 0 106 1 7 10 28 20 40
m 0 0 339 0 19 52 98 78 92
f 0 0 400 0 11 48 112 103 126
m 9 1 13 4 7 0 2 0 0
Amyloidosis E85.0
f 5 0 8 2 6 0 0 0 0
127
NHIAC
KOTAYK REGION
Table 2e.21
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
ED Total 12719 6767.2 536 1004.2 165 1698.2
Amyloidosis E85.0 607 323.0 149 279.2 32 329.4

Table 2e.22
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
ED Total 213 76 1391
m 0 0 25 0 10 9 5 1 0
f 0 0 160 20 35 48 34 15 8
m 0 0 16 0 1 9 3 3 0
Thyrotoxicosis E05
f 0 0 20 0 1 9 7 2 1
m 0 0 11 0 1 7 3 0 0
f 0 0 64 5 15 20 19 4 1
m 0 0 60 2 3 7 14 19 15
f 0 0 103 1 4 12 33 28 25
m 0 0 355 1 24 67 94 98 71
f 0 0 459 1 16 52 138 130 122
m 8 4 17 9 5 2 1 0 0
Amyloidosis E85.0
f 7 0 17 7 4 2 4 0 0
128
SHIRAK REGION
Table 2e.23
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
ED Total 9688 5582.1 551 1125.5 199 2299.2
Amyloidosis E85.0 537 309.4 46 94.0 20 231.1

Table 2e.24
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
ED Total 149 70 1421
m 4 0 67 0 15 24 19 5 4
f 3 0 192 5 40 62 51 26 8
m 0 0 14 3 2 2 2 5 0
Thyrotoxicosis E05
f 0 0 26 2 7 6 6 4 1
m 0 0 10 0 3 2 3 2 0
f 0 0 73 1 23 25 15 7 2
m 0 0 92 12 3 18 28 17 14
f 0 0 95 4 5 15 31 16 24
m 0 0 270 0 12 63 94 44 57
f 0 0 396 1 24 73 119 92 87
m 3 4 9 0 1 4 3 1 0
Amyloidosis E85.0
f 5 3 13 0 3 5 5 0 0
129
NHIAC
SYUNIK REGION
Table 2e.25
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
ED Total 5785 5376.9 61 255.2 61 1198.7
Amyloidosis E85.0 101 93.9 17 71.1 4 78.6

Table 2e.26
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
ED Total 11 24 538
m 0 0 11 0 3 6 1 1 0
f 1 1 41 2 9 14 12 3 1
m 0 0 1 0 0 1 0 0 0
Thyrotoxicosis E05
f 0 0 2 0 0 2 0 0 0
m 0 0 3 0 0 2 1 0 0
f 0 0 28 1 7 14 4 2 0
m 0 0 17 1 1 6 6 3 0
f 0 0 27 0 1 8 11 5 2
m 0 0 145 0 10 43 45 23 24
f 0 0 189 0 8 39 58 40 44
m 1 0 2 0 1 1 0 0 0
Amyloidosis E85.0
f 1 0 6 2 1 2 1 0 0
130
VAYOTS DZOR REGION

Table 2e.27
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
ED Total 2254 6044.2 22 236.8 17 981.5
Type 1 diabetes mellitus 202 541.7 9 96.9 2 115.5
Amyloidosis E85.0 95 254.7 5 53.8 3 173.2

Table 2e.28
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
ED Total 1 0 204
m 0 0 12 0 1 2 5 4 0
f 0 0 23 0 6 5 7 3 2
m 0 0 1 0 0 1 0 0 0
Thyrotoxicosis E05
f 0 0 22 1 8 10 3 0 0
m 0 0 0 0 0 0 0 0 0
f 0 0 11 0 0 6 3 1 1
m 0 0 4 0 0 1 1 1 1
f 0 0 3 0 0 2 1 0 0
m 0 0 49 0 1 13 11 10 14
f 0 0 54 0 2 12 20 9 11
m 0 0 1 0 1 0 0 0 0
Amyloidosis E85.0
f 1 0 1 0 0 1 0 0 0
131
NHIAC
TAVUSH REGION
Table 2e.29
Adults 0-14 y. o. 15-17 y. o.
Diseases ICD X
ED Total 5382 5793.5 202 868.1 88 1819.3
Amyloidosis E85.0 89 95.8 14 60.2 5 103.4

Table 2e.30
Adults
Total 18-24 25-39 40-49 50-59 60-65 65 & >
ED Total 67 40 678
m 0 0 32 2 7 6 11 3 3
f 0 0 60 8 12 16 15 5 4
m 1 0 14 2 1 5 3 2 1
Thyrotoxicosis E05
f 0 0 19 4 8 2 3 2 0
m 1 1 5 1 1 0 3 0 0
f 0 0 23 1 6 3 9 4 0
m 0 0 29 1 0 1 8 11 8
f 0 0 37 0 2 4 9 16 6
m 0 0 156 0 7 28 47 40 34
f 0 0 168 0 6 31 55 42 34
m 0 4 6 1 1 0 2 2 0
Amyloidosis E85.0
f 0 0 2 0 1 0 1 0 0
132
MALIGNANT NEOPLASM
MALIGNANT NEOPLASM PREVALENCE IN RA
Table 2m.n. 1
Number of patients with confirmed Number of patients with confirmed
malignant neoplasm diagnosed for the first malignant neoplasm diagnosed for
time in life and recorded by oncology clinics the first time in life and recorded by
Years End of the year number of patients on oncology clinics End of the year
dispensary follow up by oncology clinics number of patients on dispensary
follow up by oncology clinics
a.v. r.v. a.v. r.v.
1985 4710 140.6 17584 522.0
1987 5119 148.8 20045 578.7
1988 5227 151.0 21228 613.4
1989 5270 150.9 22067 632.0
1990 5162 145.1 20929 588.2
1991 4905 135.7 21787 602.6
1992 4462 121.1 21584 585.6
1993 4586 122.9 21670 580.7
1994 4515 120.5 21709 578.4
1995 4705 125.2 21290 565.3
1996 4757 126.1 20721 548.1
1997 4709 124.4 20602 543.4
1998 5145 135.6 21605 568.8
1999 5415 142.5 22589 593.9
2000 5413 142.3 21972 577.8
2001 5666 149.1 23451 617.1
2002 5737 178.6 24384 759.6
2003 5951 185.3 25580 796.3
2004 6174 192.1 26522 824.7
2005 6396 198.8 26512 823.6
2006 7163 222.4 27963 867.6
2007 7294 226.1 28439 880.4
2008 7336 226.8 28692 886.1
2009 7657 236.1 30117 926.8
2010 7593 233.2 31550 967.0
2011 7858 240.4 32580 995.0
2012 7877 260.5 34400 1136.5
2013 7911 261.8 36660 1215.1
2014 8365 277.6 38918 1292.7
2015 8372 278.6 40862 1362.7
2016 8376 279.9 42821 1434.0
2017 8389 281.6 43830 1474.4
2018 8447 284.5 47146 1589.9
2019 7908 266.9 50300 1699.5
2020 6934 234.1 50416 1701.3
133
NHIAC
MALIGNANT NEOPLASM PREVALENCE BY AGE GROUP

Table 2m.n. 2
2018 2019
Number of patients diagnosed for the first time in life and Number of patients diagnosed for the first time in life and
Age followed up by oncology clinics and followed up by oncology clinics
Total male female Total male female
0-14 47 7.8 28 10.0 19 6.0 77 12.8 49 15.4 28 10.0

15-17 4 4.0 1 2.1 3 5.6 12 11.8 10 18.4 2 4.2
18-24 43 16.8 20 15.4 23 18.3 49 20.1 21 16.8 28 23.6
25-34 201 38.6 75 30.3 126 46.0 246 48.6 81 33.8 165 61.9
35-44 395 96.4 138 71.7 257 118.3 510 120.5 141 70.9 369 164.4
45-54 920 269.2 388 253.8 532 281.6 940 282.9 332 224.3 608 329.9
55-59 994 462.5 477 500.0 517 432.6 1101 527.6 524 569.6 577 494.4
60-64 1245 701.8 638 826.4 607 605.8 1446 773.3 753 927.3 693 655.0
65 & > 2998 859.3 1561 1138.6 1437 678.5 3527 982.2 1925 1361.4 1602 735.9
Total 6847 230.6 3326 236.7 3521 225.1 7908 266.9 3836 274.1 4072 260.5
r.v.- per 100 000 population
MALIGNANT NEOPLASM PREVALENCE BY AGE GROUP, 2020
Table 2m.n. 3
2020
Number of patients diagnosed for the first time in life and followed up by oncology clinics
Age Total male female
0-14 60 10.0 37 11.7 23 8.2
15-17 10 9.4 6 10.6 4 8.1
18-24 50 21.3 20 16.5 30 26.5
25-34 243 49.5 74 31.8 169 65.5
35-44 511 116.4 144 69.8 367 157.6
45-54 810 246.7 286 195.2 524 288.1
55-59 888 445.6 423 486.2 465 414.1
60-64 1281 656.3 672 793.4 609 551.1
65 & > 3081 835.0 1684 1162.2 1397 623.4
Total 6934 234.1 3346 239.4 3588 229.4

r.v.- per 100 000 population
134
INCIDENCE OF CONFIRMED COMMON MALIGNANT NEOPLASM BY SEX AND AGE GROUP

(absolute value) 2018
Table 2m.n. 4
Diseases ICD X Total 0-14 15-17 18-24 25-34 35-44 45-54 55-59 60-64 65 & >
FEMALE
Breast C50 1135 1 38 112 201 194 208 381
Cervix uteri C53 228 5 29 66 39 35 54
Corpus uteri C54 223 12 35 31 61 84
Ovary C56 160 1 1 3 10 16 38 33 58
C33-
Trachea, bronchus and lung 120 2 3 18 12 21 64
C34
Stomach C16 172 1 3 4 16 19 23 106
Colon C18 229 2 8 25 26 37 131
MALE
C33-
Trachea, bronchus and lung 779 1 16 82 128 178 374
C34
Larynx C32 136 1 18 28 32 57
Stomach C16 257 6 13 44 30 36 128
Colon C18 219 3 9 22 23 43 119
Liver and intrahepatic bile

C22 54 4 10 12 11 17
ducts
Prostate C61 254 6 13 45 190
Bladder C67 332 3 8 35 52 79 155
135
NHIAC

Table 2m.n. 5
FEMALE
Breast C50 1324 6 46 153 241 205 238 435
Cervix uteri C53 274 13 42 69 49 43 58
Corpus uteri C54 248 1 5 19 45 70 108
Ovary C56 188 1 2 7 14 29 32 29 74
Trachea, bronchus and

lung C33- C34 125 2 2 17 16 21 67
Stomach C16 196 3 12 22 25 27 107
Colon C18 252 1 7 18 19 40 167
MALE

C33- C34 843 10 63 106 194 470
lung
Larynx C32 140 4 14 19 38 65
Stomach C16 266 3 8 30 37 55 133
Colon C18 252 2 9 12 37 45 147
Liver and intrahepatic

C22 85 12 14 17 42
bile ducts
Prostate C61 361 3 3 4 33 66 252
Bladder C67 393 11 32 69 84 197
136
Table 2m.n. 6
FEMALE
Breast C50 1116 1 1 46 165 212 143 193 355
Cervix uteri C53 206 9 24 49 29 25 70
Corpus uteri C54 173 3 7 11 24 41 87
Ovary C56 192 2 2 5 13 36 36 32 66

lung C33- C34 138 1 2 7 11 16 42 59
Stomach C16 147 1 11 14 15 21 85
Colon C18 229 2 9 21 24 47 126
MALE

C33- C34 641 1 4 8 41 90 156 341
lung
Larynx C32 117 2 10 22 34 49
Stomach C16 204 1 7 20 31 36 109
Colon C18 246 3 11 17 25 51 139
Liver and intrahepatic

C22 88 1 9 14 23 41
bile ducts
Prostate C61 343 1 1 9 19 62 251
Bladder C67 351 1 10 28 48 73 191
137
NHIAC
PRAVELENCE OF MALIGNANT NEOPLASM AMONG RA POPULATION, 2020
Table 2m.n. 7
From the number of patients diagnosed
End of the year
Indica Indicat
Tumor localization ICD X From Stages
tor or
Total them
I -II III IV
women
a.v. 50416 29808 a.v. 1985 1203 1542
Malignant neoplasms:Total C00-C97
r.v. 1701.3 1904.4 % 42.0 25.4 32.6
Including:
a.v. 315 52 a.v. 12 5 2
Lip C00
r.v. 10.6 3.3 % 63.2 26.3 10.5
a.v. 737 246 a.v. 32 26 22
Oral cavity and pharynx C01-C14
r.v. 24.9 15.7 % 40.0 32.5 27.5
a.v. 128 43 a.v. 4 8 13
Oesophagus C15
r.v. 4.3 2.7 % 16.0 32.0 52.0
a.v. 1878 738 a.v. 53 76 123
Stomach C16
r.v. 63.4 47.2 % 21.0 30.2 48.8
a.v. 3095 1598 a.v. 78 140 110
Colon C 18
r.v. 104.4 102.1 % 23.8 42.7 33.5
Rectosigmoid junction, rectum , anus a.v. 1480 756 a.v. 47 79 65
C19-C21
and anal canal r.v. 49.9 48.3 % 24.6 41.4 34.0
a.v. 1217 55 a.v. 26 38 37
Larynx C32
r.v. 41.1 3.5 % 25.7 37.6 36.6
a.v. 3150 555 a.v. 80 117 307
Trachea, bronchus and lung C33-C34
r.v. 106.3 35.5 % 15.9 23.2 60.9
C40, a.v. 1180 571 a.v. 35 13 28
Bone and articular cartilage , mesothelial
C41,
and soft tissue r.v. 39.8 36,5 % 46.1 17.1 36.8
C45-C49
a.v. 453 285 a.v. 20 11 9
Melanoma of skin C43
r.v. 15.3 18.,21 % 50.0 27.5 22.5
a.v. 2764 1294 a.v. 88 24 20
Other malignant neoplasms of skin C44
r.v. 93.3 82.7 % 66.7 18.2 15.2
a.v. 11693 11471 a.v. 580 139 163
Breast C50
r.v. 394.6 732.9 % 65.8 15.8 18.,5
a.v. 2601 2601 a.v. 47 87 37
Cervix uteri C53
r.v. 166.2 166.2 % 27.5 50.9 21.6
a.v. 1925 1925 a.v. 85 30 13
Corpus uteri C54
r.v. 123.0 123.0 % 66.4 23.4 10.2
a.v. 1323 1323 a.v. 37 72 42
Ovary C56
r.v. 84.5 84.5 % 24.50 47.68 27.81
a.v. 1758 0 a.v. 96 76 95
Prostate C61
r.v. 125.7 0.0 % 36.0 28.5 35.6
a.v. 3341 489 a.v. 234 40 46
Bladder C67
r.v. 112.7 31.2 % 73.1 12.5 14.4
a.v. 1633 1354 a.v. 144 45 10
Thyroid gland C73
r.v. 55.1 86.5 % 72.4 22.6 5.0
C81- a.v. 4231 1968 a.v. 69 44 47
Malignant lymphomas
C90. C96 r.v. 142.8 125.7 % 43.13 27.50 29.38
a.v. 1959 895 a.v. 31 9 4
Leukemia (sputum) C91-C95
r.v. 66.1 57.2 % 70.5 20.5 9.1
a.v. 1723 967 a.v. 80 56 147
Other neoplasmes
r.v. 58.1 61.8 % 28.3 19.8 51.9
138
PRAVELENCE OF MALIGNANT NEOPLASM AMONG YEREVAN POPULATION, 2020
Table 2m.n. 8
End of the year
Indicat
NEOPLASMS ICD X Indicator From Stages
or
Total them
I -II III IV
women
a.v. 20886 12898 a.v. 748 513 538
r.v. 1913.2 2197.3 % 41.6 28.5 29.9
Including:
a.v. 46 12 a.v. 5 1 0
Lip C00
r.v. 4.2 2.0 % 83.3 16.7 0.0
a.v. 290 91 a.v. 14 13 8
r.v. 26.6 15.5 % 40.0 37.1 22.9
a.v. 55 22 a.v. 1 5 4
Oesophagus C15
r.v. 5.0 3.7 % 10.0 50.0 40.0
a.v. 624 258 a.v. 9 28 25
Stomach C16
r.v. 57.2 44.0 % 14.5 45.2 40.3
a.v. 1465 807 a.v. 28 72 51
Colon C 18
r.v. 134.2 137.5 % 18.5 47.7 33.8
C19-C21
and anal canal r.v. 62.9 62.0 % 16.5 53.2 30.4
a.v. 449 26 a.v. 9 18 11
Larynx C32
r.v. 41.1 4.4 % 23.7 47.4 28.9
a.v. 1278 240 a.v. 14 47 112
r.v. 117.1 40.9 % 8.1 27.2 64.7
Bone and articular cartilage , C40, C41, a.v. 368 183 a.v. 6 4 12
mesothelial and soft tissue C45-C49 r.v. 33.7 31.2 % 27.3 18.2 54.5
a.v. 173 108 a.v. 5 2 3
r.v. 15.8 18.4 % 50.0 20.0 30.0
a.v. 947 446 a.v. 37 9 7
r.v. 86.7 76.0 % 69.8 17.0 13.2
a.v. 5566 5483 a.v. 292 60 66
Breast C50
r.v. 509.8 934.1 % 69.9 14.4 15.8
a.v. 783 783 a.v. 17 25 9
Cervix uteri C53
r.v. 133.4 133.4 % 33.3 49.0 17.6
a.v. 849 849 a.v. 40 13 5
Corpus uteri C54
r.v. 144.6 144.6 % 69.0 22.4 8.6
a.v. 560 560 a.v. 10 30 13
Ovary C56
r.v. 95.4 95.4 % 18.9 56.6 24.5
a.v. 887 0 a.v. 38 39 39
Prostate C61
r.v. 175.7 0.0 % 32.8 33.6 33.6
a.v. 1396 251 a.v. 82 17 19
Bladder C67
r.v. 127.9 42.8 % 69.5 14.4 16.1
a.v. 688 567 a.v. 41 19 4
Thyroid gland C73
r.v. 63,0 96,6 % 64,1 29,7 6,3
C81-C90, a.v. 1622 827 a.v. 24 16 12
Malignant lymphomas
C96 r.v. 148,6 140,9 % 46,2 30,8 23,1
a.v. 746 355 a.v. 13 5 2
r.v. 68,3 60,5 % 65,0 25,0 10,0
a.v. 665 390 a.v. 24 24 46
Other neoplasmes
r.v. 60,9 66,4 % 25,5 25,5 48,9
139
NHIAC
PRAVELENCE OF MALIGNANT NEOPLASM AMONG
ARAGATSOTN POPULATION, 2020
Table 2m.n. 9
End of the year
Indicat
or
Total them
I -II III IV
women
a.v. 1820 960 a.v. 107 39 30
r.v. 1461.8 1502.3 % 60.80 22,16 17.05
Including:
a.v. 24 4 a.v. 1 0 0
Lip C00
r.v. 19.3 6.3 % 100.0 0.0 0.0
a.v. 40 9 a.v. 3 1 2
r.v. 32.1 14.1 % 50.0 16.7 33.3
a.v. 5 1 a.v. 0 1 1
Oesophagus C15
r.v. 4.0 1.6 % 0.0 50.0 50.0
a.v. 101 40 a.v. 5 3 0
Stomach C16
r.v. 81.1 62.6 % 62.5 37.5 0.0
a.v. 87 38 a.v. 3 4 2
Colon C 18
r.v. 69.9 59.5 % 33.3 44.4 22.2
C19-C21
and anal canal r.v. 33.7 26.6 % 100.0 0.0 0.0
a.v. 61 2 a.v. 2 2 2
Larynx C32
r.v. 49.0 3.1 % 33.3 33.3 33.3
a.v. 134 22 a.v. 10 5 4
r.v. 107.6 34.4 % 52.6 26.3 21.1
a.v. 13 11 a.v. 0 0 0
r.v. 10.4 17.2 % 0.0 0.0 0.0
a.v. 136 59 a.v. 4 1 1
r.v. 109.2 92.3 % 66.7 16.7 16.7
a.v. 327 321 a.v. 19 7 1
Breast C50
r.v. 262.7 502.3 % 70.4 25.9 3.7
a.v. 92 92 a.v. 3 2 1
Cervix uteri C53
r.v. 144.0 144.0 % 50.0 33.3 16.7
a.v. 57 57 a.v. 1 1 0
Corpus uteri C54
r.v. 89.2 89.2 % 50.0 50.0 0.0
a.v. 43 43 a.v. 3 3 1
Ovary C56
r.v. 67.3 67.3 % 42.9 42.9 14.3
a.v. 44 0 a.v. 2 1 5
Prostate C61
r.v. 72.6 0.0 % 25.0 12.5 62.5
a.v. 127 15 a.v. 11 1 4
Bladder C67
r.v. 102,0 23,5 % 68.8 6.3 25.0
a.v. 56 44 a.v. 12 0 0
Thyroid gland C73
r.v. 45,0 68,9 % 100.0 0.0 0.0
C81-C90, a.v. 181 76 a.v. 6 0 0
Malignant lymphomas
C96 r.v. 145.4 118.9 % 100.0 0.0 0.0
a.v. 96 43 a.v. 3 0 0
r.v. 77.1 67.3 % 100.0 0.0 0.0
a.v. 49 28 a.v. 9 3 2
Other neoplasmes
r.v. 39.4 43.8 % 64.3 21.4 14.3
140
PRAVELENCE OF MALIGNANT NEOPLASM
AMONG ARARAT POPULATION, 2020
Table 2m.n. 10
End of the year
Indicat
or
Total them
I -II III IV
women
a.v. 3676 2115 a.v. 151 78 111
r.v. 1432.6 1587.8 % 44.4 22,9 32.6
Including:
a.v. 30 5 a.v. 2 0 0
Lip C00
r.v. 11.7 3.8 % 100.0 0.0 0.0
a.v. 40 15 a.v. 0 2 1
r.v. 15.6 11.3 % 0.0 66.7 33.3
a.v. 7 2 a.v. 0 0 1
Oesophagus C15
r.v. 2.7 1.5 % 0.0 0.0 33.3
a.v. 138 47 a.v. 3 7 9
Stomach C16
r.v. 53.8 35.3 % 15.8 36.8 47.4
a.v. 200 85 a.v. 9 6 4
Colon C 18
r.v. 77.9 63.8 % 47.4 31.6 21.1
C19-C21
and anal canal r.v. 42.1 46.5 % 16.7 41.7 41.7
a.v. 112 1 a.v. 4 2 4
Larynx C32
r.v. 43.6 0.8 % 40.0 20.0 40.0
a.v. 220 45 a.v. 4 9 28
r.v. 85.7 33.8 % 9.8 22.0 68.3
a.v. 39 29 a.v. 3 1 0
r.v. 15.2 21.8 % 75.0 25.0 0.0
a.v. 213 99 a.v. 9 2 1
r.v. 83.0 74.3 % 75.0 16.7 8.3
a.v. 815 797 a.v. 40 11 8
Breast C50
r.v. 317.6 598.3 % 67.8 18.6 13.6
a.v. 209 209 a.v. 3 9 2
Cervix uteri C53
r.v. 156.9 156.9 % 21.4 64.3 14.3
a.v. 110 110 a.v. 3 0 0
Corpus uteri C54
r.v. 82.6 82.6 % 100.0 0.0 0.0
a.v. 80 80 a.v. 3 3 3
Ovary C56
r.v. 60.1 60.1 % 33.3 33.3 33.3
a.v. 116 0 a.v. 6 5 5
Prostate C61
r.v. 94.0 0.0 % 37.5 31.3 31.3
a.v. 203 25 a.v. 21,0 1,0 3,0
Bladder C67
r.v. 79.1 18.8 % 84.0 4.0 12.0
a.v. 123 102 a.v. 12 1 1
Thyroid gland C73
r.v. 47.9 39.8 % 85.7 7.1 7.1
C81-C90, a.v. 363 159 a.v. 4 6 5
Malignant lymphomas
C96 r.v. 141.5 119.4 % 26.7 40.0 33.3
a.v. 160 71 a.v. 2 0 0
r.v. 62.4 53.3 % 100.0 0.0 0.0
a.v. 146 80 a.v. 9 5 16
Other neoplasmes
r.v. 56.9 60.1 % 30.0 16.7 53.3
141
NHIAC
ARMAVIR POPULATION, 2020
Table 2m.n. 11

End of the year
Indicat
NEOPLASMS ICD X Indicator
From or Stages
Total them
I -II III IV
women
a.v. 3481 2055 a.v. 205 99 150
r.v. 1318.6 1509.9 % 45.2 21.8 33.0
Including:
a.v. 23 4 a.v. 0 0 0
Lip C00
r.v. 8.7 2.9 % 0.0 0.0 0.0
a.v. 54 26 a.v. 7 1 2
r.v. 20.5 19.1 % 70.0 10.0 20.0
a.v. 8 2 a.v. 0 0 3
Oesophagus C15
r.v. 3.0 1.5 % 0.0 0.0 100.0
a.v. 103 43 a.v. 5 8 16
Stomach C16
r.v. 39.0 31.6 % 17.2 27.6 55.2
a.v. 181 89 a.v. 10 15 6
Colon C 18
r.v. 68.6 65.4 % 32.3 48.4 19.4
C19-C21
and anal canal r.v. 37.9 29.4 % 42.9 35.7 21.4
a.v. 90 4 a.v. 2 3 3
Larynx C32
r.v. 34.1 2.9 % 25.0 37.5 37.5
a.v. 195 24 a.v. 21 9 30
r.v. 73.9 17.6 % 35.0 15.0 50.0
a.v. 20 9 a.v. 0 0 0
r.v. 7.6 6.6 % 0.0 0.0 0.0
a.v. 260 105 a.v. 13 0 7
r.v. 98.5 77.1 % 65.0 0.0 35.0
a.v. 831 808 a.v. 50 8 16
Breast C50
r.v. 314.8 593.7 % 67.6 10.8 21.6
a.v. 205 205 a.v. 2 6 2
Cervix uteri C53
r.v. 150.6 150.6 % 20.0 60.0 20.0
a.v. 146 146 a.v. 10 4 1
Corpus uteri C54
r.v. 107.3 107.3 % 66.7 26.7 6.7
a.v. 84 84 a.v. 1 8 7
Ovary C56
r.v. 61.7 61.7 % 6.3 50.0 43.8
a.v. 88 0 a.v. 10 6 4
Prostate C61
r.v. 68.8 0.0 % 50.0 30.0 20.0
a.v. 208 25 a.v. 16 4 4
Bladder C67
r.v. 78.8 18.4 % 66.7 16.7 16.7
a.v. 152 128 a.v. 15 7 0
Thyroid gland C73
r.v. 57.6 94.0 % 68.2 31.8 0.0
C81-C90, a.v. 286 117 a.v. 7 6 6
Malignant lymphomas
C96 r.v. 108.3 86.0 % 36.8 31.6 31.6
a.v. 122 50 a.v. 3 1 0
r.v. 46.2 36.7 % 75.0 25.0 0.0
a.v. 125 68 a.v. 7 3 19
Other neoplasmes
r.v. 47.3 50.0 % 24.1 10.3 65.5
142

GEGHARKUNIK POPULATION, 2020
Table 2m.n. 12
End of the year
Indicat
or
Total them
I -II III IV
women
a.v. 3202 1729 a.v. 89 122 139
r.v. 1408.7 1512.7 % 25.4 34.9 39.7
Including:
a.v. 43 5 a.v. 1 2 2
Lip C00
r.v. 18.9 4.4 % 20.0 40.0 40.0
a.v. 56 23 a.v. 0 4 1
r.v. 24.6 20.1 % 0.0 80.0 20.0
a.v. 10 3 a.v. 1 0 0
Oesophagus C15
r.v. 4.4 2.6 % 100.0 0.0 0.0
a.v. 143 49 a.v. 2 8 16
Stomach C16
r.v. 62.9 42,9 % 7.7 30.8 61.5
a.v. 182 88 a.v. 2 7 7
Colon C 18
r.v. 80.1 77.0 % 12.5 43.8 43.8
C19-C21
and anal canal r.v. 33.4 28.0 % 13.3 33.3 53.3
a.v. 75 5 a.v. 0 4 6
Larynx C32
r.v. 33.0 4.4 % 0.0 40.0 60.,0
a.v. 196 40 a.v. 1 10 23
r.v. 86.2 35.0 % 2.9 29.4 67.6
a.v. 40 30 a.v. 4 4 0
r.v. 17.6 26.2 % 50.0 50.0 0.0
a.v. 193 83 a.v. 3 2 1
r.v. 84,9 72.6 % 50.0 33.3 16.7
a.v. 536 523 a.v. 15 17 13
Breast C50
r.v. 235.8 457.6 % 33.3 37.8 28.9
a.v. 211 211 a.v. 1 5 4
Cervix uteri C53
r.v. 184.6 184.6 % 10.0 50.0 40.0
a.v. 87 87 a.v. 2 2 2
Corpus uteri C54
r.v. 76.1 76.1 % 33.3 33.3 33.3
a.v. 77 77 a.v. 2 7 2
Ovary C56
r.v. 67.4 67.4 % 18.2 63.6 18.2
a.v. 86 0 a.v. 4 6 7
Prostate C61
r.v. 76.1 0.0 % 23.5 35.3 41.2
a.v. 235 24 a.v. 19 7 4
Bladder C67
r.v. 103.4 21.0 % 63.3 23.3 13.3
a.v. 149 120 a.v. 17 10 3
Thyroid gland C73
r.v. 65.6 105.0 % 56.7 33.3 10.0
C81-C90. a.v. 304 117 a.v. 1 6 2
Malignant lymphomas
C96 r.v. 133.7 102.4 % 11.1 66.7 22.2
a.v. 132 55 a.v. 0 3 0
r.v. 58.1 48.1 % 0.0 100.0 0.0
a.v. 124 55 a.v. 4 5 13
Other neoplasmes
r.v. 54.6 48.1 % 18.2 22.7 59.1
143
NHIAC

AMONG LORI POPULATION, 2020
Table 2m.n. 13
End of the year
Indicat
or
Total them
I -II III IV
women
a.v. 4290 2515 a.v. 204 89 136
r.v. 2017.9 2166.2 % 47.6 20.7 31.7
Including:
a.v. 42 6 a.v. 1 2 0
Lip C00
r.v. 19.8 5.2 % 33.3 66.7 0.0
a.v. 66 24 a.v. 2 1 5
r.v. 31.0 20.7 % 25.0 12.5 62.5
a.v. 7 1 a.v. 0 0 1
Oesophagus C15
r.v. 3.3 0.9 % 0.0 0.0 100.0
a.v. 187 77 a.v. 9 7 13
Stomach C16
r.v. 88.0 66.3 % 31.0 24.1 44.8
a.v. 270 147 a.v. 13 7 12
Colon C 18
r.v. 127.0 126.6 % 40.6 21.9 37.5
C19-C21
and anal canal r.v. 57.9 63.7 % 47.8 17.4 34.8
a.v. 99 6 a.v. 5 3 3
Larynx C32
r.v. 46.6 5.2 % 45.5 27.3 27.3
a.v. 292 42 a.v. 9 4 25
r.v. 137.3 36.2 % 23.7 10.5 65.8
Bone and articular cartilage , C40. C41. a.v. 98 52 a.v. 4 1 1
a.v. 41 22 a.v. 3 2 0
r.v. 19.3 18.9 % 60.0 40.0 0.0
a.v. 270 128 a.v. 10 8 1
r.v. 127.0 110.2 % 52.6 42.1 5.3
a.v. 900 889 a.v. 47 9 17
Breast C50
r.v. 423.3 765.7 % 64.4 12.3 23.3
a.v. 279 279 a.v. 6 8 4
Cervix uteri C53
r.v. 240.3 240.3 % 33.3 44.4 22.2
a.v. 180 180 a.v. 12 5 1
Corpus uteri C54
r.v. 155.0 155.0 % 66.7 27.8 5.6
a.v. 129 129 a.v. 7 8 3
Ovary C56
r.v. 111.1 111.1 % 38.9 44.4 16.7
a.v. 123 0 a.v. 12 4 5
Prostate C61
r.v. 127.5 0.0 % 57.1 19.0 23.8
a.v. 268 34 a.v. 14 2 3
Bladder C67
r.v. 126.1 29.3 % 73.7 10.5 15.8
a.v. 88 71 a.v. 14 1 0
Thyroid gland C73
r.v. 41.4 61.2 % 93.3 6.7 0.0
C81-C90, a.v. 347 166 a.v. 5 2 4
Malignant lymphomas
C96 r.v. 163.2 143.0 % 45.5 18.2 36.4
a.v. 166 81 a.v. 2 0 1
r.v. 78.1 69.8 % 66.7 0.0 33.3
a.v. 171 79 a.v. 5 3 8
Other neoplasmes
r.v. 80.4 68.0 % 31.3 18.8 50.0
144
AMONG KOTAYK POPULATION, 2020
Table 2m.n. 14
End of the year
Indicat
or
Total them
I -II III IV
women
a.v. 4371 2513 a.v. 153 67 141
r.v. 1740.0 1911.0 % 42.4 18.6 39.1
Including:
a.v. 36 2 a.v. 0 0 0
Lip C00
r.v. 14.3 1.5 % 0.0 0.0 0.0
a.v. 74 23 a.v. 3 1 1
r.v. 29.5 17.5 % 60.0 20.0 20.0
a.v. 11 4 a.v. 0 0 2
Oesophagus C15
r.v. 4.4 3.0 % 0.0 0.0 100.0
a.v. 188 69 a.v. 5 9 21
Stomach C16
r.v. 74.8 52.5 % 14.3 25.7 60.0
a.v. 246 119 a.v. 5 6 8
Colon C 18
r.v. 97.9 90.5 % 26.3 31.6 42.1
C19-C21
and anal canal r.v. 46.2 39.5 % 18.2 45.5 36.4
a.v. 107 4 a.v. 1 2 3
Larynx C32
r.v. 42.6 3.0 % 16.7 33.3 50.0
a.v. 260 53 a.v. 8 11 27
r.v. 103.5 40.3 % 17.4 23.9 58.7
a.v. 36 24 a.v. 4 1 3
r.v. 14.3 18.3 % 50.0 12.5 37.5
a.v. 272 140 a.v. 3 0 0
r.v. 108.3 106.5 % 100.0 0.0 0.0
a.v. 922 896 a.v. 39 6 10
Breast C50
r.v. 367.0 681.4 % 70.9 10.9 18.2
a.v. 248 248 a.v. 0 8 4
Cervix uteri C53
r.v. 188.6 188.6 % 0.0 66.7 33.3
a.v. 155 155 a.v. 5 0 1
Corpus uteri C54
r.v. 117.9 117.9 % 83.3 0.0 16.7
a.v. 108 108 a.v. 3 2 5
Ovary C56
r.v. 82.1 82.1 % 30.0 20.0 50.0
a.v. 140 0 a.v. 6 4 9
Prostate C61
r.v. 117.0 0.0 % 31.6 21.1 47.4
a.v. 294 45 a.v. 19 3 0
Bladder C67
r.v. 117.0 34.2 % 86.4 13.6 0.0
a.v. 154 126 a.v. 17 1 1
Thyroid gland C73
r.v. 61.3 95.8 % 89.5 5.3 5.3
C81-C90, a.v. 362 147 a.v. 9 1 6
Malignant lymphomas
C96 r.v. 144.1 111.8 % 56.3 6.3 37.5
a.v. 167 67 a.v. 2 0 0
r.v. 66.5 51.0 % 100.0 0.0 0.0
a.v. 153 97 a.v. 8 1 15
Other neoplasmes
r.v. 60.9 73.8 % 33.3 4.2 62.5
145
NHIAC

AMONG SHIRAK POPULATION, 2020
Table 2m.n. 15
End of the year
Indicat
or
Total them
I -II III IV
women
a.v. 4306 2503 a.v. 139 73 128
r.v. 1864.1 2018.5 % 40.9 21.5 37.6
Including:
a.v. 38 7 a.v. 1 0 0
Lip C00
r.v. 16.5 5.6 % 100.0 0.0 0.0
a.v. 51 15 a.v. 0 2 0
r.v. 22.08 12.10 % 0.0 100.0 0.0
a.v. 12 2 a.v. 0 1 1
Oesophagus C15
r.v. 5.2 1.6 % 0.0 50.0 50.0
a.v. 194 87 a.v. 9 3 8
Stomach C16
r.v. 84.0 70.2 % 45.0 15.0 40.0
a.v. 227 110 a.v. 3 9 12
Colon C 18
r.v. 98.3 88.7 % 12.5 37.5 50.0
C19-C21
and anal canal r.v. 41.56 37.10 % 44.4 33.3 22.2
a.v. 113 4 a.v. 0 2 1
Larynx C32
r.v. 48.9 3.2 % 0.0 66.7 33.3
a.v. 311 46 a.v. 8 6 28
r.v. 134.6 37.1 % 19.0 14.3 66.7
a.v. 57 31 a.v. 1 1 1
r.v. 24.7 25.0 % 33.3 33.3 33.3
a.v. 228 104 a.v. 4 0 2
r.v. 98.7 83.9 % 66.7 0.0 33.3
a.v. 872 852 a.v. 26 12 11
Breast C50
r.v. 377.5 687.1 % 53.1 24.5 22.4
a.v. 305 305 a.v. 11 8 3
Cervix uteri C53
r.v. 246.0 246.0 % 50.0 36.4 13.6
a.v. 180 180 a.v. 4 1 0
Corpus uteri C54
r.v. 145.2 145.2 % 80.0 20.0 0.0
a.v. 125 125 a.v. 3 5 3
Ovary C56
r.v. 100.8 100.8 % 27.3 45.5 27.3
a.v. 129 0 a.v. 7 4 10
Prostate C61
r.v. 120.6 0.0 % 33.3 19.0 47.6
a.v. 285 26 a.v. 23 1 2
Bladder C67
r.v. 123.4 21.0 % 88.5 3.8 7.7
a.v. 106 94 a.v. 6 2 0
Thyroid gland C73
r.v. 45.9 7.6 % 75.0 25.0 0.0
C81-C90, a.v. 390 191 a.v. 5 2 7
Malignant lymphomas
C96 r.v. 168.8 154.0 % 35.7 14.3 50.0
a.v. 180 88 a.v. 2 0 1
r.v. 77.9 71.0 % 66.7 0.0 33.3
a.v. 133 78 a.v. 9 6 14
Other neoplasmes
r.v. 57.6 62.9 % 31.0 20.7 48.3
146

AMONG SYUNIK POPULATION, 2020
Table 2m.n. 16
End of the year
Indicat
or
Total them
I -II III IV
women
a.v. 1711 1004 a.v. 68 45 55
r.v. 1259.9 1430.2 % 40.5 26.8 32.7
Including:
a.v. 13 2 a.v. 1 0 0
Lip C00
r.v. 9.6 2.8 % 100.0 0.0 0.0
a.v. 16 2 a.v. 1 0 0
r.v. 11.8 2.8 % 100.0 0.0 0.0
a.v. 10 5 a.v. 2 0 0
Oesophagus C15
r.v. 7.4 7.1 % 100.0 0.0 0.0
a.v. 88 22 a.v. 3 1 4
Stomach C16
r.v. 64.8 31.3 % 37.5 12.5 50.0
a.v. 97 47 a.v. 1 8 3
Colon C 18
r.v. 71.4 67.0 % 8.3 66.7 25.0
C19-C21
and anal canal r.v. 32.4 35.6 % 14.3 57.1 28.6
a.v. 47 1 a.v. 0 1 1
Larynx C32
r.v. 34.6 1.4 % 0.0 50.0 50.0
a.v. 97 18 a.v. 0 3 11
r.v. 71.4 25.6 % 0.0 21.4 78.6
mesothelial and soft tissue C45-C49 r.v. 33.1 31.,3 % 0.0 50.0 50.0
a.v. 11 9 a.v. 0 0 1
r.v. 8.1 12.8 % 0.0 0.0 100.0
a.v. 99 50 a.v. 0 0 0
r.v. 72.9 71.2 % 0.0 0.0 0.0
a.v. 358 351 a.v. 23 3 4
Breast C50
r.v. 263.6 500.0 % 76.7 10.0 13.3
a.v. 121 121 a.v. 3 4 4
Cervix uteri C53
r.v. 172.4 172.4 % 27.3 36.4 36.4
a.v. 77 77 a.v. 5 2 0
Corpus uteri C54
r.v. 109.7 109.7 % 71.4 28.6 0.0
a.v. 50 50 a.v. 1 2 2
Ovary C56
r.v. 71.2 71.2 % 20.0 40.0 40.0
a.v. 62 0 a.v. 7 3 5
Prostate C61
r.v. 94.5 0.0 % 46.7 20.0 33.3
a.v. 108 13 a.v. 8 1 2
Bladder C67
r.v. 79.5 18.5 % 72.7 9.1 18.2
a.v. 45 40 a.v. 3 4 1
Thyroid gland C73
r.v. 33.1 57.0 % 37.5 50.0 12.5
C81-C90, a.v. 146 70 a.v. 2 3 2
Malignant lymphomas
C96 r.v. 107.5 99.7 % 28.6 42.9 28.6
a.v. 76 34 a.v. 2 0 0
r.v. 56.0 48.4 % 100.0 0.0 0.0
a.v. 62 34 a.v. 1 0 4
Other neoplasmes
r.v. 45.7 48.4 % 20.0 0.0 80.0
147
NHIAC

AMONG VAYOTS DZOR POPULATION, 2020
Table 2m.n. 17
End of the year
Indicat
or
Total them
I -II III IV
women
a.v. 772 403 a.v. 37 26 35
r.v. 1605.0 1592.9 % 37.8 26.5 35.7
Including:
a.v. 7 2 a.v. 0 0 0
Lip C00
r.v. 14.6 7.9 % 0.0 0.0 0.0
a.v. 20 6 a.v. 2 0 1
r.v. 41.6 23.7 % 66.7 0.0 33.3
a.v. 1 1 a.v. 0 0 0
Oesophagus C15
r.v. 2.1 4.0 % 0.0 0.0 0.0
a.v. 29 12 a.v. 1 0 4
Stomach C16
r.v. 60.3 47.4 % 20.0 0.0 80.0
a.v. 29 14 a.v. 0 2 2
Colon C 18
r.v. 60.3 55.3 % 0.0 50.0 50.0
C19-C21
and anal canal r.v. 41.6 43.5 % 0.0 28.6 71.4
a.v. 19 2 a.v. 0 0 0
Larynx C32
r.v. 39.5 7.9 % 0.0 0.0 0.0
a.v. 43 10 a.v. 1 6 5
r.v. 89.4 39.5 % 8.3 50.0 41.7
a.v. 6 3 a.v. 0 0 0
r.v. 12.5 11.9 % 0.0 0.0 0.0
a.v. 38 19 a.v. 2 1 0
r.v. 79.0 75.1 % 66.7 33.3 0.0
a.v. 152 147 a.v. 6 4 2
Breast C50
r.v. 316.0 581.0 % 50.0 33.3 16.7
a.v. 32 32 a.v. 0 1 1
Cervix uteri C53
r.v. 126.5 126.5 % 0.0 50.0 50.0
a.v. 28 28 a.v. 1 1 2
Corpus uteri C54
r.v. 110.7 110.7 % 25.0 25.0 50.0
a.v. 16 16 a.v. 1 2 3
Ovary C56
r.v. 63.2 63.2 % 16.7 33.3 50.0
a.v. 28 0 a.v. 0 1 1
Prostate C61
r.v. 122.8 0.0 % 0.0 50.0 50.0
a.v. 97 11 a.v. 10 1 2
Bladder C67
r.v. 201.7 43.5 % 76.9 7.7 15.4
a.v. 28 22 a.v. 3 0 0
Thyroid gland C73
r.v. 58.2 87.0 % 100.0 0.0 0.0
C81-C90, a.v. 76 25 a.v. 2 0 0
Malignant lymphomas
C96 r.v. 158.0 98.8 % 100.0 0.0 0.0
a.v. 39 13 a.v. 1 0 0
r.v. 81.1 51.4 % 100.0 0.0 0.0
a.v. 28 17 a.v. 2 2 4
Other neoplasmes
r.v. 58.2 67.2 % 25.0 25.0 50.0
148

AMONG TAVUSH POPULATION, 2020
Table 2m.n. 18
End of the year
Indicat
or
Total them
I -II III IV
women
a.v. 1752 1022 a.v. 81 47 75
r.v. 1453.9 1606.9 % 39.9 23.1 36.9
Including:
a.v. 10 3 a.v. 0 0 0
Lip C00
r.v. 8.3 4.7 % 0.0 0.0 0.0
a.v. 28 11 a.v. 0 1 1
r.v. 23.2 17.3 % 0 50.0 50.0
a.v. 2 0 a.v. 0 1 0
Oesophagus C15
r.v. 1.7 0.0 % 0.0 100.0 0.0
a.v. 78 32 a.v. 2 1 6
Stomach C16
r.v. 64.7 50.3 % 22.2 11.1 66.67
a.v. 103 48 a.v. 4 3 2
Colon C 18
r.v. 85.5 75.5 % 44.4 33.3 22.2
C19-C21
and anal canal r.v. 52.3 47.2 % 27.3 36.4 36.4
a.v. 40 0 a.v. 3 0 3
Larynx C32
r.v. 33.2 0.0 % 50.0 0.0 50.0
a.v. 117 14 a.v. 4 7 14
r.v. 97.1 22.0 % 16.0 28.0 56.0
a.v. 16 8 a.v. 0 0 1
r.v. 13.3 12.6 % 0.0 0.0 100.0
a.v. 95 58 a.v. 3 1 0
r.v. 78.8 91.2 % 75.0 25.0 0.0
a.v. 381 371 a.v. 23 2 14
Breast C50
r.v. 316.2 583.3 % 59.0 5.1 35.9
a.v. 106 106 a.v. 0 11 3
Cervix uteri C53
r.v. 166.7 166.7 % 0.0 78.6 21.4
a.v. 51 51 a.v. 2 0 1
Corpus uteri C54
r.v. 80.2 80.2 % 66.7 0.0 33.3
a.v. 44 44 a.v. 3 1 0
Ovary C56
r.v. 69.2 69.2 % 75.0 25.0 0.0
a.v. 51 0 a.v. 4 3 5
Prostate C61
r.v. 89.6 0.0 % 33.3 25.0 41.7
a.v. 112 17 a.v. 11 2 3
Bladder C67
r.v. 92.9 26.7 % 68.8 12.5 18.8
a.v. 39 35 a.v. 4 0 0
Thyroid gland C73
r.v. 32.4 55.0 % 100.0 0.0 0.0
C81-C90, a.v. 145 69 a.v. 3 2 3
Malignant lymphomas
C96 r.v. 120.3 108.5 % 37.5 25.0 37.5
a.v. 69 36 a.v. 1 0 0
r.v. 57.3 56.6 % 100.0 0.0 0.0
a.v. 62 38 a.v. 2 4 6
Other neoplasmes
r.v. 51.5 59.7 % 16.7 33.3 50.0
149
NHIAC
INCIDENCE OF MALIGNANT NEOPLASM AMONG RA POPULATION BY SEX AND AGE GROUP, 2020
Table 2m.n. 19
The number of patients diagnosed for the first time in the reference year
Sex
Tumor localization
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 3346 16 11 10 6 7 13 33 41 64 80 103 183 423 672 674 456 242 225 87
NEOPLASMS- Total
f 3588 11 5 7 4 4 26 46 123 171 196 226 298 465 609 549 355 193 209 91
including:
m 18 0 0 0 0 0 0 0 0 0 0 0 2 1 4 2 3 2 1 3
Lip
f 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0
m 34 0 0 0 0 0 0 0 0 0 0 1 6 7 8 4 5 1 1 1
Oral cavity
f 21 0 0 0 0 0 0 0 2 0 0 1 1 3 4 5 1 1 2 1
m 43 0 0 0 1 0 0 1 0 2 1 2 3 3 10 13 5 1 0 1
Pharynx
f 12 0 0 0 0 0 0 0 0 0 0 0 0 4 3 4 0 0 1 0
m 27 0 0 0 0 0 0 0 0 0 1 2 3 1 5 8 3 2 1 1
Oesophagus
f 10 0 0 0 0 0 0 0 1 0 0 1 1 1 1 1 1 0 1 2
m 204 0 0 0 0 0 0 1 0 1 6 11 9 31 36 49 25 14 15 6
Stomach
f 147 0 0 0 0 0 0 1 0 7 4 5 9 15 21 31 22 13 14 5
m 246 0 0 0 0 0 0 0 3 2 9 8 9 25 51 42 43 26 20 8
Colon
f 229 0 0 0 0 0 0 1 1 4 5 9 12 24 47 41 26 33 22 4
Rectosigmoid junction, rectum , anus and anal m 128 0 0 0 0 0 0 1 1 2 2 7 11 13 25 30 16 6 12 2
canal f 125 0 0 0 0 0 1 1 1 2 1 2 20 11 29 27 11 7 9 3
m 88 0 0 0 0 0 0 0 0 0 1 2 7 14 23 17 13 5 4 2
Liver and intrahepatic bile ducts
f 53 0 0 0 0 0 0 1 0 0 1 0 2 9 13 5 7 6 6 3
m 115 0 0 0 0 0 0 0 0 1 4 3 5 18 21 31 15 11 6 0
Pancreas
f 73 0 0 0 0 0 0 0 0 1 0 0 4 9 17 8 11 5 12 6
m 117 0 0 0 0 0 0 0 0 1 1 4 6 22 34 20 15 8 5 1
Larynx
f 7 0 0 0 0 0 0 0 0 0 1 2 0 2 1 1 0 0 0 0
m 10 0 0 0 0 0 0 0 0 1 1 0 1 2 3 0 0 0 2 0
Nasal cavity, middle ear,accessory sinuses
f 3 0 0 0 0 0 0 0 0 0 0 0 2 1 0 0 0 0 0 0
m 641 0 0 0 0 1 0 3 1 3 5 14 27 90 156 164 86 51 30 10
Trachea, bronchus and lung
f 138 0 0 1 0 0 0 0 2 2 5 3 8 16 42 27 10 7 8 7
m 25 0 2 1 1 1 0 0 1 3 2 1 0 3 1 2 3 1 1 2
Bone and articular cartilage
f 24 1 0 1 0 0 0 1 0 0 1 1 2 4 1 2 3 3 2 2
m 34 0 0 0 0 0 0 0 0 1 4 2 3 4 3 4 5 1 6 1
Melanoma of skin
f 21 0 0 0 0 0 0 0 0 1 2 2 2 2 4 1 1 2 2 2
m 121 0 0 0 0 0 0 1 2 0 1 2 1 16 22 21 20 10 14 11
Other malignant neoplasms of skin
f 123 0 0 0 0 0 0 0 1 0 1 1 6 14 18 19 20 12 15 16
m 47 2 1 2 0 1 1 2 0 0 1 2 6 4 6 5 9 2 1 2
Mesothelial and soft tissue
f 43 0 0 0 0 0 0 2 1 4 0 2 6 9 5 4 4 3 3 0
m 27 0 0 0 0 0 0 0 0 1 3 1 3 2 4 2 5 2 3 1
Breast
f 1116 0 1 0 0 0 1 8 38 69 96 108 104 143 193 172 86 41 41 15
Cervix uteri f 206 0 0 0 0 0 0 3 6 7 17 22 27 29 25 28 21 8 10 3
Corpus uteri f 173 0 0 0 0 0 0 1 2 2 5 3 8 24 41 39 30 7 8 3
Ovary f 192 0 0 0 2 1 1 1 4 3 10 17 19 36 32 32 19 7 6 2
Penis m 16 0 0 0 0 0 0 1 0 0 1 0 0 2 3 3 4 0 2 0
Prostate m 343 0 0 0 0 0 0 1 0 1 0 2 7 19 62 89 71 37 41 13
150
Table 2m.n. 19 continutation
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
Testis m 29 0 0 0 0 1 1 5 3 5 4 1 2 2 1 2 0 2 0 0
m 95 0 0 0 0 0 0 2 4 1 4 7 10 12 25 16 4 4 5 1
Kidney
f 42 1 0 0 0 0 0 0 0 2 1 1 3 9 6 9 7 2 1 0
m 351 0 0 0 0 0 1 0 0 3 7 7 21 48 73 72 47 29 31 12
Bladder
f 64 0 0 1 0 0 2 1 0 0 1 4 5 3 11 11 11 2 10 2
m 91 3 3 1 0 0 1 5 3 4 4 7 4 15 17 9 7 4 3 1
Brain and other parts of central nervous system
f 85 4 0 1 1 0 1 1 2 3 5 3 5 11 21 11 8 7 1 0
m 73 0 0 0 0 1 4 6 11 13 5 8 7 7 5 2 3 1 0 0
Thyroid gland
f 273 0 0 0 0 1 11 20 53 41 26 26 26 24 22 11 3 2 5 2
Lymphoid, haematopoietic and related tissue, m 230 11 5 6 4 1 5 4 10 16 9 8 21 33 39 25 15 6 9 3
including: f 191 4 4 3 1 1 7 2 9 15 5 6 18 32 27 25 17 9 5 1
m 29 1 0 2 2 0 4 1 3 6 2 0 2 2 0 2 1 0 1 0
Hodgkin lymphoma
f 24 0 1 0 0 0 7 0 2 2 2 0 2 1 4 2 1 0 0 0
Follicular lymphoma,reticulo-sarcoma, mycosis m 70 2 2 0 0 1 0 1 5 2 5 3 8 12 10 7 5 1 4 2
fungoides,other and unspecified types f 58 1 1 0 0 0 0 1 4 3 2 2 6 9 8 9 5 6 1 0
Multiple myeloma and malignant m 31 0 0 0 0 0 0 0 1 0 0 0 3 4 13 5 2 1 1 1
immunoproliferative diseases f 26 0 0 0 0 0 0 0 0 1 1 1 0 8 3 5 4 1 1 1
m 27 8 3 4 1 0 0 1 1 3 1 0 0 1 1 0 1 1 1 0
Lymphoblastic leukaemia
f 14 3 1 3 1 1 0 1 0 1 0 0 1 0 2 0 0 0 0 0
m 23 0 0 0 0 0 0 0 0 1 0 2 4 1 5 5 3 1 1 0
Other lymphocytic leukemias
f 25 1 0 0 0 0 0 0 0 0 2 4 4 6 2 3 0 3 0
m 17 0 0 0 0 0 1 0 0 1 1 1 2 5 4 1 1 0 0
Myeloid leukaemia
f 18 0 0 0 0 0 0 0 1 5 0 0 3 5 1 2 0 1 0 0
m 14 0 0 0 1 0 0 1 0 2 0 1 1 6 1 0 1 0 0 0
Other myeloid leukemias
f 10 0 0 0 0 0 0 0 1 2 0 1 2 3 0 0 1 0 0 0
m 7 0 0 0 0 0 0 0 0 0 0 0 1 2 1 1 0 1 1 0
Other acute leukemias
f 7 0 0 0 0 0 0 0 1 0 0 0 0 1 2 2 0 1 0 0
m 12 0 0 0 0 0 0 0 0 1 0 1 2 3 3 1 1 0 0 0
Other leukemias(chronic, subacute, etc.)
f 9 0 0 0 0 0 0 0 0 1 0 0 0 1 1 3 3 0 0 0
m 193 0 0 0 1 0 0 2 3 4 1 9 29 35 42 34 16 12 5
Other Malignant Diseases
f 215 1 0 0 0 1 2 2 0 8 9 7 8 30 25 35 36 16 23 12
m 3 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0
In situ neoplasms
f 5 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 1 1 0 0
Carcinoma in situ of oral cavity, oesophagus and m 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0

stomach
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
Melanoma in situ
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
Carcinoma in situ of skin
f 4 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 1 0 0
m 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
Carcinoma in situ of cervix uteri
f 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
151
NHIAC
INCIDENCE OF MALIGNANT NEOPLASM AMONG POPULATION BY SEX AND AGE GROUP, YEREVAN, 2020
Table 2m.n. 20
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 1203 5 2 2 0 3 4 8 15 26 31 38 56 119 207 259 205 100 89 34

NEOPLASMS- Total
f 1495 5 3 2 0 1 13 15 48 60 83 109 110 174 239 221 190 81 101 40
including:
m 4 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 1 0 0 0
Lip
f 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0
m 16 0 0 0 0 0 0 0 0 0 0 1 2 3 2 2 5 1 0 0
Oral cavity
f 9 0 0 0 0 0 0 0 0 0 0 1 1 0 2 1 1 1 1 1
m 16 0 0 0 0 0 0 0 0 1 0 1 1 2 5 5 1 0 0 0
Pharynx
f 6 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 0 0 0 0
m 13 0 0 0 0 0 0 0 0 0 1 1 1 1 2 3 2 2 0 0
Oesophagus
f 3 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 1 0
m 55 0 0 0 0 0 0 0 0 0 2 4 1 3 7 17 12 5 2 2
Stomach
f 36 0 0 0 0 0 0 0 0 1 0 2 3 3 5 8 6 4 3 1
m 93 0 0 0 0 0 0 0 1 0 5 1 3 8 17 15 18 13 10 2
Colon
f 121 0 0 0 0 0 0 0 0 2 4 6 7 10 23 25 12 14 14 4
Rectosigmoid junction, rectum , anus and anal m 57 0 0 0 0 0 0 1 1 1 2 6 5 8 7 11 11 0 3 1
canal
f 49 0 0 0 0 0 0 0 0 1 0 1 6 5 10 12 6 4 3 1
m 35 0 0 0 0 0 0 0 0 0 1 0 4 5 9 10 3 2 1 0
f 23 0 0 0 0 0 0 0 0 0 0 0 0 3 6 2 5 3 2 2
m 35 0 0 0 0 0 0 0 0 1 2 0 0 3 9 6 6 5 3 0
Pancreas
f 29 0 0 0 0 0 0 0 0 0 0 0 1 3 4 2 10 2 5 2
m 45 0 0 0 0 0 0 0 0 0 1 1 0 7 12 12 7 4 1 0
Larynx
f 3 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0 0 0
m 4 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 0 1 0
Nasal cavity, middle ear,accessory sinuses
f 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0
m 220 0 0 0 0 0 0 1 0 1 1 4 8 27 44 68 37 14 13 2
f 57 0 0 1 0 0 0 0 0 1 2 1 1 8 17 14 1 2 3 6
m 4 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 1 0
f 7 1 0 0 0 0 0 0 0 0 0 1 1 1 0 1 1 1 0 0
m 10 0 0 0 0 0 0 0 0 1 0 0 1 2 1 2 1 0 2 0
Melanoma of skin
f 6 0 0 0 0 0 0 0 0 0 1 2 0 1 0 0 0 1 1 0
m 45 0 0 0 0 0 0 0 0 0 0 1 1 3 7 11 7 6 5 4
f 52 0 0 0 0 0 0 0 0 0 1 1 2 5 6 8 10 6 8 5
m 18 2 0 1 0 1 0 0 0 0 1 0 2 2 1 1 3 2 0 2
f 18 0 0 0 0 0 0 0 0 1 0 0 2 6 2 1 3 1 2 0
m 15 0 0 0 0 0 0 0 0 1 2 1 1 0 2 1 3 1 3 0
Breast
f 519 0 0 0 0 0 0 3 14 27 47 65 52 55 93 65 53 20 20 5
Cervix uteri f 62 0 0 0 0 0 0 0 1 3 6 5 5 7 9 8 11 2 4 1
Uterine body f 77 0 0 0 0 0 0 0 1 1 5 1 1 9 12 19 17 2 6 3
152
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
Ovary f 64 0 0 0 0 0 0 0 2 0 3 3 7 12 10 7 11 4 4 1
Penis m 6 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 3 0 1 0
Prostate m 148 0 0 0 0 0 0 1 0 0 0 1 2 5 22 40 38 14 17 8
Testis m 11 0 0 0 0 1 0 1 1 3 1 0 2 2 0 0 0 0 0 0
m 28 0 0 0 0 0 0 0 1 0 2 2 4 4 6 5 2 1 1 0
Kidney
f 21 0 0 0 0 0 0 0 0 0 0 1 2 3 4 5 5 0 1 0
m 117 0 0 0 0 0 0 0 0 1 1 5 6 10 21 22 18 14 10 9
Bladder
f 36 0 0 1 0 0 1 1 0 0 0 3 2 0 3 8 8 1 7 1
m 26 0 0 0 0 0 0 1 1 1 2 2 0 3 6 4 2 1 2 1
f 28 3 0 0 0 0 1 0 1 2 1 0 0 6 3 4 4 3 0 0
m 34 0 0 0 0 0 2 2 7 5 3 4 2 4 2 0 2 1 0 0
Thyroid gland
f 105 0 0 0 0 1 5 8 24 14 10 11 8 6 7 5 2 1 1 2
m 80 3 2 1 0 1 2 2 8 2 2 6 7 12 10 10 5 6 1
Lymphoid, haematopoietic and related tissue
f 75 0 3 0 0 0 5 1 5 4 1 2 3 18 10 11 7 2 2 1
m 12 1 1 0 0 1 0 1 3 1 0 1 0 0 1 1 0 1 0
Hodgkin lymphoma
f 13 0 0 0 0 0 5 0 1 2 1 0 0 0 3 0 1 0 0 0
Follicular lymphoma,reticulo-sarcoma, mycosis m 25 0 1 0 0 1 0 0 1 1 1 1 3 4 2 2 2 1 4 1

fungoides,other and unspecified types
f 18 0 1 0 0 0 0 0 3 0 0 1 1 3 1 5 2 1 0 0

immunoproliferative diseases
f 14 0 0 0 0 0 0 0 0 0 0 1 0 6 2 2 0 1 1 1
m 8 2 1 0 0 0 0 0 0 2 0 0 0 1 0 0 0 1 1
f 2 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
m 7 0 0 0 0 0 0 0 0 1 0 0 1 0 0 2 2 1 0 0
f 11 0 1 0 0 0 0 0 0 0 0 0 1 3 2 1 2 0 1 0
m 9 0 0 0 0 0 1 0 0 1 0 1 0 0 4 0 1 1 0 0
Myeloid leukaemia
f 7 0 0 0 0 0 0 0 0 2 0 0 0 3 0 2 0 0 0 0
m 4 0 0 0 0 0 0 0 0 0 0 0 0 2 1 0 1 0 0 0
f 4 0 0 0 0 0 0 0 0 0 0 0 1 2 0 0 1 0 0 0
m 3 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0
Other acute leukemias
f 3 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0
f 3 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0
m 68 0 0 0 0 0 0 0 1 1 1 0 3 8 11 13 13 8 7 2
other malignant diseases
f 86 1 0 0 0 0 1 2 0 3 2 2 4 10 10 12 17 7 11 4
m 2 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0
In situ neoplasms of which:
f 3 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0
m 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
Melanoma in situ
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
f 3 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0
153
NHIAC
INCIDENCE OF MALIGNANT NEOPLASM AMONG POPULATION BY SEX AND AGE GROUP, ARAGATSOTN, 2020
Table 2m.n. 21
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 134 1 0 0 1 0 0 2 1 5 1 6 8 21 23 28 17 5 8 7
NEOPLASMS- Total
f 106 0 1 0 2 0 1 0 10 10 6 8 12 9 18 13 6 2 6 2
including:
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Lip
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0
Oral cavity
f 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
m 4 0 0 0 1 0 0 0 0 0 0 1 0 0 0 1 0 0 0 1
Pharynx
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0
Oesophagus
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 5 0 0 0 0 0 0 0 0 0 0 0 0 2 0 2 0 0 1 0
Stomach
f 4 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 0
m 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Colon
f 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Rectosigmoid junction, rectum , anus m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
and anal canal
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pancreas
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
m 7 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 1 0 1 1
Larynx
f 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
m 23 0 0 0 0 0 0 0 0 1 0 1 0 5 6 7 1 2 0 0
f 4 0 0 0 0 0 0 0 0 0 0 0 1 0 2 1 0 0 0 0
m 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 6 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 4
f 7 0 0 0 0 0 0 0 0 0 0 0 1 1 2 1 1 0 0 1
m 3 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 0
f 3 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
Breast
f 30 0 0 0 0 0 0 0 4 2 1 3 6 6 3 1 3 1 0 0
Cervix uteri f 6 0 0 0 0 0 0 0 1 1 1 0 0 0 0 2 0 0 1 0
Corpus uteri f 3 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0
Ovary f 8 0 0 0 0 0 0 0 1 0 1 1 0 0 0 4 1 0 0 0
Prostate m 9 0 0 0 0 0 0 0 0 0 0 0 0 1 0 3 2 0 2 1
Testis m 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
m 8 0 0 0 0 0 0 0 0 0 0 0 0 2 3 2 0 0 1 0
Kidney
f 2 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0
154
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 17 0 0 0 0 0 0 0 0 0 0 0 2 4 4 2 3 0 2 0
Bladder
f 2 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0
Brain and other parts of central m 2 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0

nervous system
f 3 0 0 0 1 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0
m 3 0 0 0 0 0 0 1 0 1 0 0 1 0 0 0 0 0 0 0
Thyroid gland
f 11 0 0 0 0 0 1 0 2 0 1 2 1 0 3 0 0 0 1 0
Lymphoid, haematopoietic and m 10 1 0 0 0 0 0 1 1 1 0 0 1 0 2 2 1 0 0 0
related tissue f 7 0 1 0 1 0 0 0 0 1 1 0 0 1 1 0 0 0 1 0
m 3 0 0 0 0 0 0 1 0 1 0 0 0 0 0 1 0 0 0 0
Hodgkin lymphoma
f 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Follicular lymphoma,reticulo- m 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
sarcoma, mycosis fungoides,other
and unspecified types f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

f 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
m 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
f 2 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
m 3 0 0 0 0 0 0 0 0 0 0 0 1 0 2 0 0 0 0 0
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Myeloid leukaemia
f 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
Other leukemias(chronic, subacute, m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
etc.) f 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
m 11 0 0 0 0 0 0 0 0 1 0 0 1 1 3 2 3 0 0 0
f 8 0 0 0 0 0 0 0 0 2 0 0 2 0 0 1 1 0 1 1
155
NHIAC
INCIDENCE OF MALIGNANT NEOPLASM AMONG POPULATION BY SEX AND AGE GROUP, ARARAT, 2020
Table 2m.n. 22
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 265 1 0 0 0 0 3 4 5 4 5 6 14 40 68 53 28 19 13 2
NEOPLASMS- Total
f 262 0 0 0 0 1 1 3 13 12 13 18 25 44 46 43 12 11 16 4
including:
m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0
Lip
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Oral cavity
f 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0
Pharynx
f 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Oesophagus
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 12 0 0 0 0 0 0 0 0 0 1 1 0 3 3 2 1 0 1 0
Stomach
f 11 0 0 0 0 0 0 0 0 0 1 1 0 1 3 2 1 1 1 0
m 16 0 0 0 0 0 0 0 1 0 1 0 1 2 1 3 4 1 1 1
Colon
f 14 0 0 0 0 0 0 0 0 0 0 1 1 2 2 3 1 2 2 0
Rectosigmoid junction, rectum , m 8 0 0 0 0 0 0 0 0 0 0 0 0 2 2 3 0 0 1 0
anus and anal canal f 9 0 0 0 0 0 0 1 0 0 1 0 2 2 2 0 0 0 1 0
m 7 0 0 0 0 0 0 0 0 0 0 0 0 1 1 3 0 1 1 0
f 2 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0
m 5 0 0 0 0 0 0 0 0 0 0 0 1 0 2 2 0 0 0 0
Pancreas
f 5 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 1
m 13 0 0 0 0 0 0 0 0 0 0 0 1 4 3 2 1 1 1 0
Larynx
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 54 0 0 0 0 0 0 1 0 0 0 1 2 5 20 12 4 7 2 0
f 14 0 0 0 0 0 0 0 0 0 1 1 0 1 5 3 0 2 1 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 5 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 1 1 0 0
Ther skin neoplasms
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0
f 3 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 1 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0
Breast
f 76 0 0 0 0 0 0 1 6 5 6 7 6 12 10 15 3 0 4 1
Cervix uteri f 18 0 0 0 0 0 0 0 0 1 1 3 3 4 1 2 0 2 1 0
Corpus uteri f 9 0 0 0 0 0 0 0 0 0 0 1 0 4 1 1 2 0 0 0
Ovary f 11 0 0 0 0 0 0 0 1 0 0 0 2 1 4 3 0 0 0 0
Prostate m 25 0 0 0 0 0 0 0 0 0 0 0 3 2 6 6 4 1 2 1
Testis m 3 0 0 0 0 0 0 0 1 2 0 0 0 0 0 0 0 0 0 0
Penis m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
m 29 0 0 0 0 0 0 0 0 0 1 1 1 2 7 7 4 4 2 0
Bladder
f 4 0 0 0 0 0 1 0 0 0 0 0 1 0 1 1 0 0 0 0
156
Table 2 չ.ն. 22 continutation
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 11 0 0 0 0 0 0 1 0 0 0 0 1 0 5 2 1 1 0 0
Kidney
f 3 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 1 0 0 0
nervous system
f 8 0 0 0 0 0 0 0 0 0 1 0 0 1 4 1 0 1 0 0
m 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
Thyroid gland
f 25 0 0 0 0 0 0 1 5 3 1 3 5 1 3 2 0 1
related tissue, including:
f 16 0 0 0 0 0 0 0 1 1 1 0 4 1 4 1 1 2 0 0
m 6 0 0 0 0 0 3 0 1 0 0 0 2 0 0 0 0 0
Hodgkin lymphoma
f 3 0 0 0 0 0 0 0 0 0 0 0 2 0 1 0 0 0 0 0
Follicular lymphoma,reticulo-
m 7 0 0 0 0 0 0 0 1 0 0 0 1 3 1 0 1 0 0 0
f 3 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0
Myeloid leukaemia
f 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0
m 3 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 0
f 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
Other acute leukemias)
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 18 0 0 0 0 0 0 0 0 0 0 1 1 6 2 4 3 0 1
f 21 0 0 0 0 1 0 0 0 1 0 1 0 4 3 5 3 0 2 1
m 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
In situ neoplasms, of which:
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
157
NHIAC
INCIDENCE OF MALIGNANT NEOPLASM AMONG POPULATION BY SEX AND AGE GROUP, ARMAVIR, 2020
Table 2m.n. 23
Table of
The number 2m.n. 23 diagnosed for the first time in the reference year
patients
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 319 3 1 2 1 2 0 4 1 7 7 9 12 45 69 62 54 17 17 6
NEOPLASMS- Total
f 288 1 0 2 0 0 2 8 6 13 16 17 35 45 51 44 13 12 15 8
Including:
m 3 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0
Oral cavity
f 4 0 0 0 0 0 0 0 1 0 0 0 0 1 0 2 0 0 0 0
m 4 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 2 0 0 0
Pharynx
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0
Oesophagus
f 2 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0
m 21 0 0 0 0 0 0 1 0 0 1 0 1 5 4 4 3 0 2 0
Stomach
f 16 0 0 0 0 0 0 0 0 0 2 1 3 0 1 6 1 1 1 0
m 26 0 0 0 0 0 0 0 0 1 1 1 1 2 7 4 6 1 1 1
Colon
f 10 0 0 0 0 0 0 1 0 0 0 0 0 0 3 0 1 2 3 0
anus and anal canal
f 13 0 0 0 0 0 0 0 0 1 0 0 3 1 4 3 0 0 1 0
Liver and intrahepatic bile m 8 0 0 0 0 0 0 0 0 0 0 0 0 0 5 2 1 0 0 0
ducts f 3 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 0 0 0 0
m 7 0 0 0 0 0 0 0 0 0 0 0 0 2 2 2 1 0 0 0
Pancreas
f 3 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0
m 10 0 0 0 0 0 0 0 0 0 0 0 2 3 3 0 0 2 0 0
Larynx
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Nasal cavity, middle m 3 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 1 0
ear,accessory sinuses f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 72 0 0 0 0 0 0 0 1 0 1 2 0 10 17 19 14 7 1 0
f 9 0 0 0 0 0 0 0 0 0 0 0 0 3 3 1 0 0 2 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1
f 5 0 0 1 0 0 0 1 0 0 1 0 1 0 1 0 0 0 0 0
Other malignant neoplasms of m 19 0 0 0 0 0 0 0 0 0 0 0 0 5 1 4 3 4 2
skin f 12 0 0 0 0 0 0 0 0 0 0 0 0 2 3 1 1 2 1 2
m 4 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0
f 5 0 0 0 0 0 0 1 0 0 0 0 0 1 1 2 0 0 0 0
m 3 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0
Breast
f 95 0 0 0 0 0 1 2 0 7 6 6 12 17 16 17 4 3 2 2
Cervix uteri f 15 0 0 0 0 0 0 1 2 0 0 3 2 3 2 0 1 0 0 1
Corpus uteri f 16 0 0 0 0 0 0 1 0 1 0 0 2 3 7 1 1 0 0 0
Ovary f 20 0 0 0 0 0 0 0 0 0 2 4 1 4 2 3 2 0 1 1
Penis m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0
Prostate m 24 0 0 0 0 0 0 0 0 1 0 1 0 2 5 8 4 2 1 0
Testis m 2 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0
m 5 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 1 0 0
Kidney
f 2 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0
158
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 26 0 0 0 0 0 0 0 0 0 0 0 1 5 6 5 6 1 2 0
Bladder
f 5 0 0 0 0 0 0 0 0 0 0 0 2 1 1 1 0 0 0 0

nervous system f 5 0 0 1 0 0 0 0 0 0 0 0 2 0 2 0 0 0 0 0
m 10 0 0 0 0 1 0 0 0 1 1 4 0 0 2 0 1 0 0 0
Thyroid gland
f 22 0 0 0 0 0 0 1 2 3 3 3 4 3 2 1 0 0 0 0
related tissue f 10 1 0 0 0 0 0 0 0 0 0 0 1 2 2 2 0 2 0 0
m 2 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0
Hodgkin lymphoma
f 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
m 8 2 0 0 0 0 0 0 0 0 1 0 0 2 1 1 1 0 0 0
sarcoma, mycosis
fungoides,other and
f 4 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 2 0 0
unspecified types
Multiple myeloma and m 6 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 0 0 0 1
malignant immunoproliferative
diseases f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
m 3 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
f 2 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Myeloid leukaemia
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Other leukemias(chronic, m 2 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0
subacute, etc.) f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 18 0 0 0 0 1 0 0 0 0 1 0 2 1 1 3 7 0 1 1
f 16 0 0 0 0 0 1 0 0 1 1 0 0 2 0 3 2 1 3 2
159
NHIAC
INCIDENCE OF MALIGNANT NEOPLASM AMONG POPULATION BY SEX AND AGE GROUP, GEGHARKUNIK, 2020
Table 2m.n. 24
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 244 1 3 2 1 0 3 2 5 3 11 3 18 34 45 51 21 18 15 8
NEOPLASMS- Total
f 208 1 0 0 0 1 1 4 7 12 13 12 20 35 34 27 14 13 9 5
including:
m 5 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 2 1 0 1
Lip
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 5 0 0 0 0 0 0 0 0 1 1 0 0 0 1 2 0 0 0 0
Pharynx
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
m 3 0 0 0 0 0 0 0 0 0 0 0 2 0 0 1 0 0 0 0
Oesophagus
f 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
m 13 0 0 0 0 0 0 0 0 1 1 0 1 2 1 4 1 0 1 1
Stomach
f 14 0 0 0 0 0 0 0 0 0 0 0 1 2 2 3 3 0 2 1
m 17 0 0 0 0 0 0 0 0 0 0 0 1 2 3 4 2 3 2 0
Colon
f 10 0 0 0 0 0 0 0 0 0 1 0 1 2 2 0 2 2 0 0
anus and anal canal
f 8 0 0 0 0 0 0 0 0 0 0 1 0 1 4 0 2 0 0 0
m 8 0 0 0 0 0 0 0 0 0 0 1 0 1 5 0 0 0 0 1
f 3 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0
m 17 0 0 0 0 0 0 0 0 0 1 1 1 3 2 5 0 4 0 0
Pancreas
f 5 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 1 1 0
m 10 0 0 0 0 0 0 0 0 0 0 0 2 4 4 0 0 0 0
Larynx
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
m 42 0 0 0 0 0 0 0 0 0 1 1 4 6 10 10 6 2 0 2
f 7 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 1 1 0 0
m 2 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
m 3 0 0 0 0 0 0 0 0 0 1 0 1 0 1 0 0 0 0 0
f 5 0 0 0 0 0 0 0 0 0 0 0 2 1 0 0 0 1 0 1
m 5 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 2 1 1 0
f 5 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 2
m 2 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0
f 4 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 1 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Breast
f 49 0 0 0 0 0 0 0 2 3 6 4 6 3 9 13 1 1 1 0
Cervix uteri f 10 0 0 0 0 0 0 0 0 0 1 1 2 1 2 1 2 0 0 0
Corpus uteri f 8 0 0 0 0 0 0 0 1 0 0 0 0 4 2 1 0 0 0 0
Ovary f 12 0 0 0 0 1 0 0 0 0 1 0 0 2 3 4 0 1 0 0
Penis m 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
Prostate m 20 0 0 0 0 0 0 0 0 0 0 0 1 2 3 4 4 3 3 0
Testis m 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
160
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 7 0 0 0 0 0 0 0 2 0 2 0 1 1 1 0 0 0 0 0
Kidney
f 2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0
m 31 0 0 0 0 0 1 0 0 0 0 0 1 7 4 10 1 2 4 1
Bladder
f 5 0 0 0 0 0 0 0 0 0 0 0 0 2 1 0 0 1 1 0
Brain and other parts of central nervous m 7 1 1 0 0 0 0 1 0 0 1 0 0 1 0 1 0 1 0 0

system f 6 1 0 0 0 0 0 0 0 0 1 0 1 0 1 1 1 0 0 0
m 5 0 0 0 0 0 1 0 1 0 1 0 1 1 0 0 0 0 0 0
Thyroid gland
f 31 0 0 0 0 0 1 2 4 9 2 2 3 7 1 0 0 0 0 0
Lymphoid, haematopoietic and related m 19 0 1 2 1 0 0 0 1 1 1 0 2 3 4 2 0 0 1 0
tissue f 7 0 0 0 0 0 0 1 0 0 1 1 0 3 0 1 0 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Hodgkin lymphoma
f 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
Follicular lymphoma,reticulo-sarcoma, m 5 0 0 0 0 0 0 0 0 0 1 0 1 0 2 1 0 0 0 0
mycosis fungoides,other and
unspecified types f 3 0 0 0 0 0 0 1 0 0 0 0 0 1 0 1 0 0 0 0

f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 5 1 2 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0
f 2 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0
other myelogenous leukemias (chronic, m 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
subacute, acute myelosuppression, etc.) f 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
etc.) f 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
m 14 0 0 0 0 0 0 0 1 1 1 0 3 3 2 1 0 2
f 13 0 0 0 0 0 0 0 0 0 0 1 0 3 4 0 0 3 1 1
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
In situ neoplasms
f 2 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Carcinoma in situ of cervix uteri
f 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
161
NHIAC
INCIDENCE OF MALIGNANT NEOPLASM AMONG POPULATION BY SEX AND AGE GROUP, LORI, 2020
Table 2m.n. 25
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 241 0 0 0 0 0 0 1 4 3 5 10 14 26 56 56 26 21 16 3
NEOPLASMS- Total
f 272 1 0 1 0 0 2 2 6 11 11 10 22 46 40 57 30 13 13 7
including:
m 4 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 2
Lip
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 5 0 0 0 0 0 0 0 0 0 0 0 1 0 2 2 0 0 0 0
Oral cavity
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0
Pharynx
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Oesophagus
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 23 0 0 0 0 0 0 0 0 0 0 4 0 3 2 6 2 3 2 1
Stomach
f 14 0 0 0 0 0 0 0 0 1 1 0 0 4 0 4 2 0 1 1
m 19 0 0 0 0 0 0 0 0 1 0 2 1 0 2 4 3 4 2 0
Colon
f 17 0 0 0 0 0 0 0 0 0 0 0 1 3 5 2 0 4 2 0
anus and anal canal
f 14 0 0 0 0 0 0 0 0 0 0 0 2 1 3 5 1 0 1 1
m 6 0 0 0 0 0 0 0 0 0 0 0 2 1 0 0 2 1 0 0
f 2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0
m 10 0 0 0 0 0 0 0 0 0 0 1 0 2 1 3 3 0 0 0
Pancreas
f 9 0 0 0 0 0 0 0 0 0 0 0 2 1 1 2 0 1 1 1
Nasal cavity, middle ear,accessory m 2 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0
sinuses f 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0
m 10 0 0 0 0 0 0 0 0 0 0 0 1 2 5 1 1 0 0 0
Larynx
f 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
m 45 0 0 0 0 0 0 0 0 0 1 0 3 7 12 13 5 3 1 0
f 10 0 0 0 0 0 0 0 0 0 0 0 1 0 3 1 3 0 1 1
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
f 5 0 0 0 0 0 0 0 0 0 0 0 0 2 0 1 1 0 1 0
m 3 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0
Melanoma of skin
f 2 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0
m 10 0 0 0 0 0 0 0 1 0 0 0 0 1 3 1 1 1 2 0
f 12 0 0 0 0 0 0 0 1 0 0 0 0 1 0 4 4 0 0 2
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
f 3 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0
Breast
f 77 0 0 0 0 0 0 0 2 5 7 6 2 16 10 16 4 4 4 1
Cervix uteri f 19 0 0 0 0 0 0 0 0 0 0 1 5 4 2 1 3 2 1 0
Corpus uteri f 18 0 0 0 0 0 0 0 0 0 0 0 0 1 7 6 4 0 0 0
Ovary f 20 0 0 0 0 0 0 0 0 2 0 2 3 7 1 3 2 0 0 0
162
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
Penis m 2 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0
Prostate m 25 0 0 0 0 0 0 0 0 0 0 0 0 3 5 6 3 4 4 0
Testis m 2 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0
m 8 0 0 0 0 0 0 0 0 0 0 2 0 0 2 2 0 1 1 0
Kidney
f 4 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0
m 22 0 0 0 0 0 0 0 0 0 2 0 1 2 5 6 2 1 3 0
Bladder
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Brain and other parts of m 6 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 0 0 0 0
central nervous system f 5 0 0 0 0 0 0 0 0 0 0 0 1 0 1 2 1 0 0 0
m 2 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0
Thyroid gland
f 14 0 0 0 0 0 2 2 2 0 1 1 1 1 3 1 0 0 0 0
related tissue f 15 1 0 1 0 0 0 0 1 2 0 0 2 1 2 2 2 0 1 0
m 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
Hodgkin lymphoma
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 3 0 0 0 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0 0
sarcoma, mycosis
fungoides,other and
f 3 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 1 0
unspecified types
Multiple myeloma and m 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
malignant
immunoproliferative diseases f 2 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
f 3 1 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0
f 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Myeloid leukaemia
f 3 0 0 0 0 0 0 0 1 0 0 0 2 0 0 0 0 0 0 0
subacute, etc.) f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
subacute, etc.) f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
m 13 0 0 0 0 0 0 0 0 0 0 0 1 2 5 2 1 2 0 0
f 8 0 0 0 0 0 0 0 0 0 1 0 0 2 1 3 0 1 0 0
163
NHIAC
INCIDENCE OF MALIGNANT NEOPLASM AMONG POPULATION BY SEX AND AGE GROUP, KOTAYK, 2020
Table 2m.n. 26
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 326 2 3 1 2 0 2 7 6 6 8 9 18 52 69 56 30 19 25 11
NEOPLASMS- Total
f 324 1 1 0 1 0 2 8 12 21 18 17 23 40 69 48 28 15 11 9
including:
m 5 0 0 0 0 0 0 0 0 0 0 0 2 2 0 0 0 0 0 1
Oral cavity
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
m 5 0 0 0 0 0 0 1 0 0 0 0 1 0 2 0 1 0 0 0
Pharynx
f 2 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Oesophagus
f 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1
m 27 0 0 0 0 0 0 0 0 0 1 1 1 6 6 6 0 1 3 2
Stomach
f 19 0 0 0 0 0 0 1 0 0 0 1 1 1 5 4 2 2 2 0
m 14 0 0 0 0 0 0 0 0 0 0 1 2 6 2 0 0 3 0
Colon
f 22 0 0 0 0 0 0 0 0 1 0 1 1 3 5 4 5 1 1 0
anus and anal canal f 10 0 0 0 0 0 1 0 1 0 0 0 3 1 2 2 0 0 0 0
m 6 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 1 1 1 1
f 9 0 0 0 0 0 0 0 0 0 0 0 0 0 3 1 1 1 2 1
m 17 0 0 0 0 0 0 0 0 0 1 0 1 4 2 4 1 2 2
Pancreas
f 7 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 1 2
sinuses f 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
m 8 0 0 0 0 0 0 0 0 0 0 0 0 0 3 1 3 1 0 0
Larynx
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 70 0 0 0 0 0 0 0 0 0 0 3 2 14 19 14 7 5 4 2
f 18 0 0 0 0 0 0 0 1 0 0 1 0 2 7 2 3 1 1 0
m 6 0 0 0 1 0 0 0 1 0 2 0 0 0 0 0 2 0 0 0
f 2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1
m 5 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 2 1
Melanoma of skin
f 5 0 0 0 0 0 0 0 0 0 0 0 0 0 3 1 0 0 1 0
m 10 0 0 0 0 0 0 1 0 0 0 0 0 3 3 1 2 0 0 0
f 9 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 2 2 2 0
m 9 0 1 0 0 0 0 1 0 0 0 0 1 1 2 2 1 0 0 0
f 4 0 0 0 0 0 0 0 0 2 0 0 1 1 0 0 0 0 0 0
m 3 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 1
Breast
f 83 0 1 0 0 0 0 1 4 5 8 6 6 10 19 13 4 2 1 3
Cervix uteri f 17 0 0 0 0 0 0 2 0 0 2 1 3 2 0 3 2 2 0 0
Corpus uteri f 15 0 0 0 0 0 0 0 0 0 0 0 3 0 6 5 1 0 0 0
Ovary f 23 0 0 0 1 0 0 1 0 0 2 3 1 6 4 3 1 1 0 0
164
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
Penis m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Prostate m 28 0 0 0 0 0 0 0 0 0 0 0 1 1 8 6 6 2 3 1
Testis m 3 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0
m 4 0 0 0 0 0 0 0 0 0 0 0 1 0 2 1 0 0 0 0
Kidney
f 2 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0
m 30 0 0 0 0 0 0 0 0 1 1 1 3 3 6 4 3 4 3 1
Bladder
f 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0

nervous system
f 10 0 0 0 0 0 0 1 0 0 2 1 0 1 3 1 0 1 0 0
m 8 0 0 0 0 0 1 1 2 2 0 0 1 1 0 0 0 0 0 0
Thyroid gland
f 27 0 0 0 0 0 0 2 6 8 2 2 1 3 2 1 0 0 0 0
related tissue f 14 1 0 0 0 0 1 0 0 3 1 0 1 3 1 1 2 0 0 0
m 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Hodgkin lymphoma
f 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0

f 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0
m 6 2 1 1 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0
f 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 3 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0
Myeloid leukaemia
f 3 0 0 0 0 0 0 0 0 2 0 0 0 1 0 0 0 0 0 0
m 4 0 0 0 0 0 0 1 0 1 0 0 0 2 0 0 0 0 0 0
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
etc.) f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 19 0 0 0 0 0 0 0 0 1 0 0 0 5 2 7 1 1 2 0
f 19 0 0 0 0 0 0 0 0 1 1 1 1 3 2 4 3 2 0 1
165
NHIAC
INCIDENCE OF MALIGNANT NEOPLASM AMONG POPULATION BY SEX AND AGE GROUP, SHIRAK, 2020
Table 2m.n. 27
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 267 2 2 1 0 2 0 1 2 3 8 7 21 42 57 37 29 20 23 10
NEOPLASMS- Total
f 296 1 0 1 1 0 1 2 13 20 18 13 20 35 49 45 23 24 19 11
including:
m 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0
Lip
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Oral cavity
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0
Pharynx
f 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1
Oesophagus
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 19 0 0 0 0 0 0 0 0 0 0 1 2 3 5 2 2 1 3 0
Stomach
f 21 0 0 0 0 0 0 0 0 1 0 1 2 4 1 3 4 3 2
m 20 0 0 0 0 0 0 0 1 0 1 1 1 4 6 2 1 1 1 1
Colon
f 18 0 0 0 0 0 0 0 1 1 0 1 1 2 2 3 2 5 0 0
anus and anal canal
f 3 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 1 0
m 9 0 0 0 0 0 0 0 0 0 0 1 0 4 0 0 3 0 1 0
f 4 0 0 0 0 0 0 1 0 0 0 0 0 0 2 1 0 0 0 0
m 5 0 0 0 0 0 0 0 0 0 0 0 2 1 0 1 0 0 1 0
Pancreas
f 9 0 0 0 0 0 0 0 0 1 0 0 0 2 3 2 0 0 1 0
sinuses f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 4 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 1 0 1 0
Larynx
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 57 0 0 0 0 1 0 0 0 0 1 1 5 8 11 9 7 6 5 3
f 9 0 0 0 0 0 0 0 1 1 2 0 1 0 1 1 1 1 0 0
m 7 0 1 0 0 1 0 0 0 1 0 0 0 1 1 0 1 0 0 1
f 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1
m 7 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 3 0 1 0
Melanoma of skin
f 2 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1
m 11 0 0 0 0 0 0 0 0 0 0 0 0 1 3 2 2 1 0 1
f 7 0 0 0 0 0 0 0 0 0 0 0 0 0 3 1 0 0 1 2
m 2 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0
f 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Breast
f 81 0 0 0 0 0 0 1 2 9 7 1 3 11 14 18 4 3 5 3
166
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
Cervix uteri f 29 0 0 0 0 0 0 0 2 1 2 6 2 5 5 2 2 0 1 1
Corpus uteri f 10 0 0 0 0 0 0 0 0 0 0 1 0 2 2 3 0 1 1 0
Ovary f 17 0 0 0 1 0 0 0 0 0 0 1 3 3 3 3 1 1 1 0
Penis m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0
Prostate m 24 0 0 0 0 0 0 0 0 0 0 0 0 2 5 4 3 4 5 1
Testis m 5 0 0 0 0 0 0 1 0 0 1 0 0 0 1 2 0 0 0 0
m 11 0 0 0 0 0 0 0 0 0 0 1 1 1 3 2 0 0 2 1
Kidney
f 4 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 2 0 0
m 30 0 0 0 0 0 0 0 0 0 1 0 2 6 7 5 5 3 1 0
Bladder
f 3 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1
nervous system
f 6 0 0 0 0 0 0 0 1 0 0 0 1 1 2 0 0 0 1 0
m 2 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0
Thyroid gland
f 16 0 0 0 0 0 1 0 4 3 2 0 1 0 1 1 0 1 2 0
related tissue f 27 1 0 1 0 0 0 0 2 3 0 2 5 1 1 4 4 3 0 0
m 3 0 0 1 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0
Hodgkin lymphoma
f 2 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0

f 2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0
m 2 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
f 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 3 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0 0
f 2 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
Myeloid leukaemia
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
f 3 0 0 0 0 0 0 0 0 2 0 0 1 0 0 0 0 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
f 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0
etc.) f 3 0 0 0 0 0 0 0 0 2 0 0 1 0 0 0 0 0 0 0
m 15 0 0 0 0 0 0 0 0 0 1 0 0 2 5 4 0 3 0 0
f 23 0 0 0 0 0 0 0 0 0 3 1 1 4 3 4 4 1 2 0
167
NHIAC
INCIDENCE OF MALIGNANT NEOPLASM AMONG POPULATION BY SEX AND AGE GROUP, SYUNIK, 2020
Table 2m.n. 28
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 121 0 0 1 0 0 0 2 1 3 1 6 6 14 29 26 17 8 4 3
NEOPLASMS- Total
f 136 1 0 0 0 0 2 2 5 5 10 9 17 12 22 17 16 7 9 2
including:
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
Lip
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Oral cavity
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0
Oesophagus
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1
m 11 0 0 0 0 0 0 0 0 0 0 0 1 1 3 3 1 2 0 0
Stomach
f 4 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 1 0 0
m 15 0 0 0 0 0 0 0 0 0 0 2 0 1 3 3 3 0 0 3
Colon
f 7 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 2 1 0 0
m 3 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 1 0 0 0
Rectosigmoid junction, rectum , anus and anal canal
f 6 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 1 1 1
m 5 0 0 0 0 0 0 0 0 0 0 0 1 0 2 1 1 0 0 0
f 5 0 0 0 0 0 0 0 0 0 0 0 1 0 2 0 0 0 2 0
m 6 0 0 0 0 0 0 0 0 0 0 1 0 1 1 3 0 0 0 0
Pancreas
f 3 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 0
m 2 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0
Larynx
f 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
m 19 0 0 0 0 0 0 0 0 0 0 1 2 5 4 2 1 2 2 0
f 4 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0
m 3 0 0 1 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Melanoma of skin
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
m 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Breast
f 42 0 0 0 0 0 0 0 1 2 6 3 6 7 5 5 3 3 1 0
Cervix uteri f 13 0 0 0 0 0 0 0 0 1 1 2 4 0 0 4 0 0 1 0
Corpus uteri f 7 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 1 0 0
Ovary f 5 0 0 0 0 0 0 0 0 1 0 1 0 0 2 0 1 0 0 0
Penis m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Prostate m 18 0 0 0 0 0 0 0 0 0 0 0 0 0 5 6 4 3 0 0
Testis m 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
168
Table 2 չ.ն. 28 continutation
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 4 0 0 0 0 0 0 1 0 0 0 0 1 1 0 1 0 0 0 0
Kidney
f 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 14 0 0 0 0 0 0 0 0 1 0 0 0 3 4 3 3 0 0 0
Bladder
f 3 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
f 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0
m 4 0 0 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0
Thyroid gland
f 15 0 0 0 0 0 1 2 4 1 3 1 1 1 0 0 1 0 0 0
m 7 0 0 0 0 0 0 0 0 0 0 1 0 0 1 2 2 0 1
Lymphoid, haematopoietic and related tissue
f 8 0 0 0 0 0 0 0 0 0 0 0 2 1 2 1 1 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Hodgkin lymphoma
f 2 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0
m 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 0 0 0
Follicular lymphoma,reticulo-sarcoma, mycosis
fungoides,other and unspecified types
f 2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0
Multiple myeloma and malignant immunoproliferative m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

diseases f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0
f 2 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0
f 6 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 2 0 1 0
169
NHIAC
INCIDENCE OF MALIGNANT NEOPLASM AMONG POPULATION BY SEX AND AGE GROUP, VAYOTS DZOR, 2020
Table 2m.n. 29
TheTable
number2m.n. 29 diagnosed for the first time in the reference year
of patients
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 65 1 0 0 0 0 0 2 1 1 1 3 6 10 12 13 7 2 5 1
NEOPLASMS- Total
f 52 0 0 0 0 0 0 1 0 1 1 5 4 7 8 11 8 2 1 3
including:
m 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0
Oral cavity
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Pharynx
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 5 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 0 0 0 0
Stomach
f 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
m 4 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 1 0 0 0
Colon
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
anus and anal canal
f 4 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Pancreas
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
Larynx
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 11 0 0 0 0 0 0 1 0 0 0 0 0 0 5 4 1 0 0 0
f 2 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0
f 3 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 1
m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Breast
f 12 0 0 0 0 0 0 0 0 0 0 1 0 2 5 1 2 1 0 0
Cervix uteri f 2 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0
Corpus uteri f 4 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 1 0 0
Ovary f 6 0 0 0 0 0 0 0 0 0 0 2 1 1 0 2 0 0 0 0
Prostate m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0
Testis m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 7 0 0 0 0 0 0 0 1 0 0 1 0 2 2 0 1 0 0 0
Kidney
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
m 14 0 0 0 0 0 0 0 0 0 0 0 1 1 3 5 1 0 2 1
Bladder
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
170

Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >

nervous system
f 3 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0
m 2 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0
Thyroid gland
f 3 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0
related tissue f 2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0

f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Myeloid leukaemia
f 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
m 3 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0
f 6 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0 1 2
171
NHIAC
INCIDENCE OF MALIGNANT NEOPLASM AMONG POPULATION BY SEX AND AGE GROUP, TAVUSH, 2020
Table 2m.n. 30
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
m 148 0 0 1 1 0 1 0 0 3 2 6 10 19 32 31 20 10 10 2
NEOPLASMS- Total
f 142 0 0 1 0 1 1 1 3 6 7 8 9 17 28 23 15 13 9 0
including:
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Oral cavity
f 2 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0
Pharynx
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
Oesophagus
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 11 0 0 0 0 0 0 0 0 0 0 0 1 1 3 3 3 0 0 0
Stomach
f 7 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 4 0 0 0
m 11 0 0 0 0 0 0 0 0 0 0 0 0 2 4 3 2 0 0 0
Colon
f 5 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 0 0
Rectosigmoid junction, rectum , anus and m 6 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 2 0 0
anal canal f 8 0 0 0 0 0 0 0 0 0 0 0 0 0 2 2 1 2 1 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0
f 2 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0
m 5 0 0 0 0 0 0 0 0 0 0 0 0 0 2 2 1 0 0 0
Pancreas
f 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0
m 6 0 0 0 0 0 0 0 0 1 0 1 0 2 2 0 0 0 0 0
Larynx
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 27 0 0 0 0 0 0 0 0 1 0 0 1 3 8 5 3 3 2 1
f 4 0 0 0 0 0 0 0 0 0 0 0 1 0 1 2 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
Melanoma of skin
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0
f 5 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 0 2 0 0
m 4 0 0 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0
f 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0
m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
Breast
f 49 0 0 0 0 0 0 0 3 4 2 6 4 4 7 8 5 3 3 0
Cervix uteri f 14 0 0 0 0 0 0 0 0 0 3 0 0 3 3 4 0 0 1 0
Corpus uteri f 5 0 0 0 0 0 0 0 0 0 0 0 1 0 2 0 0 2 0 0
Ovary f 5 0 0 0 0 0 1 0 0 0 1 0 1 0 2 0 0 0 0 0
Penis m 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
Prostate m 19 0 0 0 0 0 0 0 0 0 0 0 0 1 2 6 2 3 4 1
m 2 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0
Kidney
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 21 0 0 0 0 0 0 0 0 0 1 0 3 5 6 3 1 0 2 0
Bladder
f 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
172
Sex
NEOPLASMS
Total 0-4 5-9 10-14 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 & >
Brain and other parts of central nervous m 5 0 0 0 0 0 1 0 0 0 0 3 0 1 0 0 0 0 0 0

system
f 9 0 0 0 0 0 0 0 0 0 0 1 0 2 3 1 0 2 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0
Thyroid gland
f 4 0 0 0 0 0 0 1 0 0 1 0 1 1 0 0 0 0 0 0
Lymphoid, haematopoietic and related m 7 0 0 0 1 0 0 0 0 0 1 0 3 0 1 1 0 0 0 0
tissue f 10 0 0 1 0 1 0 0 0 1 0 1 0 0 4 1 0 0 1 0
m 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
Hodgkin lymphoma
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Follicular lymphoma,reticulo-sarcoma, m 2 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0
mycosis fungoides,other and unspecified
types f 4 0 0 0 0 0 0 0 0 0 0 0 0 0 3 1 0 0 0 0

f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
f 3 0 0 1 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
f 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0
m 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
f 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
m 2 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0
f 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
m 11 0 0 0 0 0 0 0 0 0 0 0 0 1 1 4 4 1 0
f 9 0 0 0 0 0 0 0 0 0 0 0 0 1 0 2 4 1 1 0
173
NHIAC
NUMBER OF PATIENTS RECEIVING TREATMENT, RA 2020
Table 2m.n. 31
of which:
Number of’s
special treatment
Combined or
NEOPLASMS ICD X patients registered
complex (except chemistry-
in the reporting surgical Radiation therapy drug treatment
chemical- radiation
year radiological)
NEOPLASMS՝ Total C00-C97 4863 2929 202 959 588 185
including children (0-17 years old

C00-C97 64 15 1 41 4 3
inclusive)
which of them 0-14 y. o. C00-C97 55 12 37 3 3
Lip,Oral cavity, Pharynx C00C14 96 43 12 18 15 8

Oesophagus C15 20 9 5 3 2 1
Stomach C16 191 106 3 53 25 4
Colon C18 370 287 4 28 47 4
Rectosigmoid junction, rectum , anus and

C19-C21 203 130 11 20 31 11
anal canal
Liver and intrahepatic bile ducts C22 38 22 2 12 2
Pancreas C25 83 52 25 5 1
nasal cavity, middle ear,accessory C30-
115 78 12 5 17 3
sinuses,Larynx C31,C32
Trachea, bronchus and lung C33-C34 320 109 16 127 40 28
Bone and articular cartilage C40-C41 31 13 4 6 5 3
Melanoma of skin C43 48 46 0 0 2
Other malignant neoplasms of skin C44 215 192 18 1 3 1
Mesothelial and soft tissue C45- 49 60 42 5 5 8 0
Breast C50 920 415 23 285 179 18

Cervix uteri C53 178 41 28 8 32 69
Corpus uteri C54 140 99 8 5 25 3
Ovary C56 133 75 1 23 32 2
Penis C60 16 15 0 0 1 0
Prostate C61 238 172 11 32 20 3
Testis C62 28 25 0 1 2 0
Kidney C64 96 85 0 4 7 0
Bladder C67 358 322 3 9 21 3
Brain and other parts of central nervous
C70-C72 122 72 15 7 22 6
system
Thyroid gland C73 316 287 7 5 17
Lymphoid, haematopoietic and related

C81–C96 303 28 6 249 8 12
tissue
Other Malignant Diseases 225 164 8 28 20 5
174
NUMBER OF PATIENTS RECEIVING TREATMENT,

YEREVAN, 2020
Table 2m.n. 32
Number of’s of which:

special
treatment
NEOPLASMS ICD X patients Combined or complex
chemistry-
registered in surgical Radiation therapy drug treatment (except chemical-
radiation
the reporting radiological)
year
NEOPLASMS Total C00-C97 2105 1265 70 415 294 61

C00-C97 21 4 0 15 1 1
inclusive)
which of them 0-14 y. o. C00-C97 21 4 0 15 1 1

Oesophagus C15 10 4 3 2 1
Stomach C16 59 36 15 8
Colon C18 177 136 1 13 26 1
Rectosigmoid junction, rectum , anus
C19-C21 94 55 2 11 21 5
and anal canal
Liver and intrahepatic bile ducts C22 18 9 0 8 1 0
Pancreas C25 28 17 0 8 3 0
44 31 2 2 7 2
Melanoma of skin C43 16 14 0 0 2 0
Breast C50 465 200 17 136 102 10
Cervix uteri C53 58 22 8 4 11 13
Corpus uteri C54 67 46 5 3 11 2
Ovary C56 52 26 0 12 13 1
Penis C60 6 6 0 0 0 0
Prostate C61 125 101 3 12 8 1
Testis C62 12 11 0 0 1 0
Kidney C64 35 29 0 2 4 0
Bladder C67 144 128 1 4 10 1
Brain and other parts of central

C70-C72 35 18 3 3 8 3
nervous system
Thyroid gland C73 130 124 1 0 5 0

C81–C96 123 10 3 100 6 4
tissue
175
NHIAC
NUMBER OF PATIENTS RECEIVING TREATMENT, ARAGATSOTN, 2020
Table 2m.n. 33
of which:
Number of’s
Combined or
special
treatment complex
Radiation chemistry-
NEOPLASMS ICD X patients drug treatment (except
surgical therapy radiation
registered in chemical-
year

C00-C97 2 0 0 2 0 0
inclusive)
which of them 0-14 y. o. C00-C97 1 1
Oesophagus C15 1 1 0 0 0
Stomach C16 9 6 0 1 2 0
Colon C18 8 6 0 1 1
C19-C21 2 1 0 0 0 1
and anal canal
Pancreas C25 2 0 0 1 1
7 5 1 0 0 1
Breast C50 32 13 0 12 7 0
Cervix uteri C53 6 1 1 0 3 1
Corpus uteri C54 4 4 0 0 0 0
Ovary C56 6 3 0 0 3 0
Prostate C61 5 4 0 1 0 0
Testis C62 1 1 0 0 0 0
Kidney C64 6 6 0 0 0 0
Bladder C67 14 14 0 0 0 0
C70-C72 3 1 0 1 1 0
nervous system
Thyroid gland C73 13 12 0 0 1 0
Lymphoid, haematopoietic and

C81–C96 13 1 1 10 1
related tissue
176
NUMBER OF PATIENTS RECEIVING TREATMENT ,

ARARAT, 2020
Table 2m.n. 34
of which:
Number of’s
special treatment Combined or
NEOPLASMS ICD X patients complex
registered in the surgical drug treatment (except
therapy radiation
reporting year chemical-
radiological)

C00-C97 1 0 0 1 0 0
inclusive)

Stomach C16 10 7 0 2 1 0
Colon C18 19 16 0 1 2 0
C19-C21 13 9 1 0 2 1
and anal canal
Pancreas C25 4 2 0 1 1 0
13 11 1 0 1 0
Melanoma of skin C43 5 5 0 0 0
Breast C50 60 29 2 19 8 2
Cervix uteri C53 13 2 1 1 9
Ovary C56 10 7 1 2
Penis C60 1 1 0 0 0 0
Prostate C61 12 8 0 3 1 0
Testis C62 3 3 0 0 0 0
Kidney C64 9 8 0 1 0 0
Bladder C67 27 27 0 0 0 0
C70-C72 17 11 0 1 4 1
nervous system
Lymphoid, haematopoietic and C81–
26 5 0 19 0 2
related tissue C96
177
NHIAC
NUMBER OF PATIENTS RECEIVING TREATMENT , ARMAVIR, 2020

Table 2m.n. 35
of which:
Number of’s
special treatment Combined or
NEOPLASMS ICD X patients registered complex
in the reporting surgical
therapy
drug treatment (except
radiation
year chemical-
radiological)
including children (0-17 years old inclusive) C00-C97 11 6 0 3 0 2

Stomach C16 16 8 0 5 3 0
Colon C18 31 25 0 1 5 0
Rectosigmoid junction, rectum , anus and anal
C19-C21 17 12 1 2 0 2
canal
Pancreas C25 4 2 0 2 0 0
C30-
nasal cavity, middle ear,accessory sinuses,Larynx 13 7 4 1 1 0
C31,C32
Breast C50 65 31 1 20 13
Corpus uteri C54 13 9 1 3
Ovary C56 11 7 2 2 0
Penis C60 2 2 0 0 0 0
Prostate C61 13 8 1 3 1 0
Testis C62 2 1 0 0 1 0
Kidney C64 6 5 0 0 1 0
Bladder C67 24 23 0 1 0 0
Brain and other parts of central nervous system C70-C72 15 7 5 1 1 1
Lymphoid, haematopoietic and related tissue C81–C96 18 3 0 13 1 1
178
NUMBER OF PATIENTS RECEIVING TREATMENT, GEGHARKUNIK, 2020

Table 2m.n. 36
of which:
Number of’s
special Combined or
treatment complex
NEOPLASMS ICD X
patients Radiation chemistry-
surgical drug treatment (except
registered in the therapy radiation
radiological)

C00-C97 5 2 0 3 0 0
inclusive)

Stomach C16 16 8 3 2 3 0
Colon C18 22 15 2 1 1 3

C19-C21 12 7 2 1 2 0
and anal canal

Pancreas C25 6 6 0 0 0 0
Larynx C32 8 3 1 2 2 0

Breast C50 36 10 2 15 5 4
Corpus uteri C54 7 3 2 2
Ovary C56 11 5 0 3 3 0
Penis C60 1 0 0 0 1 0
Prostate C61 12 7 1 3 1
Testis C62 1 0 0 1 0 0
Kidney C64 8 7 0 0 1 0
Bladder C67 26 17 2 0 7 0
Brain and other parts of central nervous

C70-C72 8 5 1 0 2 0
system

C81–C96 19 1 0 18 0 0
tissue
179
NHIAC
NUMBER OF PATIENTS RECEIVING TREATMENT , LORI, 2020

Table 2m.n. 37
of which:
Number of’s
special Combined or
treatment complex
NEOPLASMS ICD X
patients Radiation chemistry-
surgical drug treatment (except
registered in the therapy radiation
radiological)

C00-C97 1 0 0 1 0 0
inclusive)
which of them 0-14 y. o. C00-C97 1 1

Stomach C16 18 7 6 2 3
Colon C18 23 18 0 2 3 0

C19-C21 14 12 1 1 0 0
and anal canal
Pancreas C25 9 8 0 0 0 1
10 9 0 0 1 0
Breast C50 52 30 0 8 13 1
Ovary C56 13 8 0 1 3 1
Penis C60 2 2 0 0 0 0
Prostate C61 14 8 2 1 2 1
Testis C62 1 1 0 0 0 0
Kidney C64 11 11 0 0 0 0
Bladder C67 19 17 0 0 0 2

C70-C72 7 4 1 0 1 1
nervous system
Lymphoid, haematopoietic and related C81–

15 1 1 10 0 3
tissue C96
180
NUMBER OF PATIENTS RECEIVING TREATMENT ,KOTAYK, 2020

Table 2m.n. 38
of which:
Number of’s
special
treatment Combined or
registered in surgical drug treatment (except
therapy radiation
the reporting chemical-
year radiological)

C00-C97 10 0 1 7 2 0
inclusive)

Stomach C16 22 16 0 4 2 0
Colon C18 30 25 0 3 2 0
C19-C21 15 11 0 3 1 0
and anal canal
Pancreas C25 11 5 0 6 0 0
Larynx C32 7 7 0 0 0 0
Breast C50 66 33 0 26 7 0
Ovary C56 11 7 1 1 2 0
Penis C60 1 1 0 0 0 0
Prostate C61 23 13 4 6 0 0
Testis C62 3 3 0 0 0 0
Kidney C64 3 3 0 0 0 0
Bladder C67 30 25 0 3 2 0
C70-C72 13 10 3 0 0 0
nervous system
Lymphoid, haematopoietic and related C81–

29 3 1 24 1 0
tissue C96
181
NHIAC
NUMBER OF PATIENTS RECEIVING TREATMENT, SHIRAK, 2020

Table 2m.n. 39
of which:
Number of’s
special
therapy radiation
year radiological)
C00-
NEOPLASMS՝ Total 326 198 14 69 33 12
C97
including children (0-17 years C00-
8 2 0 5 1 0
old inclusive) C97
C00-
which of them 0-14 y. o. 7 1 0 5 1 0
C97
Stomach C16 13 7 0 5 1 0
Colon C18 23 19 0 1 3 0
Rectosigmoid junction, rectum , C19-
10 8 1 0 0 1
anus and anal canal C21
Pancreas C25 7 3 0 4 0 0
3 2 0 0 1 0
C33-
Trachea, bronchus and lung 22 14 0 5 3 0
C34
C40-
Bone and articular cartilage 5 2 0 1 2 0
C41
Breast C50 57 28 0 21 8 0
Ovary C56 8 6 0 0 2 0
Penis C60 2 2 0 0 0 0
Prostate C61 10 5 0 2 3 0
Testis C62 4 4 0 0 0 0
Kidney C64 6 5 0 0 1 0
Bladder C67 27 26 0 0 1 0
Brain and other parts of central C70-
10 7 2 0 1 0
nervous system C72
Lymphoid, haematopoietic and C81–

27 2 0 24 0 1
related tissue C96
182
NUMBER OF PATIENTS RECEIVING TREATMENT, SYUNIK, 2020

Table 2m.n. 40
of which:
Number of’s
special
therapy radiation
year radiological)

C00-C97 1 0 0 1 0 0
inclusive)
Stomach C16 8 5 0 3 0 0
Colon C18 18 13 0 4 1 0

C19-C21 6 4 1 0 1 0
and anal canal
Pancreas C25 5 4 0 1 0 0
Larynx C32 2 2
Breast C50 31 20 0 5 6 0
Ovary C56 5 3 0 2 0 0
Prostate C61 12 9 0 2 1 0
Testis C62 1 1 0 0 0 0
Kidney C64 3 2 0 1 0 0
Bladder C67 14 13 0 1 0 0

C70-C72 2 1 0 0 1 0
nervous system

C81–C96 9 0 0 9 0 0
related tissue
183
NHIAC
NUMBER OF PATIENTS RECEIVING TREATMENT ,VAYOTS DZOR, 2020

Table 2m.n. 41
of which:
Number of’s
special
treatment
Combined or
NEOPLASMS ICD X patients
complex (except chemistry-
registered in surgical Radiation therapy drug treatment
chemical- radiation
year

C00-C97 1 0 0 1 0 0
inclusive)
Stomach C16 3 0 0 3 0 0
Colon C18 4 2 1 1
Rectosigmoid junction, rectum ,

C19-C21 6 3 1 0 1 1
anus and anal canal
Pancreas C25 1 0 0 1 0 0
Breast C50 7 4 0 2 1
Ovary C56 2 0 0 1 1 0
Prostate C61 1 1 0 0 0 0
Kidney C64 6 6 0 0 0 0
Bladder C67 14 13 0 0 1 0

C70-C72 1 0 0 1 0 0
nervous system

C81–C96 5 0 0 5 0 0
related tissue
184
NUMBER OF PATIENTS RECEIVING TREATMENT ,TAVUSH, 2020

Table 2m.n. 42
of which:
Number of’s
special
Combined or
treatment
NEOPLASMS ICD X complex
patients drug chemistry-
surgical Radiation therapy (except
registered in the treatment radiation
chemical-
reporting year
radiological)

C00-C97 3 1 0 2 0 0
inclusive)
Stomach C16 15 6 0 6 2 1
Colon C18 13 11 0 2
C19-C21 13 7 1 2 3 0
and anal canal
Pancreas C25 5 4 0 1 0 0
Larynx C32 7 2 1 0 4 0
Breast C50 47 17 1 19 9 1
Ovary C56 4 3 0 0 1 0
Penis C60 1 1 0 0 0 0
Prostate C61 10 8 0 2 0 0
Kidney C64 3 3 0 0 0 0
Bladder C67 19 19 0 0 0 0
C70-C72 11 8 0 0 3 0
nervous system
C81–C96 18 2 0 16 0 0
tissue
185
NHIAC
MATERNAL AND
CHILD HEALTH
186
MATERNAL AND CHILD HEALTH
NUMBER OF PREGNANCIES AND HEALTH CHARACTERISTICS
Table 3.1
1990 1995 2000 2005 2010 2015 2019 2020
a.v. % a.v. % a.v. % a.v. % a.v. % a.v. % a.v. % a.v. %
Number of full-term
/completed
76493 47901 35108 37789 46114 44370 38772 38686
pregnancies,
TOTAL
including:
Term birth 70390 92 44924 93.8 32664 93 35452 93.8 42050 91.2 39890 89.9 34165 88.1 33917 87.7
Preterm birth 3453 4.9 1610 3.4 1317 3.8 1268 3.4 1884 4.1 1996 4.5 1976 5.1 1987 5.1
Miscarriage:
spontaneous and 2650 3.5 1367 2.8 1127 3.2 1069 2.8 2180 4.7 2484 5.6 2631 6.8 2782 7.2
induced abortions
Examined by the
72460 94.7 45819 95.7 32456 92.4 36271 96 44533 96.6 43335 97.7 37846 97.6 37891 97.9
therapist
including:
By week 12 of the
Bվ. բgց - 26146 54.6 15131 43.1 16515 43.7 27738 60.2 29500 66.5 27994 72.2 29320 75.8
pregnancy
The number of women who had completed childbearing and hadfollowing characteristics
genitourinary
614 0.8 1633 3.4 6104 17.4 5312 14.1 5260 11.4 5850 13.2 4328 11.2 4219 10.9
system diseases *
circulatory system
981 1.3 580 1.2 364 1 233 0.6 128 0.3 274 0.6 290 0.7 356 0.9
diseases
Anemia 1958 2.6 5116 10.7 5500 15.7 4042 10.7 5909 12.8 5720 12.9 4888 12.6 5815 15.0
Hypertensive
disorders during 2194 2.9 1098 2.3 964 2.7 1074 2.8 1521 3.3 1239 2.8 1274 3.3 1566 4.0
pregnancy
including:
preeclampsia and
64 0.08 47 0.1 105 0.3 175 0.5 191 0.4 216 0.5 276 0.7 461 1.2
eclampsy
Venous
complications during - - 1337 2.8 1537 4.4 1547 4.1 2068 4.5 2614 5.9 2798 7.2 2806 7.3
pregnancy
Prenatal bleeding
due to blood - - 10 0.02 4 0.01 1 0.003 - - 23 0.05 66 0.17 127 0.33
coagulation disorders
*** 1990-1991- kidney diseases
*1992- diseases of genitourinary system
% from the number of women who had completed childbearing
187
NHIAC
CHILDBIRTH AND POSTPARTUM COMPLICATIONS
Table 3.2
1990 1995 2000 2005 2010 2015 2019 2020
a.v. r.v.* a.v. r.v.** a.v. r.v.** a.v. r.v.** a.v. r.v.** a.v. r.v.** a.v. r.v.** a.v. r.v.**
Bleeding related
to placenta
previa and 611 7.6 417 9.2 495 14 665 17.5 926 20.7 886 21.0 692 19.2 652 17.8
placental
detachment
Abnormalities of
6168 77.1 3099 68.2 2122 60.1 2940 77.4 2611 58.4 2541 60.3 2733 75.8 3159 86.4
labor activity
Third and fourth
degree perineal 26 0.32 17 0.37 17 0.48 31 0.82 14 0.31 17 0.40 13 0.36 18 0.49
rupture
Uterine rupture 9 0.11 7 0.15 9 0.25 2 0.05 5 0.11 3 0.07 1 0.03 3 0.08
Labor and
14 0.17 20 0.44 27 0.76 28 0.74 58 1.3 9 0.2 8 0.22 10 0.27
postpartum sepsis
including:
peritonitis after
the cesarean 2 0.02 5 0.11 1 0.03 4 0.11 12 0.27 5 0.12 4 0.11 4 0.11
section
Venous
- - 858 18.9 1393 39.5 1376 36.2 1208 27.0 1684 40.0 1928 53.5 1630 44.6
complications
Hypertensive
disorders during 2383 29.8 1579 34.7 1687 47.8 1722 45.3 2003 44.8 2356 55.9 2262 62.7 1918 52.4
pregnancy
including:
Preeclampsia
91 1.14 120 2.64 449 12.7 540 14.2 344 7.7 355 8.4 402 11.1 463 12.7
and eclampsia
Anemia 1105 13.8 2707 59.56 4607 130.6 4675 123.1 5038 112.6 4289 101.8 3286 91.1 4353 119.0
Genitourinary
246 3.07 952 20.94 3542 100.4 3697 97.3 2735 61.1 2609 61.9 2060 57.1 2577 70.5
system diseases **
Circulatory
356 4.44 210 4.62 333 9.4 199 5.2 130 2.9 372 8.8 387 10.7 439 12.0
system diseases
Placental and
postpartum 2485 31.04 1614 35.51 1403 39.8 1096 28.8 963 21.5 630 15.0 690 19.1 534 14.6
bleeding
1990-1991 renal diseases

1992 genitourinary diseases
**r.v- per 1000 births
188
SURGICAL OPERATIONS
Table 3.3
The number of obstetrics operations / without abortions and operations/
Number of Number of
Number of
Total Year births Total Year births
Year births
stationeries stationeries
stationeries
1980 67944 - - 828 12.2 197 2.9 687 10.1 640 9.4 91 1.3
1985 78672 - - 954 12.1 245 3.1 519 6.6 1347 17.1 72 0.9
1990 80039 20637 257.8 1073 13.4 218 2.7 342 4.3 2687 33.6 72 0.9
1992 69070 18802 272.2 919 13.3 294 4.3 321 4.6 2584 37.4 58 0.8
1993 55086 12439 225.8 827 15.0 156 2.8 269 4.9 2226 40.4 42 0.8
1994 46285 11492 248.4 647 14.0 130 2.8 307 6.6 1889 40.8 50 1.1
1995 45445 9580 210.8 615 13.5 141 3.1 198 4.4 2093 46.1 57 1.3
1996 45612 10247 224.7 569 12.5 116 2.5 165 3.6 2316 50.8 52 1.1
1997 41976 12086 287.9 602 14.3 123 2.9 161 3.8 2483 59.2 39 0.9
1998 38625 13394 346.8 570 14.8 75 1.9 138 3.6 2432 63.0 26 0.7
1999 36187 13246 366.0 561 15.5 76 2.1 155 4.3 2404 66.4 16 0.4
2000 35279 13971 396.0 521 14.8 68 1.9 156 4.4 2553 72.4 24 0.7
2001 33009 13296 402.8 460 13.9 57 1.7 99 3.0 2520 76.3 15 0.5
2002 33423 12804 383.1 483 14.5 166 5.0 132 3.9 2729 81.7 10 0.3
2003 36909 14526 393.6 520 14.1 58 1.6 139 3.8 3266 88.5 12 0.3
2004 37906 14423 380.5 476 12.6 62 1.6 144 3.8 3611 95.3 13 0.3
2005 37992 14010 368.8 427 11.2 50 1.3 155 4.1 4248 111.8 15 0.4
2006 38053 14272 375.1 419 11.0 63 1.7 156 4.1 4512 118.6 16 0.4
2007 40319 15221 377.5 446 11.1 48 1.2 226 5.6 5638 139.8 14 0.3
2008 41462 15981 385.4 474 11.4 42 1.0 119 2.9 6234 150.4 16 0.4
2009 44554 17354 389.5 459 10.3 42 0.9 122 2.7 7882 176.9 14 0.3
2010 44739 18014 402.6 438 9.8 38 0.8 111 2.5 8439 188.6 11 0.2
2011 43301 19289 445.5 454 10.5 47 1.1 79 1.8 9385 216.7 13 0.3
2012 42709 18310 428.7 455 10.7 52 1.2 149 3.5 9558 223.8 4 0.1
2013 41923 18596 443.6 453 10.8 50 1.2 140 3.3 9949 237.3 4 0.1
2014 43332 19871 458.6 414 9.6 43 1.0 86 2.0 11156 257.5 3 0.1
2015 42123 20050 476.0 447 10.6 48 1.1 95 2.3 11472 272.3 3 0.1
2016 40809 19376 474.8 419 10.3 42 1.0 100 2.5 11525 282.4 0 0.0
2017 37832 20174 533.3 384 10.2 28 0.7 109 2.9 11727 310.0 1 0.03
2018 36769 19161 521.1 420 11.4 13 0.4 183 5.0 11961 325.3 0 0.0
2019 36064 20207 560.3 376 10.4 23 0.6 120 3.3 12403 343.9 3 0.1
2020 36570 20931 572.4 394 10.8 22 0.6 69 1.9 13144 359.4 0 0
r.v. - per 1000 births
189
NHIAC
CHILDBIRTH AT MEDICAL OBSTETRICS AND GYNECOLOGY FACILITIES

Table 3.4
1985 1990 1995 2000 2005 2010 2015 2018 2019 2020
Number of births -Total 78672 80039 45445 35279 37992 44739 42123 36769 36064 36570
including:
Normal labor
absolute value 51426 48392 24869 16885 23475 29595 21811 18316 16791 19741
% 65.4 60.5 54.7 47.9 61.8 66.2 51.8 49.8 46.6 54.0
Multiple births
absolute value 585 683 376 339 352 442 519 474 492 499
% 0.7 0.8 0.8 1.0 0.9 1.0 1.2 1.3 1.4 1.4
USE OF CONTRACEPTIVES
Table 3.5
1990 1995 2000 2005 2010 2015 2018 2019 2020
Number followed up women at the end of current year
Use of intrauterine device (IUD), loop

Absolute value 15474 9541 16790 7677 5844 6570 6607 5955 6106
per 1000 fertile age women 16.9 9.4 15.4 8.3 6.5 8.5 8.8 8.0 8.2
Use of hormonal contraception
Absolute value 813 1207 37726 3774 2430 3611 6004 4950 4949
Use of intrauterine device (IUD), loop
Absolute value 6424 2754 7280 2625 2614 2562 2029 1909 1663
190
NUMBER OF MISCARRIAGES (ABORTIONS)
Table 3.6
Number of miscarriage/abortion
including: Per 1000 fertile age women

Years
Per 100 Number of live

stillbirth births and stillbirths
Total
Drug- vacuum Drug- vacuum and per 1,000 fertile age
spontaneou Total newborn* women *
induced*** aspiration induced *** aspiration
s ***
1983 33158 - - - 38.2 - - 43.0 88.8

1985 33896 - - - 38.4 - - 41.7 92.1
1990 26094 - - 2213 28.7 - 2.4 32.3 88.8
1991 27264 - - 3154 29.9 - 3.4 34.7 84.9
1992 27958 - - 2091 29.5 - 2.2 39.3 75.1
1993 27907 - - 1816 28.7 - 1.9 47.0 61.2
1994 30571 - - 1137 31.3 - 1.2 59.4 52.6
1995 30726 - - 2910 30.5 - 2.9 62.3 48.9
1996 31323 - - 2065 30.5 - 2.0 64.6 47.3
1997 25266 - - 603 24.3 - 0.58 57.1 42.5
1999 14403 - - 344 13.5 - 0.3 39.1 34.5
2000 11769 3687 - 311 10.9 - 0.28 34.0 32.0
2001 10419 2817 - 386 9.5 - 0.35 32.2 29.5
2002 9767 2641 - 395 10.7 - 0.43 30.1 35.5
2003 10730 2951 - 220 11.8 - 0.24 29.7 39.7
2004 10645 3062 - 158 11.6 - 0.17 28.2 41.3
2005 10925 3188 99 11.9 - 0.11 28.9 41.2
2006 11132 3344 - - 12.0 - - 29.1 41.4
2007 11501 3567 - - 12.4 - - 28.3 43.9
2008 12469 3437 - - 13.5 - - 29.8 45.2
2009 13797 3648 - - 15.0 - - 30.5 49.3
2010 12295 3718 - - 13.5 - - 26.9 50.2
2011 12130 3796 165 - 13.5 0.18 - 27.4 49.1
2012 13730 4277 429 341 16.8 0.52 0.42 31.7 52.9
2013 12871 4160 385 295 15.9 0.48 0.37 30.3 52.7
2014 12019 3640 53 74 15.1 0.07 0.09 27.5 55.1
2015 11259 2752 71 84 14.4 0.09 0.11 26.5 54.5
2016 10736 2235 178 110 13.9 0.23 0.14 26.0 53.6
2017 10228 2098 156 66 13.4 0.21 0.09 26.7 50.4
2018 10647 1669 146 97 14.1 0.19 0.13 28.6 49.4
2019 11348 2479 270 186 15.2 0.36 0.25 31.0 49.0
2020 11219 1963 427 74 15.1 0.57 0.1 30.5 49.4
**** Data on live births and stillbirths are taken from the absolute numbers published by NSS
**The indicator is calculated from 2000
*** The indicator is calculated from 2011
191
NHIAC
NUMBER OF MISCARRIAGES (ABORTIONS) BY CAUSES AND REGIONS, 2020
Table 3.7
Gegharkunik
VayotsDzor
Aragatsotn
RA Total
Armavir
Yerevan
Tavush
Kotayk
Syunik
Shirak
Ararat
Lori
Total (without
vacuum aspiration and 10718 4395 359 631 741 492 1108 865 734 612 112 669
medical abortion)
including:
Spontaneous 1963 925 25 165 109 80 150 87 218 125 32 47
Induced-permitted 6846 2160 293 457 564 365 770 647 462 446 79 603
Induced – upon
1909 1310 41 9 68 47 188 131 54 41 1 19
medical indication
NUMBER OF ABORTIONS THROUGH VACUUM ASPIRATION (MINI)

AND MEDICINE INTAKE, BY REGIONS, 2020
Table 3.8
Gegharkunik
VayotsDzor
Aragatsotn
RA Total
Armavir
Yerevan
Tavush
Kotayk
Syunik
Shirak
Ararat
Lori
Vacuum aspiration 74 13 12 31 18
Drug-induced 427 66 34 58 89 155 10 15
192
NUMBER OF ABORTIONS BY PERIOD AND REGIONS, 2020
Table 3.9
Gegharkunik
VayotsDzor
Aragatsotn
RA Total
Armavir
Yerevan
Tavush
Kotayk
Syunik
Shirak
Ararat
Lori
Prior to week 12 9391 3673 339 567 641 471 1032 821 530 571 110 636
12-22 weeks
1327 722 20 64 100 21 76 44 204 41 2 33
(inclusive)
NUMBER OF ABORTIONS PER 1000 FERTILE AGE WOMEN BY REGIONS, 2020
Table 3.10
Gegharkunik
VayotsDzor
Aragatsotn
RA Total
Armavir
Yerevan
Tavush
Kotayk
Syunik
Shirak
Ararat
Lori
Total number of
10718 4395 359 631 741 492 1108 865 734 612 112 669
abortions
Per 1000 fertile

14.4 16.1 11.5 9.7 10.9 8.5 21.0 13.6 12.5 18.1 9.4 22.5
age women
including:
Induced-
6846 2160 293 457 564 365 770 647 462 446 79 603
permitted
Per 1000 women
9.2 7.9 9.4 7.0 8.3 6.3 14.6 10.2 7.9 13.2 6.6 20.3
in fertile age
Induced – upon
medical 1909 1310 41 9 68 47 188 131 54 41 1 19
indication
Per 1000 women

2.6 4.8 1.3 0.1 1.0 0.8 3.6 2.1 0.9 1.2 0.1 0.6
in fertile age
193
NHIAC
BREAKDOWN OF LIVE BIRTHS BY BODY WEIGHT
Table 3.11
Body weight at birth
in gramms % from the number of live births

Live births – Total
Years 3500 g.
(abs. value) Less than 1000-2499 2500-3499 Less than 1000-2499 2500-3499 3500 g. and
and
1000 g. g. g. 1000 g. g. g. above
above
1990 80022 115 5094 51366 23447 0.14 6.4 64.2 29.3
1995 45430 56 3587 31470 10317 0.12 7.9 69.3 22.7
1997 41785 110 3190 28791 9694 0.3 7.6 68.9 23.2
1998 38467 81 3182 25835 9369 0.2 8.3 67.2 24.3
1999 35961 104 2947 24385 8525 0.3 8.2 67.8 23.7
2000 35142 101 2798 23503 8740 0.3 8.0 66.9 24.8
2001 32912 89 2500 21948 8375 0.3 7.6 66.7 25.4
2002 33332 92 2721 22164 8355 0.3 8.2 66.5 25.1
2003 36538 130 2798 23905 9705 0.4 7.7 65.4 26.6
2004 37602 112 2710 23886 10894 0.3 7.2 63.5 29.0
2005 37681 103 2633 25022 9923 0.3 7.0 66.4 26.3
2006 37706 78 2897 24460 10271 0.2 7.7 64.9 27.2
2007 40055 62 2872 26657 10464 0.2 7.2 66.5 26.1
2008 41258 72 2958 27475 10753 0.2 7.2 66.6 26.0
2009 44306 79 3257 29725 11245 0.2 7.3 67.1 25.4
2010 44330 97 3276 29305 11652 0.2 7.4 66.1 26.3
2011 42882 89 3242 28567 10984 0.2 7.6 66.6 25.6
2012 42346 86 3249 28328 10683 0.2 7.7 66.9 25.2
2013 41668 91 3314 27726 10537 0.2 8.0 66.5 25.3
2014 43061 89 3872 28760 10340 0.2 9.0 66.8 24.0
2015 41841 114 3491 28512 9724 0.3 8.3 68.2 23.2
2016 40613 98 3366 27576 9573 0.2 8.3 67.9 23.6
2017 37709 109 3729 25371 8500 0.3 9.9 67.3 22.5
2018 36577 106 2978 24544 8949 0.3 8.1 67.1 24.5
2019 35985 121 3155 24174 8535 0.3 8.8 67.2 23.7
2020 36601 121 3142 24587 8751 0.3 8.6 67.2 23.9
194
PREMATURITY, PRENATAL MORTALITY AND STILLBIRTHS

AT THE MEDICAL OBSTETRICS AND GYNECOLOGY FACILITIES
Table 3.12
Number of stillbirths and newborns who died
Number of premature per 1000 live Number of stillbirths per 1000 still births and
Years within 6 days postpartum per 1000 stillbirths
births live-births
and live births
1990 56.5 17.6 10.1
1995* 61.9 15.6/22.9 8.5/15.0
1996 66.0 18.0/25.2 8.8/14.5
1997 68.0 17.5/25.2 8.2/13.5
1998 70.8 16.9/23.1 7.9/12.6
1999 71.9 17.1/24.8 8.9/14.5
2000 69.2 16.3/23.7 8.3/13.4
2001 67.8 14.8/21.1 8.0/12.0
2002 68.9 13.4/20.5 7.1/12.2
2003 64.9 13.1/26.8 7.9/19.0
2004 68.1 12.1/24.8 7.6/18.0
2005 61.7 11.9/24.0 7.3/17.4
2006 60.9 14.4/25.6 8.6/18.4
2007 59.3 13.4/20.5 9.2/15.3
2008 62.5 12.8/20.0 9.0/15.3
2009 62.7 10.9/19.1 7.5/15.0
2010 67.2 11.3/23.1 7.9/18.9
2011 71.5 10.3/24.4 7.0/20.0
2012 65.0 9.5/22.5 7.1/18.8
2013 64.6 9.3/20.2 6.5/16.5
2014 68.7 8.9/20.5 6.7/17.2
2015 66.9 8.9/21.8 7.0/19.2
2016 74.3 7.8/20.2 5.8/17.4
2017 76.6 7.6/19.0 6.2/16.5
2018 76.5 7.2/20.1 6.1/18.3
2019 86.4 6.8/18.0 5.7/16.0
2020 79.0 6.7/15.2 5.5/12.8
* The numerator is calculated excluding the number of fetuses and the denominator is calculated including these numbers.
195
NHIAC
MORBIDITY OF NEWBORNS
Table 3.13
1990 1995 2000 2005 2010 2015 2019 2020
Number of sick-borns and newborns who were fallen sick per 1000 mature borns
Total morbidity 83.4 84.1 94.0 86.1 71.8 94.1 95.1 102.1
including:
Inborn abnormalities 8.3 11.0 15.5 13.4 12.9 16.0 16.6 18.2
Labor traumas 7.7 8.1 9.4 9.2 10.4 11.2 12.0 12.3
Intra-uterine hypoxia and asphyxia during the

32.0 33.4 43.5 33.5 21.9 15.8 13.0 13.2
delivery
Congenital pneumonia 2.1 1.1 1.4 2.7 3.2 5.2 9.2 9.6
Septicemia 0.1 0.09 0.4 0.2 0.4 0.9 0.7 0.8
Haemolitic disease 4.7 4.4 4.1 3.8 4.4 6.7 9.0 7.9
Number of sick-borns and newborns who were fallen sick per 1000 mature borns
Total morbidity 550.0 544.3 626.4 616.1 570.0 674.2 679.9 706.4
including:
Congenital abnormalities 25.5 46.2 58.4 38.7 41.0 47.5 57.6 43.6
Labor traumas 33.5 21.0 25.5 23.2 10.1 7.1 12.9 43.9
Intra-uterine hypoxia and asphyxia during the

239.0 266.3 324.7 340.9 219.9 102.2 85.3 75.4
delivery
Congenital pneumonia 25.5 14.6 27.1 31.0 46.7 77.9 94.6 93.7
Septicemia 1.1 1.1 4.9 4.7 12.8 23.6 20.9 29.0
Haemolitic disease 12.2 14.9 13.2 11.2 6.0 18.2 21.6 25.6
196
LETHALITY OF NEWBORNS
(with weight of 1000 g. and above)
Table 3.14
Number of death per 100 newborns who fell ill
Years
Full term births Full term births
1980 5.3 20.7
1985 4.2 19.1
1990 2.5 12.7
1991 3.1 12.6
1992 3.4 13.8
1993 3.6 15.7
1994 2.7 11.5
1995 2.4 12.4
1996 3.1 15.8
1997 2.9 12.6
1998 2.8 10.7
1999 1.8 11.0
2000 3.0 11.7
2001 2.7 12.9
2002 2.7 11.0
2003 2.5 9.1
2004 2.0 8.9
2005 2.3 8.3
2006 2.3 12.3
2007 1.7 8.4
2008 2.1 7.0
2009 1.3 7.3
2010 1.9 6.6
2011 1.5 6.3
2012 1.1 4.1
2013 1.2 4.9
2014 0.6 4.6
2015 0.6 3.7
2016 0.5 3.4
2017 0.5 2.8
2018 0.4 2.0
2019 0.4 1.8
2020 0.3 2.5
197
NHIAC
BIRTH, LIVEBIRTHS, EARLY NEONATAL AND PERINATAL

MORTALITY RATES
BY REGIONS, 2020
Table 3.15
Early
Number of Number of Number of dead infants 0-6 Perinatal
Regions Number of births neonatal
livebirths stillbirths days old mortality rate
mortality rate
RA 36570 36601 473 91 15.2 2.5
including
Yerevan 21626 21637 375 73 20.4 3.4
Aragatsotn 633 634 1 0 1.6 0
Ararat 1487 1486 11 1 8.0 0.7
Armavir 1232 1231 5 0 4.0 0
Gegharkunik 1894 1900 6 1 3.7 0.5
Lori 2212 2225 12 4 7.2 1.8
Kotayk 1988 1990 13 2 7.5 1.0
Shirak 2951 2943 42 5 15.7 1.7
Syunik 1227 1227 4 2 4.9 1.6
VayotsDzor 269 271 0 0 0 0
Tavush 1051 1057 4 3 6.6 2.8
LETHALITY OF NEWBORNS (0-27 days) IN RA

Table 3.16
Years Absolute number neonatal mortality rate
2014 287 6.7
2015 262 6.3
2016 249 6.1
2017 235 6.2
2018 182 5.0
2019 169 4.7
2020 204 5.6
EARLY NEONATAL MORTALITY (0-6 days)

/MATERNAL AND NEONATAL DEPARTMENTS/
Table 3.17
Absolute number
Year early neonatal mortality rate
(childbirth and neonatal care units)
2014 217 5.0

2015 191 4.6
2016 177 4.4
2017 156 4.1
2018 116 3.2
2019 102 2.8
2020 135 3.7
198
ILLNESS OF CHILDREN 0-2 YEARS OLD, REPUBLIC OF ARMENIA, 2020
Table 3.18
Diseases ICD–10
0-1 age group 1-2 age group
a.v. r.v. a.v. r.v.
Total Diseases : A00-T98 33558 93268.5 34280 95032.2

Certain infectious and parasitic diseases A00-B99 1334 3707.6 2015 5586.1
including: intestinal infectious diseases A00-A09 672 1867.7 868 2406.3
Covid–19 U07.1. 21 58.4 37 102.6
U07.2
Diseases of the blood and blood-forming organs and certain disorders
D50–D89 2208 6136.7 1692 4690.6
including: anemia D50–D64 2141 5950.5 1616 4479.9
Endocrine, nutritional and metabolic diseaseներ. E00-E90 795 2209.6 601 1666.1
including: congenital hypothyroidism E03.1 41 114.0 45 124.8
Severe malnutrition with nutritional oedema, nutritional marasmus,

E40. E41.
unspecified severe protein-energy malnutrition, protein-energy 101 280.7 76 210.7
E43. Е44.0
malnutrition of moderate and mild degree
Rickets II-III E55.0 part 166 461.4 112 310.5
Classical phenylketonuria E70.0 14 38.9 4 11.1
Mucoviscidosis E84.0,E84.1 7 19.5 6 16.6
E84.8 E84.9
Diseases of the nervous system G00-G99 466 1295.2 451 1250.3
including myopathies G71-G72 18 50.0 19 52.7
Cerebral palsy G80 35 97.3 57 158.0
Hydrocephalus G91 48 133.4 41 113.7
Diseases of the eye and adnexa H00–H59 2311 6423.0 2012 5577.7
including: Background retinopathy H35 229 636.5 147 407.5
Diseases of the ear and mastoid process H60–H95 2354 6542.5 2343 6495.3
Respiratory diseases J00-J99 15680 43579.8 18215 50496.2
J00-J06.
including: acute respiratory infections, influenza 13653 37946.1 16113 44669.0
J10-J11
Pneumonia J12-J18 744 2067.8 850 2356.4
Diseases of the digestive system K00-K93 2324 6459.1 2411 6683.9
Diseases of the genitourinary system N00-N99 1067 2965.5 1187 3290.6
individual conditions that occur in the perinatal area P00-P96 2293 6373.0 597 1655.0
Congenital malformations, deformations and chromosomal Q00-Q99 935 2598.7 523 1449.9
abnormalities
Including microcephaly Q02 10 27.8 12 33.3
Malformations of aqueduct of Sylvius Q03 33 91.7 18 49.9
Spinabifida Q05 7 19.5 11 30.5

Congenital glaucoma Q15.0 4 11.1 3 8.3
Congenital deafness Q16 5 13.9 3 8.3
Circulatory and respiratory diseases Q20- Q28 424 1178.4 233 645.9
Cleft palate Q35 14 38.9 15 41.6
Cleft lip Q36 18 50.0 6 16.6
Congenital deformities of hip Q65 149 414.1 41 113.7
Osteogenesis imperfecta Q78.0 3 8.3 4 11.1
Down syndrome Q91 25 69.5 22 61.0

Injury, poisoning and certain other consequences of external causes S00-T98 276 767.1 485 1344.5
Other diseases 1515 4210.7 1748 4845.9
199
NHIAC
ILLNESS OF CHILDREN 0-2 YEARS OLD, REPUBLIC OF ARMENIA,YEREVAN 2020
Table 3.19
Disease ICD–10
0 –1 1 -2
r.v.
Total Diseases : A00-T98 7328 7500
Certain infectious and parasitic diseases A00-B99 246 299
including: intestinal infectious diseases A00-A09 63 89
Covid–19 U07.1. U07.2 21 37
D50–D89 366 300
including: anemia D50–D64 341 283
Endocrine, nutritional and metabolic diseaseներ. E00-E90 182 134
including: congenital hypothyroidism E03.1 19 24
E40. E41. E43.
unspecified severe protein-energy malnutrition, protein-energy malnutrition 8 16
Е44.0
of moderate and mild degree
Rickets II-III E55.0 part 11 13
Classical phenylketonuria E70.0 2 2
E84.0,E84.1
Mucoviscidosis 0 5
E84.8 E84.9
Diseases of the nervous system G00-G99 217 199
including myopathies G71-G72 2 3
Cerebral palsy G80 16 26
Hydrocephalus G91 23 28
Diseases of the eye and adnexa H00–H59 638 501
including: Background retinopathy H35 79 62
Diseases of the ear and mastoid process H60–H95 468 470
Respiratory diseases J00-J99 2938 4064
including: acute respiratory infections, influenza J00-J06. J10-J11 2366 3507
Pneumonia J12-J18 149 158
Diseases of the digestive system K00-K93 370 278
Diseases of the genitourinary system N00-N99 205 223
Individual conditions that occur in the perinatal area P00-P96 732 104
Congenital malformations, deformations and chromosomal abnormalities Q00-Q99 372 191
Including microcephaly Q02 1 1
Malformations of aqueduct of Sylvius Q03 10 2
Spina bifida Q05 2 3
Congenital glaucoma Q15.0 2 1
Congenital deafness Q16 2 0
Circulatory and respiratory diseases Q20- Q28 177 90
Cleft palate Q35 2 4
Cleft lip Q36 2 0
Osteogenesis imperfecta Q65 46 16
Down syndrome Q91 10 14
Injury, poisoning and certain other consequences of external causes S00-T98 48 88
Other diseases 546 649
200
ILLNESS OF CHILDREN 0-2 YEARS OLD, REPUBLIC OF ARMENIA, ARAGATSOTN 2020
Table 3.20
Disease ICD–10
0 –1 1 -2
r.v.
145 99
involving the immune mechanism D50–D89
unspecified severe protein-energy malnutrition, protein-energy malnutrition E40, E41, E43, 2 4
of moderate and mild degree Е44.0
including: acute respiratory infections, influenza J00-J06, J10-J11 877 893
Cleft lip Q36 0 1
Osteogenesis imperfecta Q78.0 0 4
201
NHIAC
ILLNESS OF CHILDREN 0-2 YEARS OLD, REPUBLIC OF ARMENIA, ARARAT 2020
Table 3.21
Disease ICD–10
0 –1 1 -2
r.v.
268 234
involving the immune mechanism D50–D89
unspecified severe protein-energy malnutrition, protein-energy malnutrition E40, E41, E43, 33 6
of moderate and mild degree Е44.0
E84.0 E84.1
3 0
Mucoviscidosis E84.8 E84.9
0 2
Cleft palate Q35
Cleft lip Q36 0 0
202
ILLNESS OF CHILDREN 0-2 YEARS OLD, REPUBLIC OF ARMENIA, ARMAVIR 2020
Table 3.22
Disease ICD–10
0 –1 1 -2
r.v.
D50–D89 186 153
E40, E41, E43,
Е44.0
E84.0 E84.1
1 0
Mucoviscidosis E84.8 E84.9
Q35 2 2
Cleft palate
Cleft lip
Q36 4 0

203
NHIAC
ILLNESS OF CHILDREN 0-2 YEARS OLD, REPUBLIC OF ARMENIA,

GEGHARKUNIK 2020
Table 3.23
Disease ICD–10
0 –1 1 -2
r.v.
D50–D89 178 81
E40. E41. E43.
Е44.0
Mucoviscidosis E84.0,E84.1
0 1
E84.8 E84.9
Cleft lip Q36 4 0
204
ILLNESS OF CHILDREN 0-2 YEARS OLD, REPUBLIC OF ARMENIA, LORI 2020
Table 3.24
Disease ICD–10
0 –1 1 -2
r.v.
D50–D89 469 335
E40. E41. E43.
Е44.0
E84.0,E84.1
Mucoviscidosis 0 0
E84.8 E84.9
Cleft lip Q36 3 1
205
NHIAC
ILLNESS OF CHILDREN 0-2 YEARS OLD, REPUBLIC OF ARMENIA, KOTAYK 2020
Table 3.25
Disease ICD–10
0 –1 1 -2
r.v.
D50–D89 160 150
E40. E41. E43.
Е44.0
Cleft lip Q36 3 1
206
ILLNESS OF CHILDREN 0-2 YEARS OLD, REPUBLIC OF ARMENIA, SHIRAK 2020
Table 3.26
Disease ICD–10
0 –1 1 -2
r.v.
D50–D89 172 154
E40. E41. E43.
Е44.0
Mucoviscidosis E84.0,E84.1
3 0
E84.8 E84.9
Cleft lip Q36 0 1
207
NHIAC
ILLNESS OF CHILDREN 0-2 YEARS OLD, REPUBLIC OF ARMENIA, SYUNIK 2020
Table 3.27
Disease ICD–10
0 –1 1 -2
r.v.
D50–D89 138 54
E40. E41. E43.
Е44.0
Cleft lip Q36 0 1
208
ILLNESS OF CHILDREN 0-2 YEARS OLD, REPUBLIC OF ARMENIA, VAYOTS DZOR 2020
Table 3.28
Disease ICD–10
0 –1 1 -2
r.v.
D50–D89 22 12
209
NHIAC
ILLNESS OF CHILDREN 0-2 YEARS OLD, REPUBLIC OF ARMENIA, TAVUSH 2020
Table 3.29
Disease ICD–10
0 –1 1 -2
r.v.
D50–D89 104 120
E40. E41. E43.
Е44.0
Cleft lip Q36 2 1
210
IMMUNIZATION
212
IMMUNIZATION
COMMUNICABLE DISEASES COVERED BY IMMUNIZATION PROGRAM
Table 4.1
Total diseases
1990 1995 2000 2005 2010 2015 2019 2020 1990 1995 2000 2005 2010 2015 2019 2020
Diseases
absolute value relative value**
Poliomyelitis 12 3 - - - - - - 0.33 0.8 - - - - - -
Acute flaccid
- - 22 10 13 17 16 9 - - 0.6 0.31 0.40 0.57 0.54 0.30
paralysis*
Diphtheria 7 29 - - - - - - 0.2 0.8 - - - - - -
Measles 879 187 15 2281 2 33 7 - 24.7 5.0 0.39 70.9 0.06 1.1 0.24 -
Pertussis 469 12 10 6 4 27 46 14 13.2 0.3 0.26 0.19 0.12 0.9 1.6 0.47
Tetanus 2 1 1 2 3 - - 1 0.06 0.03 0.02 0.06 0.09 - - 0.03
Mumps 1592 806 3431 167 38 4 1 2 45.0 21.4 90.2 5.2 1.17 0.13 0.03 0.06
Rubella 1742 2135 673 620 - - - - 49.0 57.0 17.69 19.3 - - - -
including ` up to 14 years old
1990 1995 2000 2005 2010 2015 2019 2020 1990 1995 2000 2005 2010 2015 2019 2020
absolute value relative value**
Poliomyelitis 12 3 - - - - - - 1.1 0.3 - - - - - -
Acute flaccid
- - 22 9 13 17 16 9 - - 2.4 1.32 2.2 2.9 2.7 1.5
paralysis*
Diphtheria 2 18 - - - - - - 0.2 1.6 - - - - - -
Measles 757 161 14 928 - 19 1 - 70.0 15.0 1.56 136.4 - 3.2 0.17 -
Pertussis 460 12 10 6 4 27 39 12 42.5 1.1 1.11 0.88 0.67 4.6 6.5 2.0
Tetanus 1 - - - 1 - - 1 0.1 - - - 0.17 - - 0.17
Mumps 1508 763 2892 131 31 4 1 2 139.3 71.0 322.4 19.3 5.22 0.68 0.17 0.33
Rubella 1647 2051 646 444 - - - - 152.1 190.8 72.0 65.3 - - - -
*Control established since 1996
** Relative value per 100000 population
RATE OF VACCINATION AMONG CHILDREN (%)

Table 4.2
Vaccines 1990 1995 2000 2005 2010 2015 2018 2019 2020
Hepatitis B - - - 89.2 94.3 97.92 97.03 97.21 97.29

BCG (Tuberculosis) 83.5 84.0 96.8 94.8 99.1 99.3 98.67 98.76 99.00
DTP/Hepatitis B/
85.3 98.0 93.3 85.6 93.8 94.36 92.48 91.75 91.70
Haemophilus influenza B
OPV 3 (Polio) 91.9 93.0 96.2 89.4 95.5 96.22 94.1 93.67 86.12
Rota-2 - - - - - 93.35 92.54 91.68 92.16
MMR -1 95.2 96.0 91.6 94.4 97.3 97.00 95.28 95.29 94.44
213
NHIAC
HEALTH RESOURCES
AND
FACILITIES
214
NHIAC
MAIN RESOURCES
Table 5.1
TOTAL 1980 1985 1990 1995 2000 2005* 2010 2015 2019 2020
Number of physicians of
all specialities ( 10885 12713 14519 12657 12270 12307 13591 13117 13958 14396
including: dentists)
Number of mid-level
25323 30620 34953 31324 22632 18364 18649 17632 16772 16744
medical personnel
Number of hospital
171 171 180 183 146 145 130 132 125 126
facilities
Number of hospital beds
26 28.1 30.5 28.7 20.8 14.4 12.2 12.5 11.8 12.9
(1000)
Number of PHC
475 497 529 509 503 458 504 504 494 500
facilities *****
MoH, regional and municipal
Number of
pharmaceutists with 168 167 176 179 143 111 90 87 79 78
higher education
Number of
pharmaceutists with 25590 27482 29732 28271 20483 9862 7835 7874 6922 7640
secondary education
Number of hospitals 462 484 516 501 497 398 381 363 355 352
Number of hospital beds 44 44 44 45 46 58 100 96 61 63
*** including: private dental surgical clinics

** including: private medical and dental surgeries since 2006
***Since 2007 data on YSMU human resources is extracted from the MoH database and is presented in the section “ Other departments/agencies”
****Since 2011 data on interns and graduate students of the National Institute of Health is extracted from the MoH database and is presented in the section
‘Personnel of Yerevan State Medical University’ up to section “Other departments”.
***** Excluding MOU ( information presented in Ttable 5.8 (1-2)
215
NHIAC
MAIN HEALTH RESOURCES AND SERVICE UTILIZATION, 2020*
Table 5.2
MoH, regional and
TOTAL Other departamental
municipal healthcare Private facilities
institutions
facilties
Number of physicians of all specialities
Absolute value 14027 6557 3986 3484
Per 10000 populations 47.3 22.1 13.5 11.8
Number of mid-level medical personnel
Absolute value 16528 11136 4367 1025
Per 10000 populations 55.8 37.6 14.7 3.5
Number of hospitals providing medical care

Number of hospitals providing medical
126 78 41 7
care
Number of hospital beds at the end of the year

Absolute value 12871 7640 4368 863
Per 10000 populations 43.4 25.8 14.7 2.9
Number of hospitalizations
Absolute value 394470 197980 162991 33499
per 100 population 13.3 6.7 5.5 1.1
Annual average bed occupancy(day) 235 231 232 285
Average per patient, per day

length of stay for hospital in- 7.4 8.7 5.9 7.4
patients
Number of PHC facilities
Number of PHC facilities

500 352 127 21
(excluding health posts)
Number of PHC visits (thousand) 10150.7 8528.3 1388.7 233.7
Average number of PHC visits

3.4 2.9 0.47 0.08
per capita
*Excluding private medical and dental surgical clinics
216
HEALTH RESOURCES AND FACILITIES
PRIVATE SECTOR UTILIZATION AND RESOURCES *
Table 5.3
2004 2012 2013 2014 2015 2018 2019 2020
Number of physicians of all

specialities ( including: 2335 2965 2972 3122 3227 3385 3479 3986
dentists)
Supply of physicians per

7.3 9.8 9.9 10.4 10.8 11.4 11.8 13.5
10000 population
Number of mid-level medical
3371 4024 3956 4128 3997 4084 4267 4367
personnel
Number of hospital facilities 21 32 34 36 39 36 39 41
Number of hospital beds 3463 3700 3772 3927 3970 3867 3988 4368
Number of hospitalizations 79461 148239 139070 152339 149009 161029 175975 162991
Annual average bed

185 255 239 247 245 248 258 232
occupancy (day)
The average number of days
8.1 6.4 6.5 6.3 6.4 6.0 5.8 5.9
spent in bed
Number of outpatient
36 118 121 126 123 127 120 127
facilities
Total number of visits of PHC

592401 1644994 1641189 1800881 2016468 2381781 2055102 1388724
facilities
from which:
Ambulatory visits 546940 1588821 1582285 1741475 1950915 2336648 1952782 1350947
Home visits 45461 51161 51770 52322 54470 34430 39316 27097
Average per capita

0.18 0.54 0.54 0.60 0.67 0.79 0.66 0.46
ambulatory visits
Number of diseases of patients living in distrincts of PHCU
TOTAL 58860 98160 100122 106902 121440 129499 137886 168955
from which:
Adults 46333 88137 89872 96363 105662 115008 122014 152833
Children ( 0 – 14 y.o) 10955 8631 8802 9055 12951 12682 13401 13272
Teenagers (15 – 17 y.o.) 1572 1392 1448 1484 2827 1809 2471 2850
* The data was collected in 2004
217
NHIAC
INPATIENT AND OUTPATIENT MEDICAL
FACILITIES (excluding health posts)
Table 5.4
Including: MoH, regional and municipal
RA total
institutions
Years
Total planned capacity of
PHCU Hospitals PHCU
PHCU
1980 475 171 462 168
1985 497 171 484 167
1989 524 179 511 175
1990 529 180 516 176
1991 547 183 537 179
1992 526 187 516 183
1993 527 186 517 182
1994 515 185 504 181
1995 509 183 501 179
1996 506 173 499 169
1997 497 178 488 172
1998 497 179 487 172
1999 504 174 497 171
2000 503 146 497 143
2001 459 142 456 142
2002 446 135 444 135
2003 452 137 449 135
2004 448 140 440 133
2005 458 145 398 111
2006 460 140 386 106
2007 467 135 380 99
2008 474 130 374 94
2009 487 127 377 91
2010 504 130 381 90
2011 506 130 379 90
2012 513 127 377 89
2013 514 129 374 89
2014 509 130 364 88
2015 504 132 363 87
2016 505 129 358 84
2017 501 125 355 82
2018 501 124 355 79
2019 494 125 355 79
2020 500 126 352 78
218
DISTRIBUTION OF PHCU BY TYPES

/excluding health posts/
Table 5.5
MoH, regional and municipal institutions
1980 1985 1990 1995 2000 2005 2010 2015 2019 2020
PHCF– TOTAL 462 484 516 501 497 398 381 363 355 352
including:
Number of PHCF in
131 135 136 138 73 64 72 63 60 59
Hospitals
Self-sustainable PHCF *–
216 233 256 279 357 307 296 289 285 284
Total
including:
Polyclinics 25 31 34 39 78 70 38 40 37 37
PHC healthcare centers 5 6 11 9 6 4 4 3 3 3
Rural Ambulatories 178 188 202 218 231 225 248 242 241 241
Pediatric polyclinics 8 8 9 10 35 4 1 2 2 2
Women's Consultations - - - - 3 1 1 - -
Other facilities - - - 3 4 3 4 2 2 1
Dispansaries 30 32 36 31 25 18 10 10 10 9
Independent dental
17 24 33 39 41 9 3 1 - -
polyclinics TOTAL:
including:
Adult 13 18 23 29 31 3 3 1 - -
Pediatric 4 6 10 10 10 6 - - - -
 Medical institution with legal status
219
NHIAC
PHC AND HOSPITAL FACILITIES

Table 5.6
Number of healthcare facilities
PHCU Inpatient
2018 2019 2020 2018 2019 2020
RA TOTAL 501 494 500 124 125 126
including:
MoH, regional and
355 355 352 79 79 78
municipal
YEREVAN TOTAL 144 138 146 52 53 55
excluding municipal
99 93 102 38 39 42
departments
including municipal
45 45 44 14 14 13
departments
ARAGATSOTN 23 24 24 6 6 5
Ashtarak 12 13 13 1 2 2
Aparan 4 4 4 2 1 1
Aragats 1 1 1 1 1 1
Talin 6 6 6 2 2 1
ARARAT 61 60 60 6 6 6
Artashat 23 23 23 1 1 1
Vedi 12 11 - 2 2 -
Masis 19 19 19 1 1 1
Ararat 7 7 18 2 2 4
ARMAVIR 61 60 60 4 4 4
Armavir 28 28 29 1 1 2
Baghramyan 7 7 7 - - -
Vagharshapat 25 24 24 2 2 2
-
Metsamor 1 1 1 1 -
GEGHARKUNIK 40 40 40 7 7 7
Vardenis 8 8 8 1 1 1
Gavar 7 7 7 1 1 1
Martuni 18 18 18 2 2 2
Tshambarak 2 2 2 1 1 1
Sevan 5 5 5 2 2 2
LORI 41 41 40 7 7 7
Gugark 5 5 5 - - -
Spitak 5 5 5 1 1 1
Stepanavan 4 4 4 1 1 1
Tashir 2 2 2 1 1 1
Tumanyan 10 10 10 1 1 1
Vanadzor 15 15 14 3 3 3
220
PHC AND HOSPITAL FACILITIES

continuation 5.6
Number of healthcare facilities
PHCU Inpatient
2018 2019 2020 2018 2019 2020
KOTAYK 47 47 46 10 10 10
Kotayk 23 23 22 5 5 5
Nairi 12 12 12 2 2 2
Hrazdan 7 7 12 2 2 3
Charencavan 5 5 - 1 1 -
SHIRAK 32 32 32 15 15 15
Amasia 1 1 1 - - -
Ani 4 4 4 1 1 1
Artik 6 6 6 2 2 2
Akhuryan 7 7 7 2 2 2
Ashotsk 1 1 1 1 1 1
Gyumri 13 13 13 9 9 9
SYUNIK 17 17 17 7 7 7
Goris 6 6 6 2 2 2
Kapan 4 4 4 3 3 3
Meghri 1 1 1 1 1 1
Sisian 6 6 6 1 1 1
VAYOTS
8 8 8 3 3 3
DZOR
Vayk 2 2 3 1 1 2
Eghegnadzor 5 5 5 1 1 1
Jermuk 1 1 - 1 1 -
TAVUSH 27 27 27 7 7 7
Ijevan 9 9 9 2 2 2
Noyemberyan 9 9 9 1 1 1
Tavush 7 7 7 3 3 3
Dilijan 2 2 2 1 1 1
221
NHIAC
BREAKDOWN OF INPATIENT HEALTHCARE FACILITIES

BY TYPE AND BY NUMBER OF BEDS, 2020
Table 5.7
Maternity Maternity
Independed Dispensaries with
United hospitals Health centers hospitals without hospitals with Total
hospitals inpatient units
antenatal units antenatal units
Number Number Number Number Number Number Number
Facilities Facilities Facilities Facilities Facilities Facilities Facilities
of beds of beds of beds of beds of beds of beds of beds
RA TOTAL 31 2760 68 8720 11 237 5 181 3 312 8 661 126 12871
including:
YEREVAN – total 19 2040 29 5691 2 71 2 277 3 296 55 8375
including:
excluding
municipal 14 1516 22 3666 1 25 2 277 3 296 42 5780
departments
including
municipal 5 524 7 2025 1 46 13 2595
departments
ARAGATSOTN 4 189 1 7 5 196
Ashtarak 2 81 2 81
Aparan 1 68 1 68
Aragats 1 7 1 7
Talin 1 40 1 40
ARARAT 4 330 1 108 1 50 6 488
Artashat 1 130 1 130
Vedi
Masis 1 110 1 110
Ararat 2 90 1 108 1 50 4 248
ARMAVIR 1 110 3 255 4 365
Armavir 2 205 2 205
Baghramyan
Vagharshapat 1 110 1 50 2 160
Metsamor
GEGHARKUNIK 1 30 4 710 1 30 1 30 7 800
Vardenis 1 30 1 30
Gavar 1 80 1 80
Martuni 1 170 1 30 2 200
Tshambarak 1 30 1 30
Sevan 2 460 2 460
LORI 1 40 5 440 1 35 7 515
Gugark
Spitak 1 100 1 100
Stepanavan 1 54 1 54
Tashir 1 40 1 40
Tumanyan 1 60 1 60
Vanadzor 1 40 1 186 1 35 3 261
222
BREAKDOWN OF INPATIENT HEALTHCARE FACILITIES

BY TYPE AND BY NUMBER OF BEDS, 2020
continuation 5.7
Maternity
Maternity hospitals Dispensaries with
Independed hospitalsUnited hospitals Health centers hospitals without Total
with antenatal units inpatient units
antenatal units
Number of Number Number Number Number of Number Number

Facilities Facilities Facilities Facilities Facilities Facilities Facilities
beds of beds of beds of beds beds of beds of beds
KOTAYK 3 68 4 210 1 5 1 35 1 160 10 478
Kotayk 1 10 1 55 1 5 1 35 1 160 5 265
Nairi 1 50 1 40 2 90
Hrazdan 1 8 2 115 3 123
Charencavan
SHIRAK 5 435 4 228 3 58 1 30 2 90 15 841
Amasia
Ani 1 5 1 5
Artik 1 25 1 26 2 51
Akhuryan 1 15 1 27 2 42
Ashotsk 1 88 1 88
Gyumri 5 435 1 100 1 30 2 90 9 655
SYUNIK 1 37 5 344 1 80 7 461
Goris 1 37 1 90 2 127
Kapan 2 159 1 80 3 239
Meghri 1 45 1 45
Sisian 1 50 1 50
VAYOTS
2 80 1 5 3 85
DZOR
Vayk 1 35 1 5 2 40
Eghegnadzor 1 45 1 45
Jermuk
TAVUSH 4 243 3 24 7 267
Ijevan 1 76 1 5 2 81
Noyemberyan 1 52 1 52
Tavush 1 30 2 19 3 49
Dilijan 1 85 1 85
223
NHIAC
DISTRIBUTION OF OUTPATIENT HEALTH CARE FACILITIES BY TYPES
(including health posts) , 2020
Table 5.8
Independed Dispensaries
Providing narrow
Adult Pediatricpo Adult Without With the
PHC facilities professional
polyclinics lyclinics polyclinics hospital hospital
medical care
RA TOTAL 38 2 11 57 241 2 8
YEREVAN total 21 2 2 50 1 3
excluding municipal departments 1 2 50 3
including municipal departments 20 2 1
ARAGATSOTN 3 16
Ashtarak 1 10
Aparan 3
Aragats
Talin 2 3
ARARAT 2 50
Artashat 1 20
Vedi
Masis 1 16
Ararat 14
ARMAVIR 1 1 52
Armavir 1 24
Baghramyan 1 6
Vagharshapat 22
Metsamor
GEGHARKUNIK 2 30
Vardenis 1 6
Gavar 1 5
Martuni 15
Tshambarak 1
Sevan 3
LORI 4 2 3 18 1
Gugark 5
Spitak 1 3
Stepanavan 2
Tashir 1
Tumanyan 1 7
Vanadzor 4 1 2 1
KOTAYK 2 3 1 30 1
Kotayk 1 2 1 13 1
Nairi 1 10
Hrazdan 1 7
Charencavan
SHIRAK 7 12 1 2
Amasia 1
Ani 3
Artik 4
Akhuryan 5
Ashotsk
Gyumri 6 1 2
SYUNIK 10 1
Goris 5
Kapan 1 1
Meghri
Sisian 4
VAYOTS DZOR 5
Vayk 1
Eghegnadzor 4
Jermuk
TAVUSH 1 1 18
Ijevan 1 6
Noyemberyan 1 7
Tavush 4
Dilijan 1
224
DISTRIBUTION OF OUTPATIENT HEALTH CARE FACILITIES BY TYPES 2018
(including health posts) , 2020
Table 5.8
Med. units Outpatient units

Other outpatient Outpatient facilities- Medical-
within united
facilities Total obstetrician unit
children and hospitals
adults
adolescents
38 6 92 5 500 625 RA TOTAL
20 4 38 5 146 YEREVAN ` TOTAL
excluding municipal
14 27 5 102
departments
including municipal
6 4 11 44
departments
5 24 92 ARAGATSOTN
2 13 20 Ashtarak
1 4 17 Aparan
1 1 19 Aragats
1 6 36 Talin
2 6 60 43 ARARAT
1 1 23 17 Artashat
Vedi
1 1 19 11 Masis
4 18 15 Ararat
3 3 60 39 ARMAVIR
2 2 29 10 Armavir
7 8 Baghramyan
1 1 24 21 Vagharshapat
Metsamor
2 6 40 54 GEGHARKUNIK
1 8 27 Vardenis
1 7 5 Gavar
1 2 18 1 Martuni
1 2 13 Tshambarak
2 5 8 Sevan
6 1 5 40 94 LORI
5 8 Gugark
1 5 17 Spitak
1 1 4 17 Stepanavan
1 2 21 Tashir
1 1 10 26 Tumanyan
4 1 1 14 5 Vanadzor
3 6 46 29 KOTAYK
1 3 22 16 Kotayk
1 12 6 Nairi
2 2 12 7 Hrazdan
Charencavan
1 1 8 32 97 SHIRAK
1 16 Amasia
1 4 13 Ani
2 6 19 Artik
2 7 28 Akhuryan
1 1 21 Ashotsk
1 1 2 13 Gyumri
1 5 17 103 SYUNIK
1 6 18 Goris
2 4 44 Kapan
1 1 11 Meghri
1 1 6 30 Sisian
3 8 35 VAYOTS DZOR
2 3 15 Vayk
1 5 20 Eghegnadzor
Jermuk
7 27 39 TAVUSH
2 9 15 Ijevan
1 9 11 Noyemberyan
3 7 10 Tavush
1 2 3 Dilijan
225
NHIAC
AVAILABILITY AND DISTRIBUTION OF INPATIENT FACILITIES BY TYPES
AND BY REGIONS , 2020
Table 5.9.1
Gegharqunik
Vayots Dzor
Aragatsotn
Armavir
RA total
Yerevan
Tavush
Kotayk
Syunik
Shirak
Ararat
Lori
Number of healthcare
faciltities 126 55 5 6 4 7 7 10 15 7 3 7
including:
Unified Medical Centers
(hospitals and 68 29 4 4 3 4 5 4 4 5 2 4
polyclinics)
Independent facilities
31 19 1 1 1 3 5 1
(hospitals)
Health centers (hospitals
11 1 1 1 1 3 1 3
and polyclinics)
Maternity hospitals
5 2 1 1 1
without antenatal clinic
Maternity hospitals with
3 2 1
antenatal clinic
Dyspensaries delivering
hospital care 8 3 1 1 2 1
Subordination
MoH 14 11 1 2
Regional 64 6 4 6 4 6 7 6 10 6 3 6
Other departments 7 6 1
Private 41 32 1 2 4 1 1
226
MEDICAL FACILITIES BY DIFFERENT INSTITUTIONS AND BY REGIONS, 2020
Table 5.9.1 .1
Gegharqunik
Vayots Dzor
Aragatsotn
Armavir
RA total
Yerevan
Tavush
Kotayk
Syunik
Shirak
Ararat
Lori
RA Total
Number of healthcare
126 55 5 6 4 7 7 10 15 7 3 7
facilitiesTotal
MoH subordination
Healthcare facilitiesTotal 14 11 1 2
including:
Unified Medical Centers 4 3 1
Independent healthcare facilities 6 5 1
Dyspanseries 4 3 1
Regional subordination
Healthcare facilitiesTotal 64 6 4 6 4 6 7 6 10 6 3 6
including:
Unified Medical Centers 37 2 3 4 3 3 5 4 3 5 2 3
Independent healthcare facilities 8 3 1 1 1 2
Health centers 10 1 1 1 1 2 1 3
Maternity hospitals without

4 1 1 1 1
female consultations
Maternity hospitals with female
1 1
consultations
Dyspensaries 4 1 2 1
Other agencies subordination

Healthcare facilities Total 7 6 1
including:
Unified Medical Centers 4 4
Independent healthcare facilities 2 2
Health centers 1 1
Private and privatized medical facilities

Healthcare facilities Total 41 32 1 2 4 1 1
including:
Unified Medical Centers 22 19 1 1 1
Independent healthcare facilities 16 10 2 3 1
Maternity hospitals without

1 1
female consultations
Maternity hospitals with female
2 2
consultations
227
AVAILABILITY AND DISTRIBUTION OF PRIMARY HEALTHCARE FACILITIES (outpatient services)

BY TYPES AND BY REGIONS, 2020
Table 5.9.2
Gegharqunik
Vayots Dzor
Aragatsotn
Armavir
Yerevan
RA total
Tavush
Kotayk
Syunik
Shirak
Ararat
Lori
Polyclinics
(independent aand 85 35 3 4 4 4 8 6 10 5 2 4
unified) Total
including:
Pediatric (unified and
5 5
independent)
independent polyclynics 40 23 1 2 4 2 7 1
including:
Adult 38 21 1 2 4 2 7 1
Pediatric 2 2
Unified polyclynics
45 12 3 4 3 2 4 4 3 5 2 3
within MC
including: adult 42 9 3 4 3 2 4 4 3 5 2 3
Pediatric 3 3
Rural ambulatories 241 16 50 52 30 18 30 12 10 5 18
Health centers (providing

11 2 3 2 3 1
outpatient services)
Health centers (providing
nаrrow outpatient 57 50 2 1 3 1
services)
Dyspensaries providing
2 1 1
outpatient cares
Օbstetric points 625 92 39 54 94 29 97 103 35 39
Total 85 35 3 4 4 4 8 6 10 5 2 4
MoH subordinate 2 2
Regional 71 24 3 4 4 4 8 6 8 5 2 3
Other departments
3 2 1
Private and public 9 7 1 1
227
OUTPATIENT CARE ACTIVITIES

/excluding health posts /
Table 5.10
1980 1990 1995 2000 2005 2010 2015 2019 2020
PHC visits (thousand)

27816.4 27930.0 18121.5 7803.6 7731.0 11595.6 12247.5 12434.3 10300.5
- Total
From which:
Ambulatory visits 24758.7 24618.2 16355.3 6725.4 6773.0 10401.7 11127.8 11372.9 9206.3
Home visits 2252.5 2419.8 1397.2 737.3 963.2 807.3 623.8 540.3 474.7
Average per capita

9.0 7.8 4.8 2.1 2.4 3.6 4.1 4.2 3.5
visits
From which
Aaverage per capita

7.6 4.7 2.0 2.3 3.4 3.8 3.9 3.2
PHC visits "
Notes .
* 'The Total number of encounters includes visits to doctors, home visits, and emergency calls involving all PHC specialties.
* The number of visits to PHC includes visits to all PHC specialties and home visits.
Since 2004, the Total number of visits includes also the activity of private dental surgeries (2004 data were recalculated). Since 2006 the Total number
of visits also includes private medical cabinets.
229
NHIAC
PRIMARY HEALTH CARE VISITS
/ excluding health posts and private dental cabinets /
Table 5.11
2018 2019 2020
Total Total Total
per capita per capita per capita
(thousand) (thousand) (thousand)
YEREVAN 5398.3 5.0 5285.6 4.9 4053.9 3.7
ARAGATSOTN 364.4 2.9 349.6 2.8 320.9 2.6
Ashtarak 217.4 3.6 200.6 3.4 182.0 3.1
Aparan 43.6 2.0 43.5 2.1 42.6 2.0
Aragats 23.8 1.8 25.1 1.9 21.6 1.6
Talin 79.6 2.5 80.4 2.5 74.7 2.3
ARARAT 905.4 3.5 929.1 3.6 814.1 3.2
Artashat 379.4 4.3 386.4 4.4 305.4 3.5
Vedi 137.5 2.0 144.3 2.1 - -
Masis 251.6 3.2 275.4 3.5 263.0 3.3
Ararat 136.9 6.7 123.0 6.0 245.7 2.7
ARMAVIR 888.2 3.4 920.0 3.5 867.1 3.3
Armavir 328.5 3.2 354.4 3.4 409.5 3.7
Baghramyan 43.4 2.2 47.7 2.5 47.2 2.4
Vagharshapat 449.6 3.4 447.5 3.4 410.4 3.1
Metsamor 66.7 7.8 70.4 8.4 - -
GEGHARKUNIK 719.4 3.1 754.1 3.3 649.0 2.9
Vardenis 168.1 4.5 205.2 5.5 173.4 4.6
Gavar 108.6 2.2 114.0 2.3 94.6 2.0
Martuni 293.2 3.3 276.2 3.1 223.3 2.5
Tshambarak 39.4 3.0 36.3 2.8 29.7 2.3
Sevan 110.1 2.8 122.4 3.1 128.0 3.2
LORI 926.5 4.3 931.3 4.3 817.1 3.8
Gugark 44.1 2.3 44.6 2.3 28.0 1.5
Spitak 86.9 2.4 84.4 2.4 70.1 2.0
Stepanavan 75.1 2.9 63.3 2.4 57.0 2.2
Tashir 60.6 3.3 65.5 3.7 53.7 3.1
Tumanyan 163.8 4.3 169.3 4.4 122.3 3.2
Vanadzor 496.0 6.3 504.2 6.5 486.0 6.3
KOTAYK 864.9 3.4 926.8 3.7 839.6 3.3
Kotayk 375.6 3.4 400.9 3.6 363.2 3.3
Nairi 177.3 3.1 184.7 3.2 174.8 3.1
Hrazdan 205.9 3.3 225.9 3.6 301.6 3.6
Charencavan 106.1 5.2 115.3 5.6 - -
SHIRAK 924.4 3.9 950.9 4.1 774.4 3.3
Amasia 9.2 1.5 11.4 1.8 9.9 1.6
Ani 47.6 2.5 51.1 2.7 39.2 2.1
Artik 110.7 2.3 131.1 2.7 76.0 1.6
Akhuryan 134.6 3.6 130.1 3.5 90.6 2.4
Ashotsk 27.9 3.0 26.5 2.8 18.2 2.0
Gyumri 594.4 5.2 600.7 5.3 540.5 4.8
SYUNIK 512.0 3.7 522.3 3.8 488.1 3.6
Goris 146.7 3.6 141.4 3.5 133.2 3.3
Kapan 235.2 4.1 240.6 4.3 193.7 3.4
Meghri 39.5 3.7 39.6 3.7 40.7 3.8
Sisian 90.6 3.0 100.7 3.4 120.5 4.1
VAYOTS DZOR 182.3 3.7 182.6 3.7 178.1 3.7
Vayk 45.2 3.5 43.4 3.4 65.3 3.8
Eghegnadzor 112.0 3.5 112.8 3.6 112.8 3.6
Jermuk 25.1 6.0 26.4 6.3 - -
TAVUSH 397.0 3.2 378.8 3.1 353.6 2.9
Ijevan 114.2 2.4 115.2 2.4 112.8 2.4
Noyemberyan 97.5 3.5 77.9 2.8 67.0 2.5
Tavush 88.3 3.6 85.7 3.5 81.3 3.4
Dilijan 97.0 4.2 100.0 4.3 92.5 4.1
3.4
RA TOTAL 12082.8 4.1 12131.1 4.1 10155.9
230
PREVENTIVE EXAMINATIONS AND DETECTED DEVIATIONS

OF 0-14 YEARS OLD CHILDREN
Table 5.12
Number of
Year examined With hearing With disorders of

With vision leisons With speech defects With scoliosis
leisons posture
children % of all % of all % of all % of all % of all
Total Total Total Total Total
examined examined examined examined examined
1980 846800 1300 0.15 18843 2.2 4355 0.51 395 0.05 12322 1.45
1985 982400 1750 0.18 20733 2.1 6048 0.61 493 0.05 14929 1.52
1990 934936 1948 0.2 18144 1.94 6482 0.69 657 0.07 14069 1.5
1995 831875 1683 0.2 11874 1.43 5014 0.6 555 0.07 10327 1.24
2000 693822 1226 0.17 9286 1.33 3527 0.5 248 0.03 4944 0.71
2004 616865 1030 0.17 8029 1.3 2994 0.49 279 0.05 4211 0.68
2005 615271 1163 0.19 8895 1.45 3126 0.51 364 0.06 4332 0.7
2006 584583 1035 0.18 9908 1.69 3539 0.61 375 0.06 4109 0.7
2007 581885 1029 0.18 9719 1.67 3731 0.64 403 0.07 3788 0.65
2008 577542 1042 0.18 10638 1.84 3575 0.62 510 0.09 4024 0.7
2009 575771 1048 0.18 10589 1.84 3869 0.67 510 0.09 3693 0.64
2010 574060 973 0.17 10308 1.80 3520 0.61 656 0.11 3136 0.55
2011 571432 936 0.16 10314 1.80 3881 0.68 600 0.10 3125 0.55
2012 574943 905 0.16 10980 1.91 3843 0.67 613 0.11 3312 0.58
2013 570605 951 0.17 12162 2.13 3808 0.67 604 0.11 3764 0.66
2014 568171 952 0.17 12372 2.18 3562 0.63 605 0.11 4046 0.71
2015 578802 1193 0.21 11873 2.05 3462 0.60 589 0.10 3540 0.61
2016 584708 1217 0.21 12503 2.14 3457 0.59 568 0.10 3649 0.62
2017 579640 1434 0.25 12695 2.19 3131 0.54 595 0.10 3985 0.69
2018 579895 1342 0.23 14103 2.43 3240 0.56 659 0.11 4036 0.70
2019 579125 1347 0.23 14539 2.51 3306 0.57 766 0.13 3562 0.62
2020* 454220 1299 0.29 15481 3.41 2659 0.59 1170 0.26 4634 1.02
231
NHIAC
NUMBER OF PATIENTS ON DISPENSARY CONTROL AT THE END OF THE

YEARS BY DIFFERENT DISEASES
Table 5.13.1
TOTAL NUMBER OF 15 YEARS AND ABOVE ON DISPENSARYCONTROL AT THE END OF THE YEAR
1995 2000 2005 2010 2015 2019 2020
Diabetes mellitus 33644 1244.6 34062 1162.5 35332 1383.0 49360 1848.6 72599 3012.8 92263 3909.3 101424 4288.9
Glaucoma 2660 98.4 2367 80.8 2807 109.9 4669 174.9 6391 265.2 7693 326.0 7486 316.6
Rheumatism 10057 372.0 7440 253.9 4976 194.8 4100 153.6 3642 151.1 3017 127.8 2940 124.3
Hypertensive Diseases 25461 941.8 23998 819.0 29592 1158.3 59784 2239.0 97548 4048.1 112239 4755.7 114172 4828.0
Ishaemic heart disease 51298 1897.6 36526 1246.6 24509 959.4 35375 1324.9 54295 2253.2 58826 2492.5 58975 2493.9
Cerebrovascular
9272 343.0 7646 260.9 6910 270.5 8785 329.0 11388 472.6 12148 514.7 11938 504.8
diseases
Pneumonia 2482 91.8 1389 47.4 1463 57.3 1933 72.4 1172 48.6 1142 48.4 2846 120.3
Bronchitis-chronic and
unspecified, 15763 583.1 12166 415.2 9576 374.8 9320 349.1 9502 394.3 9983 423.0 10194 431.1
emphysema
Bronchial asthma,
4264 157.7 4163 142.1 4313 168.8 4033 151.0 4080 169.3 4153 176.0 4077 172.4
asthmatic status
Stomach and
18144 671.2 13418 457.9 10021 392.3 8803 329.7 8400 348.6 7506 318.0 6873 290.6
duodenum ulcer
Diseases of gall-bladder
15665 579.5 10283 350.9 7333 287.0 6891 258.1 6969 289.2 6405 271.4 5875 248.4
and biliar tracts
Nephritis, nephrotic
2636 97.5 2275 77.6 - - - - - - - - - -
syndrome, nephrosis1
Glomerular and
tubulo-intestinal
diseases of kidneys, - - - - 4176 163.5 4398 164.7 5165 214.3 4634 196.3 4589 194.1
other diseases of
kidneys and ureter2
Erosion and ectropion
3636 187.2 1483 75.9 1363 108.6 1955 146.9 2750 220.6 2425 196.7 2247 182.2
of uterine cervix 3
Reactive arthrites,
rheumatoid arthritis,
generalized injuries of 9305 344.2 8729 297.9 6398 250.4 6012 225.2 8271 343.2 8463 358.6 8117 343.2
connected tissue,
spondilopathies
r.v. per 100 000 population
232
NUMBER OF PATIENTS ON DISPENSARY CONTROL AT THE END OF

THE YEARS BY DIFFERENT DISEASES
(0-14 years old)
Table 5.13.2
NUMBER OF PATIENTS ON DISPENSARYCONTROL AT THE END OF THE YEARS
1995 2000 2005 2010 2015 2019 2020
Diabetes mellitus 167 15.7 141 16.2 174 26.2 211 35.6 212 36.0 422 70.4 489 81.7
Anemia 2363 222.3 2858 327.6 2638 397.0 2952 498.2 3075 522.2 3101 517.2 2722 454.8
Chronic otitis 2089 196.5 1312 150.4 1055 158.8 997 168.3 941 159.8 1036 172.8 1060 177.1
Rheumatism 2058 193.6 941 107.9 484 72.8 290 48.9 128 21.7 69 11.5 53 8.9
Chronic diseases of
the stumps and
12696 1194.2 6600 756.6 4047 609.0 4679 789.7 4760 808.3 5084 847.9 3751 626.7
glands. harpoon
abscess
Pneumonia 2342 220.3 1661 190.4 1105 166.3 1344 226.8 941 159.8 980 163.4 434 72.5
Bronchial asthma,
319 30.0 329 37.7 390 58.7 453 76.5 540 91.7 655 109.2 662 110.6
asthmatic status
Diseases of gall-
bladder and biliar 888 83.5 557 63.8 481 72.4 522 88.1 528 89.7 496 82.7 367 61.3
tracts
Nephritis, nephrotic
syndrome, 630 59.3 609 69.8 - - - - - - - - - -
1
nephrosis
Glomerular and
tubulo-intestinal
diseases of kidneys, - - - - 900 135.4 854 144.1 1104 187.5 966 161.1 767 128.2
other diseases of
kidneys and ureter2
Congenital defects of
the circulatory 1891 177.9 1503 172.3 963 144.9 1352 228.2 1533 260.3 1830 305.2 1839 307.3
system
1. iIn 2004 according to ICD X this is not specified
2. Calculated according to ICD X of 2004
233
NHIAC
NUMBER OF PATIENTS ON DISPENSARY CONTROL AT THE END OF THE YEAR
Table 5.14
Number of patients on including:
dispensary follow up at the
Years end of the year –TOTAL 15 years and above 0-14 years old
a.v. r.v.* a.v. r.v. * a.v. r.v. *
1990 839599 23400.2 647342 25933.1 192257 17609.2
1995 537030 14258.4 442041 16351.9 94989 8935.1
2000 407606 10719.7 355509 12133.0 52097 5972.4
2001 383363 10088.5 338520 11371.2 44843 5448.7
2002 384965 11991.6 343251 13615.1 41714 6052.5
2003 388129 12083.0 343723 13809.1 44406 6141.1
2004 382762 11902.5 337409 13389.2 45353 6518.1
2005 401114 12460.1 348600 13645.4 52514 7902.8
2006 436113 13531.7 379433 14660.7 56680 8928.8
2007 448247 13877.2 393527 15042.5 54720 8912.1
2008 464883 14357.1 409750 15539.7 55133 9170.5
2009 478943 14739.0 422561 15922.9 56382 9464.8
2010 502529 15402.7 444736 16656.2 57793 9754.1
2011 541285 16531.3 480581 17894.1 60704 10313.3
2012 567234 18739.8 506758 20631.8 60476 10596.8
2013 583962 19355.1 522177 21387.5 61785 10734.0
2014 608277 20204.5 547517 22550.1 60760 10429.1
2015 633311 21120.2 575455 23880.8 57856 9824.4
2016 651573 21820.2 593271 24819.9 58302 9785.5
2017 660582 22221.6 604761 25485.1 55821 9308.2
2018 679135 22902.7 629770 26626.5 49365 8226.1
2019 690886 23343.1 639920 27114.1 50966 8500.0
2020 702249 23698.2 649952 27484.4 52297 8738.0
* r.v. per 100 000 population
234
SERVICE UTILIZATION AND BED CAPACITY
Table 5.15
including: MoH, regional and municipal departments
Average per
Number of beds Number of Annual average patient, per day
Years Number of beds
TOTAL length of stay for
hospitalizations bed occupancy
hospital in-patients
a.v. r.v.* a.v. r.v.* a.v. r.v.** a.v. r.v.
1985 28112 83.5 27482 81.6 510031 15.2 315 16.6
1990 30482 85.0 29732 82.9 467172 13.1 247 15.6
1995 28711 76.2 28271 75.1 281309 7.5 152 15.2
2000 20795 54.7 20483 53.9 192007 5.0 116 12.7
2001 16157 42.5 16157 42.5 186828 4.9 136 11.7
2002 13968 43.5 13968 43.5 197365 6.1 153 10.9
2003 14208 44.2 14048 43.7 219376 6.8 164 10.5
2004 14259 44.3 13524 42.1 225376 7.0 171 10.3
2005 14353 44.6 9862 30.6 156588 4.9 171 10.8
2006 14276 44.3 9912 30.8 162575 5.0 172 10.5
2007 13126 40.6 8732 27.0 170478 5.3 203 10.4
2008 12358 38.2 8022 24.8 180744 5.6 228 10.1
2009 12068 37.1 7830 24.1 186658 5.8 230 9.6
2010 12160 37.3 7835 24.0 189580 5.8 226 9.3
2011 12236 37.4 7848 24.0 197590 6.0 223 8.9
2012 12241 40.4 7866 26.0 210503 7.0 229 8.6
2013 12268 40.7 7805 25.9 214376 7.1 235 8.5
2014 12514 41.6 7899 26.2 231824 7.7 245 8.4
2015 12532 41.8 7874 26.3 222598 7.4 239 8.4
2016 12493 41.8 7569 25.3 222593 7.4 245 8.4
2017 12457 41.9 7503 25.2 218212 7.3 244 8.4
2018 12153 41.0 7206 24.3 215588 7.3 235 7.8
2019 11778 39.8 6922 23.4 227270 7.7 256 7.9
2020 12871 43.4 7640 25.8 197980 6.7 231 8.7
* r.v. per 10 000 population

**r.v. per 100 population
235
NHIAC
SERVICE UTILIZATION AND BED CAPACITY BY REGIONS
Table 5.16
Number of beds
absolute value per 10 000 population
2018 2019 2020 2018 2019 2020

RA TOTAL 12153 11778 12871 41.0 39.8 43.4
MoH, regional and municipal 7206 6922 7640 24.3 23.4 25.8
YEREVAN total 7884 7563 8375 X X X
including municipal departments 2288 2376 2595 21.2 21.9 23.8
excluding municipal
5596 5187 5780 X X X
departments
ARAGATSOTN 152 167 196 12.1 13.4 15.7
Ashtarak 45 65 81 7.7 11.1 13.9
Aparan 55 50 68 25.9 23.7 32.2
Aragats 7 7 7 5.2 5.2 5.2
Talin 45 45 40 14.1 14.2 12.7
ARARAT 488 488 488 19.0 19.0 19.0
Artashat 130 130 130 14.8 14.8 14.8
Vedi 90 90 - 13.0 13.0 -
Masis 110 110 110 13.9 13.9 13.9
Ararat 158 158 248 77.5 77.5 27.6
ARMAVIR 355 355 365 13.5 13.5 13.8
Armavir 130 130 205 12.6 12.6 18.4
Baghramyan - - - - - -
Vagharshapat 150 150 160 11.3 11.3 12.0
Metsamor 75 75 - 88.2 89.3 -
GEGHARKUNIK 730 730 800 32.0 32.1 35.2
Vardenis 30 30 30 8.0 8.0 8.1
Gavar 80 80 80 16.3 16.5 16.5
Martuni 130 130 200 14.7 14.7 22.5
Tshambarak 30 30 30 22.7 22.7 22.9
Sevan 460 460 460 115.3 115.3 115.2
LORI 481 481 515 22.3 22.6 24.2
Gugark - - - - - -
Spitak 65 65 100 18.3 18.3 28.2
Stepanavan 50 50 54 19.1 19.2 20.9
Tashir 40 40 40 22.2 22.6 22.5
Tumanyan 60 60 60 15.7 15.8 15.9
Vanadzor 266 266 261 33.9 34.5 33.9
KOTAYK 488 478 478 19.4 19.1 19.0
Kotayk 275 265 265 24.8 23.9 23.8
Nairi 90 90 90 15.7 15.7 15.7
Hrazdan 88 88 123 14.0 14.1 14.9
Charencavan 35 35 - 17.1 17.2 -
SHIRAK 830 821 841 35.6 35.5 36.4
Amasia - - - - - -
Ani 10 5 5 5.3 2.7 2.7
Artik 51 51 51 10.6 10.7 10.7
Akhuryan 42 42 42 11.2 11.3 11.3
Ashotsk 92 88 88 98.9 94.6 95.7
Gyumri 635 635 655 55.9 56.5 58.4
SYUNIK 428 378 461 31.1 27.5 33.9
Goris 118 98 127 29.2 24.2 31.8
Kapan 215 185 239 38.0 32.8 42.6
Meghri 45 45 45 41.7 42.1 43.3
Sisian 50 50 50 16.8 16.8 17.1
VAYOTS DZOR 85 85 85 17.3 17.5 17.7
Vayk 35 35 40 26.9 27.1 23.8
Eghegnadzor 45 45 45 14.2 14.3 14.4
Jermuk 5 5 - 11.9 12.2 -
TAVUSH 232 232 267 19.0 19.1 22.2
Ijevan 86 86 81 18.1 18.1 17.2
Noyemberyan 52 52 52 19.0 19.1 19.2
Tavush 54 54 49 22.2 22.4 20.9
Dilijan 40 40 85 17.4 17.5 37.4
236
SERVICE UTILIZATION AND BED CAPACITY BY REGIONS
Number of hospitalizations Average per 1 patient length of

Annual average bed
stay (ALOS) for hospital
absolute value per 100 population occupancy (day)
admissions
2018 2019 2020 2018 2019 2020 2018 2019 2020 2018 2019 2020
406393 435470 394470 13.7 14.7 13.3 238 259 235 7.1 7.0 7.4 RA TOTAL
215588 227270 197980 7.3 7.7 6.7 235 256 231 7.8 7.9 8.7 Public and private
291402 306581 277101 X X X 254 279 250 6.9 6.9 7.3 YEREVAN total
including municipal
97543 107371 97808 9.1 9.9 9.0 248 257 238 5.8 5.6 6.4
departments
excluding municipal
193859 199210 179293 X X X 257 289 255 7.5 7.6 7.9
departments.
5231 6642 5638 4.1 5.3 4.5 164 206 182 4.8 5.3 5.8 ARAGATSOTN
2167 3151 2508 3.6 5.4 4.3 204 260 191 4.3 5.4 6.2 Ashtarak
1246 1436 1439 5.8 6.8 6.8 110 130 141 4.9 4.8 5.2 Aparan
470 561 558 3.5 4.2 4.1 396 477 538 5.9 6.0 6.8 Aragats
1348 1494 1133 4.2 4.7 3.6 156 174 154 5.2 5.2 5.4 Talin
13396 16802 14517 5.2 6.5 5.7 235 243 248 7.8 7.1 8.3 ARARAT
4493 7533 4860 5.1 8.6 5.5 251 256 233 4.9 4.4 6.2 Artashat
2912 3220 - 4.2 4.7 - 177 210 - 5.5 5.9 - Vedi
3835 3855 4440 4.8 4.9 5.6 194 204 262 5.5 5.9 6.6 Masis
2156 2194 5217 10.6 10.8 5.8 288 277 250 21.2 19.8 11.8 Ararat
12851 14931 12685 4.9 5.7 4.8 189 223 185 5.2 5.3 5.3 ARMAVIR
5544 6189 6955 5.4 6.0 6.2 254 282 201 5.9 6.0 5.9 Armavir
- - - - - - - - - - - - Baghramyan
5492 6591 5730 4.1 5.0 4.3 164 204 165 4.5 4.7 4.6 Vagharshapat
1815 2151 - 21.1 25.6 - 125 157 - 5.1 5.5 - Metsamor
11091 11844 12158 4.8 5.2 5.3 275 276 278 18.4 17.0 17.4 GEGHARKUNIK
923 1010 907 2.4 2.7 2.4 115 134 118 3.7 4.0 3.9 Vardenis
2420 2522 2851 4.9 5.2 5.9 157 152 117 5.2 4.8 3.3 Gavar
4912 5350 5874 5.5 6.0 6.6 168 167 218 4.4 4.1 5.8 Martuni
786 733 614 5.9 5.6 4.7 140 123 110 5.4 5.1 5.4 Tshambarak
2050 2229 1912 5.1 5.6 4.8 343 347 347 79.1 71.1 84.4 Sevan
17862 20404 19329 8.3 9.5 9.1 228 251 236 6.1 5.9 6.1 LORI
- - - - - - - - - - - - Gugark
2487 2727 2888 7.0 7.7 8.1 195 206 223 5.1 4.9 6.6 Spitak
2066 2074 1822 7.9 8.0 7.0 231 225 172 5.6 5.4 5.0 Stepanavan
1075 1145 903 5.9 6.4 5.1 133 133 109 4.9 4.6 4.8 Tashir
2063 2319 2056 5.4 6.1 5.4 194 226 182 5.6 5.9 5.3 Tumanyan
10171 12139 11660 12.9 15.5 15.1 258 291 284 6.7 6.4 6.4 Vanadzor
14435 15131 13589 5.7 6.0 5.4 230 242 214 7.8 7.7 7.5 KOTAYK
7002 7380 6137 6.3 6.6 5.5 223 235 195 8.8 8.5 8.4 Kotayk
2055 2261 2089 3.6 4.0 3.7 259 287 277 11.3 11.5 12.0 Nairi
3638 3690 5363 5.8 5.9 6.5 205 203 228 4.9 4.8 4.8 Hrazdan
1740 1800 - 8.5 8.8 - 273 271 - 5.5 5.3 - Charencavan
20347 21522 19328 8.7 9.3 8.4 163 165 148 6.6 6.3 6.3 SHIRAK
- - - - - - - - - - - - Amasia
159 139 55 0.8 0.7 0.3 57 120 38 3.6 4.3 3.4 Ani
1644 1834 1978 3.4 3.8 4.2 146 176 178 4.5 4.9 4.6 Artik
1947 2121 2519 5.2 5.7 6.8 198 228 260 4.3 4.5 4.3 Akhuryan
1954 1715 892 21.0 18.4 9.6 153 131 66 7.2 6.7 6.5 Ashotsk
14643 15713 13884 12.8 13.9 12.3 165 165 150 7.1 6.7 6.8 Gyumri
9987 10536 9914 7.2 7.7 7.3 180 212 181 7.7 7.6 7.9 SYUNIK
4136 4264 3487 10.2 10.5 8.6 173 213 151 4.9 4.9 4.6 Goris
3943 3967 4111 6.9 7.0 7.3 216 251 206 11.8 11.6 11.6 Kapan
857 804 837 7.9 7.5 7.9 110 102 128 5.7 5.7 6.9 Meghri
1051 1501 1479 3.5 5.1 5.0 102 164 175 4.9 5.4 5.9 Sisian
1889 2138 1767 3.8 4.4 3.7 111 127 103 5.0 5.1 4.9 VAYOTS DZOR
747 706 757 5.7 5.5 4.5 99 91 84 4.6 4.5 4.4 Vayk
1094 1347 1010 3.4 4.2 3.2 126 157 119 5.2 5.3 5.3 Eghegnadzor
48 85 - 1.1 2.0 - 63 110 - 6.6 6.5 - Jermuk
7902 8939 8444 6.4 7.3 7.0 156 172 178 4.6 4.5 5.0 TAVUSH
3093 3859 3485 6.5 8.2 7.4 120 163 166 3.3 3.6 4.0 Ijevan
1293 1521 1384 4.7 5.6 5.1 117 142 135 4.7 4.9 5.0 Noyemberyan
2415 2495 2184 9.7 10.3 9.1 244 225 234 5.4 4.9 5.2 Tavush
1101 1064 1391 4.8 4.6 6.1 168 160 187 6.1 6.0 7.0 Dilijan
237
NHIAC
SERVICE UTILIZATION AND BED CAPACITY, 2001-2020
Table 5.17
Number of beds Number of hospitalizations Annual average
bed occupancy Average number of
Absolute Per 10000 per 100
Absolute value (day) bed days
Year value populations population
2001 16157 42.5 186828 4.9 136 11.7
2002 13968 43.5 197365 6.1 153 10.9
2003 14208 44.2 220561 6.9 163 10.5
2004 14259 44.3 235008 7.3 169 10.3
2005 14353 44.6 253810 7.9 173 9.8
2006 14276 44.3 269546 8.4 178 9.4
2007 13126 40.6 285680 8.9 201 9.3
2008 12358 38.2 306635 9.5 223 9.0
2009 12068 37.1 317726 9.8 227 8.6
2010 12160 37.3 323962 9.9 223 8.3
2011 12236 37.4 346999 10.6 225 7.9
2012 12241 40.4 375316 12.4 236 7.7
2013 12268 40.7 373069 12.3 236 7.8
2014 12514 41.6 406552 13.5 246 7.5
2015 12532 41.8 393540 13.1 240 7.6
2016 12493 41.8 399734 13.4 240 7.6
2017 12457 41.9 397633 13.3 241 7.6
2018 12153 41.0 406393 13.7 238 7.1
2019 11778 39.8 435470 14.7 259 7.0
2020 12871 43.4 394470 13.3 235 7.4
NUMBER OF HOSPITAL DEATHS AND HOSPITAL LETHALITY*, 2000-2001
Table 5.18
including:`
Total deaths in hopsital
Year Adults and teenagers 0-14 years old
absolute value hospital lethality absolute value hospital lethality absolute value hospital lethality
2000 3670 1.9 2943 1.9 727 1.9
2001 3493 1.9 2830 1.9 663 1.9
* Hospital lethality - % from the number of discharged and dead patients spital lethality
238
NUMBER OF HOSPITAL DEATHS AND HOSPITAL LETHALITY*, 2002-2020
Table 5.19
Total deaths in hospital including:
adults 15-17 years old 0-14 years old

Year Hospital
absolute value absolute Hospital absolute Hospital absolute Hospital
lethality
value lethality value lethality value lethality
2002 3517 1.8 2887 1.9 9 0.1 621 1.8
2003 3583 1.7 2969 1.7 11 0.1 603 1.7
2004 3721 1.6 3131 1.7 10 0.1 580 1.5
2005 3934 1.6 3329 1.7 17 0.1 588 1.5
2006 4167 1.6 3577 1.7 13 0.1 577 1.4
2007 4030 1.4 3532 1.6 10 0.1 488 1.1
2008 4318 1.4 3808 1.6 20 0.1 490 1.1
2009 4326 1.4 3788 1.5 10 0.1 528 1.1
2010 4477 1.4 3903 1.5 15 0.1 559 1.1
2011 4691 1.4 4146 1.6 10 0.1 535 0.9
2012 4971 1.4 4504 1.6 7 0.1 460 0.7
2013 5014 1.4 4565 1.6 7 0.1 442 0.7
2014 5244 1.3 4802 1.6 11 0.1 431 0.5
2015 5382 1.4 4975 1.7 7 0.1 400 0.5
2016 5509 1.4 5130 1.7 10 0.1 369 0.5
2017 5259 1.3 4920 1.6 7 0.1 332 0.4
2018 5290 1.3 4991 1.6 9 0.1 290 0.3
2019 5557 1.3 5301 1.6 7 0.1 249 0.3
2020 9382 2.4 9087 3.0 5 0.07 290 0.4
239
NHIAC
NUMBER OF BEDS BY MAIN SPECIALITIES
Table 5.20
2017 2018 2019 2020
absolute value absolute value absolute value absolute value

per per per per
includin 10000 includin 10000 10000 includin 10000
Bed profile g: g: g:
pop pop including: pop pop
MoH, MoH, MoH, MoH,
(from ( from (from (from
TOTAL
TOTAL
TOTAL
TOTAL
regional regional regional regional
total) total) total) total)
and and and local and
local local local
Therapeutic 1 2101 1049 7.1 1992 1008 6.7 1906 946 6.4 1700 702 5.7
Surgical 1 3018 1337 10.2 3005 1319 10.1 2788 1216 9.4 2448 915 8.3
Oncological 1 606 550 2.0 606 520 2.0 591 540 2.0 519 492 1.8
Infectious 1 629 569 2.1 626 569 2.1 570 565 1.9 2419 2047 8.2
from which children2 195 195 3.3 195 195 3.2 195 195 3.3 25 5 0.4
• Pediatric
- - - - - - - - - 2200 1853 7.4
(somatic)2
• Covid-19 and
1219 738 20.3 1189 702 19.8 1282 717 21.4 1302 660 21.8
Callcenter
• Neurologic 383 97 1.3 378 108 1.3 374 81 1.3 325 37 1.1
Pregnant women and

1253 771 16.6 1277 783 17.0 1230 742 16.5 1170 711 15.7
women in childbirth 3
Gynaecological 4 525 249 3.4 527 248 3.4 516 239 3.3 505 239 3.2
Tuberculosis 358 358 1.2 288 288 1.0 233 233 0.8 135 135 0.5
from which children2 30 30 0.5 20 20 0.3 15 15 0.3 15 15 0.3
Psychiatric 1378 1343 4.6 1243 1208 4.2 1270 1223 4.3 1388 1342 4.7
Narcological 80 80 0.3 80 80 0.3 80 80 0.3 75 75 0.3
Ophthalmological 226 65 0.8 237 66 0.8 226 56 0.8 215 46 0.7
Ear-Throat-nose 241 56 0.8 250 56 0.8 235 37 0.8 204 15 0.7
Dermato-
100 100 0.3 100 100 0.3 100 100 0.3 100 100 0.3
venerological
1.Therapeutic, cardiological, gastroenterological, allergological, rehabilitation treatment, physiotherapeotic, endocrinologic, haemotological, nephrological,
rheumatological, pulmonological beds are included in the number of beds for therapeutic patients.
For surgical patients - surgical, neurosurgical, toracal surgery, cardiological,vascular surgery, traumatological, burn, orthopedical, urological, stomatological,
proctological, purulent surgery
For oncological patients- oncological, radiological, x - ray surgary;
For pregnant and woman in childbirth - pregnant and woman in childbirth, pathology of pregnancy;
For gynaecological patients-gynaecological, for abortions
2 Pediatric beds include all pediatric beds excluding infectious,tuberculosis’,dermatovenerological and psychiatric beds
The indicator is calculated from the total number of children
3 The indicator is calculated from the total number of fertile age females
4.The indicator is calculated from the total number of female population
240
DISTRIBUTION OF PATIENTS DISCHARGED

FROM HOSPITAL OR DEAD BY MAIN DISEASES, 2020
Table 5.21
15 years and above
ICD X
Discharged patients Deaths %** per 1000 population
RA TOTAL A00-T98 304365 9092 100.0 128.8

including:`
A00-B99 39883 3368 13.8 16.9
diseases
including:
Covid 19 U07.1-U07.2 34582 3264 12.1 14.6
Neoplasms C00-D48 22280 544 7.3 9.4

forming organs and certain disorders D50-D89 497 15 0.2 0.2
E00-E90 7356 101 2.4 3.1
diseases
Diseases of nervous system F00-F99 7783 40 2.5 3.3
Diseases of the eye and adnexa G00-G99 5266 50 1.7 2.2

H00-H59 12745 - 4.0 5.4
process
Diseases of nervous system H60-H95 687 - 0.2 0.3
Diseases of the circulatory system I00-I99 47035 2807 15.9 19.9
Diseases of the respiratory system J00-J99 25463 1005 8.4 10.8
Diseases of the digestive system K00-K93 22078 488 7.2 9.3

L00-L99 4980 17 1.6 2.1
tissue
M00-M99 9743 10 3.1 4.1
Diseases of the genitourinary system N00-N99 15757 105 5.1 6.7
Pregnancy, childbirth and the O00-O75.

59264 6 18.9 79.5
puerperium * O81-O99
deformations and chromosomal Q00-Q99 1740 12 0.6 0.7
abnormalities
P00-P96 6 - 0.002 0.003
perinatal period
clinical and laboratory findings, not R00-R99 1199 133 0.4 0.5
S00-T98 20603 391 6.7 8.7
* The indicator is calculated from 1000 females in fertile age
%- The percentage from number of discharged or dead patients
241
NHIAC
DISTRIBUTION OF PATIENTS DISCHARGED

FROM HOSPITAL OR DEAD BY MAIN DISEASES, 2020
Table 5.21( continuation )
0-14 years
ICD X
Discharged patients Deaths %** per 1000 population
RA TOTAL A00-T98 69397 290 100.0 115.9

including:`
A00-B99 7629 9 11.0 12.7
diseases
including:
U07.1-
Covid 19 1803 - 2.6 3.0
U07.2
Neoplasms C00-D48 955 5 1.4 1.6

forming organs and certain disorders D50-D89 250 - 0.4 0.4
E00-E90 675 2 1.0 1.1
diseases
Diseases of nervous system F00-F99 68 - 0.1 0.1
Diseases of the eye and adnexa G00-G99 1989 6 2.9 3.3

H00-H59 1655 - 2.4 2.8
process
Diseases of nervous system H60-H95 441 - 0.6 0.7
Diseases of the circulatory system I00-I99 240 4 0.3 0.4
Diseases of the respiratory system J00-J99 28358 24 40.7 47.3
Diseases of the digestive system K00-K93 6996 4 10.0 11.7

L00-L99 2468 - 3.5 4.1
tissue
M00-M99 832 - 1.2 1.4
Diseases of the genitourinary system N00-N99 3484 1 5.0 5.8
Pregnancy, childbirth and the O00-O75.

- - - -
puerperium * O81-O99
deformations and chromosomal Q00-Q99 2068 49 3.0 3.5
abnormalities
P00-P96 5110 172 7.6 8.5
perinatal period
clinical and laboratory findings, not R00-R99 844 - 1.2 1.4
S00-T98 5335 14 7.7 8.9
* *The indicator is calculated from 1000 females in fertile age

242
HOSPITAL LETHALITY
FROM DIFFERENT DISEASES
Table 5.22
15 years and above
1990 2000 2015 2019 2020
a.v. % a.v. % a.v. % a.v. % a.v. %
All diseases 4186 1.1 2943 1.9 4982 1.6 5308 1.6 9092 2.9
including:
Respiratory tuberculosis 53 5.3 72 4.7 49 3.2 40 5.1 24 6.3
Diabetes mellitus 149 3.1 104 4.8 112 1.6 121 1.7 95 2.2
Acute rheumatic fever 30 1.7 5 1.7 1 1.3 - - - -
Chronic rheumatic
50 3 19 3.5 14 2.0 18 2.5 15 5.2
heart disease
Acute myocardial
675 18 555 15.7 953 15.4 923 14.2 787 14.9
infarction
Ishaemic heart disease

and othe acute and 25 1.8 21 2.2 12 1.7 51 2.6 13 0.7
subacute types
Cerebrovascular
682 10.6 704 16.8 1220 13.4 1251 12.4 1243 13.9
diseases
Pneumonia 52 1.3 26 2.9 57 2.2 117 3.0 595 6.9
Stomach and duodenum

71 1.2 50 2.7 68 4.1 94 5.8 103 8.2
ulcer
Diseases of gall-bladder
58 0.7 24 1.1 33 0.6 34 0.5 24 0.3
and biliary tracts
Fractures 225 2.8 59 1.8 52 0.9 62 0.8 73 1.0
Burns 34 2.5 12 4.3 13 5.0 19 6.0 26 5.2
0-14 y.o. children
All diseases 1674 1.6 727 1.9 400 0.5 249 0.3 290 0.4
including:
Diabetes mellitus - - - - - - - - 1 0.3
Acute rheumatic fever 1 0.2 - - - - - - - -
Pneumonia 149 2.9 29 1.5 13 0.3 12 0.2 20 0.5
Fractures 16 0.7 1 0.1 - - 3 0.1 7 0.3
Burns 55 4.6 21 5.4 1 0.2 3 0.7 - -
243
NHIAC
INFANT (under-1) LETHALITY IN HOSPITAL
Table 5.23
including: Number of
infants who died
Number of Number of dead Acute from pneumonia
discharged and
Intestinal
Years
children - all diseases respiratory Pneumonia within 24 hrs of

dead infants - infectious hospital
infection
TOTAL admission
a.v. %1 a.v. %1 a.v. %1 a.v. %1 a.v. %2
1980 38761 1434 3.7 92 3.7 91 0.7 386 5.5 214 55.4
1985 42497 1671 3.9 264 4.0 178 1.1 255 6.1 93 36.5
1990 36485 1403 3.8 215 3.8 121 1.0 123 4.5 40 32.5
1995 15915 734 4.6 91 4.7 87 2.1 59 5.1 22 37.3
1999 14137 635 4.5 38 2.6 42 1.4 39 3.1 20 39.2
2000 11771 603 5.1 21 1.7 27 1.0 25 2.6 4 16.0
2001 10556 570 5.4 12 1.2 38 1.5 26 3.3 10 38.5
2002 10786 540 5.0 15 1.6 21 0.8 15 1.7 6 40.0
2003 11214 524 4.7 9 0.9 22 0.7 26 2.9 15 57.7
2004 11910 520 4.4 10 0.9 26 0.9 19 2.1 12 63.2
2005 12362 529 4.3 10 0.8 12 0.4 19 1.8 13 68.4
2006 12962 520 4.0 4 0.3 8 0.2 16 1.6 14 87.5
2007 13283 438 3.3 4 0.3 7 0.2 18 1.8 18 100.0
2008 13290 440 3.3 2 0.1 6 0.2 18 1.8 18 100.0
2009 15125 462 3.1 5 0.3 5 0.1 26 2.0 24 92.3
2010 16796 500 3.0 2 0.1 12 0.2 17 1.1 14 82.4
2011 17910 464 2.6 4 0.2 4 0.1 12 1.0 11 91.7
2012 19589 412 2.1 2 0.1 - - 6 0.6 - -
2013 19510 387 2.0 2 0.1 2 0.03 17 1.3 3 17.6
2014 21535 367 1.7 4 0.2 2 0.02 13 0.9 6 46.2
2015 21624 345 1.6 1 0.05 - - 11 0.7 5 45.5
2016 21782 322 1.5 - - - - 10 0.7 7 70.0
2017 20977 284 1.4 - - 1 0.01 7 0.4 3 42.9
2018 20124 233 1.2 - - 3 0.04 9 0.5 1 11.1
2019 21731 205 0.9 1 0.06 1 0.01 5 0.3 1 20.0
2020 16483 251 1.5 - - - - 12 1.2 1 8.3
1 - %- The percentage of the number of discharged or dead patients

2- %-The percentage of dead from pneumonia
244
EARLY NEONATAL (0-6 DAYS) AND INFANT (UNDER-1) LETHALITY WITHIN THE
FIRST 24 HOURS OF HOSPITAL ADMISSION
Table 5.24
including: from which`
Total number Total number of cases of
including
of infant infant mortality within 24
Years
At the age of 0-6 days Within 24 hours Pneumonia

mortality cases hours of hospitalization2
1
postpartum
(a.v.)
3
a.v. % a.v. %4 a.v. %3 a.v. %5
Missing
1980 1434 441 30.8 - 394 27.5 214 54.3
data
1985 1671 578 34.6 183 31.7 327 22 93 28.4
1990 1403 600 42.8 207 34.5 231 19.3 40 17.3
1995 734 322 43.9 129 40.1 134 18.3 22 16.4
1999 635 377 59.4 192 50.9 69 10.9 20 29.0
2000 603 368 61 208 56.5 69 11.4 4 5.8
2001 570 357 62.6 186 52.1 92 16.1 10 10.9
2002 540 345 63.9 136 39.4 146 27 6 4.1
2003 524 356 67.9 181 50.8 64 12.2 15 23.4
2004 520 346 66.5 86 24.9 86 16.5 12 14
2005 529 363 68.6 147 40.5 84 15.9 13 15.5
2006 520 361 69.4 199 55.1 68 13.1 14 20.6
2007 438 292 66.7 141 48.3 110 25.1 18 16.4
2008 440 298 67.7 160 53.7 75 17 18 24
2009 462 278 60.2 137 49.3 71 15.4 24 33.8
2010 500 288 57.6 145 50.3 77 15.4 14 18.2
2011 464 281 60.6 147 52.3 47 10.1 11 23.4
2012 412 230 55.8 109 47.4 15 3.6 0 0
2013 387 223 57.6 119 53.4 42 10.9 3 7.1
2014 367 217 59.1 120 55.3 46 12.5 6 13.0
2015 345 191 55.4 83 43.5 44 12.8 5 11.4
2016 322 177 55.0 67 37.9 38 11.8 7 18.4
2017 284 156 54.9 55 35.3 32 11.3 3 9.4
2018 233 116 49.8 48 41.4 15 6.4 1 6.7
2019 205 102 49.8 44 43.1 36 17.6 1 2.8
2020 251 135 53.8 45 33.3 15 6.0 1 6.7
1 Data on deaths in the first 24 hours after birth in 1980 were included in the total number of deaths in the 24 hours of hospitalization.
2 Excluding children who have died in maternity hospitals and departments.
3 as % of infant morality
4 as % of early neonatal mortality (0-6 days)
5 as % children who died in the first 24 hours after birth
245
NHIAC
EMERGENCY CARE
Table 5.25
1985 1990 1995 2000 2005 2010 2015 2019 2020
Number of emergency
44 44 45 46 58 104 101 66 69
stations (departments)
Occupied/recruited medical
94.5 76.3 81.8 83.3 92 92.2 96.6 97.5 95.3
positions (%)
Number of occupied medical

633 593 630 380 391 412 532 588 581
positions
Number of full-time
417 466 296 279 238 213 150 191 192
physicians
Number of teams*
Medical – of general profile 449 431 440 258 190 347 207 163 178
Medical - specialized 88 96 116 56 20 22 19 17 14
Medical – feldsher 189 339 279 178 118 115 37 45 43
Number of people who received care during the emergency team visit
Absoute value 757276 816159 326348 331115 338666 386598 495959 521039 619457
per 1 000 population 226.4 226.8 86.8 87.1 105.3 118.7 165.1 175.9 209.2
In addition, outpatient care

59053 62612 42457 9290 12618 10404 15010 29443 27901
was delivered
Ratio of served patiens (%)
By medical teams 67.6 59.5 62.5 71.7 78.2 74.1 89.5 89.8 87.3
including
medical specialized 14.3 11.6 12.9 11.4 18.7 15.0 12.7 12.1 7.8
Curative 32.4 40.5 37.5 28.3 21.8 25.9 10.5 10.2 12.7
Number of emergency
3 1 2 2 2 0 0 0 0
hospitals
Number of beds 1600 750 1065 885 510 0 0 0 0
Number of patients in
28898 13832 12799 8889 12243 0 0 0 0
Emergency hospitals
* Team is the functional unit of the Emergency station (department) which ensure to conduct doctors labour for per night (6 hours)
246
INPATIENT EMERGENCY SURGICAL CARE
Table 5.26
Intestinal obstruction
Hospitalized Operated Postoperative lethality
From which:
Years
% of the all
including: % of all patients % of hospitalized
Total Total operated patients
after 24 hours admissions hospitalized after after 24 hours
24 hours
1980 448 179 40.0 316 147 14.9 26.5
1985 599 227 37.9 381 185 10.2 16.2
1988 622 232 37.3 340 178 11.5 14.6
1990 614 239 38.9 357 200 10.4 15.0
1991 715 281 39.3 478 226 11.3 15.0
1992 786 371 47.2 569 274 9.8 12.0
1993 820 367 44.7 666 306 11.7 13.7
1994 705 303 43.0 570 256 11.2 19.1
1995 620 266 42.9 503 222 8.7 15.8
1996 588 240 40.8 438 196 11.9 16.3
1997 644 283 43.9 492 219 8.3 15.5
1998 786 383 48.7 573 295 10.1 14.2
1999 822 433 52.7 620 330 8.2 11.2
2000 734 327 44.6 535 224 7.3 11.2
2001 646 296 45.8 468 199 10.3 16.6
2002 687 331 48.2 488 260 11.7 13.1
2003 716 384 53.6 545 309 6.8 8.1
2004 666 335 50.3 528 274 7.8 9.5
2005 794 333 41.9 592 249 9.1 14.1
2006 771 327 42.4 557 228 9.3 13.2
2007 916 346 37.8 730 254 6.7 11.0
2008 814 320 39.3 639 256 7.2 14.8
2009 785 400 51.0 605 317 7.4 7.6
2010 724 312 43.1 532 229 7.1 9.2
2011 640 285 44.5 503 205 9.7 15.6
2012 733 369 50.3 540 240 7.8 8.8
2013 776 373 48.1 594 265 7.6 9.4
2014 793 383 48.3 573 267 6.3 7.5
2015 762 323 42.4 577 226 7.8 11.1
2016 855 326 38.1 688 236 6.4 8.9
2017 812 410 50.5 603 292 9.0 13.4
2018 823 319 38.8 567 212 10.6 13.2
2019 861 436 50.6 597 286 6.4 9.1
2020 796 435 54.6 562 287 6.9 8.4
247
NHIAC

continuation 5. 26
Acute appendicitis
Years
From which:
including: % of the all
% of all patients % of hospitalized
Total after 24 Total operated patients
admissions hospitalized after after 24 hours
hours
24 hours
14075 3279 23.3 13927 3227 0.2 0.7 1980
14212 4435 31.2 14004 4360 0.1 0.3 1985
14664 3834 26.1 14461 3754 0.11 0.32 1988
13378 3680 27.5 13212 3635 0.09 0.2 1990
12725 3562 28.0 12617 3539 0.09 0.3 1991
10195 3240 31.8 10061 3196 0.15 0.3 1992
8791 2390 27.2 8601 2342 0.16 0.3 1993
7128 2013 28.2 7036 1980 0.15 0.35 1994
7936 2456 30.9 7826 2414 0.08 0.08 1995
8072 2923 36.2 7969 2883 0.07 0.17 1996
7408 2817 38.0 7326 2796 0.07 0.14 1997
7658 2905 37.9 7539 2873 0.06 0.17 1998
7207 2781 38.6 7115 2756 0.08 0.21 1999
6216 2492 40.1 6089 2459 0.14 0.28 2000
6201 2684 43.3 6075 2627 0.14 0.22 2001
6628 3052 46.0 6411 2990 0.12 0.13 2002
6491 2915 44.9 6392 2883 0.05 0.07 2003
6362 2366 37.2 6233 2323 0.1 0.13 2004
6786 3040 44.8 6688 3004 0.09 0.13 2005
6680 2996 44.9 6601 2959 0.06 0.07 2006
6844 3225 47.1 6766 3189 0.09 0.09 2007
7240 3291 45.5 7147 3262 0.06 0.06 2008
6137 2695 43.9 6069 2672 0.08 0.07 2009
6333 2748 43.4 6063 2731 0.05 0.04 2010
5660 2283 40.3 5601 2248 0.07 0.13 2011
5288 2139 40.5 5183 2100 0.12 0.24 2012
4890 1748 35.7 4827 1720 0.12 0.29 2013
4717 1801 38.2 4623 1753 0.04 0.11 2014
4399 1593 36.2 4351 1575 0.02 - 2015
3831 1542 40.3 3790 1522 0.05 0.13 2016
3589 1499 41.8 3541 1470 0.14 0.34 2017
3865 1476 38.2 3736 1456 - - 2018
3838 1332 34.7 3758 1294 0.11 0.23 2019
3335 1063 31.9 3271 1040 0.09 0.29 2020
248
continuation 5. 26
Perforative ulcer of stomach and duodenum
Years
From which: patients % of the all

including: after % of all % of Hospitalized
Total Total Hospitalized after 24 operated patients
24 hours admissions after 24 hours
hours
1980 144 34 23.6 144 34 4.9 17.6
1985 161 49 30.4 161 49 5.6 12.2
1988 195 31 15.9 195 31 6.2 12.9
1990 239 71 29.7 235 67 5.1 14.9
1991 359 88 24.5 357 87 4.5 11.5
1992 610 139 22.8 601 139 3.3 7.9
1993 684 154 22.5 678 150 5.7 12.7
1994 476 96 20.2 475 95 5.3 14.7
1995 621 194 31.2 606 193 5.8 5.2
1996 423 118 27.9 419 115 4.8 10.4
1997 343 82 23.9 341 81 5.9 12.3
1998 434 94 21.7 426 91 5.6 7.7
1999 368 95 25.8 358 91 3.9 7.7
2000 307 92 30.0 294 86 4.1 8.1
2001 294 109 37.1 293 109 2.0 2.8
2002 304 107 35.2 290 104 5.9 8.7
2003 317 94 29.7 293 85 7.5 12.9
2004 367 92 25.1 343 79 5.2 8.9
2005 358 110 30.7 326 94 7.7 10.6
2006 304 79 26.0 290 76 4.8 13.2
2007 245 83 33.9 235 79 3.4 3.8
2008 310 89 28.7 302 86 5.3 11.6
2009 296 84 28.4 270 71 3.7 7.0
2010 325 83 25.5 316 83 4.4 8.4
2011 264 62 23.5 263 61 4.6 13.1
2012 271 78 28.8 259 70 3.9 7.1
2013 291 71 24.4 278 61 6.1 8.2
2014 221 82 37.1 202 73 6.9 8.2
2015 245 74 30.2 235 67 7.7 10.4
2016 266 51 19.2 256 44 6.3 15.9
2017 245 70 28.6 228 59 8.3 22.0
2018 275 84 30.5 247 73 7.7 16.4
2019 230 125 54.3 215 112 11.2 17.9
2020 309 153 49.5 291 140 8.2 13.6
249
NHIAC
continuation 5. 26
Gastrointestinal bleedings
From which:
Years
including:
% of all patients % of the all % of Hospitalized
Total after 24 Total operated patients
admissions Hospitalized after 24 hours
hours
after 24 hours
Missing data. - - - - - - 1980
Missing data. - - - - - - 1985
579 403 69.9 82 21 14.6 28.6 1988
347 134 38.6 49 22 18.4 27.3 1990
725 510 70.3 98 71 25.5 14.1 1991
739 424 57.4 197 107 15.2 21.5 1992
610 300 49.2 216 111 21.7 11.7 1993
525 265 50.5 177 97 14.7 14.4 1994
480 245 51.0 146 71 12.3 12.7 1995
524 281 53.6 194 117 13.4 18.8 1996
482 229 47.5 160 99 12.5 18.2 1997
576 315 54.7 197 119 10.7 14.3 1998
573 324 56.5 175 97 8.6 9.3 1999
619 286 46.2 174 67 7.5 11.9 2000
585 280 47.9 170 56 5.9 7.1 2001
670 380 56.7 167 75 7.2 14.7 2002
639 350 54.8 138 69 10.1 13.0 2003
691 329 47.6 175 68 8.6 7.4 2004
723 380 52.6 159 56 5.7 8.9 2005
871 444 51.0 165 55 9.1 16.4 2006
811 455 56.1 148 71 12.8 7.0 2007
682 349 51.2 117 47 12.0 17.0 2008
708 359 50.7 125 79 13.6 11.4 2009
620 314 50.6 123 45 7.3 13.3 2010
613 335 54.6 143 50 8.4 10.0 2011
585 276 47.2 133 31 12.0 29.0 2012
479 268 55.9 82 38 14.6 15.8 2013
570 267 46.8 99 32 10.1 15.6 2014
649 292 45.0 81 36 19.8 11.1 2015
637 313 49.1 68 25 8.8 12.0 2016
602 302 50.2 88 34 13.6 23.5 2017
736 281 38.2 113 21 9.7 23.8 2018
732 295 40.3 113 45 9.7 15.6 2019
793 390 49.2 163 24 6.1 16.7 2020
250
continuation 5. 26
Strangulated hernia
From which: % of the all

Years
including: after % of all patients operated % of Hospitalized

Total Total
24 hours admissions Hospitalized after patients after 24 hours
24 hours
1980 690 107 15.5 633 105 2.1 10.5
1985 1013 249 24.6 816 241 2.6 7.1
1988 932 203 21.8 862 196 1.4 5.6
1990 986 184 18.7 907 181 1.4 3.9
1991 1178 323 27.4 1084 311 2.3 4.8
1992 1239 301 24.3 1183 278 2.6 7.6
1993 1381 290 21.0 1335 284 1.7 6.0
1994 1229 286 23.2 1169 274 2.5 7.7
1995 1132 219 19.3 1054 211 1.3 3.3
1996 986 248 25.2 925 242 2.1 6.2
1997 1274 286 22.4 1227 284 1.7 7.4
1998 1681 380 22.6 1623 372 1.2 3.2
1999 1914 536 28.0 1813 499 1.0 2.2
2000 1914 521 27.2 1865 515 1.1 2.7
2001 1451 356 24.5 1418 353 1.6 4.2
2002 1472 454 30.8 14.44 450 1.0 2.0
2003 1674 503 30.0 1642 495 1.1 2.6
2004 2106 380 18.0 2057 373 0.8 3.2
2005 1974 456 23.1 1954 456 0.8 2.2
2006 1936 434 22.4 1912 432 1.0 2.8
2007 1852 416 22.5 1827 408 0.9 2.2
2008 1871 435 23.2 1773 431 0.9 1.9
2009 1949 543 27.9 1919 536 0.8 1.7
2010 1790 295 16.5 1739 290 0.8 2.8
2011 1813 358 19.7 1792 354 0.8 1.7
2012 1726 324 18.8 1709 323 1.1 1.9
2013 1539 276 17.9 1520 273 1.3 3.7
2014 1583 313 19.8 1565 309 0.8 3.2
2015 1476 284 19.2 1463 284 1.0 1.4
2016 1424 322 22.6 1407 317 1.6 4.7
2017 1439 356 24.7 1423 354 1.2 3.4
2018 1438 371 25.8 1387 358 0.7 2.0
2019 1295 361 27.9 1238 351 1.1 2.6
2020 1282 348 27.1 1255 337 1.0 2.7
251
NHIAC
continuation 5. 26
cute inflammation of the gallbladder
From which:
Years
% of the all
including: % of all patients % of Hospitalized
TOTAL TOTAL operated patients
after 24 hours admissions Hospitalized after after 24 hours
24 hours
974 377 38.7 426 183 5.4 7.1 1980
1360 808 59.4 546 403 3.1 3.2 1985
1991 859 43.1 948 543 1.9 2.2 1988
1977 877 44.4 1057 569 1.7 2.6 1990
1791 959 53.5 1226 692 2.8 3.2 1991
1754 811 46.2 1218 596 1.8 2.3 1992
1650 849 51.4 1136 596 1.9 1.7 1993
1408 837 59.4 987 608 2.1 2.5 1994
1603 777 48.5 1194 610 2.1 2.3 1995
1551 926 59.7 1188 787 2.4 2.3 1996
1699 1120 65.9 1391 968 1.9 1.9 1997
1936 1106 57.1 1591 981 1.7 1.6 1998
1995 1179 59.1 1639 1010 1.6 1.5 1999
1719 1016 59.1 1457 888 1.2 1.8 2000
1681 1033 61.5 1469 940 1.7 1.5 2001
1627 1075 66.1 1394 971 1.2 1.4 2002
1726 1010 58.5 1510 896 1.7 2.1 2003
2077 1086 52.3 1895 986 1.6 2.1 2004
2090 1220 58.4 1907 1114 1.0 0.8 2005
2311 1340 58.0 2110 1223 1.4 1.6 2006
2273 1305 57.4 2078 1202 0.7 0.7 2007
2399 1321 55.1 2155 1188 1.3 1.4 2008
2370 1215 51.3 2195 1135 1.0 1.3 2009
2466 1234 50.0 2258 1142 0.8 0.4 2010
2636 1272 48.3 2405 1148 0.8 0.6 2011
2881 1491 51.8 2644 1355 1.1 1.2 2012
3043 1794 59.0 2866 1688 0.9 1.1 2013
3092 1947 63.0 2852 1843 0.8 0.7 2014
2944 1356 46.1 2766 1261 0.6 0.8 2015
2769 1310 47.3 2571 1191 0.9 1.3 2016
3113 1666 53.5 2954 1571 0.8 1.2 2017
3093 1526 49.3 2863 1448 0.9 0.9 2018
3597 2181 60.6 3317 2002 0.7 0.4 2019
4824 1251 25.9 4659 1184 0.4 0.4 2020
252
continuation 5. 26
Acute inflammation of the pancreatitis
from which:
Years
% of the all
including: after % of all patients % of Hospitalized
Total Total operated patients
24 hours admissions Hospitalized after after 24 hours
24 hours
1990 174 73 42.0 40 20 17.5 35.0
1991 138 45 32.6 57 12 17.5 50.0
1992 113 56 49.6 35 25 20.0 24.0
1993 118 63 53.4 32 18 15.6 -
1994 114 64 56.1 23 14 21.7 21.4
1995 110 53 48.2 21 11 14.3 27.3
1996 159 65 40.9 65 21 12.3 33.3
1997 160 97 60.6 46 39 19.6 23.1
1998 213 101 47.4 57 33 17.5 21.2
1999 167 85 50.9 26 16 23.1 31.3
2000 183 84 45.9 41 17 14.6 23.5
2001 125 88 70.4 32 25 15.6 12.0
2002 178 98 55.1 37 22 16.2 9.1
2003 167 87 52.1 42 24 14.3 20.8
2004 186 101 54.3 56 42 10.7 9.5
2005 209 120 57.4 49 25 8.2 12.0
2006 229 154 67.2 54 29 5.6 3.4
2007 223 98 43.9 87 22 6.9 4.5
2008 183 103 56.3 61 28 14.8 21.4
2009 163 77 47.2 70 33 8.6 18.2
2010 208 111 53.4 73 28 16.4 25.0
2011 193 101 52.3 55 17 10.9 11.8
2012 173 87 50.3 44 18 22.7 33.3
2013 195 90 46.2 57 18 5.3 16.7
2014 236 110 46.6 55 24 5.5 8.3
2015 210 113 53.8 52 16 13.5 12.5
2016 235 130 55.3 42 5 9.5 40.0
2017 220 117 53.2 76 29 6.6 10.3
2018 186 67 36.0 54 10 3.7 10.0
2019 238 112 47.1 41 11 14.6 45.5
2020 304 126 41.4 132 14 5.3 35.7
253
NHIAC
continuation 5. 26
Extrauterine pregnancy
from which:
Years
including: % of
% of all patients % of the all
Total after 24 Total operated patients Hospitalized
admissions Hospitalized after
hours after 24 hours
24 hours
828 158 19.1 828 158 0.4 1.3 1980
954 188 19.7 954 188 - - 1985
1053 159 15.1 1053 159 - - 1988
1074 226 21.0 1073 225 - - 1990
1005 217 21.6 1005 217 0.2 0.92 1991
919 234 25.5 919 234 - - 1992
827 166 20.1 827 166 0.1 - 1993
647 155 24.0 647 155 - - 1994
615 176 28.6 615 176 0.16 0.57 1995
569 156 27.4 569 156 - - 1996
602 102 16.9 602 102 - - 1997
575 0 0 570 121 - - 1998
561 9 16.6 561 93 0.18 1.1 1999
521 141 27.1 521 141 0.38 1.4 2000
462 100 21.6 460 100 - - 2001
487 110 22.6 483 110 - - 2002
520 108 20.8 520 108 - - 2003
476 65 13.7 476 65 - - 2004
427 34 8.0 427 34 - - 2005
419 62 14.8 419 62 - - 2006
446 64 14.3 446 64 - - 2007
474 55 11.6 474 55 - - 2008
459 78 17.0 459 78 - - 2009
438 60 13.7 438 60 - - 2010
454 59 13.0 454 59 - - 2011
455 41 9.0 455 41 - - 2012
453 54 11.9 453 54 - - 2013
414 53 12.8 414 53 - - 2014
447 52 11.6 447 52 - - 2015
419 25 6.0 419 25 - - 2016
384 18 4.7 384 18 - - 2017
420 25 6.0 420 25 - - 2018
376 26 6.9 376 26 - - 2019
394 62 15.7 394 62 - - 2020
254
DENTAL CARE (excluding private dental clinics)
Table 5.27
1980 1985 1990 1995 2000 2005 2010 2015 2019 2020
Number of independent dental polyclinics

Adults 13 17 23 29 31 32 49 47 40 38
Pediatric 4 6 10 10 10 9 7 7 6 6
Number of outpatient
facilities with dental 230 240 251 209 192 132 126 125 153 135
departments
Number of physical
persons working as 494 746 1063 1060 969 969 1740 1240 1318 1410
dentists
Including central,
regional and 478 732 1044 1041 834 463 884 134 233 191
community levels
Supply of dentists per

10000 population
1.6 2.2 3 2.8 2.2 1.4 2.7 0.5 0.8 0.6
(national, regional and
community levels)
Number of dentists
(national, regional and 429 391 303 164 80 32 8 7 - -
community levels)
Total number of persons examined during preventive examinations
Absolute number 709115 890179 839467 493665 78036 131969 152313 130863 75305 57223
% from total
22.7 26.7 23.5 13.1 2.1 4.1 4.7 4.4 2.5 1.9
population
% of relevant age group
15 and older
16.6 14.4 17.2 8.4 1.3 1.8 1.8 1.7 1.1 1.6
population
Children under 14 37.0 40.9 37.5 25.0 4.5 12.7 17.5 15.4 8.3 3.3
examined population who need treatment as % of total examined population
15 and older
53.9 52.2 52.3 53.4 54.0 48.1 48.7 54.3 59.0 43.6
population
Children under 14 65.5 60.8 54.3 51.4 63.2 60.0 62.9 63.0 65.4 61.3
population who received treatment as % of population who need treatment
PHCF 52.4 59.5 60.2 58.5 45.6 50.3 33.0 40.0 49.6 29.8
Number of patients
55.1 66.3 64.5 47.0 42.5 22.1 46.6 50.5 42.8 43.5
who received denture
255
NHIAC
HUMAN
RESOURCES
256
HUMAN RESOURCES
NUMBER OF GRADUATES FROM HIGHER MEDICAL EDUCATION INSTITUTES
BY SPECIALTIES, 2015-2020
Table 6.1
Profession 2015 2016 2017 2018 2019 2020
YSMU Private YSMU private YSMU Private YSMU Private YSMU Private YSMU Private
Medicine 277 101 565 172 433 152 485 135 515 130 422 117
Military medecine 10 - - - - - - - - - - -
Stamotology 115 202 217 497 155 232 138 132 148 227 194 310
Pharmacology 41 30 119 26 61 31 84 34 152 124 121 39
Public health 10 - 11 - 6 - - - 95 99 - -
Total 453 333 912 695 655 415 707 301 910 580 737 466
GRADUATES NUMBER OF YEREVAN STATE MEDICAL UNIVERSITY NAMED AFTER M.HERATSI
Table 6.2
including:
Departments
Total graduates
Years
Physicians Medicine Pediatrics Sanitary Public health Dental Pharmacology

epidemiologic
1980 440 387 236 79 50 - 22 53
1985 543 497 223 152 46 - 76 46
1990 506 463 174 172 44 - 63 53
1992 654 593 261 139 49 - 144 61
1993 718 666 303 158 55 - 150 52
1994 759 716 386 155 57 - 118 43
1995 665 613 314 133 37 - 129 52
1996 875 792 403 129 42 - 218 83
1997 798 770 448 205 47 - 70 28
1998 622 581 297 168 50 - 66 41
1999 449 413 201 102 45 - 65 36
2000 380 349 168 74 45 - 62 31
2001 384 338 176 60 34 - 68 46
2002 409 380 207 79 21 - 73 29
2003 366 312 185 38 21 - 68 54
2004 406 361 219 33 24 - 85 45
2005 441 400 318 - - - 82 41
2006 402 367 288 - - - 79 35
2007 391 359 287 - - - 72 32
2008 428 369 281 - - - 88 59
2009 460 401 266 - - - 135 59
2010 507 449 317 - - - 132 58
2011 377 377 377 - - - - -
2012 683 584 334 - - - 250 99
2013 686 590 325 - - - 265 96
2014 610 547 328 - - - 219 63
2015 453 412 287 10 115 41
2016 912 793 565 - - 11 217 119
2017 655 594 433 - - 6 155 61
2018 707 623 485 - - - 138 84
2019 910 758 515 - - 95 148 152
2020 737 616 422 - - - 194 121
257
NHIAC
NUMBER OF GRADUATES FROM SECONDARY MEDICAL EDUCATION INSTITUTIONS
BY SPECIALTIES 2015-2020
Table 6.3
Profession 2015 2016 2017 2018 2019 2020
State Private State. Private State. Private State. Private State. Private State. Private
Nursing 1079 80 679 71 572 50 485 86 429 62 504 27
Obstetric 490 30 266 40 215 21 187 23 118 27 128 20
Pharmaceutics 548 74 458 78 420 40 289 114 358 102 356 120
Dental 380 88 372 91 251 72 131 86 214 102 262 103
Medical cosmetology 92 61 180 65 131 47 89 50 104 28 115 35
Nursing management 179 - 155 13 127 8 96 - 38 - 93 11
Medical massage 19 - 21 - 8 - 11 - 6 - 14 -
General patient care 18 - 19 - 20 - 1 - 6 - - -
Total - - - - - - - - - - 25 -
Nursing 2805 333 2150 358 1744 238 1289 359 1273 321 1497 316
NUMBER OF GRADUATES FROM SECONDARY MEDICAL EDUCATION INSTITUTIONS

(state educational institutions)
Table 6.4
including: by departments
Years
Number of Number of
institutions graduates – Sanitary
Therape Obstetric Medical- Pharma Therap
therape Nursing Dental Med.
utic al laboratory ceutical eutic
utic
1980 6 2076 171 30 175 1522 117 31 30 - -
1985 6 2187 173 54 210 1636 51 - 63 - -
1990 7 2581 230 56 201 1968 70 - 56 - -
1995 6 1828 213 18 238 1283 52 - 24 - -
2000 10 2838 - - 989 1468 12 280 89 - -
2005 12 1641 - - 375 730 15 217 304 - -
2006 12 1402 - - 349 660 8 151 234 - -
2007 11 1616 - - 375 745 5 217 274 - -
2008 12 3048 56 - 636 1363 9 422 562 - -
2009 12 3319 - - 655 1477 - 459 668 11 49
2010 12 3413 - - 831 1516 - 370 579 34 83
2011 11 2976 - - 698 1432 - 328 483 14 21
2012 11 2473 - - 553 1075 - 309 480 14 42
2013 11 2385 - - 433 999 - 402 478 16 57
2014 11 2462 - - 417 1000 - 418 503 28 96
2015 12 2805 - - 490 1276 - 380 548 19 92
2016 18 2150 - - 266 853 - 372 458 21 180
2017 18 1744 - - 215 719 - 251 420 8 131
2018 15 1289 - - 187 582 - 131 289 11 89
2019 15 1273 - - 118 473 - 214 358 6 104
2020 12 1497 - - 128 622 - 262 356 14 115
* Data calculated from 2009
258
HUMAN RESOURCES
HEALTHCARE PERSONNEL BY REGIONS*, 2018-2020
Table 6.5
Physicians of all specialties Mid-level staff
( including dentists. a.v.) (a.v.)
2018 2019 2020 2018 2019 2020
RA-TOTAL 12869 13437 14027 16293 16423 16528
NATIONAL. REGIONAL AND 5940 6566 6557 11153 11121 11136
LOCAL LEVELS
YEREVAN 9370 9764 10397 8303 8486 8780
ARAGATSOTN 218 231 227 539 535 520
Ashtarak 115 122 119 223 228 226
Aparan 40 43 43 96 95 97
Aragats 17 16 16 68 66 60
Talin 46 50 49 152 146 137
ARARAT 434 451 431 984 979 921
Artashat 184 197 168 370 376 351
Vedi 80 85 - 165 170 -
Masis 99 110 117 243 267 237
Ararat 71 59 146 206 166 333
ARMAVIR 371 395 388 882 875 834
Armavir 155 161 180 371 373 426
Baghramyan 14 16 16 44 46 47
Vagharshapat 175 190 192 377 373 361
Metsamor 27 28 - 90 83 -
GEGHARKUNIK 333 362 358 821 810 821
Vardenis 35 35 34 145 135 130
Gavar 76 105 95 167 184 166
Martuni 103 107 112 247 256 254
Tshambarak 23 19 21 60 66 67
Sevan 96 96 96 202 169 204
LORI 493 513 515 1057 1021 1016
Gugark 8 8 9 28 26 26
Spitak 60 67 68 133 114 130
Stepanavan 49 50 59 114 110 105
Tashir 29 32 34 69 76 75
Tumanyan 65 71 68 168 166 163
Vanadzor 282 285 277 545 529 517
KOTAYK 486 556 566 966 1023 1009
Kotayk 220 270 273 410 472 457
Nairi 90 92 94 161 166 176
Hrazdan 127 142 199 296 289 376
Charentsavan 49 52 - 99 96 -
SHIRAK 565 571 554 1291 1268 1257
Amasia 3 3 4 28 28 28
Ani 21 25 24 71 78 66
Artik 54 55 51 150 151 150
Akhuryan 61 46 54 146 128 123
Ashotsk 17 14 14 36 35 64
Gyumri 409 428 407 860 848 826
SYUNIK 257 240 243 717 685 671
Goris 83 73 75 211 213 211
Kapan 106 105 107 335 304 280
Meghri 26 25 26 60 58 62
Sisian 42 37 35 111 110 118
VAYOTS DZOR 102 110 97 212 212 205
Vayk 36 37 47 57 59 83
Yeghegnadzor 59 66 50 141 139 122
Jermuk 7 7 - 14 14 -
TAVUSH 240 244 251 521 529 494
Ijevan 67 82 73 146 169 146
Noyemberyan 42 45 47 108 108 111
Tavush 53 40 44 147 133 124
Dilijan 78 77 87 120 119 113
* Without data of private medical and dental cabinets
259
NHIAC
HEALTHCARE PERSONNEL BY REGIONS*, 2018-2020
Physicians of all specialties Mid-level staff

( including dentists. per 10 000 population) (per 10 000 population)
2018 2019 2020 2018 2019 2020
43.4 45.4 47.3 54.9 55.5 55.8 RA-TOTAL
20.0 22.2 22.1 37.6 37.6 37.6 NATIONAL. REGIONAL AND
LOCAL LEVELS
X X X X X X YEREVAN
17.4 18.5 18.2 43.0 42.9 41.8 ARAGATSOTN
19.6 20.9 20.4 37.9 39.1 38.8 Ashtarak
18.9 20.4 20.4 45.3 45.0 46.0 Aparan
12.6 11.9 11.9 50.4 48.9 44.4 Aragats
14.4 15.7 15.5 47.6 45.9 43.4 Talin
16.9 17.6 16.8 38.3 38.2 35.9 ARARAT
20.9 22.4 19.2 42.0 42.8 40.1 Artashat
11.6 12.3 - 23.8 24.5 - Vedi
12.5 13.9 14.8 30.8 33.8 29.9 Masis
34.8 28.9 16.3 101.0 81.4 37.1 Ararat
14.1 15.0 14.7 33.4 33.2 31.6 ARMAVIR
15.0 15.6 16.2 36.0 36.2 38.2 Armavir
7.3 8.3 8.3 22.8 24.0 24.5 Baghramyan
13.1 14.3 14.4 28.3 28.0 27.1 Vagharshapat
31.8 33.3 - 105.9 98.8 - Metsamor
14.6 15.9 15.8 36.0 35.6 36.1 GEGHARKUNIK
9.3 9.4 9.2 38.7 36.1 34.9 Vardenis
15.5 21.6 19.6 34.0 37.9 34.3 Gavar
11.6 12.1 12.6 27.9 28.9 28.6 Martuni
17.4 14.4 16.0 45.5 50.0 51.1 Tshambarak
24.1 24.1 24.1 50.6 42.4 51.1 Sevan
22.9 24.1 24.2 49.0 47.9 47.8 LORI
4.2 4.2 4.7 14.6 13.8 13.7 Gugark
16.9 18.9 19.2 37.5 32.1 36.7 Spitak
18.7 19.2 22.9 43.5 42.3 40.7 Stepanavan
16.1 18.1 19.1 38.3 42.9 42.1 Tashir
17.0 18.7 18.0 44.0 43.7 43.2 Tumanyan
36.0 36.9 36.0 69.5 68.5 67.2 Vanadzor
19.3 22.2 22.5 38.4 40.8 40.2 KOTAYK
19.8 24.3 24.5 36.9 42.5 41.0 Kotayk
15.7 16.1 16.4 28.1 29.0 30.7 Nairi
20.3 22.8 24.1 47.2 46.5 45.6 Hrazdan
23.9 25.5 - 48.3 47.1 - Charentsavan
24.2 24.7 24.0 55.3 54.8 54.4 SHIRAK
4.8 4.8 6.6 45.2 45.2 45.9 Amasia
11.2 13.4 12.8 37.8 41.7 35.1 Ani
11.2 11.5 10.7 31.2 31.7 31.5 Artik
16.3 12.4 14.5 39.0 34.5 33.1 Akhuryan
18.3 15.1 15.2 38.7 37.6 69.6 Ashotsk
36.0 38.1 36.3 75.8 75.4 73.7 Gyumri
18.7 17.5 17.9 52.1 49.9 49.4 SYUNIK
20.5 18.0 18.8 52.2 52.6 52.8 Goris
18.7 18.6 19.1 59.2 53.9 49.9 Kapan
24.1 23.4 25.0 55.6 54.2 59.6 Meghri
14.1 12.5 11.9 37.2 37.0 40.3 Sisian
20.8 22.7 20.2 43.3 43.7 42.6 VAYOTS DZOR
27.7 28.7 28.0 43.8 45.7 49.4 Vayk
18.6 21.0 16.0 44.3 44.1 39.0 Yeghegnadzor
16.7 17.1 - 33.3 34.1 - Jermuk
19.6 20.1 20.8 42.6 43.5 41.0 TAVUSH
14.1 17.3 15.5 30.7 35.7 30.9 Ijevan
15.3 16.5 17.3 39.4 39.7 41.0 Noyemberyan
21.8 16.6 18.7 60.5 55.2 52.8 Tavush
33.9 33.8 38.3 52.2 51.8 49.8 Dilijan
260
HUMAN RESOURCES
NUMBER OF PHYSYCIANS AND MID-LEVEL PERSONNEL OF MEDICAL AND EDUCATIONAL

INSTITUTIONS OF RA, 2017
Table 6.6.1
Number of doctors/physicians * Number of mid level personnel
a.v. r.v.* a.v. r.v.
Total RA 12964 43.6 16796 56.5
Yerevan 9444 87.6 8586 79.7
Aragatsotn 227 17.9 572 45.0
Ararat 436 16.9 941 36.5
Armavir 392 14.8 910 34.4
Gegharkunik 316 13.8 885 38.5
Lori 508 23.4 1093 50.3
Kotayk 502 20.0 986 39.2
Shirak 534 22.7 1316 55.9
Syunik 264 19.1 743 53.7
Vayots Dzor 105 21.2 231 46.6
Tavush 236 19.1 533 43.2
*calculated per 10,000 inhabitants

Table 6.6.2
Number of doctors/physicians Number of mid level personnel
a.v. r.v. a.v. r.v.
Total RA 13366 45.1 16595 56.0
Yerevan 9717 89.8 8490 78.5
Aragatsotn 228 18.2 544 43.4
Ararat 439 17.1 988 38.5
Armavir 390 14.8 894 33.9
Gegharkunik 339 14.8 826 36.2
Lori 520 24.1 1083 50.3
Kotayk 536 21.3 1005 39.9
Shirak 584 25.0 1304 55.9
Syunik 263 19.1 723 52.5
Vayots Dzor 105 21.4 214 43.7
Tavush 245 20.0 524 42.9
261
NHIAC
Table 6.6.3
a.v. r.v. a.v. r.v.
Total RA 13958 47.2 16772 56.7
Yerevan 10170 93.8 8721 80.5
Aragatsotn 239 19.2 542 43.5
Ararat 457 17.8 986 38.4
Armavir 414 15.7 890 33.7
Gegharkunik 367 16.1 814 35.8
Lori 532 24.9 1048 49.1
Kotayk 594 23.7 1061 42.3
Shirak 578 25.0 1274 55.1
Syunik 244 17.8 690 50.3
Vayots Dzor 113 23.3 214 44.1
Tavush 250 20.6 532 43.8

Table 6.6.4
a.v. r.v. a.v. r.v.
Total RA 14396 48.6 16744 56.5
Yerevan 10698 98.0 8938 81.9
Aragatsotn 233 18.7 524 42.1
Ararat 433 16.9 923 36.0
Armavir 394 14.9 838 31.7
Gegharkunik 361 15.9 823 36.2
Lori 535 25.2 1038 48.8
Kotayk 592 23.6 1030 41.0
Shirak 557 24.1 1259 54.5
Syunik 244 18.0 672 49.5
Vayots Dzor 97 20.2 205 42.6
Tavush 252 20.9 494 41.0
262
PROVISION OF PHYSICIANS, 2019
Table 6.7
2019
a.v. r.v.
Physicians providing Physicians providing
Title immediate medical care immediate medical care
RA Total including: RA Total including:
PHCF Hospital PHCF Hospital
Physicians – Total 13958 5172 4821 47,16 17,47 16,29
including:
Directors and their deputies 704 308 221 2,38 1,04 0,75
Therapeutic profile 3737 1960 1053 16,56 8,69 4,67
including:
 Family doctors 664 620 1 2,24 2,09 0,00
 Cardiologists 536 105 263 2,38 0,47 1,17
 Oncologist 116 47 17 0,51 0,21 0,08
 Neuropathologists 321 114 119 1,42 0,51 0,53
 Endocrinologist 270 134 67 1,20 0,59 0,30
Ophthalmologists 338 115 146 1,50 0,51 0,65
Ear-nose-throat physician 265 88 109 1,17 0,39 0,48
Psychiatrists profile 174 71 67 0,59 0,24 0,23
Phthisiators 102 61 26 0,34 0,21 0,09
Dermatologist - venereologists 219 131 19 0,97 0,58 0,08
Obstetrician gynecologist 934 359 452 5,98 2,30 2,89
Pediatric gynecologist 20 13 4 0,61 0,39 0,12
Pediatric profile 1161 565 400 16,51 8,03 5,69
Surgical profile 1975 169 1254 8,75 0,75 5,56
Pediatric Surgical profile 178 19 126 2,53 0,27 1,79
Dentists 1691 535 8 7,49 2,37 0,04
Pediatric dentists 117 72 1 1,66 1,02 0,01
Hygienic and anti-epidemic doctors 295 32 66 1,00 0,11 0,22
Instrumental laboratory profile 1360 533 607 4,60 1,80 2,05
 The number of doctors in therapeutic profiles includes therapeutists, pulmonologists, rheumatologists, gastroenterologists, nephrologists,
allergologists, dietologists / neutiologists, hematologists, physiotherapists, emergency physicians, geneticicans, infectionists, prophatologists,
intensive therapists, cardiologists, oncologists, neurologists, endocrinologists, family doctors.
 Surgical profiles - surgeons, narrow surgical specialists` cardiovascular, thoracic, abdominal, endocrine, oncologists, plastic and
reconstructive, aesthetic, neurosurgeons, anesthesiologist-reanimatologists, traumatologists-orthopedists, urologists, endoscopists,
proctologists, microsurgicians, burn specialists, cardiologist reanimatologists.
 Pediatricians profile includes: Pediatricians, neonatologists, narrow pedicatric specialists` cardiologists, endocrinologists, oncologists,
neurologists, ophthalmologists, allergologists, development pediatricians, pulmonologists, nephrologists, gastroenterologists,
rheumatologists, infectionists, dermatologists, hematologists, adolescent doctors, nose-throat-throat specialists.
 Pediatirc surgical profile - pediatric surgeons, traumatologists-orthopedists, neurosurgeons, urologists, anesthetists-reanimatologists,
 Psychiatric profile - psychiatrists, psychotherapists, psychiatrists- narcologist
 Hygienic epidemic profile - toxicologists, microbiologists, epidemiologists, parasitologists, microbiologists, virologists.
 Instrumental and laboratory profiles - ECG and radioisotope, CTM specialists, sonographists, X-Ray specialists, radiologists, virologists,
fungalists, bacteriologists, laboratory assistants for various profiles.
PROVISION OF PHYSICIANS, 2020
Table 6.8
2020
a.v. r.v.
Physicians providing Physicians providing
Title immediate medical care immediate medical care
RA Total including: RA Total including:
PHCF Hospital PHCF Hospital
Physicians – Total 14396 5410 4981 48.6 18.26 16.81
including:
Directors and their deputies 628 332 223 2.12 1.12 0.75
Therapeutic profile 3903 1980 1094 17.30 8.78 4.85
including:
 Family doctors 683 613 8 2.30 2.07 0.03
 Cardiologists 551 117 233 2.44 0.52 1.03
 Oncologist 158 49 55 0.70 0.22 0.24
 Neuropathologists 322 113 125 1.43 0.50 0.55
 Endocrinologist 302 140 72 1.34 0.62 0.32
Ophthalmologists 363 127 151 1.61 0.56 0.67
Ear-nose-throat physician 297 105 123 1.32 0.47 0.55
Psychiatrists 188 81 62 0.63 0.27 0.21
Phthisiators 101 58 22 0.34 0.20 0.07
Dermatologist - venereologists 232 136 21 1.03 0.60 0.09
Obstetrician gynecologist 877 331 400 5.60 2.11 2.56
Pediatric gynecologist 19 7 11 0.57 0.21 0.33
Pediatric profile 1162 554 402 16.44 7.84 5.69
Surgical profile 2107 192 1326 9.34 0.85 5.88
Pediatric Surgical profile 199 23 132 2.81 0.33 1.87
Dentists 1480 525 12 6.56 2.33 0.05
Pediatric dentists 124 73 4 1.75 1.03 0.06
Hygienic and anti-epidemic doctors 308 35 72 1.04 0.12 0.24
Instrumental laboratory profile 1376 595 626 4.64 2.01 2.11
 The number of doctors in therapeutic profiles includes therapeutists, pulmonologists, rheumatologists, gastroenterologists, nephrologists,
allergologists, dietologists / neutiologists, hematologists, physiotherapists, emergency physicians, geneticicans, infectionists, prophatologists,
intensive therapists, cardiologists, oncologists, neurologists, endocrinologists, family doctors.
 Surgical profiles - surgeons, narrow surgical specialists` cardiovascular, thoracic, abdominal, endocrine, oncologists, plastic and
reconstructive, aesthetic, neurosurgeons, anesthesiologist-reanimatologists, traumatologists-orthopedists, urologists, endoscopists,
proctologists, microsurgicians, burn specialists, cardiologist reanimatologists.
 Pediatricians profile includes: Pediatricians, neonatologists, narrow pedicatric specialists` cardiologists, endocrinologists, oncologists,
neurologists, ophthalmologists, allergologists, development pediatricians, pulmonologists, nephrologists, gastroenterologists,
rheumatologists, infectionists, dermatologists, hematologists, adolescent doctors, nose-throat-throat specialists.
 Pediatirc surgical profile - pediatric surgeons, traumatologists-orthopedists, neurosurgeons, urologists, anesthetists-reanimatologists,
 Psychiatric profile - psychiatrists, psychotherapists, psychiatrists- narcologist
 Hygienic epidemic profile - toxicologists, microbiologists, epidemiologists, parasitologists, microbiologists, virologists.
 Instrumental and laboratory profiles - ECG and radioisotope, CTM specialists, sonographists, X-Ray specialists, radiologists, virologists,
fungalists, bacteriologists, laboratory assistants for various profiles.
HUMAN RESOURCES
HUMAN RESOURCES IN RA
(physicians by speciality), 2020
Table 6.9
including:
Number of human
resources in inpatient and PHC institutions
Professions Hospital facilities (polyclinics, ambulatories,
outpatient facilities
dispensaries, counseling)
Physicians – Total * 10391 35.07 4981 16.81 5410 18.26
Directors and their deputies 555 1.87 223 0.75 332 1.12
Family doctors 621 2.10 8 0.03 613 2.07

Therapists - Total 755 3.35 144 0.64 611 2.71
from which local 509 2.26 0 0.00 509 2.26
Adolescent physician 14 1.29 0 0.00 14 1.29
Allergologist and immunologist 19 0.08 9 0.04 10 0.04

Gerontologist 1 0.00 0 0.00 1 0.00
Homeopath 8 0.03 3 0.01 5 0.02
Venereologist 21 0.07 6 0.02 15 0.05
Nephrologist 42 0.19 39 0.17 3 0.01
Endocrinologist 212 0.94 72 0.32 140 0.62
Gastroenterologist 62 0.27 33 0.15 29 0.13
Rheumatologist 38 0.17 22 0.10 16 0.07
Nutritionist 5 0.02 3 0.01 2 0.01
Aviation doctor 1 0.00 0 0.00 1 0.00
Pediatricians - Total 576 8.15 151 2.14 425 6.01
from which local 351 4.96 2 0.03 349 4.94
Neonatologist 147 2.46 143 2.39 4 0.07
Pediatric allergologist and immunologist 13 0.18 3 0.04 10 0.14
Pediatric pulmonologist 6 0.08 6 0.08 0 0.00
Pediatric cardiologist 29 0.41 16 0.23 13 0.18
Pediatric nephrologist 7 0.10 7 0.10 0 0.00
Pediatric endocrinologist 11 0.16 0 0.00 11 0.16
Pediatric gastroenterologist 8 0.11 5 0.07 3 0.04
Pediatric rheumatologist 3 0.04 1 0.01 2 0.03
Pediatric infectionist 11 0.16 8 0.11 3 0.04
Pediatric neuropathologist 31 0.44 14 0.20 17 0.24
Child and adolescent psychiatrist 6 0.08 0 0.00 6 0.08
Pediatric dermatologist 8 0.11 0 0.00 8 0.11
Pediatric traumatologist and orthopedist 24 0.34 22 0.31 2 0.03
Pediatric surgeon 62 0.88 41 0.58 21 0.30
Pediatric Ophthalmologist 38 0.54 12 0.17 26 0.37
265
NHIAC
RA HUMAN RESOURCES
Table 6.9 (continuation)

including:
Number of human resources
in inpatient and outpatient PHC institutions
facilities
Pediatric ear-nose-throat physician 37 0.52 21 0.30 16 0.23
Pediatric gynecologist 18 0.54 11 0.33 7 0.21
Pediatric hematologist 10 0.14 10 0.14 0 0.00

Pediatric oncologist 7 0.10 5 0.07 2 0.03
Pediatric Urologist 0 0.00 0 0.00 0 0.00
Pediatric dentist therapist 63 0.89 0 0.00 63 0.89
Pediatric dentist surgeon 8 0.11 4 0.06 4 0.06
Orthopedic dentist 3 0.04 0 0.00 3 0.04
Pediatric orthodontist 3 0.04 0 0.00 3 0.04
Pediatric Neurosurgeon 8 0.11 8 0.11 0 0.00
Pediatric anesthetist / reanimatologist 61 0.86 61 0.86 0 0.00
Neuropathologist 238 1.05 125 0.55 113 0.50
Psychiatrist 96 0.43 43 0.19 53 0.23
Narcologist 30 0.10 9 0.03 21 0.07
Psychotherapist 17 0.06 10 0.03 7 0.02
Clinical psychologist 12 0.04 7 0.02 5 0.02
Cardiologist 350 1.55 233 1.03 117 0.52
Interventional cardiologist 55 0.19 55 0.19 0 0.00
Cardiologist reanimatologist 36 0.12 32 0.11 4 0.01

Dermatologist-venereologist 157 0.70 21 0.09 136 0.60
Doctor cosmetologist 32 0.11 3 0.01 29 0.10
Surgeon 334 1.48 245 1.09 89 0.39
Abdominal surgeon 19 0.06 18 0.06 1 0.00
Thoracic surgeon 35 0.12 31 0.10 4 0.01
Microsurgeon 32 0.11 32 0.11 0 0.00
Endocrine surgeon 22 0.07 21 0.07 1 0.00
Proctologist 43 0.15 41 0.14 2 0.01
Traumatologist and orthopedist 162 0.72 143 0.63 19 0.08
Burns doctor 4 0.01 4 0.01 0 0.00
Oncologist 104 0.46 55 0.24 49 0.22
Oncologist surgeon 7 0.02 7 0.02 0 0.00
Radiation oncologist 8 0.03 7 0.02 1 0.00
266
HUMAN RESOURCES
RA HUMAN RESOURCES

including:
Number of human resources PHC institutions
in inpatient and outpatient (polyclinics,
Professions Hospital facilities
facilities ambulatories,
Anticancer chemotherapeutist 26 0.09 26 0.09 0 0.00
Ophthalmologist 278 1.23 151 0.67 127 0.56
Ear-nose-throat physician 228 1.01 123 0.55 105 0.47
Electrocardiographist 63 0.21 25 0.08 38 0.13
Obstetrician gynecologist 731 4.67 400 2.56 331 2.11
Perinatologist 1 0.01 1 0.01 0 0.00
Reprodulocologist 45 0.60 18 0.24 27 0.36
Endocrinologist gynecologist 15 0.10 3 0.02 12 0.08
Emergency doctor 325 1.10 173 0.58 152 0.51
Anesthesiologist 383 1.29 377 1.27 6 0.02
Pain manager 5 0.02 4 0.01 1 0.00
Intensive therapist 43 0.15 41 0.14 2 0.01
Toxicologist 10 0.03 7 0.02 3 0.01
Physiotherapist 68 0.23 24 0.08 44 0.15
Manual therapist 10 0.03 5 0.02 5 0.02
Reflexotherapist 28 0.09 8 0.03 20 0.07
Kinesiotherapy physician 22 0.07 14 0.05 8 0.03
Barotherapist 1 0.00 1 0.00 0 0.00
Palliative care physician 3 0.01 0 0.00 3 0.01
Radioisotope specialist 15 0.05 14 0.05 1 0.00
Radiologist 193 0.65 107 0.36 86 0.29
Sonographist 401 1.35 186 0.63 215 0.73
Computed tomography and nuclear magnetic
82 0.28 52 0.18 30 0.10
resonance diagnostics specialist
Specialist of radionuclide diagnosis (Nuclear medicine) 19 0.06 7 0.02 12 0.04
Interventional radiologist 3 0.01 3 0.01 0 0.00
Genetic 11 0.04 0 0.00 11 0.04
Hematologist. transfuziologist 46 0.20 30 0.13 16 0.07
Pulmonologist 16 0.05 9 0.03 7 0.02
Phthisiatrist 80 0.27 22 0.07 58 0.20
Infectionist 119 0.53 74 0.33 45 0.20
Endoscopist 47 0.16 30 0.10 17 0.06
Urologist 123 0.42 93 0.31 30 0.10
Neurosurgeon 44 0.20 44 0.20 0 0.00
267
NHIAC
RA HUMAN RESOURCES

including:
Number of human resources in
PHC institutions (polyclinics,
inpatient and outpatient
Professions Hospital facilities ambulatories, dispensaries,
facilities
counseling)
Vascular neurosurgeon/ including
5 0.02 4 0.01 1 0.00
endovascular neurosurgeon /
Plastic and reconstructive surgeon 65 0.22 55 0.19 10 0.03
Aesthetic surgeon 5 0.02 5 0.02 0 0.00
Heart surgeon 21 0.07 19 0.06 2 0.01
Vascular surgeon 65 0.22 63 0.21 2 0.01
Pathologist and clinical morphologist 49 0.17 39 0.13 10 0.03
Forensic medical expert 5 0.02 3 0.01 2 0.01
Pathological physiologist 9 0.03 9 0.03 0 0.00
Clinical biochemist 18 0.06 7 0.02 11 0.04
Laboratory hematologist 9 0.03 6 0.02 3 0.01
Clinical cytologist 11 0.04 6 0.02 5 0.02
Laboratory immunologist 15 0.05 14 0.05 1 0.00
Laboratory Genetic 7 0.02 3 0.01 4 0.01
Clinical laboratory assistant 362 1.22 184 0.62 178 0.60
Bacteriologist 14 0.05 10 0.03 4 0.01
Virologist 6 0.02 1 0.00 5 0.02
Fungologist 1 0.00 0 0.00 1 0.00
Parasitologist 2 0.01 1 0.00 1 0.00
Sports doctor 4 0.01 2 0.01 2 0.01
Family dentist 96 0.32 1 0.00 95 0.32
Dental therapist 296 1.31 7 0.03 289 1.28
Surgeon dentist 40 0.18 2 0.01 38 0.17
Orthodent dentist 34 0.15 1 0.00 33 0.15
Maxillofacial surgeon 71 0.24 66 0.22 5 0.02
Specialist in public health and preventive
5 0.02 0 0.00 5 0.02
medicine
Epidemiologist of infectious diseases 15 0.05 7 0.02 8 0.03
Epidemiologist of non-communicable diseases 3 0.01 2 0.01 1 0.00
Hospital epidemiologist 59 0.20 45 0.15 14 0.05
Epidemiologist of particularly dangerous
1 0.00 0 0.00 1 0.00
infections
Microbiologist 17 0.06 10 0.03 7 0.02
Laboratory Parasitologist 2 0.01 1 0.00 1 0.00
Medical statistician 54 0.18 31 0.10 23 0.08
Other specialist 119 0.40 47 0.16 72 0.24
Pharmaceutical organizer and manager 52 0.18 30 0.10 22 0.07
Clinical pharmacologist 16 0.05 13 0.04 3 0.01
268
HUMAN RESOURCES
RA HUMAN RESOURCES
(mid-level, junior and other personnel), 2020
Table 6.10
including:

inpatient and outpatient PHC institutions
facilities

Mid-level personnel- Total 16014 54.04 8497 28.67 7517 25.37
Family nurse 1680 5.67 225 0.76 1455 4.91
Pediatric nurse 969 13.71 305 4.31 664 9.39
Nurse neonatologist 216 3.61 216 3.61 0 0.00
Bandaging nurse 472 1.59 415 1.40 57 0.19
Nurse anesthesiologist 486 1.64 485 1.64 1 0.00
Urgent and emergency care nurse 813 2.74 487 1.64 326 1.10
Physiotherapeutic and rehabilitation nurse 312 1.05 191 0.64 121 0.41
Psychiatry and narcology nurse 283 0.96 217 0.73 66 0.22

Dental nurse 378 1.28 7 0.02 371 1.25
Diagnostic radiology nurse 425 1.43 258 0.87 167 0.56
Functional diagnostic nurse 208 0.70 88 0.30 120 0.40
Nurse in preventive medicine 177 0.60 65 0.22 112 0.38
Pat anatomic and clinical morphological
33 0.11 22 0.07 11 0.04
nurse
Nursing manager 250 0.84 139 0.47 111 0.37
Public health nurse 328 1.11 234 0.79 94 0.32
Nurse with middle-level medical / incomplete

772 2.61 606 2.05 166 0.56
higher medical education
Midwife 1041 13.97 625 8.39 416 5.58
Curative nurse 55 0.19 26 0.09 29 0.10
Dental technician 99 0.33 1 0.00 98 0.33
Laboratory nurse 1003 3.38 521 1.76 482 1.63
X-ray technicians and laboratory assistants 365 1.23 222 0.75 143 0.48
Sanitary epidemiologists and physicians
27 0.09 21 0.07 6 0.02
assistants
Instructor – disinfectants and disinfection
53 0.18 27 0.09 26 0.09
specialist
Middle medical statistician 134 0.45 37 0.12 97 0.33
Other middle staff 5435 18.34 3057 10.32 2378 8.02

Pharmacist 204 0.69 89 0.30 115 0.39
Therapeutic massagist 28 0.09 14 0.05 14 0.05
Children’s massagist 10 0.03 0 0.00 10 0.03
Sports massagist 3 0.01 2 0.01 1 0.00
Point massagist 3 0.01 3 0.01 0 0.00
Ergotherapist 4 0.01 3 0.01 1 0.00
269
NHIAC
YEREVAN, HUMAN RESOURCES

Table 6.10.1
including:
facilities
Family doctors 58 0.53 1 0.01 57 0.52
from which local 332 3.96 0 0.00 332 3.96

Gerontologist 1 0.01 0 0.00 1 0.01
Homeopath 8 0.07 3 0.03 5 0.05
Venereologist 19 0.17 6 0.05 13 0.12
Nephrologist 31 0.37 29 0.35 2 0.02
Rheumatologist 35 0.42 21 0.25 14 0.17
Nutritionist 5 0.05 3 0.03 2 0.02
Aviation doctor 1 0.01 0 0.00 1 0.01
from which local 235 9.30 0 0.00 235 9.30
Neonatologist 95 4.37 95 4.37 0 0.00
Pediatric Allergologist and immunologist 11 0.44 3 0.12 8 0.32
Pediatric Cardiologist 27 1.07 16 0.63 11 0.44
Pediatric Nephrologist 7 0.28 7 0.28 0 0.00
Pediatric Endocrinologist 9 0.36 0 0.00 9 0.36

Pediatric Gastroenterologist 7 0.28 4 0.16 3 0.12
Pediatric Rheumatologist 2 0.08 1 0.04 1 0.04
Pediatric Neuropathologist 29 1.15 12 0.47 17 0.67
Child and adolescent psychiatrist 6 0.24 0 0.00 6 0.24
Pediatric dermatologist 8 0.32 0 0.00 8 0.32

270
HUMAN RESOURCES
Table 6.10.1 (continuation)

including:

facilities

Pediatric Ear-nose-throat physician 34 1.35 19 0.75 15 0.59
Pediatric hematologist 10 0.40 10 0.40 0 0.00
Pediatric Oncologist 7 0.28 5 0.20 2 0.08
Pediatric Dentist Therapist 57 2.26 0 0.00 57 2.26
Pediatric Dentist surgeon 7 0.28 4 0.16 3 0.12

Pediatric orthodontist 3 0.12 0 0.00 3 0.12
Pediatric Neurosurgeon 8 0.32 8 0.32 0 0.00
Psychiatrist 53 0.63 28 0.33 25 0.30
Narcologist 23 0.21 8 0.07 15 0.14
Clinical psychologist 12 0.11 7 0.06 5 0.05
Cardiologist 263 3.13 192 2.29 71 0.85
Surgeon 180 2.15 135 1.61 45 0.54
Abdominal surgeon 19 0.17 18 0.16 1 0.01
Microsurgeon 32 0.29 32 0.29 0 0.00

Proctologist 39 0.36 37 0.34 2 0.02
Burns doctor 4 0.04 4 0.04 0 0.00
Oncologist 78 0.93 54 0.64 24 0.29
Oncologist surgeon 7 0.06 7 0.06 0 0.00

271
NHIAC

including:
facilities

Perinatologist 1 0.04 1 0.04 0 0.00

Pain manager 2 0.02 2 0.02 0 0.00
Toxicologist 7 0.06 7 0.06 0 0.00
Barotherapist 1 0.01 1 0.01 0 0.00
Palliative care physician 3 0.03 0 0.00 3 0.03
Radiologist 122 1.12 76 0.70 46 0.42
Sonographist 279 2.56 136 1.25 143 1.31
70 0.64 48 0.44 22 0.20
Specialist of radionuclide diagnosis (Nuclear
12 0.11 6 0.05 6 0.05
medicine)
Genetic 11 0.10 0 0.00 11 0.10
Pulmonologist 15 0.14 9 0.08 6 0.05
Phthisiatrist 20 0.18 0 0.00 20 0.18
Infectionist 74 0.88 44 0.52 30 0.36
Endoscopist 36 0.33 27 0.25 9 0.08
Urologist 92 0.84 71 0.65 21 0.19
Neurosurgeon 42 0.50 42 0.50 0 0.00

Vascular neurosurgeon/ including endovascular
4 0.04 4 0.04 0 0.00
neurosurgeon /
272
HUMAN RESOURCES

including:
facilities
Plastic and reconstructive Surgeon 59 0.54 49 0.45 10 0.09
Aesthetic surgeon 5 0.05 5 0.05 0 0.00
Heart surgeon 21 0.19 19 0.17 2 0.02
Laboratory Genetic 7 0.06 3 0.03 4 0.04
Bacteriologist 14 0.13 10 0.09 4 0.04
Virologist 2 0.02 0 0.00 2 0.02
Fungologist 1 0.01 0 0.00 1 0.01
Parasitologist 2 0.02 1 0.01 1 0.01

Sports doctor 4 0.04 2 0.02 2 0.02
Family dentist 68 0.62 1 0.01 67 0.61
Surgeon dentist 19 0.23 1 0.01 18 0.21
4 0.04 0 0.00 4 0.04
medicine
Epidemiologist of non-communicable
2 0.02 2 0.02 0 0.00
diseases
Epidemiologist of particularly dangerous
1 0.01 0 0.00 1 0.01
infections
Microbiologist 13 0.12 8 0.07 5 0.05
Laboratory Parasitologist 2 0.02 1 0.01 1 0.01
273
NHIAC

Table 6.10.2
including:
PHC institutions
(polyclinics,
in inpatient and outpatient
Professions Hospital facilities ambulatories,
facilities
dispensaries,
counseling)
Family nurse 412 3.77 174 1.59 238 2.18

Pediatric nurse 519 20.54 108 4.27 411 16.27
Bandaging nurse 320 2.93 299 2.74 21 0.19
Nurse Anesthesiologist 314 2.88 313 2.87 1 0.01

Dental nurse 269 2.46 6 0.05 263 2.41
Pat anatomic and clinical morphological nurse 16 0.15 16 0.15 0 0.00
Nursing manager 156 1.43 95 0.87 61 0.56
Nurse with middle-level medical / incomplete higher
556 5.09 519 4.75 37 0.34
medical education
Midwife 554 20.34 358 13.14 196 7.20
Curative nurse 30 0.27 19 0.17 11 0.10
Sanitary epidemiologists and physicians assistants 22 0.20 19 0.17 3 0.03
Instructor – disinfectants and disinfection specialist 29 0.27 17 0.16 12 0.11

Pharmacist 51 0.47 38 0.35 13 0.12
Children’s massagist 10 0.09 0 0.00 10 0.09
Point massagist 3 0.03 3 0.03 0 0.00
274
HUMAN RESOURCES
ARAGATSOTN REGION, HUMAN RESOURCES

Table 6.11.1
including:

facilities

Family doctors 41 3.29 1 0.08 40 3.21
from which local 9 0.97 0 0.00 9 0.97

from which local 6 1.91 0 0.00 6 1.91
Neonatologist 1 0.38 1 0.38 0 0.00
Psychiatrist 3 0.32 0 0.00 3 0.32
Cardiologist 3 0.32 0 0.00 3 0.32
Surgeon 12 1.29 8 0.86 4 0.43
Oncologist 1 0.11 0 0.00 1 0.11

Radiologist 6 0.48 1 0.08 5 0.40
Sonographist 13 1.04 3 0.24 10 0.80
Phthisiatrist 3 0.24 0 0.00 3 0.24
Infectionist 1 0.11 1 0.11 0 0.00
Urologist 1 0.08 0 0.00 1 0.08
Family dentist 9 0.72 0 0.00 9 0.72

1 0.08 0 0.00 1 0.08
medicine
275
NHIAC
ARAGATSOTN REGION,HUMAN RESOURCES

Table 6.11.2
including:

facilities

Family nurse 110 8.84 3 0.24 107 8.60
Pediatric nurse 32 10.18 12 3.82 20 6.36
Bandaging nurse 6 0.48 4 0.32 2 0.16

Dental nurse 5 0.40 0 0.00 5 0.40
Nursing manager 3 0.24 2 0.16 1 0.08
3 0.24 0 0.00 3 0.24
Midwife 34 10.91 15 4.81 19 6.10
Curative nurse 8 0.64 0 0.00 8 0.64

276
HUMAN RESOURCES
ARARAT REGION, HUMAN RESOURCES
Table 6.12.1
including:

Professions facilities Hospital facilities (polyclinics, ambulatories,
Family doctors 77 3.00 0 0.00 77 3.00

from which local 30 1.55 0 0.00 30 1.55

Venereologist 1 0.04 0 0.00 1 0.04
Rheumatologist 2 0.10 1 0.05 1 0.05
from which local 22 3.48 2 0.32 20 3.16
Neonatologist 15 2.80 13 2.43 2 0.37
Psychiatrist 5 0.26 1 0.05 4 0.21
Narcologist 1 0.04 0 0.00 1 0.04
Cardiologist 7 0.36 3 0.16 4 0.21
Surgeon 17 0.88 14 0.72 3 0.16
Oncologist 3 0.16 0 0.00 3 0.16
Pain manager 2 0.08 2 0.08 0 0.00
277
NHIAC

including:
Radiologist 7 0.27 5 0.19 2 0.08

Sonographist 11 0.43 8 0.31 3 0.12
1 0.04 1 0.04 0 0.00
2 0.08 1 0.04 1 0.04
medicine)
Phthisiatrist 4 0.16 0 0.00 4 0.16
Infectionist 5 0.26 4 0.21 1 0.05
Endoscopist 2 0.08 0 0.00 2 0.08
Urologist 1 0.04 1 0.04 0 0.00
Virologist 2 0.08 1 0.04 1 0.04
Microbiologist 1 0.04 1 0.04 0 0.00
278
HUMAN RESOURCES
Table 6.12.2
including:
PHC institutions
facilities
Family nurse 204 7.95 6 0.23 198 7.72
Pediatric nurse 65 10.27 33 5.22 32 5.06
Bandaging nurse 31 1.21 27 1.05 4 0.16

Dental nurse 15 0.58 0 0.00 15 0.58
Nursing manager 16 0.62 9 0.35 7 0.27

8 0.31 5 0.19 3 0.12
Midwife 54 8.27 29 4.44 25 3.83
Curative nurse 4 0.16 4 0.16 0 0.00

7 0.27 5 0.19 2 0.08
specialist

Pharmacist 28 1.09 4 0.16 24 0.94
279
NHIAC
ARMAVIR REGION, HUMAN RESOURCES
Table 6.13.1
including:

facilities

Family doctors 70 2.65 0 0.00 70 2.65

from which local 16 0.79 0 0.00 16 0.79
Nephrologist 2 0.10 2 0.10 0 0.00

from which local 8 1.28 0 0.00 8 1.28
Neonatologist 4 0.64 4 0.64 0 0.00
Psychiatrist 1 0.05 0 0.00 1 0.05
Narcologist 1 0.04 0 0.00 1 0.04
Cardiologist 11 0.55 7 0.35 4 0.20
Surgeon 11 0.55 9 0.45 2 0.10
Oncologist 2 0.10 0 0.00 2 0.10
280
HUMAN RESOURCES

including:
Professions
facilities Hospital facilities (polyclinics, ambulatories,
Radiologist 6 0.23 2 0.08 4 0.15
Sonographist 13 0.49 3 0.11 10 0.38
Pulmonologist 1 0.04 0 0.00 1 0.04
Phthisiatrist 5 0.19 0 0.00 5 0.19
Infectionist 6 0.30 4 0.20 2 0.10

Endoscopist 1 0.04 0 0.00 1 0.04
Urologist 5 0.19 3 0.11 2 0.08
Surgeon dentist 2 0.10 0 0.00 2 0.10

281
NHIAC
Table 6.13.2
including:

Family nurse 145 5.49 0 0.00 145 5.49
Pediatric nurse 96 15.35 38 6.08 58 9.28
Bandaging nurse 16 0.61 10 0.38 6 0.23

Dental nurse 13 0.49 0 0.00 13 0.49
1 0.04 1 0.04 0 0.00
nurse
Nursing manager 3 0.11 2 0.08 1 0.04
Nurse with middle-level medical /
6 0.23 0 0.00 6 0.23
incomplete higher medical education
Midwife 49 7.18 25 3.66 24 3.52
Curative nurse 2 0.08 0 0.00 2 0.08
Pharmacist 4 0.15 1 0.04 3 0.11
282
HUMAN RESOURCES
GEGHARKUNIK REGION, HUMAN RESOURCES
Table 6.14.1
including:

facilities

Family doctors 65 2.86 0 0.00 65 2.86
from which local 14 0.81 0 0.00 14 0.81
Nephrologist 1 0.06 1 0.06 0 0.00
from which local 13 2.35 0 0.00 13 2.35
Neonatologist 6 1.30 4 0.87 2 0.43
Psychiatrist 10 0.58 6 0.35 4 0.23
Cardiologist 6 0.35 2 0.12 4 0.23
Surgeon 17 0.99 12 0.70 5 0.29
Oncologist 3 0.17 0 0.00 3 0.17
Pain manager 1 0.04 0 0.00 1 0.04
Radiologist 7 0.31 4 0.18 3 0.13
Sonographist 16 0.70 10 0.44 6 0.26
Phthisiatrist 3 0.13 0 0.00 3 0.13
283
NHIAC
GEGHARKUNIK REGION, HUMAN RESOURCES

including:

facilities

Infectionist 4 0.23 3 0.17 1 0.06
Endoscopist 1 0.04 0 0.00 1 0.04
Urologist 4 0.18 4 0.18 0 0.00
Surgeon dentist 5 0.29 0 0.00 5 0.29
284
HUMAN RESOURCES
GEGHARKUNIK REGION,HUMAN RESOURCES
Table 6.14.2
including:

facilities

Family nurse 140 6.16 0 0.00 140 6.16
Pediatric nurse 49 8.85 27 4.88 22 3.98
Bandaging nurse 11 0.48 8 0.35 3 0.13
Dental nurse 7 0.31 0 0.00 7 0.31
Nursing manager 11 0.48 5 0.22 6 0.26
9 0.40 0 0.00 9 0.40
Midwife 58 10.04 36 6.23 22 3.81

Curative nurse 4 0.18 3 0.13 1 0.04
5 0.22 0 0.00 5 0.22
specialist

Pharmacist 13 0.57 3 0.13 10 0.44
285
NHIAC
LORI REGION, HUMAN RESOURCES
Table 6.15.1
including:
Family doctors 24 1.13 0 0.00 24 1.13
from which local 60 3.77 0 0.00 60 3.77
Nephrologist 3 0.19 3 0.19 0 0.00
from which local 39 7.31 0 0.00 39 7.31
Neonatologist 7 1.57 7 1.57 0 0.00
Pediatric Gastroenterologist 1 0.19 1 0.19 0 0.00
Pediatric Dentist surgeon 1 0.19 0 0.00 1 0.19
Psychiatrist 5 0.31 1 0.06 4 0.25
Narcologist 1 0.05 0 0.00 1 0.05
Cardiologist 14 0.88 6 0.38 8 0.50
Surgeon 21 1.32 14 0.88 7 0.44
286
HUMAN RESOURCES


including:
facilities
Proctologist 1 0.05 1 0.05 0 0.00
Oncologist 4 0.25 1 0.06 3 0.19
Radiologist 9 0.42 4 0.19 5 0.24
Sonographist 21 0.99 8 0.38 13 0.61
1 0.05 1 0.05 0 0.00
Phthisiatrist 6 0.28 0 0.00 6 0.28
Infectionist 4 0.25 3 0.19 1 0.06
Endoscopist 1 0.05 1 0.05 0 0.00
Urologist 3 0.14 3 0.14 0 0.00
Neurosurgeon 1 0.06 1 0.06 0 0.00
Family dentist 4 0.19 0 0.00 4 0.19
Surgeon dentist 3 0.19 0 0.00 3 0.19
Epidemiologist of non-communicable
1 0.05 0 0.00 1 0.05
diseases
287
NHIAC

Table 6.15.2
including:

facilities

Family nurse 70 3.29 5 0.24 65 3.06
Pediatric nurse 68 12.74 18 3.37 50 9.37
Bandaging nurse 14 0.66 7 0.33 7 0.33

Dental nurse 23 1.08 0 0.00 23 1.08
1 0.05 1 0.05 0 0.00
nurse
Nursing manager 23 1.08 8 0.38 15 0.71
Midwife 66 12.53 36 6.83 30 5.69

Curative nurse 3 0.14 0 0.00 3 0.14
1 0.05 0 0.00 1 0.05
assistants
2 0.09 2 0.09 0 0.00
specialist
Pharmacist 4 0.19 3 0.14 1 0.05
Ergotherapist 1 0.05 0 0.00 1 0.05
288
HUMAN RESOURCES
KOTAYK REGION, HUMAN RESOURCES

Table 6.16.1
including:


Family doctors 114 4.54 0 0.00 114 4.54
from which local 5 0.27 0 0.00 5 0.27

Venereologist 1 0.04 0 0.00 1 0.04
from which local 2 0.32 0 0.00 2 0.32
Neonatologist 7 1.32 7 1.32 0 0.00
Psychiatrist 6 0.32 4 0.21 2 0.11
Narcologist 2 0.08 0 0.00 2 0.08
Cardiologist 12 0.64 6 0.32 6 0.32

Surgeon 22 1.17 17 0.90 5 0.27
Proctologist 1 0.04 1 0.04 0 0.00
Oncologist 4 0.21 0 0.00 4 0.21

289
NHIAC

(physicians by speciality) 2020

including:
facilities
Toxicologist 1 0.04 0 0.00 1 0.04
Radiologist 11 0.44 6 0.24 5 0.20

Sonographist 14 0.56 4 0.16 10 0.40
3 0.12 0 0.00 3 0.12
3 0.12 0 0.00 3 0.12
medicine)
Phthisiatrist 27 1.07 22 0.88 5 0.20
Infectionist 9 0.48 5 0.27 4 0.21
Endoscopist 1 0.04 0 0.00 1 0.04
Urologist 8 0.32 5 0.20 3 0.12

Vascular neurosurgeon/ including
1 0.04 0 0.00 1 0.04
endovascular neurosurgeon /
Family dentist 6 0.24 0 0.00 6 0.24
Surgeon dentist 3 0.16 0 0.00 3 0.16
290
HUMAN RESOURCES
Table 6.16.2
including:

facilities

Family nurse 166 6.61 0 0.00 166 6.61
Pediatric nurse 20 3.17 18 2.85 2 0.32
Bandaging nurse 16 0.64 14 0.56 2 0.08

Dental nurse 12 0.48 0 0.00 12 0.48
Nursing manager 14 0.56 9 0.36 5 0.20
132 5.26 56 2.23 76 3.03
Midwife 61 9.59 31 4.87 30 4.72

1 0.04 1 0.04 0 0.00
assistants
1 0.04 1 0.04 0 0.00
specialist
Pharmacist 73 2.91 34 1.35 39 1.55
291
NHIAC
SHIRAK REGION, HUMAN RESOURCES

Table 6.17.1
including:
facilities
Family doctors 74 3.20 1 0.04 73 3.16
from which local 17 0.98 0 0.00 17 0.98

Nephrologist 2 0.12 2 0.12 0 0.00
from which local 10 1.74 0 0.00 10 1.74
Neonatologist 3 0.61 3 0.61 0 0.00
Psychiatrist 6 0.35 2 0.12 4 0.23
Narcologist 2 0.09 1 0.04 1 0.04
Cardiologist 13 0.75 7 0.40 6 0.35
Surgeon 22 1.27 14 0.81 8 0.46
Proctologist 2 0.09 2 0.09 0 0.00
Oncologist 5 0.29 0 0.00 5 0.29
292
HUMAN RESOURCES

including:

facilities

Toxicologist 2 0.09 0 0.00 2 0.09
Reflexotherapist 1 0 1
Radiologist 14 0.61 5 0.22 9 0.39
Sonographist 17 0.74 6 0.26 11 0.48
4 0.17 2 0.09 2 0.09
2 0.09 0 0.00 2 0.09
medicine)
Phthisiatrist 4 0.17 0 0.00 4 0.17
Infectionist 10 0.58 6 0.35 4 0.23
Endoscopist 3 0.13 1 0.04 2 0.09
Urologist 4 0.17 3 0.13 1 0.04
Neurosurgeon 1 0.06 1 0.06 0 0.00
Virologist 1 0.04 0 0.00 1 0.04
Family dentist 5 0.22 0 0.00 5 0.22
Surgeon dentist 4 0.23 1 0.06 3 0.17
293
NHIAC
Table 6.17.2
including:
facilities
Family nurse 191 8.27 15 0.65 176 7.62
Pediatric nurse 58 10.06 22 3.82 36 6.25
Bandaging nurse 33 1.43 26 1.13 7 0.30

Dental nurse 15 0.65 1 0.04 14 0.61
10 0.43 1 0.04 9 0.39
nurse
Nursing manager 13 0.56 2 0.09 11 0.48

40 1.73 8 0.35 32 1.39
Midwife 71 12.10 40 6.82 31 5.28

5 0.22 1 0.04 4 0.17
specialist
Pharmacist 9 0.39 2 0.09 7 0.30
Sports massagist 1 0.04 0 0.00 1 0.04
Ergotherapist 3 0.13 3 0.13 0 0.00
294
HUMAN RESOURCES
SYUNIK REGION, HUMAN RESOURCES
Table 6.18.1
including:

Family doctors 44 3.24 0 0.00 44 3.24

from which local 4 0.37 0 0.00 4 0.37
Nephrologist 3 0.28 2 0.19 1 0.09

from which local 5 1.74 0 0.00 5 1.74
Neonatologist 4 1.69 4 1.69 0 0.00
Pediatric Rheumatologist 1 0.35 0 0.00 1 0.35
Psychiatrist 2 0.19 1 0.09 1 0.09
Cardiologist 11 1.03 7 0.65 4 0.37
Surgeon 12 1.12 9 0.84 3 0.28
Radiologist 6 0.44 4 0.29 2 0.15
Sonographist 10 0.74 7 0.52 3 0.22
Phthisiatrist 2 0.15 0 0.00 2 0.15
Infectionist 3 0.22 3 0.22 0 0.00
Endoscopist 1 0.07 1 0.07 0 0.00
295
NHIAC
SYUNIK REGION, HUMAN RESOURCES

including:

Urologist 3 0.22 2 0.15 1 0.07

Virologist 1 0.07 0 0.00 1 0.07
Family dentist 2 0.15 0 0.00 2 0.15

Surgeon dentist 3 0.28 0 0.00 3 0.28
296
HUMAN RESOURCES
SYUNIK REGION,HUMAN RESOURCES

Table 6.18.2
including:
facilities
Family nurse 101 7.43 11 0.81 90 6.62

Pediatric nurse 21 7.30 16 5.56 5 1.74
Bandaging nurse 13 0.96 11 0.81 2 0.15

Dental nurse 5 0.37 0 0.00 5 0.37
Nursing manager 5 0.37 4 0.29 1 0.07
Midwife 45 13.33 28 8.30 17 5.04
Curative nurse 2 0.15 0 0.00 2 0.15

Instructor – disinfectants and disinfection specialist 1 0.07 1 0.07 0 0.00
Pharmacist 16 1.18 4 0.29 12 0.88
297
NHIAC
VAYOTS DZOR REGION, HUMAN RESOURCES

Table 6.19.1
including:
facilities
Family doctors 6 1.25 0 0.00 6 1.25

from which local 9 2.42 0 0.00 9 2.42
from which local 4 3.64 0 0.00 4 3.64

Neonatologist 1 1.09 1 1.09 0 0.00
Psychiatrist 1 0.27 0 0.00 1 0.27
Cardiologist 3 0.81 1 0.27 2 0.54
Surgeon 6 1.62 5 1.35 1 0.27
Radiologist 2 0.42 0 0.00 2 0.42
Sonographist 1 0.21 0 0.00 1 0.21
Phthisiatrist 2 0.42 0 0.00 2 0.42
Urologist 1 0.21 1 0.21 0 0.00
Family dentist 1 0.21 0 0.00 1 0.21
Surgeon dentist 1 0.27 0 0.00 1 0.27
298
HUMAN RESOURCES
VAYOTS DZOR REGION, HUMAN RESOURCES

Table 6.19.2
including:
facilities
Family nurse 35 7.27 0 0.00 35 7.27
Pediatric nurse 18 16.40 4 3.64 14 12.76
Bandaging nurse 3 0.62 3 0.62 0 0.00

Dental nurse 4 0.83 0 0.00 4 0.83
Nursing manager 2 0.42 0 0.00 2 0.42
Midwife 15 12.62 8 6.73 7 5.89
Curative nurse 1 0.21 0 0.00 1 0.21
299
NHIAC
TAVUSH REGION, HUMAN RESOURCES

Table 6.20.1
including:

inpatient and outpatient PHC institutions (polyclinics,
Professions Hospital facilities ambulatories, dispensaries,
facilities
counseling)

Family doctors 48 3.98 5 0.41 43 3.57
from which local 13 1.40 0 0.00 13 1.40

Rheumatologist 1 0.08 0 0.00 1 0.08
from which local 7 2.51 0 0.00 7 2.51
Neonatologist 4 1.74 4 1.74 0 0.00
Psychiatrist 4 0.43 0 0.00 4 0.43
Cardiologist 7 0.76 2 0.22 5 0.54
Surgeon 14 1.51 8 0.86 6 0.65
Oncologist 4 0.43 0 0.00 4 0.43

Radiologist 3 0.25 0 0.00 3 0.25
Sonographist 6 0.50 1 0.08 5 0.41
3 0.25 0 0.00 3 0.25
Phthisiatrist 4 0.33 0 0.00 4 0.33
Infectionist 3 0.32 1 0.11 2 0.22
Endoscopist 1 0.08 0 0.00 1 0.08
300
HUMAN RESOURCES


including:

Professions PHC institutions
facilities Hospital facilities (polyclinics, ambulatories,

Urologist 1 0.08 0 0.00 1 0.08

Family dentist 1 0.08 0 0.00 1 0.08

301
NHIAC

Table 6.20.2
including:
facilities
Family nurse 106 8.79 11 0.91 95 7.88
Pediatric nurse 23 8.24 9 3.22 14 5.01
Bandaging nurse 9 0.75 6 0.50 3 0.25

Dental nurse 10 0.83 0 0.00 10 0.83
1 0.08 0 0.00 1 0.08
nurse
Nursing manager 4 0.33 3 0.25 1 0.08

18 1.49 18 1.49 0 0.00
Midwife 34 11.46 19 6.40 15 5.05
Curative nurse 1 0.08 0 0.00 1 0.08

3 0.25 0 0.00 3 0.25
specialist
Pharmacist 6 0.50 0 0.00 6 0.50
302

Statistica 2021

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Statistica 2021

Uploaded by

Copyright:

Available Formats

UDC 61

«Health and Health Care» Yearbook, Republic of Armenia 2021/

D. Andreasyan, A. Bazarchyan,N. Galstyan, M. Matevosyan, L. Mirzoyan, L. Mosoyan,G. Muradyan, I.

NATIONAL INSTITUTE OF HEALTH NAMED AFTER ACADEMICIAN

National Health Information Analytic Center

HEALTH AND HEALTHCARE

CHAPTER 1 DEMOGRAPHIC CHARACTERISTICS 13

Table 1.2 De jure population by regions (thsd. persons) 14

Table 1.3 Average life expectancy at birth 15

Table 1.4 Natural movement of population by regions 16

Table 1.5 Natural movement of population by regions and by sex 18

Table 1.6.2 Deaths by main causes 25

Table 1.6.3 Mortality by causes of death, by regions, 27

Table 1.6.4 Mortality by main ncd's death, by regions, 29

Table 1.6.5 Mortality by causes of death, by age groups and by sex, 30

Table 1.7 Male mortality by age 32

Table 1.8 Female mortality by age 33

Table 1.8.1 Mortality of the RA population from COVID-19, regions 34

Table 1.9 Natural movement of population and child mortality 35

Table 1.10 Maternal mortality 36

Table 1.11 Maternal mortality (tri-annual average ratio) * 36

CHAPTER 2 HEALTH CHARACTERISTICS 37

Table 2.1.1 Incidence of diseases (15 years and above ) 38

Table 2.1.2 Incidence of diseases (0-14 years old) 42

Table 2.1.3 Pravelence of diseases (15 years and above) 46

Table 2.1.4 Pravelence of diseases (0-14 years old) 50

Table 2.2.1 Incidence of diseases by regions (18 years and above) 54

Table 2.2.2 Incidence of diseases by regions (15-17 years old) 58

Table 2.2.3 Incidence of diseases by regions (0-14 years old) 62

Table 2.2.4 Pravelence of disease by regions (18 years and above) 66

Table 2.2.5 Pravelence of disease by regions (15-17 years old) 70

Table 2.2.6 Pravelence of disease by regions (0-14 years old) 74

Table 2.2.9 Incidence of women’s diseases by specific diseases 80

Table 2.2.10 Incidence of women’s diseases by specific diseases 80

Table 2.3.1 Incidence of mental/psychic disorders by age group 2019 81

Table 2.3.3 Prevalence of alcoholic psychosis alcoholism narcomania and toxicomania 82

Table 2.4.1 Prevalence of infection diseases 84

Table 2.4.2 Incidence of diseases (15 years and above ) 84

Table 2.5.1 Incidence of diseases (0-14 years old) 85

Table 2.5.2 Pravelence of diseases (15 years and above) 86

Table 2.6 Pravelence of diseases (0-14 years old) 87

Table 2.7.1 Prevalence of active tuberculosis 88

Table 2.8.1 Prevalence of sexual transmitted diseases in Republic of Armenia 90

Table 2.8.2 Incidence of syphilis by age and sex 2018 90

Table 2.8.3 Incidence of syphilis by age and sex 2019 91

Table 2.8.4 Incidence of syphilis by age and sex 2020 91

Table 2.9.1 Prevalence of HIV/AIDS by sex 91

Table 2.9.2 HIV/AIDS test results 92

Table 2.10 Number of poisonings, 2018 94

Table 2.11 Number of poisonings, burns and corrosions, 2019 95

Table 2.12 Number of poisonings, burns and corrosions, 2020 96

Table 2.12.2 Number of recorded poisonings, 2018-2020 98

Table 2 a 1 Incidence of CSD among the adult population in regions 101

Prevalence of CSD among the adult population in regions

Table 2 e.1 Incidence of ED among RA population by regions 117

Table 2 e.2 Incidence of ED among adolescents aged 15 to 17 y.o. by regions 117

Table 2 e.3 Incidence of ED among children aged 0 to 14 y.o. by regions 117

Table 2 m.n. 1 Malignant neoplasm prevalence in RA 133

Table 2 m.n. 2 Prevalence of malignant neoplasm’s by age group 2018-2019 134

Table 2 m.n. 3 Prevalence of malignant neoplasm’s by age group, 2020 134

Table 2 m.n. 7 Prevalence of malignant neoplasm’s among RA population 138

Table 2 m.n. 8 Prevalence of malignant neoplasm’s among Yerevan population 139

Table 2 m.n. 9 Prevalence of malignant neoplasm’s among Aragatsotn population 140